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Translational Research: Seeing the Possibilities
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5569 — 8:30 Enantiomorphism Of The Human 
Cornea Based On Corneal Topography 3D Atlas 
Analysis. Georges M. Durr1, E. Auvinet1,2A, J.A. 
Ong1,2B, M. Gilca2B, M-E. Choronzey1, J. Meunier2A,1, 
I. Brunette1,2B. 1Maisonneuve–Rosemont Hospital 
Research Center, Montreal, QC, Canada; AComputer 
Science and Operations Research, BOphthalmology, 
2University of Montreal, Montreal, QC, Canada. 
5570 — 8:45 A Novel Approach To Determine 
Theoretical Head Tilt Effect On Ocular 
Cyclotorsion Measurements During Laser 
Refractive Surgery. Adam L. Prickett1A, W. 
Chamon1B, K.M. Bui2, J. Hallak1A, P. Bakhtiari3, 
D.T. Azar4. AOphthalmology, BOphthalmology & 
Visual Sciences, 1University of Illinois at Chicago, 
Chicago, IL; 2Ophthalmology, University of Illinois 
Chicago, Chicago, IL; 3Ophthalmology, Illinois Eye 
and Ear Infirmary, Chicago, IL; 4Ophthalmology 
and Visual Sci, Univ of Illinois at Chicago, 
Chicago, IL. 
5571 — 9:00 Long-term Outcomes Of 
Photorefractive Keratectomy For Low To 
High Myopia: Up To 19 Years Of Follow-
up. Anders Vestergaard1A, J. Grauslund1B, A. 
Ivarsen2, J. Hjortdal2, A.K. Sjolie1B. ADepartment 
of Ophthalmology, BOphthalmology, 1Odense 
University Hospital, Odense, Denmark; 
2Ophthalmology, Aarhus University Hospital, 
Aarhus, Denmark. 
5572 — 9:15 Incidence, Risk Factors, and 
Outcomes of LASIK Flap Striae Requiring 
Flap Re-Lift and Irrigation. Harmanjit Singh1, 
V. Gupta2, E. Adiguzel3, A. Wallerstein3,4, M. 
Cohen3,5, M. Harissi-Dagher1,3. 1Ophthalmology, 
University of Montreal, Montreal, QC, Canada; 
2Ophthalmology, McMaster University, Hamilton, 
ON, Canada; 3LASIK MD, Montreal, QC, Canada; 
4Ophthalmology, University of McGill, Montreal, 
QC, Canada; 5Ophthalmology, University of 
Sherbrooke, Montreal, QC, Canada. 
Thursday – Papers – 5569 – 5583
5573 — 9:30 Effect of Spherical Aberration 
and Total Higher Order Aberrations on Distance 
Corrected Near Vision and Contrast Sensitivity 
in Presbyopic Patients after Laser Blended 
Vision. Timothy J. Archer1A, D.Z. Reinstein1, M. 
Gobbe1A. ARefractive Surgery, 1London Vision 
Clinic, London, United Kingdom.*CR 
5574 — 9:45 Spherical Aberration change as 
a function of pupil size: a comparison between 
Small Incision Lenticule Extraction (SMILE) 
and non-linear aspheric LASIK in moderate 
to high myopia. Dan Z. Reinstein, T.J. Archer, 
M. Gobbe. London Vision Clinic, London, United 
Kingdom.*CR 
5575 — 10:00 Femtosecond Laser Based Small 
Incision Lenticule Extraction For Moderate And 
High Myopia. Jesper Hjortdal, S. Asp, A. Ivarsen, 
A. Vestergaard. Ophthalmology, Aarhus University 
Hospital, Aarhus, Denmark.*CR, f 
Room 114





5576 — 8:30 A Comparative Evaluation Of 
Translational Read-through Inducing Drugs 
For Treatment Of Ush. Kerstin Nagel-Wolfrum1, 
T. Goldmann1, F. Möller1, N. Overlack1, V. 
Belakhov2, T. Baasov2, U. Wolfrum1. 1Cell and 
Matrix Biology, Johannes Gutenberg University of 
Mainz, Mainz, Germany; 2Edith and Joseph Fischer 
Enzyme Inhibitors Laboratory, Schulich Faculty of 
Chemistry, Technion-Israel Institute of Technology, 
Haifa, Israel. 
5577 — 8:45 Gene Therapy For Choroideremia 
- Initial Report On A New Clinical Trial. Robert 
E. MacLaren1,2, M. Groppe1, A.R. Barnard1, T. 
Tolmachova3, M.J. During4, S.M. Downes5, A.J. 
Lotery6, G.C. Black7, A.R. Webster8,2, M.C. Seabra3. 
1Nuffield Laboratory of Ophthalmology, University 
of Oxford, Oxford, United Kingdom; 2Moorfields 
Eye Hospital NHS Foundation Trust, London, 
United Kingdom; 3Molecular Medicine, Imperial 
College London, London, United Kingdom; 4Ohio 
State University Medical Center, Columbus, 
OH; 5Oxford Eye Hospital, Oxford University 
Hospitals NHS Trust, Oxford, United Kingdom; 
6Ophthalmology - Eye Unit, Southampton General 
Hospital, Southampton, United Kingdom; 7Genetic 
Medicine, University of Manchester, Manchester, 
United Kingdom; 8UCL Institute of Ophthalmology, 
London, United Kingdom.*CR, f 
5578 — 9:00 Adenoviral and Lentiviral 
Vectors for Efficient Gene Transfer to Mouse 
Retina. Agostina Puppo1, G. Cesi1, D. Palmer2, P. 
Piccolo1, R.J. Parks3, P. Ng2, N. Brunetti-Pierri1, A. 
Auricchio1,4. 1TIGEM- Telethon Institute of Genetics 
and Medicine, Naples, Italy; 2Dept. of Molecular 
and Human Genetics, Baylor College of Medicine, 
Houston, TX; 3Ottawa Hospital Research Institute, 
Ottawa, ON, Canada; 4Dept. of Pediatrics, Medical 
Genetics, “Federico II” University, Naples, Italy. 
5579 — 9:15 Suppression of the 
Neurodegeneration of Experimental Optic 
Neuritis by Single-subunit Yeast NADH-
Ubiquinone Oxidoreductase (NDI1). Venu Talla, 
S.S. Ozdemir, T-H. Chou, V. Porciatti, J. Guy. 
Ophthalmology, Bascom Palmer Eye Institute, 
University of Miami, Miami, FL. 
5580 — 9:30 A Novel Method To Transfect 
Retinal Pigment Epithelial Cells Without 
Detaching The Retina. Francine F. Behar-Cohen1,2A, 
E. Touchard2B, B. Marianne2C, M. Savoldelli1, M-C. 
Naud2A, J-C. Jeanny2A. 1Ophthalmology, Hotel Dieu 
de Paris, Universite Paris Descartes, Paris, France; 
APhysiopathology ocular diseases, BPhysiopathologie 
of ocular dseases, CPhysiopathology of ocular 
diseases, 2Inserm UMRS872, Paris, France.*CR 
5581 — 9:45 Progeny Of Pronuclear Injections 
Of Mutant Human Mitochondrial Genes. Hong 
Yu1, T-H. Chou1, V. Porciatti2, W.W. Hauswirth3, 
V. Chiodo3, S.L. Boye3, J. Guy1. 1Ophthalmology, 
Bascom Palmer Eye Inst, Univ of Miami, Miami, 
FL; 2Bascom Palmer Eye Inst, Univ of Miami Miller 
Sch Med, Miami, FL; 3Ophthalmology, University of 
Florida, Gainesville, FL. 
5582 — 10:00 Increased Longevity of Rescue 
of Light-Induced Retinal Damage in an Adult 
Mouse Using Peptide for Ocular Delivery (POD) 
as a Gene Transfer Vector. Rajendra Kumar-Singh, 
C. Binder, S. Cashman. Ophthalmology, Tufts 
University, Boston, MA.*CR 
Room 305
Thursday, May 10, 2012, 8:30 AM-10:15 AM





5583 — 8:30 The N-fatty Acyl Group In A 
Bovine Guanylyl Cyclase Activating Protein-1 
Provides Intramolecular Tuning Of Its Calcium 
Sensitivity And Interaction With The Effector 
Enzyme. Igor V. Peshenko1, E.V. Olshevskaya1, S. 
Lim2, J.B. Ames2, A.M. Dizhoor1. 1Pennsylvania 
College of Optometry, Salus University, Elkins 
Park, PA; 2Department of Chemistry, University of 




















*Refer to Program Number in the Commercial Relationships (CR) Index for Disclosures   –   f Refer to Program Number in the Clinical Trial (CT) Registration Index  –   T Travel Grant Awardee
Palm A
Thursday, May 10, 2012, 8:30 AM-10:15 AM
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5597 — 8:30 In Vivo Optical Recording From 
Mouse Retinal Ganglion Cells. Lu Yin1A, A.H. 
Cetin2, Y. Geng1A,1B, R. Sharma1A,1B, K. Ahmad1A, E.M. 
Callaway2, D.R. Williams1A,1B, W.H. Merigan1A,1C. 
ACenter for Visual Science, BInstitute of Optics, 
CFlaum Eye Institute, 1University of Rochester, 
Rochester, NY; 2Systems Neurobiology Laboratories, 
Salk Institute for Biological Studies, La Jolla, 
CA.*CR 
5598 — 8:45 In Vivo Chorio-Capillaries 
Imaging Using Adaptive Optics Optical 
Coherence Angiography. Kazuhiro Kurokawa, K. 
Sasaki, S. Makita, Y. Yasuno. Computational Optics 
Group, University of Tsukuba, Tsukuba, Japan.*CR 
5599 — 9:00 Photoreceptor and RPE 
Disruptions Observed Outside Clinically Visible 
Geographic Atrophy Lesions in the Living Eye 
with Fluorescence Adaptive Optics Scanning 
Laser Ophthalmoscopy (FAOSLO). Ethan A. 
Rossi1A, D.R. Williams1A,1B, A. Dubra2A,2B, H. Song1A, 
M.A. Folwell1A, L.R. Latchney1C, M.M. Chung1C,1A. 
ACenter for Visual Science, BInstitute of Optics, 
CFlaum Eye Institute, 1University of Rochester, 
Rochester, NY; AOphthalmology, BBiophysics, 
2Medical College of Wisconsin, Milwaukee, WI.*CR 
5600 — 9:15 In Vivo Two-Photon Imaging Of 
Mouse Retina. Robin Sharma1A,1B, Y. Geng1A,1B, 
L. Yin1B, W.H. Merigan1B,1C, D.R. Williams1A,1B, 
J.J. Hunter1B,1C. AInstitute of Optics, BCenter for 
Visual Science, CFlaum Eye Institute, 1University of 
Rochester, Rochester, NY.*CR 
5601 — 9:30 Imaging The Living Human Cone 
Inner Segment. Ravi S. Jonnal1A, O.P. Kocaoglu1B, 
Q. Wang1B, Z. Liu1A, D.T. Miller1B. AProgram in Vision 
Science, BSchool of Optometry, 1Indiana University, 
Bloomington, IN.*CR 
5602 — 9:45 Measuring Individual Cone 
Directionalities Using Scanning Laser 
Ophthalmoscopy. Diego Rativa Millan1,2, B. 
Vohnsen3. 1School of Physics, University College of 
Dublin, Dublin, Ireland; 2Department of Electronics 
and Systems, Universidade Federal de Pernambuco, 
Recife, Brazil; 3School of Physics, University 
College Dublin, Dublin, Ireland. 
5603 — 10:00 Adaptive Optics-Assisted Optical 
Coherence Tomography For Patient Imaging. 
Barry Cense1, K. Sudo1, K. Kurokawa2, Y. Yasuno3. 
1Ctr for Optical Resrch & Education, Utsunomiya 
University, Utsunomiya, Japan; 2Institude of Applied 
Physics, Computational Optics Group, Tsukuba, 
Japan; 3Computational Optics Group, University of 
Tsukuba, Tsukuba, Japan.*CR 
5584 — 8:45 Alzheimer Retina Pathology in 
a Novel Animal Model of Neuropathology in 
Diabetes. Peter Frederikse1, R. Kaswala2, W. Klein3, 
C. Kasinathan2. 1Phamacology & Physiology, UMD 
New Jersey Medical School, Newark, NJ; 2Oral 
Biology, UMD New Jersey Dental School, Newark, 
NJ; 3Neurobiology & Physiology, Northwestern 
University, Evanston, IL.*CR 
5585 — 9:00 Rescue Of Photoreceptor 
Degeneration In Rd1 Mice By Systemic Treatment 
With Valproic Acid. Kenneth P. Mitton, E.E. 
Guzman, D. Byrd, T. Tran, J. Sotzen. Eye Research 
Institute, Oakland University, Rochester, MI. 
5586 — 9:15 GSK3-Mediated Phosphorylation 
Regulates the Stability of NRL. Jerome E. Roger, 
K. Ranganath, H. Breit, J. Chang, A. Swaroop. 
Neurobiol-Neurodegnt’n Rep Lab, NEI / National 
Institutes of Health, Bethesda, MD. 
5587 — 9:30 Aberrent Regulation of NFkB 
Activity in Immunoproteasome-deficient Retinal 
Pigment Epithelial Cells. Deborah A. Ferrington, 
M. Maldonado, M.R. Terluk, R.J. Kapphahn, N.D. 
Huess, D.S. Gregerson, C. Yuan. Ophthalmology, 
University of Minnesota, Minneapolis, MN. 
5588 — 9:45 Cis-regulation of Lif mRNA 
stability in Muller cells. Cavit Agca, G. Traber, 
C. Caprara, C. Beck, I-P. Meneau, C. Grimm. 
Ophthalmology, University of Zurich, Zurich, 
Switzerland. T 
5589 — 10:00 Tet3 is an Essential Epigenetic 
factor for Eye development. Stephen P. Sugrue1, 
G. Xu2, Y. Kato3, Y. Xu4, Y. Shi4. 1Anatomy & 
Cell Biology, University of Florida, Gainesville, 
FL; 2Institute of Biochemistry and Cell Biology, 
Chinese Academy of Sciences, Shanghai, China; 
3Department of Biomedical Sciences, Florida State 
University College of Medicine, Tallahassee, FL; 
4Endocrinology Division, Brigham and Women’s 
Hospital, Boston, MA. 
Room 315




5590 — 8:30 Deletion Of Cdk1 In The Ocular 
Lens Leads To A Disruption Of The Lens 
Epithelial Cell Proliferation, Differentiation, 
And Nuclear Retention. Blake R. Chaffee1, 
M.L. Robinson1, F. Shang2A, T. Clement3, M. 
Eddy4, B. Wagner1, A. Taylor2B. 1Zoology, Miami 
University, Oxford, OH; AHuman Nutrition Res 
Ctr on Aging, BNutrition &Vision Res-USDA-
HNRCA, 2Tufts University, Boston, MA; 3National 
Institute of Environmental Health Sciences, NIH, 
Research Triangle Park, NC; 4National Institute of 
Enviornmental Health Sciences, Research Triangle 
Park, NC. 
5591 — 8:45 Inactivation of JNK Signals 
Formation Of The Organelle Free Zone (OFZ), 
A Process That Involves Classical Autophagic 
Molecules. Subhasree Basu, S. Rajakaruna, A S. 
Menko. Pathology Anatomy & Cell Biology, Thomas 
Jefferson University, Philadelphia, PA. 
5592 — 9:00 Glutaredoxin (Grx2) Gene 
Knockout Suppresses Fiber Cell Differentiation 
and Delays De-nucleation of the Mouse Lens. 
Marjorie F. Lou1,2, S. Basu3, Y. Yu1, H. Wu1, A 
S. Menko3. 1Veterinary Medicine & Biomedical 
Sciences, University of Nebraska-Lincoln, Lincoln, 
NE; 2Department of Ophthalmology, University of 
Nebraska Medical Center, Omaha, NE; 3Pathology 
Anatomy & Cell Biology, Thomas Jefferson 
University, Philadelphia, PA. 
5593 — 9:15 K6W Mutant Ubiquitin Activates 
Calpain in Lens. Ke Liu1, A. Caceres1, J. Peng2, F. 
Shang1, J. Gao3, X. Sun3, R.T. Mathias3, A. Taylor1. 
1Human Nutrition Rsrch Ctr on Aging, Tufts 
University, Boston, MA; 2Structural Biology, St. 
Jude Children’s Research Hospital, Memphis, TN; 
3Physiology & Biophysics, State Univ of NY-Stony 
Brook, Stony Brook, NY. 
5594 — 9:30 Dlg-1 and Scrib are Modulators 
of Wnt/PCP in the Mouse Ocular Lens. Shalini 
Shatadal1A, R. Rachel1B, A. Griep1A. ACell and 
Regenerative Biology, BAnatomy, 1Univ of Madison-
WI, Madison, WI. 
5595 — 9:45 Post-translational Modifications 
of BFSP1. Roy A. Quinlan1, A. Tapodi1, E.W. 
Tate2, W.P. Heal2, A.R. Prescott3. 1School of 
Biological/Biomedical Sciences, Biophysical 
Sciences Inst, Durham Univ, Durham, United 
Kingdom; 2Department of Chemistry, Imperial 
College, London, United Kingdom; 3School of Life 
Sciences, CHIPs and Division of Cell Biology and 
Immunology, Dundee University, Dundee, United 
Kingdom. 
5596 — 10:00 Chromatin Remodeling 
Enzymes Snf2h/smarca5 And Brg1/smarca4 
Are Independently Required For Mouse 
Lens Morphogenesis. Shuying He1A, J. Sun1A, J. 
Kokavec1B, T. Stopka2, A. Skoultchi1B, J. Zavadil3, 
A. Cvekl1A. AOphthalmology & Visual Sciences and 
Genetics, BCell Biology, 1Albert Einstein College 
of Medicine, Bronx, NY; 2Institute of Pathological 
Physiology and Center of Experimental Hematology, 
First Faculty of Medicine, Charles University, 
Prague, Czech Republic; 3New York University 
Langone Medical Center, New York, NY. 
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5604 — 8:30 Optic Nerve Misprojections in 
the Zebrafish Mutant belladonna: A Disease 
Model for Infantile Nystagmus Syndrome. 
Sabina P. Huber-Reggi1, C-C. Chen2, L. Holliger1, 
D. Straumann2, S.C. Neuhauss1, M-Y. Huang2,1. 
1Institute of Molecular Life Sciences, University 
of Zurich, Zurich, Switzerland; 2Department of 
Neurology, University Hospital Zurich, Zurich, 
Switzerland. T 
5605 — 8:45 A Velocity Based Method For 
Measuring Optokinetic Nystagmus Using Off 
The Shelf Video Equipment. Jason Turuwhenua1A, 
T-Y. Yu1B, Z. Mazharullah1A, B. Thompson1B. 
AAuckland Bioengineering Institute, BDepartment 
of Optometry and Vision Science, 1University of 
Auckland, Auckland, New Zealand. 
5606 — 9:00 Uncorrected Antisaccade 
Errors Predict Cognitive Problems After Mild 
Traumatic Brain Injury In Younger Children. 
Larry A. Abel1, A. Phillipou1, J.M. Douglas2. 
1Optometry & Vision Sciences, University 
of Melbourne, Carlton, Australia; 2Human 
Communication Sciences, La Trobe University, 
Bundoora, Australia. 
5607 — 9:15 Fatigue and Hypoglycemia Impair 
Saccade Velocity and Accuracy but not Visual 
Perception. Benjamin Thompson1A, S. Duncan1B, 
G. Kuhn2, J.M. Black1A, N. Gant1B. AOptometry 
and Vision Science, BSport and Exercise Science, 
1University of Auckland, Auckland, New Zealand; 
2Psychology, Brunel University, London, United 
Kingdom. 
5608 — 9:30 Saccadic Adaptation In 
Amblyopia. Rana Arham Raashid1A, M. 
Chandrakumar1A, A. Blakeman2, H. Goltz1A, 
A.M. Wong1B. ANeuroscience and Mental Health, 
BDepartment of Ophthalmology and Vision 
Sciences, 1The Hospital for Sick Children, Toronto, 
ON, Canada; 2University of Toronto, Toronto, ON, 
Canada. 
5609 — 9:45 Effect of Compliance to Glasses 
Wear on the Outcome of Visual Acuity after 
Refractive Adaptation. Gail Maconachie1, S. 
Farooq2, G. Bush3, F.A. Proudlock1, I. Gottlob1. 
1Ophthalmology, University of Leicester, Leicester, 
United Kingdom; 2Bradford Teaching Hospitals, 
Bradford, United Kingdom; 3Medical Physics, 
University Hospitals of Leicester, Leicester, United 
Kingdom. f T 
5610 — 10:00 Pre-operative Visual Acuity and 
Contrast Sensitivity Deficits in Children with 
Small, Partial, or Non-Central Cataracts. Eileen 
E. Birch1,2, V. Subramanian1, C.S. Cheng1, D. Stager, 
Jr.3. 1Retina Foundation of the Southwest, Dallas, 
TX; 2Ophthalmology, UT Southwestern Medical 
Center, Dallas, TX; 3Pediatric Ophthalmology & 
Adult Strabismus, Plano, TX. 
Grand B








5611 — 8:30 Predictors Of Ocular Surface 
Squamous Neoplasia Recurrence After Exisional 
Surgery. Carol L. Karp, A. Galor, P. Oellers, A. Kao, 
A. Abdelaziz, W. Feuer, S. Dubovy. Ophthalmology, 
Bascom Palmer Eye Institute, Miami, FL. 
5612 — 8:45 Multi-disciplinary Management Of 
Eyelid Merkel Cell Carcinoma. Qasiem J. Nasser1A, 
A. Khan1A, W. Morrison1B, T. El-Sawy1A, S. Frank1B, B. 
Esmaeli1A. ASection of Ophthalmology, Department 
of Head and Neck Surgery, BDepartment of Radiation 
Oncology, 1The University of Texas MD Anderson 
Cancer Center, Houston, TX. 
5613 — 9:00 Mir211 Is Dysregulated In 
Conjunctival Melanocytic proliferations. 
Alexandre P. Moulin1A, M. Nicolas1, A. 
Schalenbourg1, M. Hamedani1, Z. Leonidas1, L. 
Duncan2. APathology, Ophthalmology, 1Jules Gonin 
Eye Hospital, Lausanne University, Lausanne, 
Switzerland; 2Dermatopathology, Massachusetts 
General Hospital, Harvard Medical School, Boston, 
MA. 
5614 — 9:15 Lymphoid Enhancing Factor-
1(lef-1) Gene Mutation and Its Differential mRNA 
Expression in Eyelid Sebaceous Carcinoma. 
Perumal Jayaraj1A, S. Sen1A, A. Sharma1B, S. 
Kashyap1A, A. Rai2, N. Pushker1C, M.S. Bajaj1C, 
S. Ghose1C, R. Azad1C. ADepartment of Ocular 
Pathology, BDepartment of Ocular Microbiology, 
COphthalmoplasty service, 1Dr.R.P.Centre, A.I.I.M.S, 
New Delhi, India; 2Division of Biochemistry and 
Biotechnology, National Centre for Disease Control,, 
New Delhi, India. T 
5615 — 9:30 Primary Intraocular Lymphoma: 
A Twenty-year Review Of Incidence, Clinical 
Features, Treatment And Outcomes. Steve 
D. Levasseur1A, L.A. Wittenberg1A, V.A. White1B. 
ADepartment of Ophthalmology & Visual Sciences, 
BDepartment of Ophthalmology & Visual Sciences, 
Department of Pathology, 1University of British 
Columbia, Vancouver, BC, Canada. 
Thursday – Papers – 5604 – 5621
5616 — 9:45 Invasion of Lymphatic Vessels 
into the Eye after Open Globe Injury. Ludwig M. 
Heindl1,2, J.M. Wessel2, C. Hofmann-Rummelt2, G.O. 
Naumann2, F.E. Kruse2, C. Cursiefen1,2. 1Department 
of Ophthalmology, University of Cologne, Cologne, 
Germany; 2Department of Ophthalmology, 
University of Erlangen, Erlangen, Germany. 
5617 — 10:00 Molecular Histopathology 
Using Gold Nanorods And Optical Coherence 
Tomography. Jared L. Matthews1, S. Prabhulkar2, 
A. de la Zerda3A, S. Gambhir3B, R. Awdeh4. 
1Bascom Palmer Eye Institute, Coral Gables, FL; 
2Ophthalmology, Bascom Palmer Eye Institute, 
University of Miami, FL; AElectrical Engineering 
and Radiology, BBioengineering & Materials Science 
and Engineering, 3Stanford University, Palo Alto, 
CA; 4Ophthalmology, Bascom Palmer Eye Institute, 
Miami, FL. 
Grand D
Thursday, May 10, 2012, 8:30 AM-10:15 AM





5618 — 8:30 Peripalliary Nerve Fiber Layer 
and Retinal Pigment Epithelium Reflectance 
Ratio for Glaucoma Diagnosis. Ou Tan1, X. 
Zhang1, R. Varma2, D. Huang1. 1Casey Eye Institute, 
Oregon Health & Science Univ, Portland, OR; 
2Ophthalmology, USC, Doheny Eye Institute, Los 
Angeles, CA.*CR, f 
5619 — 8:45 Evaluating A ‘Random Forest’ 
Decision Tree Classifier To Identify Eyes With 
Glaucomatous Visual Field Loss Applied To 
Measurements From Multiple Imaging Devices. 
Ryo Asaoka1,2, R.A. Russell2,1, R. Malik1, G. 
Verdon-Roe1, D.F. Garway-Heath1,2. 1Glaucoma 
Research Unit, NIHR Biomedical Research 
Centre for Ophthalmology, Moorfields Eye 
Hospital NHS Foundation Trust and UCL Institute 
of Ophthalmology, London, United Kingdom; 
2Department of Optometry and Visual Science, City 
University London, London, United Kingdom. 
5620 — 9:00 Diagnostic Innovations in 
Glaucoma Study (DIGS): Diagnosing Glaucoma 
with Spectral Domain Optical Coherence 
Tomography in Patients Suspected of Having the 
Disease. Renato Lisboa, M.T. Leite, R.N. Weinreb, 
L.M. Zangwill, F.A. Medeiros. Ophthalmology, 
Hamilton Glaucoma Center, La Jolla, CA.*CR, f 
5621 — 9:15 Detecting Glaucoma with 
Pupillography. Dolly S. Chang, K.S. Arora, H.A. 
Quigley, H.D. Jampel, P. Ramulu, M.V. Boland, 
D. Welsbie, D.S. Friedman, W. Supakontanasan. 
Ophthalmology, Wilmer Eye Institute Johns 
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5622 — 9:30 Agreement Between Contrast 
Sensitivity Perimetry (CSP) And Clinical 
Measures Of Glaucomatous Damage: Validation 
Of A Neural Model For A Longitudinal Study. 
William H. Swanson1, V.E. Malinovsky1, M.W. Dul2,3, 
J.K. Torbit1, B.M. Sutton1, R. Malik4. 1School of 
Optometry, Indiana University, Bloomington, IN; 
2Clinical Sciences, SUNY College of Optometry, 
New York, NY; 3SUNY Eye Institute, New York, 
NY; 4Glaucoma Research Unit, NIHR Biomed 
Resrch Ctr for Ophthal, London, United Kingdom. 
5623 — 9:45 Are Certain Eye Movement 
Patterns Linked To Better Face Recognition 
Performance In Patients With Central 
Glaucomatous Visual Field Loss? Fiona C. 
Glen1, D.P. Crabb1, N.D. Smith1, R. Burton1, D.F. 
Garway-Heath2,3. 1Department of Optometry & 
Visual Science, City University London, London, 
United Kingdom; 2NIHR Biomedical Research 
Centre for Ophthalmology, Moorfields Eye Hospital 
NHS Foundation Trust, London, United Kingdom; 
3Institute of Ophthalmology, University College 
London, London, United Kingdom. 
5624 — 10:00 Correlation of Brain Volumes 
and Functional Deficits in Glaucoma. Alice L. 
Williams1, J. Lackey2, S. Wizov3A, S. Gatla3A, R. 
Sergott3B, T. Chia4, S. Lai2, G.L. Spaeth3A. 1Temple 
University School of Medicine, Philadelphia, 
PA; 2Department of Radiology, Thomas Jefferson 
University, Philadelphia, PA; AWilliam A. and 
Anna V. Goldberg Glaucoma Service, BNeuro-
ophthalmology, 3Wills Eye Institute, Philadelphia, 
PA; 4Thomas Jefferson University School of 
Medicine, Philadelphia, PA. f T 
Grand H




5625 — 8:30 Inhibition of Receptor 
Interacting Protein Kinase Delays Necrotic 
Cone Photoreceptor Cell Death in a Mouse 
Model of Inherited Retinal Degeneration. Yusuke 
Murakami1, H. Matsumoto1, M. Roh1, J. Suzuki1, K. 
Takeuchi1, D. Mantopoulos1, T. Hisatomi2, Y. Ikeda2, 
J.W. Miller1, D. Vavvas1. 1Angiogenesis Laboratory, 
Massachusetts Eye and Ear Infirmary, Boston, MA; 
2Ophthalmology, Kyushu University, Fukuoka, 
Japan.*CR 
5626 — 8:45 Successful Photoreceptor-Directed 
Gene Therapy with AAV2/5-hRPGR Reverses 
Post-Receptoral Remodeling in Canine Models of 
X-linked RP. Gustavo D. Aguirre1, A.V. Cideciyan2, 
A.S. Lewin3A, S. Iwabe1, H. Khanna4, A. Swaroop5, 
W.W. Hauswirth3B, S.G. Jacobson2, W.A. Beltran1. 
1Clinical Studies, Univ of Penn Sch Veterinary Med, 
Philadelphia, PA; 2Dept of Ophthalmology, Scheie 
Eye Institute, Philadelphia, PA; AMolecular Genetics 
& Microbio, BOphthalmology, 3University of Florida, 
Gainesville, FL; 4Ophthalmology, University of 
Massachusetts Medical School, Worcester, MA; 
5N-NRL, Bldg 6, National Eye Institute, Bethesda, 
MD.*CR 
5627 — 9:00 Rhodopsin Mutants Destabilize 
Rod Outer Segment Disk Membranes. Mohammad 
Haeri, S.E. Reks, B.E. Knox. Ophthalmology & 
Neurosciences & Physiology, SUNY Upstate 
Medical University, SUNY Eye Institute, Syracuse, 
NY. 
5628 — 9:15 Endothelial Progenitor Cells 
With Low Aldehyde Dehydrogenase Activity 
Recruited Monocyte-Derived Macrophages 
Through CCL2 Secretion And Rescued Vessel 
And Photoreceptor With Retinal Degeneration. 
Shinichi Fukuda1A,1B, M. Nagano1B, T. Yamashita1B, 
K. Kimura1B, K. Akimoto1B, I. Tsuboi1B, S. 
Ueno2, M. Kondo3, T. Oshika1A, O. Ohneda1B. 
AOphthalmology, BRegenerative Medicine and Stem 
Cell Biology, 1Tsukuba University, Tsukuba, Japan; 
2Ophthalmology, Nagoya Univ School of Med, 
Nagoya, Japan; 3Ophthalmology, Mie University 
Graduate School of Medicine, Tsu, Japan. 
5629 — 9:30 Phenotypic conservation in RPGR 
mutations. Kari E. Branham1, S. Zahid1, N.W. 
Khan1, M.I. Othman1, A. Moncrief1, P.A. Sieving2, 
A. Swaroop2A, K. Jayasundera1, J.R. Heckenlively1. 
1Ophthalmology and Visual Sciences, University 
of Michigan, Ann Arbor, MI; AN-NRL, Bldg 6, 
2National Eye Institute, Bethesda, MD. 
5630 — 9:45 CRB2 and CRB1 in Retinal 
Development and Maintenance. Celso H. Alves1, 
L. Pellissier1, B. Park1, A. Sanz Sanz1, S. Beck2, G. 
Huber2, N. Tanimoto2, M. Garrido2, F. Richard3, J. 
Wijnholds1. 1Neuromedical Genetics, Netherlands 
Inst for Neuroscience, Amsterdam, The Netherlands; 
2Ocular Neurodegeneration Centre for Ophtalmology, 
Institute for Ophtalmic Research, Tubingen, 
Germany; 3Ingénieur d’étude CNRS / ACMO, 
Université de la Méditerranée, Developmental 
Biology Institute of Marseille Luminy (IBDML), 
Marseille, France. 
5631 — 10:00 Knockout Of Ccr2 Promotes 
Photoreceptor Survival In A Model Of Retinitis 
Pigmentosa. Atsushi Otani1,2, C. Guo2, A. Oishi2, 
N. Yoshimura2. 1Ophthalmology, Japanese Red 
Cross Wakayama Med Ctr, Wakayama, Japan; 
2Ophthalmology, Kyoto University, Kyoto, Japan. 
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5632 — A28 Reported Decreases in Vision 
During and After Pregnancy in Women with 
Retinitis Pigmentosa. Pamela E. Jeter1, G. 
Dagnelie1, M. Khan2, A.K. Bittner1. 1Ophthalmology, 
Johns Hopkins University, Baltimore, MD; 2Civil 
Hospital Karachi, Karachi, Pakistan. 
5633 — A29 Cataract, Visual Impairment, 
Blindness And Risk Of Mortality In Rural 
Population Of The Andhra Pradesh Eye Disease 
Study, India. Rohit C. Khanna1, G.V. Murthy2, S. 
Krishnaiah1, H.B. Pant3, P. Giridhar1, C.E. Gilbert2, 
G.N. Rao1. 1Allen Foster Research Centre for 
Community Eye Health, LV Prasad Eye Institute, 
Hyderabad, India; 2International Centre for Eye 
Health, London School of Hygiene & Tropical 
Medicine, London, United Kingdom; 3Indian 
Institute of Public Health, Hyderabad, India. 
5634 — A30 Determining National Vision Health 
Priorities: Healthy People 2020 Vision Objectives. 
Asel Ryskulova1, R. Janiszewski2, R. Hines1. 1Office 
of Analysis and Epidemiology, National Center for 
Health Statistics, CDC, Hyattsville, MD; 2National 
Eye Institute, National Institutes of Health, Bethesda, 
MD. 
5635 — A31 Uncorrected refractive errors and 
ocular pathology found in outreach clinics in 
Malawi and Ethiopia. Rachel V. North1,2. 1Sch of 
Optom & Vision Sci, Cardiff University, Cardiff, 
United Kingdom; 2Vision Aid Overseas, Crawley, 
United Kingdom. 
5636 — A32 Ophthalmology Inpatient 
Consultations For Patients With Acute And 
Chronic Leukemia At A Boston Tertiary Care 
Hospital. Nancy Huynh, H-Y. Chang, S. Borboli-
Gerogiannis. Ophthalmology, Massachusetts Eye & 
Ear Infirmary, Boston, MA. 
5637 — A33 Direct Comparison of Current 
Pediatric Pseudoisochromatic Color Vision Tests 
in Preschool Children. Michele E. Mercer1A, R.J. 
Adams1B. APsychology, BPsychology/Pediatrics, 
1Memorial University, St John’s, NL, Canada. 
5638 — A34 Danish Rural Eye Study (DRES): 
Preliminary Data on Visual Impairment in 
Randomly Selected Adults of Denmark. Tracy 
B. Hoeg1A, B. Moldow2, H. Buch Hesgaard3, D. 
Erngaard2, K. Klemp2, M. La Cour4, C. Ellervik1B. 
AOphthalmology, BClinical Biochemistry, 1Naestved 
Hospital, University of Copenhagen, Naestved, 
Denmark; 2Ophthalmology, Naestved Hospital, 
Naestved, Denmark; 3Ophthalmology, Glostrup 
Hospital, Glostrup, Denmark; 4Ophthalmology, 
Glostrup Hospital, University of Copenhagen, 
Glostrup, Denmark. 
5639 — A35 A Comparison of Visuocortical 
Function in Premature Infants with Grade I/II 
and Grade III/IV Intraventricular Hemorrhage. 
William V. Good1, C. Hou1, A. Norcia1,2. 1Smith-
Kettlewell Eye Research Institute, San Francisco, 
CA; 2Department of Psychology, Stanford University, 
Stanford, CA. 
5640 — A36 The Prevalence and Causes of 
Visual Impairment and Blindness in a Multi-
Ethnic Asian Population: The Singapore 
Epidemiology of Eye Disease (SEED) Study. Tien 
Y. Wong1,2, Y. Zheng1, W-L. Wong1, E.L. Lamoureux, 
III2,1, J-J. Wang2,3, P. Mitchell3, N. Cheung2, T. 
Aung1,4, S. Saw1,5, C. Cheng1,4. 1Singapore Eye 
Research Institute, Singapore National Eye Centre, 
Singapore, Singapore; 2Centre for Eye Research 
Australia, University of Melbourne, Melbourne, 
Australia; 3Centre for Vision Research, University 
of Sydney, Sydney, Australia; 4Department of 
Ophthalmology, Yong Loo Lin School of Medicine, 
National University of Singapore, Singapore, 
Singapore; 5Saw Swee Hock School of Public 
Health, National University of Singapore, Singapore, 
Singapore. 
5641 — A37 Epidemiology of Chinese Patients 
in the Ophthalmology Clinic of a New York City 
Public Hospital. Sze H. Wong1, L.G. Chen1, C.C. 
Teng1,2. 1Ophthalmology, NYU School of Medicine, 
New York, NY; 2Einhorn Clinical Research Center, 
New York Eye and Ear Infirmary, New York, NY. 
5642 — A38 Genetic Determinants of Serum 
Lutein and Zeaxanthin Levels in the Carotenoids 
in Age-Related Eye Diseases Study. Chitra 
K. Karki1, S.K. Iyengar2, B. Truitt2, R.P. Igo, 
Jr.2, E. Johnson3, L. Tinker4, K.J. Meyers1, J.A. 
Mares1. 1Ophthalmology and Visual Sciences, 
University of Wisconsin-Madison, Madison, WI; 
2Epidemiology & Biostatistics, Case Western 
Reserve University, Cleveland, OH; 3Jean Mayer 
USDA Human Nutrition, Research Center on Aging, 
Tufts University, Boston, MA; 4Cancer Prevention 
Research Program, Fred Hutchinson Cancer 
Research Center, Seattle, WA.*CR 
5643 — A39 Genetic Testing for Myotonic 
Dystrophy in Early-onset Cataract - 10 years 
data. Shiao Wei Wong. Ophthalmology, NHS, 
Aberdeen, United Kingdom. 
5644 — A40 Heritability Of Ocular Biometry 
Parameters Using Structural Equation Modeling 
In A Study Of Angle-closure Glaucoma. Robert 
Wojciechowski1, P.Y. Ramulu2, S. Kavitha3, P. 
Sundaresan4, R. Jayanthi3, D.S. Friedman2, R. 
Venkatesh3. 1Epidemiology, Johns Hopkins School 
of Public Health, Baltimore, MD; 2Ophthalmology, 
Wilmer Eye Institute/Johns Hopkins, Baltimore, MD; 
3Aravind Eye Hospital, Pondicherry, India; 4Genetics, 
Aravind Med Res Foundation, Madurai, India. 
5645 — A41 Polymorphism in Vascular 
Endothelial Growth Factor and Its Receptor 
Genes in Polypoidal Choroidal Vasculopathy 
in a Korean Population. Dong Ho Park, I. Kim. 
Ophthalmology, Kyungpook National Univ Hospital, 
Daegu, Republic of Korea. 
Thursday – Posters – 5632 – 5650
5646 — A42 Rare Variant Analysis of Refractive 
Error in the AREDS Cohort. Joan E. Bailey-
Wilson1, C.L. Simpson1, R. Wojciechowski1,2, C. 
Mottet1, S. Szymczak1, D. Stambolian3. 1National 
Human Genome Research Inst, National Institutes 
of Health, Baltimore, MD; 2Epidemiology, Johns 
Hopkins Bloomberg School of Public Health, 
Baltimore, MD; 3Ophthalmology-Stellar Chance Lab, 
University of Pennsylvania, Philadelphia, PA. 
Hall B/C A43-A79
Thursday, May 10, 2012, 8:30 AM-10:15 AM
Visual Psychophysics & Physiological Optics / 





5647 — A43 Changes In Cone Photoreceptors 
With An Adaptive Optics Fundus Camera In 
Cases Of Occult Macular Dystrophy, Light-
damaged Maculopathy, And Cone-rod Dystrophy. 
Naoki Tojo, T. Ueda, T. Oiwake, T. Nakamura, A. 
Miyakoshi, T. Yagou, M. Oka, A. Hayashi. Dept of 
Ophthal and Visual Science, Toyama University Sch 
of Med, Toyama, Japan. 
5648 — A44 High Resolution Adaptive 
Optics Imaging Compliments Standard SD-
OCT Imaging in Macular Diseases. Gibran S. 
Khurshid1A, A. Boretsky2, P. Gupta1A, C. Tung1A, 
B.F. Godley1B, M. Motamedi1C, E.F. van Kuijk3. 
AOphthalmology & Visual Sciences, BOphthal 
& Visual Sciences, COphthalmology and Visual 
Sciences, 1Univ of Texas Medical Branch, Galveston, 
TX; 2Ctr for Biomed Engineering, Univ of Texas 
Medical Branch, Houston, TX; 3Ophthalmology 
MMC 493, Univ of Minnesota, Minneapolis, MN. 
5649 — A45 Spectral and Phase Analyses of 
Ocular Hemodynamics using Combined STdOCT 
and Ultrasonic Method. Monika E. Danielewska1A, 
D. Szlag2, D. Iskander1B, M. Wojtkowski2. AInstitute 
of Physics, BInstitute of Biomedical Engineering and 
Instrumentation, 1Wroclaw University of Technology, 
Wroclaw, Poland; 2Institute of Physics, Nicolaus 
Copernicus University, Torun, Poland. 
5650 — A46 High-resolution Imaging Of 
The White Dot Structure Observed In Fundus 
Albipunctatus. Yukiko Makiyama1, S. Ooto1, M. 
Hangai1, K. Takayama1, A. Oishi1, K. Ogino1, S. 
Nakagawa1, K. Yonezawa2, Y. Sato2, N. Yoshimura1. 
1Ophthalmology and Visual Science, Kyoto 
University Grad School of Med, Kyoto, Japan; 
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5668 — A64 Limitations To Adaptive Optics 
Imaging Quality In Highly Powered Eyes. 
Xiaolin Zhou, P. Bedggood, A. Metha. Department 
of Optometry and Vision Sciences, University of 
Melbourne, Melbourne, Australia. 
5669 — A65 The Repeatability of Photoreceptor 
Reflectance Changes in the Living Human 
Retina. Robert F. Cooper1, J. Rha2A, A.M. 
Dubis2B, A. Dubra2A,2C, J. Carroll2A,2B. 1Biomedical 
Engineering, Marquette University, Milwaukee, 
WI; AOphthalmology, BCell Biology, Neurobiology 
& Anatomy, CBiophysics, 2Medical College of 
Wisconsin, Milwaukee, WI.*CR 
5670 — A66 Adaptive Optics Without Altering 
Visual Perception. Nathaniel W. Hart, D.E. Koenig, 
H.J. Hofer. College of Optometry, University of 
Houston, Houston, TX. 
5671 — A67 Retinal Structure and 
Visual Function in Patients with Blue Cone 
Monochromatism. Xunda Luo1, A.V. Cideciyan1, 
A. Sumaroka1, S.B. Schwartz1, A.J. Roman1, J.B. 
Goldberg1, B. Bauman2, B. Wissinger2, S. Kohl2, 
S.G. Jacobson1. 1Department of Ophthalmology, 
Scheie Eye Institute, Philadelphia, PA; 2Center for 
Ophthalmology, Institute for Ophthalmic Research, 
Molecular Genetics Laboratory, Tuebingen, 
Germany. 
5672 — A68 Assessing the Relationship Between 
Cone Density and Foveal Morphology. Adam M. 
Dubis1A, S.O. Hansen1B, R.F. Cooper2, B.R. Hansen2, 
J. Carroll1A,1B. ACell Biology, Neurobiology and 
Anatomy, BOphthalmology, 1Medical College 
of Wisconsin, Wauwatosa, WI; 2Biomedical 
Engineering, Marquette University, Milwaukee, WI. 
5673 — A69 Disrupted RPE and intact 
photoreceptors observed in vivo with Fluorescence 
Adaptive Optics Scanning Laser Ophthalmoscopy 
years following accidental laser exposures in 
humans. Jennifer J. Hunter1A,1B, E.A. Rossi1B, W. 
Fischer1A, A. Dubra2A,2B, M.M. Chung1A,1B. AFlaum 
Eye Institute, BCenter for Visual Science, 1University 
of Rochester, Rochester, NY; AOphthalmology, 
BBiophysics, 2Medical College of Wisconsin, 
Milwaukee, WI. 
5674 — A70 Measuring the Performance of an 
Adaptive Optics Flood Illuminated Camera for 
Imaging the Cone Mosaic in the Clinical Setting. 
Jonathan D. Fay, A. Faridi, A. Garg, M.E. Pennesi. 
Casey Eye Institute, Oregon Health and Science 
University, Portland, OR. 
5675 — A71 Fluorescence Adaptive Optics 
Scanning Laser Ophthalmoscopy Demonstrates 
Intraretinal Spots and Low Cone Density in 
Fundus Albipunctatus. Hongxin Song1A, D.R. 
Williams1A,1B, L. Latchney1C, A. Dubra2, M.M. 
Chung1A,1C. ACenter for Visual Science, BInstitute 
of Optics, CFlaum Eye Institute, 1University of 
Rochester, Rochester, NY; 2Ophthalmology, Medical 
College of Wisconsin, Milwaukee, WI.*CR 
5651 – 5675 – Thursday – Posters
5651 — A47 The Nile Rat Model of Diabetes- 
a Cone-Rich Retina with a Nocturnal Eye 
Design Enables Enhanced Resolution of the 
Retina. Melanie C. Campbell1A, M.L. Kisilak1A, 
K. Bunghardt1B, E.L. Irving1C, N. Gibson1D, L. 
Emptage1B, Y. Sauve2, V. Choh1C. APhysics & 
Astronomy/Sch of Optom, BPhysics & Astronomy, 
CSchool of Optometry, DPsychology, 1University 
of Waterloo, Waterloo, ON, Canada; 2Dept of 
Ophthalmology, University of Alberta, Edmonton, 
AB, Canada. 
5652 — A48 Pattern of Retinal Ischemia during 
Acute Retinal Hypoperfusion. Feng Liang, J-A. 
Sahel, J-F. Girmens, M. Paques. CHNO des 15-20, 
Paris, France. 
5653 — A49 Improved Retinal Blood Flow 
Analysis Method Using Abnormal Frame 
Information Automatically Detected From 
AOSLO Image Sequence. Hiroshi Imamura1, 
P. Fletcher2, K. Nozato1, S. Ueda1, A. Uji3, N. 
Yoshimura3. 1Canon Inc, Tokyo, Japan; 2Canon 
Information Systems Research Australia, Sydney, 
Australia; 3Ophthalmology, Kyoto University 
Graduate School of Medicine, Kyoto City, Japan.*CR 
5654 — A50 Characterization of Diabetic 
Retinopathy Lesions Using Adaptive Optics 
Scanning Laser Ophthalmoscopy. Sonja G. 
Prager1,2, S.H. Radwan1,3, H. Kwak1, P.S. Silva1, 
S.A. Burns4, L.P. Aiello1, J.K. Sun1. 1Beetham Eye 
Institute, Joslin Diabetes Center/Harvard Medical 
School, Boston, MA; 2Department of Ophthalmology 
and Optometry, Medical University Vienna, Vienna, 
Austria; 3Ophthalmology, Cairo University, Cairo, 
Egypt; 4School of Optometry, Indiana University, 
Bloomington, IN. 
5655 — A51 Structural analysis of small vessels 
In The Human Retina : an adaptive optics study. 
Michel Paques1, K. Nakashima1, F. Rossant2, J.A. 
Sahel3. 1Clinical Investigation Center 503, Quinze-
Vingts Hospital, INSERM, Paris, France; 2ISEP, 
Paris, France; 3UMR-S 968, Institut de la Vision, 
Paris, France.*CR 
5656 — A52 New Features Of Diabetic 
Retinopathy Lesions Detected By Adaptive Optics 
Scanning. Toke Bek. Dept of Ophthalmology, Aarhus 
University Hospital, Aarhus C, Denmark. 
5657 — A53 In Vivo Investigation of the Retinal 
Microscopy in Patients with Type 1 Diabetes 
Mellitus. Mariacristina Parravano1, M. Lombardo1, 
G. Lombardo2, B. Boccassini1, S. Lioi1, M. Varano1. 
1Ophthalmology, Fondazione GB Bietti-IRCCS, 
Rome, Italy; 2CNR-IPCF Unit of Support Cosenza, 
LiCryL Laboratory, University of Calabria, Rende, 
Italy. 
5658 — A54 Measurement Of Retinal Blood 
Flow In Diabetic Retinopathy Using Adaptive 
Optics Scanning Laser Ophthalmoscopy. 
Akihito Uji1, M. Hangai1, S. Ooto1, T. Murakami1, 
N. Yoshimura1, H. Imamura2, K. Nozato2. 
1Ophthalmology, Kyoto Univ Graduate Sch of Med, 
Kyoto City, Japan; 2Canon INC., Tokyo, Japan.*CR 
5659 — A55 Adaptive Optics and SD OCT in 
Macular Telangiectasia Type 2. Alain Gaudric1, K. 
Nakashima2, V. Krivosic1, N. Chateau3, J.A. Sahel4, 
M. Paques2. 1Ophthalmology, Lariboisiere Hospital-
University Paris 7, Paris, France; 2Ophthalmology, 
Clinical Investigation Center 503 Quinze-Vingts 
Hospital, INSERM, Paris, France; 3Imagine Eyes, 
Orsay, France; 4Ophthalmology, UMR-S 968 Institut 
de la Vision, Paris, France.*CR 
5660 — A56 Oximetry Imaging Of The Retinal 
Microvasculature Using Adaptive Optics. Phillip 
A. Bedggood, A. Metha. Optometry & Vision 
Sciences, University of Melbourne, Parkville, 
Australia. 
5661 — A57 Effectiveness In Detecting Area Of 
Photoreceptor Disruption By Dioptric Adaptive 
Optics Scanning Laser Ophthalmoscope (d-aoslo) 
With Wider Field Of View. Yoshiyuki Kitaguchi1, T. 
Fujikado2, H. Kanda2, T. Morimoto2, T. Yamaguchi3, 
T. Mihashi3, K. Nishida4. 1Ophthalmology, Sumitomo 
hospital, Osaka, Japan; 2Applied Visual Science, 
Osaka University, Suita, Japan; 3Topcon Rearch 
Institute, Itabashi, Japan; 4Ophthalmology, Osaka 
University, Osaka, Japan.*CR 
5662 — A58 Foveal Microvasculature And Its 
Relationship To Retinal Thickness. Toco Y. Chui1, 
A.E. Elsner2A, S.A. Burns2B. 1Optometry, Indiana 
University, Bloomington, IN; AOptometry, BSchool of 
Optometry, 2Indiana University, Bloomington, IN. 
5663 — A59 Variations Of The Eye’S Image 
Optical Quality And The Sampling Limit Of 
Resolution Of The Cone Mosaic With Axial 
Length. Marco Lombardo1, S. Serrao1, P. Ducoli1, G. 
Lombardo2. 1IRCCS Fondazione G.B. Bietti, Rome, 
Italy; 2CNR-IPCF Unit of Support Cosenza, LiCryL 
Laboratory, University of Calabria, Rende, Italy. 
5664 — A60 Distribution of Outer Nuclear 
Layer Thickness in SDOCT Images. Joel A. 
Papay, C.A. Clark, T.Y. Chui, L. Zhao, A.E. Elsner. 
Optometry, Indiana University, Bloomington, IN. 
5665 — A61 Perifoveal Retinal Thickness and 
Temporal Contrast Sensitivity in Axial Myopia. 
Nancy J. Coletta1, Y. Pilz2, A. Ciepiela1. 1Vision 
Science, New England College of Optometry, 
Boston, MA; 2School of Optometry, University of 
California, Berkeley, CA. 
5666 — A62 In vivo Imaging of Photoreceptor 
Loss Associated with Dry Age-Related Macular 
Degeneration Using Adaptive Optics Scanning 
Laser Ophthalmoscopy. Adam Boretsky1A, F. 
Khan1A, G. Burnett1B, R. harris1B, M. Stephens1B, M. 
Motamedi1A, E.F. van Kuijk2. ACenter for Biomedical 
Engineering, BSchool of Medicine, 1Univ of Texas 
Medical Branch, Galveston, TX; 2Ophthalmology 
MMC 493, Univ of Minnesota, Minneapolis, MN. 
5667 — A63 Adaptive Optics Scanning 
Ophthalmoscopy With Amplitude Pupil 
Apodization. Yusufu N. Sulai1A,1B, A. Dubra2A,2B. AThe 
Institute of Optics, BFlaum Eye Institute, 1University 
of Rochester, Rochester, NY; AOphthalmology, 
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5676 — A72 Determinants Of Normal 
Human Cone Photoreceptor Density 
Measured By Adaptive Optics Scanning Laser 
Ophthalmoscope. Sung Pyo Park1,2, J. Chung2, F. 
Hirose3, S.H. Tsang1, S. Chang1. 1Department of 
Ophthalmology, Columbia university medical center, 
New York, NY; 2Department of Ophthalmology, 
Kangdong Sacred Heart Hospital, Seoul, Republic of 
Korea; 3Canon INC., Tokyo, Japan.*CR 
5677 — A73 Spatially-resolved Adaptive 
Optics Photopigment Densitometry for Assessing 
Photoreceptor Function. Benjamin D. Masella1A,1B, 
J.J. Hunter1C,1B, D.R. Williams1B,1A. AThe Institute 
of Optics, BCenter for Visual Science, CFlaum Eye 
Institute, 1University of Rochester, Rochester, 
NY.*CR 
5678 — A74 Photoreceptor Analysis using 
Entrance-Pupil Structuring and Motorized 
Confocal Scanning. Brian Vohnsen, D. Rativa 
Millan, B. Lochocki, C. Vela-Garcia. School 
of Physics, University College Dublin, Dublin, 
Ireland.*CR 
5679 — A75 Light Radiated from Myoids 
for Oblique Incidences upon Foveal Cones. 
Jean-Marie Gorrand1, M. Doly2. 1Biophysique des 
Handicaps Sensoriels, School of Medicine, Clermont 
Ferrand, France; 2Biophysique des Handicaps 
Sensoriels, Universite d’Auvergne, Clermont-
Ferrand, France. 
5680 — A76 Extending The Field Of 
View In Adaptive Optics Scanning Laser 
Ophthalmoscopy. Franz Felberer1A, J.S. 
Kroisamer1B, C.K. Hitzenberger1A, M. Pircher1A. 
ACenter for Medical Physics and Biomedical 
Engineering, BOphthalmology, 1Medical University 
of Vienna, Vienna, Austria. 
5681 — A77 Optics Design For Confocal 
Scanning Laser Ophthalmoscope. Chaohong Li1, 
H. Chen1, Y. Li1, Z. Tang2. 1School of Ophthalmology 
and Optometry, Wenzhou Medical College, 
Wenzhou, China; 2Suzhou Microclear Instruments 
Co., Ltd, Suzhou, China. 
5682 — A78 Spectral-domain Optical Coherence 
Tomography In Acute Macular Neuroretinopathy. 
Imen Chtioui1, V. Martinet1, G. Azar1, B. Wolff1, P-L. 
Cornut2, J-A. Sahel1. 1Fondation Ophtalmologique 
Adolphe de Rothschild, Paris, France; 2hopital 
Edouard Herriot, Lyon, France. 
5683 — A79 Simulation Of Fundus Image 
Measurements - One Step Toward Virtual Clinical 
Trial. Ying-Ling Chen1, L. Shi2, J.L. Lewis3, M. 
Wang4. 1Univ of Tennessee Space Inst, Tullahoma, 
TN; 2University of Tennessee Space Institute, 
Tullahoma, TN; 3E-Vision Technologies, Inc, 
Tullahoma, TN; 4Wang Vision Institute, Nashville, 
TN.*CR 
Hall B/C A99-A125





5684 — A99 Oscillatory Potential Contribution 
to the ERG: A New Mean to Identify Disease 
Onset. Nataly Trang1, M. Gauvin1, R. Koenekoop1, 
J. Little1, J-M. Lina2, P. Lachapelle1. 1Department 
of Ophthalmology, Neurology and Neurosurgery, 
McGill University-Montreal Children’s Hospital 
Research Institute, Montreal, QC, Canada; 2École 
de technologie supérieure, Montreal, QC, Canada. 
5685 — A100 Topographic Mapping Of 
Functioning Cone And Rod System In Inherited 
Retinal Degenerations With Confirmed Gene 
Mutations. Ieva Sliesoraityte1, E. Troeger1, S. 
Kohl2, B. Wissinger3A, E. Zrenner3B. 1Institute for 
Ophthalmic Research, University of Tuebingen, 
Tuebingen, Germany; 2Institute for Ophthalmic 
Research, Molecular Genetics Laboratory, 
Tuebingen, Germany; AMolecular Genetics 
Laboratory, BInstitute for Ophthalmic Research, 
3Centre for Ophthalmology, Tuebingen, Germany. 
5686 — A101 Molecular Modeling of RS1 
Structure Indicates Two Classes of Missense 
Variants With Mild and Severe XLRS 
Phenotypes. Yuri V. Sergeev1A, P.A. Sieving1, A. 
Vincent2, A.G. Robson2,3, A.T. Moore3, A.R. Webster3, 
G.E. Holder2,3. AOGVFB, 1National Eye Institute, 
Bethesda, MD; 2Electrophysiology, Moorfields 
Eye Hospital, London, United Kingdom; 3Institute 
of Ophthalmology, University College, London, 
United Kingdom. 
5687 — A102 Retinal Function Assessed 
By Full-field ERG In Ranibizumab Treated 
Neovascular AMD Patients. Karen B. 
Pedersen1, F. Møller2, A. Sjølie2, S. Andreasson3. 
1Ophthalmology, Glostrup Hospital, Glostrup, 
Denmark; 2Ophthalmology, Odense University 
Hospital, Odense, Denmark; 3Ophthalmology, Lund 
University Hospital, Lund, Sweden. 
5688 — A103 Preventing AMD: Trust Your 
Genes More Than Your Pigmentation. Anna 
Polosa, P. Lachapelle. Ophthalmology/Neurology-
Neurosurgery, McGill Univ/Montreal Children’s 
Hosp, Montreal, QC, Canada. 
5689 — A104 Full Field Electroretinogram 
Using A Fiber Electrode Prototype In Patients 
With Retinal Dystrophy. Josenilson M. Pereira, 
D.M. Rocha, P.Y. Sacai, S.E. Watanabe, S.R. 
Salomao, A. Berezovsky. Ophthalmology, Univ 
Federal de Sao Paulo, Sao Paulo, Brazil. 
Thursday – Posters – 5676 – 5695
5690 — A105 Discrete Wavelet Transform 
(DWT) Of The ERG More Accurately Predicts 
The End Stage Of Retinal Degenerative 
Disorders. Mathieu Gauvin1,2, J Racine1, J. Daloze1, 
R. Koenekoop1, J. Little1, M Hebert3, J. Lina2, 
P Lachapelle1. 1Department of Ophthalmology, 
Neurology and Neurosurgery, McGill University 
- Montreal Children’s Hospital Research Institute, 
Montreal, QC, Canada; 2Electrical Engineering, 
École de Technologie Supérieure, Montreal, QC, 
Canada; 3Ophthalmology, Laval University - Centre 
de recherche Université Laval Robert-Giffard, 
Quebec, QC, Canada. 
5691 — A106 Electrophysiological Case Study 
Of Fundus Albipunctatus With Cone Dystrophy. 
Vincent Nguyen, A. Choi, D. Pye, M. Kalloniatis. 
Centre for Eye Health, The University of New 
South Wales, Kengsinton, Australia. 
5692 — A107 Two New Mutations in RP1L1 
Gene in Occult Macular Dystrophy Patients 
Associated with a Depolarizing Pattern of Focal 
Macular ERG. Shuhei Kameya1, T. Kabuto1, H. 
Takahashi1, Y. Goto-Fukuura1, T. Igarashi2, K. 
Yamaki1, A. Mizota3, Y. Miyake4,5, H. Takahashi2. 
1Ophthalmology, Chiba Hokusoh Hosp Nippon Med 
Sch, Inzai, Japan; 2Ophthalmology, Nippon Medical 
School, Bunkyo-Ku, Japan; 3Ophthalmology, Teikyo 
University, Itabashi-ku, Japan; 4Ophthalmology, 
National Institute of Sensory Organs, National 
Hospital Organaization Tokyo Medical Center, 
Tokyo, Japan; 5Aichi Medical University, Aichi-
gun, Japan. 
5693 — A108 Cortical Impact of Genetic 
Retinal Degeneration of Ganglion Cell Origin 
and With Early Visual Loss. Catarina A. Mateus1, 
A.A. Reis1,2, J. Castelhano1, E. Silva2, M. Castelo-
Branco1. 1Visual Neuroscience, IBILI-Faculty 
of Med-Univ of Coimbra, Coimbra, Portugal; 
2Ophthalmology, University Hospital of Coimbra, 
Coimbra, Portugal. 
5694 — A109 Phenotypic Characterization in 
Two Patients with Identified Rhodopsin Gene 
Mutation: Impact of Retinal Degeneration 
on Cortical Structure. Andreia C. Pereira1, C. 
Mateus1, A. Reis1,2, B. Quendera1, S. Ferreira1, 
M. Almeida3, E. Silva2, M. Castelo-Branco1. 
1Visual Neuroscience Laboratory, IBILI-Faculty 
of Medicine-University of Coimbra, Coimbra, 
Portugal; 2Ophthalmology, University Hospital 
of Coimbra, Coimbra, Portugal; 3Center for 
Neuroscience and Cell Biology, University of 
Coimbra, Coimbra, Portugal. 
5695 — A110 Environmental and Therapeutic 
Approaches to Limit the Consequences of 
Postnatal Hyperoxia. Allison L. Dorfman1A, B. 
Campanaro2, K. Uy2, A. Polosa1A, M. Djavari1A, 
P. Wintermark1B, S. Chemtob3, P. Lachapelle1A. 
AOphthalmology, BNeonatology, 1McGill University/
Montreal Children’s Hospital, Montreal, QC, 
Canada; 2Département de Sciences Biomédicales, 
Université de Montréal, Montreal, QC, Canada; 
3Pediatrics & Pharmacology, Research Centre/ Ste. 
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5711 — A126 Clinical Verification of Input-
Lag Correction for Comparison of pVEP signals 
acquired using CRT and TFT displays. Balazs L. 
Varsanyi1A, B.V. Nagy2, A. Magyar1A, A. Farkas1A, J. 
Nemeth1B. ADepartment of Ophthalmology, BDept of 
Ophthalmology, 1Semmelweis University, Budapest, 
Hungary; 2Experimental Psychology, University of 
Sao Paulo, Sao Paulo, Brazil. 
5712 — A127 The Limited Ability Of Neurons In 
Visual Area 2 (v2) To Integrate Contour Elements 
Over Extended Space In Infant Macaque 
Monkeys. Bin Zhang1,2, G. Shen2, X. Tao2, E.L. 
Smith, III2, Y.M. Chino2. 1College of Optometry, Nova 
Southeastern University, Plantation, FL; 2College of 
Optometry, University of Houston, Houston, TX. 
5713 — A128 The Use of Optokinetic Response 
to Quantitatively Measure Visual Acuity in Adult 
Zebrafish. Peony C. Tam, F. Rassamdana, K. Dang, 
D. Cameron. Optometry, Western University of 
Health Sciences, Pomona, CA. 
5714 — A129 Visual Acuity Deficit Measurement 
in Adult bugeye Zebrafish Using Optokinetic 
Response. Faydim Rassamdana, P. Tam, K. Dang, D. 
Cameron. Optometry, Western University of Health 
Sciences, Pomona, CA. 
5715 — A130 Mapping The Spatiotemporal 
(S-T) Domain And Gain Of Putative M- And 
P-dominated Limbs Of The Human Cortical 
Contrast Response Function (CRF) Using The 
Sweep Vep (svep). Russell D. Hamer1,2, G.S. 
Souza3,4, T.L. Costa1, B.D. Gomes3, L.C. Silveira3,4, 
D.F. Ventura1. 1Departamento de Psicologia 
Experimental, Instituto de Psicologia, São Paulo, 
Brazil; 2Smith-Kettlewell Eye Research Institute, 
San Francisco, CA; 3Insituto de Ciencias Biologicas, 
Universidade Federal do Para, Belem, Brazil; 
4Nucleo de Medicina Tropical, Universidade Federal 
do Parã, Belem, Brazil. 
5716 — A131 Topographic maps of VEP Elicited 
By Pseudorandom Stimulation with The Swept 
Parameter Technique. Keiko Momose. Faculty of 
Human Sciences, Waseda University, Tokorozawa, 
Japan. 
5717 — A132 Effects of the presentation mode 
and color contrast in visual evoked potential 
elicited by pseudo-random stimuli. Givago S. 
Souza, V.R. da Silva, C.S. Araujo, B.B. Risuenho, 
B.D. Gomes, L.L. Silveira. Insituto de Ciencias 
Biologicas, Universidade Federal do Para, Belem, 
Brazil. 
5696 — A111 Central Retinal Vein Occlusion: 
Oct And Ferg Findings In Affected And Fellow 
Eyes. Mirella Lizzano, G. Ruberto, C. Tinelli, P. 
Piccinini, J. Dispinseri, G. Vandelli, P.E. Bianchi. 
Ophtalmology Policlinico S. Matteo, IRCCS 
Policlinico San Matteo, Pavia, Italy. 
5697 — A112 Focal Macular Electroretinogram 
Elicited By Hemicircular Stimuli In Eyes 
With Branch Retinal Vein Occlusion. Shunsuke 
Yasuda1, S. Ueno1, C-H. Piao1, M. Kondo1,2, H. 
Terasaki1. 1Ophthalmology, Nagoya Univ Graduate 
Sch of Med, Nagoya, Japan; 2Ophthalmology, Mie 
Univ Graduate Sch of Med, Tsu, Japan. 
5698 — A113 Optimizing Filter Setting In 
The 2 Global Flash Multifocal ERG In POAG. 
Anna A. Polunina, S.A. Kramer, M.G. Todorova, A. 
Schötzau, A.M. Palmowski-Wolfe. Ophthalmology, 
University of Basel, Basel, Switzerland. T 
5699 — A114 Visual Impairment in Leber 
Hereditary Optic Neuropathy Carriers of the 
Same Pedigree. Aldina A. Reis1,2, C. Mateus1, E. 
Silva1,2, M. Castelo-Branco1. 1Visual Neuroscience 
Laboratory, IBILI-Faculty of Med-Univ of 
Coimbra, Coimbra, Portugal; 2Ophthalmology, 
University Hospital of Coimbra, Coimbra, Portugal. 
5700 — A115 Alternation of Photopic Negative 
Response of Multifocal Electroretinogram in 
Patients with Optic Nerve Atrophy. Muneyoshi 
Kaneko, S. Machida, T. Sugawara, K. Otaka, D. 
Kurosaka. Department of Ophthalmology, Iwate 
Medical Univ School of Med, Morioka, Japan. 
5701 — A116 Transcorneal Electrical 
Stimulation in Patients with Nonarteritic 
Anterior Ischemic Optic Neuropathy. Lubka 
Naycheva, A. Schatz, T. Röck, G. Willmann, K. 
Bartz-Schmidt, E. Zrenner, F. Gekeler. Centre 
for Ophthalmology, University of Tuebingen, 
Tuebingen, Germany.*CR, f 
5702 — A117 Effects of Nicotine on Flicker 
ERGs: Application of DFT and T-Circ2. 
Stefanie B. Varghese1A, N. Naser1A, T.P. Than1B, 
K.T. Keyser1A, E. Hartmann1B. AVision Science, 
BOptometry, 1Univ of Alabama at Birmingham, 
Birmingham, AL. 
5703 — A118 The Characteristics Of Cone-
driven Oscillatory Potentials In Human 
Electroretinogram. Bo Lei1, H. Peng1, J. Yin1, Q. 
Li2. 1Ophthalmology, The First Affiliated Hospital of 
Chongqing Medical University, Chongqing, China; 
2Ophthalmology, University of Florida, Gainesville, 
FL. 
5704 — A119 The Effects Of Light Adaptation 
On The Harmonic Components Of The Flicker 
Electroretinogram. Philip R. Nolan, J. McAnany. 
Opthalmology and Visual Sciences, University of 
Illinois at Chicago, Chicago, IL. 
5705 — A120 Trichromatic And Dichromatic 
Electroretinograms Using A Chromatic-
Achromatic Temporal Compound Stimulus. 
Neil R. Parry1, I.J. Murray2, A. Panorgias2, D.J. 
McKeefry3, B.B. Lee4, J.J. Kremers5. 1Vision 
Science Centre, Manchester Royal Eye Hospital, 
Manchester, United Kingdom; 2Optometry & 
Vis Sci, FLS, Univ of Manchester, Manchester, 
United Kingdom; 3School of Optometry and 
Vision Science, University of Bradford, Bradford, 
United Kingdom; 4Biological Sciences, SUNY 
College of Optometry, New York, NY; 5Dept of 
Ophthalmology, University of Erlangen, Erlangen, 
Germany. 
5706 — A121 Scleral Depression Depresses the 
Photopic ERG. Scott E. Brodie1, J.H. Francis2, 
B. Marr2, D.H. Abramson2. 1Ophthalmology, 
Mount Sinai School of Medicine, New York, NY; 
2Ophthalmic Oncology, Memorial Sloan-Kettering 
Cancer Center, New York, NY. 
5707 — A122 Reproducibility Of Visual 
Electrophysiology Recordings Between 
Laboratories: The Importance Of Regular 
Calibration. Richard P. Hagan1,2, K.J. Quinn1, 
L. Milner1,2, R.L. Robinson1,2, A.F. Taktak1, A.C. 
Fisher1,2. 1Department of Medical Physics & Clin 
Eng, Royal Liverpool Univ Hospital, Liverpool, 
United Kingdom; 2Clinical Eye Research Centre, 
Royal Liverpool University Hospital, Liverpool, 
United Kingdom. 
5708 — A123 Generation of Steady State 
Pattern Electroretinograms Explained by 
Convolution of Transient Responses. Jonathon 
A. Toft-Nielsen1, J. Bohorquez1, V. Porciatti2, O. 
Ozdamar1. 1Biomedical Engineering, University of 
Miami, Miami, FL; 2Bascom Palmer Eye Inst, Univ 
of Miami Miller Sch Med, Miami, FL. 
5709 — A124 Temporal Interactions 
Between the b-wave and d-wave of the Human 
Electroretinogram. pan Shi, K.A. Godwin, P.J. 
DeMarco. Psychological and Brain Sciences, 
University of Louisville, Louisville, KY. 
5710 — A125 Characterising Human L- and 
M-cone ERGs Using a Four Primary System. 
Declan J. McKeefry1, N.K. Challa2, I.J. Murray3, 
J.J. Kremers4, N.R. Parry5. 1Optometry, Bradford 
School of Optometry & Vision Science, Bradford, 
United Kingdom; 2Electrophysiology, L.V.Prasad 
Eye Institute, Hyderabad, India; 3Optometry & 
Vis Sci, FLS, Univ of Manchester, Manchester, 
United Kingdom; 4Dept of Ophthalmology, 
University of Erlangen, Erlangen, Germany; 5Vision 
Science Centre, Manchester Royal Eye Hospital, 
Manchester, United Kingdom. 
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5718 — A133 Contribution of P and M 
Pathways to Pseudo-Random Binary Sequence 
Visual Evoked Cortical Potential across the 
Contrast and Spatial Frequency Domains. 
Carolina d. Araujo, G.S. Souza, B.D. Gomes, 
L.L. Silveira. Instituto de Ciencias Biologicas, 
Universidade Federal do Para, Belem, Brazil. 
5719 — A134 A Short-Duration Visual 
Evoked Potential (VEP) Test Protocol. Vance M. 
Zemon1, P.M. Weinger1, A. Harewood2, V. Nunez2, 
J-P. Michel2, S. Azizgolshani2, J. Izrailova2, G. 
Hu3, P. Butler4, J. Gordon2. 1Ferkauf Grad School 
of Psychology, Yeshiva University, Bronx, NY; 
2Psychology Department, Hunter College, New 
York, NY; 3VeriSci Corp., Raritan, NJ; 4Nathan 
Kline Institute for Psychiatric Research, Orangeburg, 
NY.*CR 
5720 — A135 The Step VEP has a Consistent 
VA Relationship with Psychophysics for all VA, 
Age, and Aetiology and Increases the Completion 
Rate of Paediatric VA Assessment to 96%. Alison 
M. Mackay1,2. 1Medical Physics, Leeds Teaching 
Hospitals, Leeds, United Kingdom; 2Clinical Physics, 
Royal Hospital for Sick Children, Glasgow, United 
Kingdom. 
5721 — A136 Corneal Dry-responsive Neurons 
in the Trigeminal Nucleus Respond to Innocuous 
Cooling in the Rat. Ian D. Meng1, M. Kurose2. 
1Biomedical Sciences, University of New England, 
Biddeford, ME; 2Oral Biological Sciences, Niigata 
University School of Dentistry, Niigata, Japan. 
5722 — A137 Pharmacological Enhancement 
of LTP in Primary Visual Cortex via activation 
of Alpha 2a/c Adrenergic Receptors. Ursula V. 
Staubli, N. Rangel-Diaz, J. Donello, A. Foster, D. 
Gil. Biological Sciences, Allergan Inc, Irvine, CA. 
5723 — A138 Stimulus Timing-Dependent 
Synaptic Modification in Rat Visual Cortex 
Induced by Training Stimuli Paired with 
Postsynaptic Subthreshold Depolarizations. 
Xuefeng Shi1,2, K. Zhao1,2. 1Ped Ophthal & 
Strabismus, Tianjin Eye Institute and Hospital, 
Tianjin, China; 2Tianjin Key Laboratory of 
Ophthalmology and Visual Science, Tianjin, 
China. T 
5724 — A139 Measuring The Spatial And 
Temporal Dynamics Of Frontal Eye Field 
Receptive Fields. Matthew A. Smith1A,1B, J. Mayo1B,2, 
M.A. Sommer3, A. DiTomasso1A. AOphthalmology, 
BCenter for Neuroscience, 1University of Pittsburgh, 
Pittsburgh, PA; 2Neurobiology, Harvard Medical 
School, Boston, MA; 3Dept. of Biomedical 
Engineering and Center for Cog. Neurosci., Duke 
University, Durham, NC. 
Hall B/C A140-A152





5725 — A140 Monitoring Of Patients On 
Hydroxychloroquine For At Least Five Years: 
A follow-up Of 21 Patients. Danielle Amana1, 
I. Ingster-Moati2, E. Albuisson3, C. Girard4, B. 
Delbosc4. 1Department of Ophthalmology, Orleans 
Hospital, Orleans, France; 2Ophthalmology, 
University Paris 7 Diderot, Necker Hospital, Paris, 
France; 3Biostatistics Department, University 
of Medicine, Vandoeuvre-les-Nancy, France; 
4Department of Ophthalmology, University Hospital, 
Besancon, France. 
5726 — A141 Full-field Electroretinogram 
Changes In Patients In Therapy With 
Chloroquine And Hydroxychloroquine: Time 
And Dose Effect. Giulio Ruberto1A, C. Tinelli1B, P. 
Piccinini1A, L. Bossolesi1A, M. Raimondi1A. AClinica 
Oculistica, BBiometric Service, 1IRCCS Policlinico 
San Matteo, Pavia, Italy. 
5727 — A142 Correlations Between Visual 
Acuity (VA), Humphrey Visual Fields (HVF), 
And Multifocal Electroretinogram (mfERG) 
In Patients With Retinal Toxicity Secondary To 
Hydroxychloroquine (Plaquenil) Therapy (PT). 
Inna V. Glybina. Ophthalmology, Wayne State Univ/
Kresge Eye Inst, Detroit, MI. 
5728 — A143 Ganzfeld-electroretinogram In 
Patients With Coronary Heart Disease. Katja 
Goebel1, A. Reffken2A, H. Drexler2B, C. Erb3,2A. 
1Ophthalmology, Schloss Park Clinic, Berlin, 
Germany; AOphthalmology, BKardiology, 2Hannover 
Medical School, Hannover, Germany; 3Eye clinic, 
Wittenbergplatz, Berlin, Germany. 
5729 — A144 Electrophysiology And Fluorescein 
And Indocyanine Green Angiography In Susac 
Syndrome. Julia M. Promesberger1A, A.F. Alex1A, I. 
Kleffner1B, J-M. Dörr2, N. Eter1A. AOphthalmology, 
BNeurology, 1University hospital of Muenster, 
Muenster, Germany; 2NeuroCure Clinical Research 
Center, Charité, University hospital of Berlin, Berlin, 
Germany. 
5730 — A145 Flash Electroretinogram In 
Children With Mitochondrial Diseases. Frederic 
Nicot1, A. Bron1, C. Creuzot-Garcher1, F. Renault2. 
1Ophthalmology, CHU Dijon, Dijon, France; 
2Neurophysiology Unit, Hôpital Armand Trousseau, 
Paris, France. 
5731 — A146 Flicker Electroretinogram 
- Temporal Response Function In Children 
On Vigabatrin (VGB). Aparna Raghuram1,2, 
O. Kolawole1,3, R.M. Hansen1,2, A.B. Fulton1,2. 
1Department of Ophthalmology, Childrens Hospital 
Boston, Boston, MA; 2Harvard Medical School, 
Boston, MA; 3Northeastern University, Boston, MA. 
Thursday – Posters – 5718 – 5737
5732 — A147 Seizure Related Retinal 
Dysfunction Is Not Associated With Increased 
Risk Of Retinal Toxicity With Vigabatrin. 
Ananthavalli Kumarappah1, M.T. McFarlane2, T. 
Wright2, C. Westall2. 1Institute of Medical Sciences, 
University of Toronto, Toronto, ON, Canada; 
2Ophthalmology and Vision Sciences, Hospital for 
Sick Children, Toronto, ON, Canada.*CR 
5733 — A148 Electroretinogram Anomalies In 
Psychiatric Disorders: The Possible Implication 
Of GSK3. Joelle Lavoie1, J-M. Beaulieu1, M. 
Hebert2. 1CRULRG, Quebec, QC, Canada; 
2Ophthalmology, Laval University, Quebec, QC, 
Canada. T 
5734 — A149 Habituation of the Ganglion 
Cell Response to Sustained Pattern Stimulation: 
Reduced by Multiple Sclerosis. Antonello Fadda1, 
A. Di Renzo2, F. Martelli1, D. Marangoni3A, A. 
Batocchi3B, D. Giannini1, B. Falsini3A. 1Technologies 
and Health, Istituto Superiore di Sanita, Roma, Italy; 
2Ophthalmology, GB Bietti Eye Foundation-IRCCS, 
Roma, Italy; AOphthalmology, BNeurology, 3Catholic 
University, Rome, Italy. 
5735 — A150 Effects of Nicotine on Processing 
in the Visual Pathways. Naser T. Naser1A, 
V.M. Zemon2, S.B. Varghese1A, K.T. Keyser1A, E. 
Hartmann1B. AVision Science, BDepartment of 
Optometry, 1University of Alabama at Birmingham, 
Birmingham, AL; 2Ferkauf Grad School of 
Psychology, Yeshiva University, Bronx, NY.*CR 
5736 — A151 Evaluation of visual function 
in patients with Clinical Isolated Syndrome 
using multifocal visual evoked potentials and 
optic coherence tomography. Roman Blanco1, 
C. Perez-Rico2, L. Rubio3, M. Roldan4, L. Ayuso3. 
1Departamento de Oftalmologia, HUGU, Sescam 
/ UAH, Spain; 2Departamento de Oftalmologia, 
Universidad Alcalá, UAH, Spain; 3Departamento de 
Neurología, Hospital Principe de Asturias, Alcala 
de Henares (Madrid), Spain; 4Departamento de 
Oftalmologia, Universidad de Alcala, Alcala de 
Henares (Madrid), Spain. 
5737 — A152 Transient and Steady-State Short-
Duration Visual Evoked Potential (VEP) Battery 
in Children with and without Autism Spectrum 
Disorder. Paige M. Weinger1, V.M. Zemon1, V. 
Nunez2, T. Navalta2, G. Hu3, P. Butler4, J. Gordon2. 
1Ferkauf Grad School of Psychology, Yeshiva 
University, Bronx, NY; 2Psychology Department, 
Hunter College, New York, NY; 3VeriSci Corp, 
Raritan, NJ; 4Nathan Kline Institute for Psychiatric 
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5751 — A269 Risk Factors for Prevalence, 
Incidence and Progression of Diabetic 
Retinopathy Among Non-insulin Dependent 
Diabetes in Taiwan. Shwu-Jiuan Sheu1A,2, 
W-L. Ho1A, J-Y. Lin1A, N-C. Liu1A, S-C. Chen1A, 
Y-H. Horng1A, H-C. Lam1B. ADepartment of 
Ophthalmology, BDepartment of Endocrinology, 
1Kaohsiung Veterans Gen Hospital, Kaohsiung, 
Taiwan; 2Ophthalmology, National Yang Ming 
University, Taipei, Taiwan. 
5752 — A270 The Incidence Of Vitrectomy 
For The Complications Of Proliferative Diabetic 
Retinopathy. David H. Steel1,2, D. Vaideanu1, S.S. 
Sandhu3. 1Sunderland Eye Infirmary, Sunderland, 
United Kingdom; 2Institute of Genetic Medicine, 
University of Newcastle, Newcastle Upon Tyne, 
United Kingdom; 3Medical Retina Unit, Centre for 
Eye Research Australia, Melbourne, Australia. 
5753 — A271 Risk factors Associated 
with Progression from Nonproliferative to 
Proliferative Diabetic Retinopathy. Kristen 
H. Nwanyanwu1A, N. Talwar1A, T.W. Gardner1A, 
J.S. Wrobel1B, J.D. Stein1A. AOphthalmology and 
Visual Sciences, BInternal Medicine, 1University of 
Michigan, Ann Arbor, MI. 
Hall B/C A272-A301
Thursday, May 10, 2012, 8:30 AM-10:15 AM




5754 — A272 Fractal-Based Oscillation of 
Venous Density Within the Macula During 
Progression of Diabetic Retinopathy. Patricia A. 
Parsons-Wingerter1, K. Radhakrishnan2. 1Research & 
Technology Directorate, John Glenn NASA Research 
Center, Cleveland, OH; 2Dept. of Pathology/
Cancer Center, SOM, University of New Mexico, 
Albuquerque, NM. 
5755 — A273 (Pro)renin Receptor Is Associated 
With Angiogenic Activity In Proliferative 
Diabetic Retinopathy. Atsuhiro Kanda1A,1B, K. 
Noda1A,1B, W. Saito1A, S. Ishida1A,1B. ADepartment of 
Ophthalmology, BLaboratory of Ocular Cell Biology 
& Visual Science, 1Hokkaido Univ Grad Sch of Med, 
Sapporo, Japan. 
5756 — A274 Angiogenic and Vasculogenic 
Factors in the Vitreous from Patients with 
Proliferative Diabetic Retinopathy. Mohd I. 
Nawaz1, M.S. Ola1, M.M. Siddiquei1, K. Geboes2, A.A. 
El-Asrar1. 1Ophthalmology, Kind Saud University, 
Riyadh, Saudi Arabia; 2Laboratory of Histochemistry 
and Cytochemistry, University of Leuven, Leuven, 
Belgium. T 
5757 — A275 Influence of Diabetic Vitreous on 
the Endothelial Cells Activity, the Role of Anti-
VEGF and Matrix Components. Yousef Yafai, C. 
Jochmann, W. Eichler, P. Wiedemann. Eye Hospital, 
University of Leipzig, Leipzig, Germany. 
Hall B/C A256-A271
Thursday, May 10, 2012, 8:30 AM-10:15 AM
Clinical & Epidemiologic Research
516 Diabetic Retinopathy Epidemiology 
Moderator: Robin D Hamilton 
5738 — A256 Efficacy of Diabetic Retinopathy 
Screenings for Patients Who Were at High-Risk 
for Sight-Threatening Retinopathy in a County 
Healthcare System. Glen Y. Ozawa1, T. Litvin1, 
J.A. Cuadros1, S. Ramaswamy2A, M.S. Muller3, 
A.E. Elsner2B, T.J. Gast3. 1UC Berkeley School of 
Optometry, Berkeley, CA; ASchool of Optometry, 
BOptometry, 2Indiana University, Bloomington, IN; 
3AEON Imaging, LLC, Bloomington, IN.*CR 
5739 — A257 Cases of Legal Blindness and 
Visual Impairment Avoided Using Ranibizumab 
for Diabetic Macular Edema in the United 
States. Rohit Varma1, N.M. Bressler2, Q. Doan3, 
P.P. Lee4, I.J. Suner5, M. Danese3, C.M. Dolan6, A. 
Turpcu6, J. Ward6, J.S. Ehrlich6. 1Ophthalmology, 
USC, Doheny Eye Institute, Los Angeles, CA; 
2Ophthalmology, Wilmer Eye Institute, Baltimore, 
MD; 3Outcomes Insights, Westlake Village, CA; 
4Ophthalmology, Duke University Eye Center, 
Durham, NC; 5Retina Associates of Florida, Tampa, 
FL; 6Genentech Inc., South San Francisco, CA.
*CR, f 
5740 — A258 Cognitive impairment (CI) 
does not correlate with severity of diabetic 
retinopathy (DR) in people with Type 2 Diabetes 
(T2D). Roxanne R. Crosby-Nwaobi1, A. Forbes1, 
S. Sivaprasad2. 1King’s College London, London, 
United Kingdom; 2Ophthalmology, King’s College 
Hospital, London, London, United Kingdom. 
5741 — A259 Diabetic Retinopathy Inpatient 
Study. Jessica J. Kovarik1, L.A. Willard2, E.L. 
Waxman1. 1Ophthalmology, UPMC Eye Center, Eye 
and Ear Institute, University of Pittsburgh School of 
Medicine, Pittsburgh, PA; 2Medicine, UPMC Mercy 
Hospital, Pittsburgh, PA. 
5742 — A260 How much does glycated 
hemoglobin A
1c
 explain the risk of diabetic 
retinopathy in persons with type 2 diabetes? 
The Diabetes Management Project (DMP). Jing 
Xie1, S. Selvarajah1, R. Kawasaki1, T. Nicolaou1, 
S. Sanmugasundram1, J. Wang1,2, T. Wong1,3, E. 
Lamoureux1,3. 1Department of Ophthalmology, 
Centre for Eye Research Australia, East Melbourne, 
Australia; 2Department of Ophthalmology, Centre 
for Vision Research, Sydney, Australia; 3National 
University of Singapore, Singapore Eye Research 
Institute, Singapore, Singapore. 
5743 — A261 Telemedicine-based Digital 
Retinal Imaging Improves Diabetic Retinopathy 
Screening Compliance. Seema Garg1, B. King1, P. 
Jani1, S. Weir1, T. Karnowski2, S. Li3, E. Chaum3. 
1Dept of Ophthalmology, University of North 
Carolina, Chapel Hill, NC; 2Oak Ridge National 
Laboratory, Memphis, TN; 3Hamilton Eye Institute, 
University of Memphis, Memphis, TN.*CR 
5744 — A262 Access To Eye Care By Patients 
With Diabetes: A Retrospective Analysis. Ann P. 
Murchison1, L.A. Hark1, J.A. Haller1, J.A. Malunda1, 
B. Leiby2, Y. Dai2, L. Pizzi3. 1Research, Wills Eye 
Institute, Philadelphia, PA; 2Biostatistics, Jefferson 
Medical College, Philadelphia, PA; 3Pharmacy, 
Jefferson School of Pharmacy, Philadelphia, PA. 
5745 — A263 Risk Factors for Proliferative 
Diabetic Retinopathy in a Latino American 
Population. Muneeswar Gupta Nittala, S.R. Sadda. 
Ophthalmology, Doheny Eye Institute, Los Angeles, 
CA.*CR 
5746 — A264 An Edutainment Tool for 
Increased Compliance with DR Screening and 
Management, Part 2: Efficacy Study. Anne M. 
Edwards1, G. Zamora1, A. Matiella2, P. Soliz1. 
1VisionQuest Biomedical LLC, Albuquerque, NM; 
2The Fotonovela Production Company, Santa Fe, 
NM.*CR 
5747 — A265 Efficient Early Diagnosis of 
Diabetic Retinopathy using zero-dilation 
Scanning Laser Ophthalmoscopy. Dirk De 
Brouwere1, P. van Etten2, J. Martinez3, M. Mensink1. 
1i-Optics bv, The Hague, The Netherlands; 
2Rotterdam Eye Institute, Rotterdam, The 
Netherlands; 3Rotterdam Eye Hospital, Rotterdam, 
The Netherlands.*CR 
5748 — A266 Diabetes and Diabetic 
Retinopathy in an Australian Cardiac 
Population: the Australian Heart Eye Study. 
Adam J. Plant1,2, G. Burlutsky1, J. Chiha3, 
A. Thiagalingam3, P. Kovoor3, P. Mitchell1,2. 
1Ophthalmology, Centre for Vision Research, 
Sydney, Australia; 2University of Sydney, Sydney, 
Australia; 3Cardiology, Westmead Hospital, Sydney, 
Australia. 
5749 — A267 Associations Between Diabetic 
Retinopathy and Plasma Levels of High-
Sensitive C-Reactive Protein or Von Willebrand 
Factor in Long-Term Type 1 Diabetic Patients. 
Jakob Grauslund1A, J.V. Laursen1A, S.S. Hoffmann1A, 
A. Green1B, M. Nybo1C, A. Sjølie1A. AOphthalmology, 
BCentre for National Clinical Databases, South, 
CClinical Biochemistry and Pharmacology, 1Odense 
University Hospital, Odense, Denmark. 
5750 — A268 Sight impairment certification 
amongst patients attending diabetic retinopathy 
screening in East London. Tunde Peto1, R. 
Bourkiza1, M. Subash1, J. Da Costa1, D. Qatarneh1, 
C. Bunce2. 1NIHR Biomedical Research Centre 
for Ophthalmology, at Moorfields Eye Hospital 
NHS Foundation Trust and UCL Institute of 
Ophthalmology, London, United Kingdom; 2UCL 
Institute of Ophthalmology, London, United 
Kingdom. 
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Thursday – Posters – 5758 – 5781
5758 — A276 COMPAng1 Prevents Decreases 
in Visual Acuity and Retinal Thinning in the 
Diabetic Mouse. Judd M. Cahoon, H. Uehara, L. 
Luo, T.K. Olsen, T.R. Miya, V.R. Jessop, B.J. Archer, 
B.K. Ambati. Ophthalmology & Visual Sciences, 
University of Utah, Salt Lake City, UT. T 
5759 — A277 Angiopoietin-like Protein 
6 (ANGPTL6) has Angiogenic Activity on 
Retinal Endothelial Cells under High Glucose 
Concentrations. Hirotaka Yokouchi, T. Oshitari, S. 
Yamamoto. Ophthalmology, Chiba Univ Graduate 
School of Med, Chiba, Japan. 
5760 — A278 Role of Nrf2 in the regulation 
of diabetic retinopathy. Junsong Gong1, Z. Xu1, 
Y. Wei1, H. Huang1, C. Eberhart1, R. Thimmulapp2, 
S. Biswal2, E.J. Duh1. 1Wilmer Eye Institute, Johns 
Hopkins Univ School of Medicine, Baltimore, MD; 
2Bloomberg School of Public Health, Baltimore, MD. 
5761 — A279 Increased Oxygen Saturation 
In Retinal Vessels Of Patients With Diabetic 
Retinopathy Requiring Treatment. Christina M. 
Joergensen1, T. Bek1, S. Hardarson2. 1Department 
of Ophthalmology, Aarhus University Hospital, 
Aarhus C, Denmark; 2Department of Ophthalmology, 
University of Iceland/Landspítali, University 
Hospital, Reykjavik, Iceland. 
5762 — A280 Thioredoxin Interacting Protein 
Is Required For S-glutathionylation And 
Redox Regulation Of VEGF Angiogenic Signal. 
Mohammed A. Abdelsaid1,2, A.B. El-Remessy1,3. 1Clin 
& Experimental Therapeutics, University of Georgia, 
Augusta, GA; 2Georgia Health Science University, 
Vision Discovery Institute, Georgia Health Science 
University, GA; 3Vision Discovery Insititute, Georgia 
Health Science University, GA. 
5763 — A281 Polyamines Contribute to Diabetic 
Retinal Edema. Bruce A. Berkowitz1A, L. Hawel, 
III2, C. Byus2, D.P. Bissig3, R. Roberts1B. AAnatomy/
Cell Biol & Ophthal, BAnatomy & Cell Biol, 1Wayne 
State Univ Sch of Med, Detroit, MI; 2University of 
California, Riverside, Riverside, CA; 3Anatomy and 
Cell Biology, Wayne State Univ School of Med, 
Detroit, MI. 
5764 — A282 Overexpression of IL-1 Receptor 
Antagonist in the Rat Retina by AAV2-mediated 
Gene Transfer Prevents Capillary Loss in 
Experimental Diabetes. Chiara Gerhardinger1,2, Y. 
Liu1,2, Z. Dagher1. 1Schepens Eye Research Institute 
Massachusetts Eye and Ear, Boston, MA; 2Harvard 
Medical School, Boston, MA. 
5765 — A283 Lipoprotein-associated 
Phospholipase Inhibition Regulates Retinal 
Vasopermeability During Experimental Diabetes. 
Alan W. Stitt1, P. Canning1, P.J. Luthert2, J.V. Glenn1, 
L-D. Allen1, V. Prise1, P.S. Adamson3. 1Centre for 
Vision & Vascular Science, Queens University 
Belfast, Belfast, United Kingdom; 2Pathology, 
UCL Institute of Ophthalmology, London, United 
Kingdom; 3Ophthalmology Discovery Performance 
Unit, GlaxoSmithKline, Stevenage, United 
Kingdom.*CR 
5766 — A284 HFD-induced Retinal 
Microvascular Degeneration: Suggested Role Of 
Thioredoxin Interacting Protein (TXNIP). Islam 
N. Mohamed1,2A, S. Hafez1,2B, M. Abdelsaid1,2A, S. 
Matragoon1,2A, B. Pillai1,2A, A. Ergul1,2B, J.D. Imig3, 
A.B. El-Remessy1,2A. 1Clinical and Experimental 
Therapeutics, University of Georgia, Augusta, 
GA; AVision Discovery Institute, BPhysiology, 
2Georgia Health Sciences University, Augusta, GA; 
3Pharmacology and Toxicology, Medical College of 
Wisconsin, Milwaukee, WI. 
5767 — A285 Comparison of the Effect 
of Streptozotocin (STZ)-Induced Diabetic 
Retinopathy on the Early Electroretinogram 
(ERG) of Sprague Dawley and Long Evans Rats. 
Mark Vezina. Ocular And Neuroscience, Charles 
River Laboratories - Preclinical Services, Senneville, 
QC, Canada.*CR 
5768 — A286 Chemokine Mediated Monocyte 
Trafficking into the Retina: Role of Inflammation 
in Diabetic Retinopathy. Arup Das1A, S. 
Rangasamy1B, P. McGuire1B. AMSC10-5610 Surgery, 
BCell Biology & Physiology, 1Univ of New Mexico 
Sch of Med, Albuquerque, NM. 
5769 — A287 Neural And Vascular Gene 
Expression Changes In The Diabetic Rat Retina. 
Jennifer C. Lau1A, R.A. Linsenmeier1B, J.R. Moskal1C, 
R.A. Kroes1C. AChemical & Biological Engineering, 
BBiomedical Engineering and Neurobiology, CFalk 
Center for Molecular Therapeutics, 1Northwestern 
University, Evanston, IL. 
5770 — A288 Overexpression of ProNGF 
Induces Apoptosis and Acellular Capillary 
Formation Via Activation of P75NTR. Azza B. 
El-Remessy1, M.M. Al-Gayyar1, S. Matragoon1, 
H. Saragovi2. 1Clin & Experimental Therapeutics, 
University of Georgia, Augusta, GA; 2Pharmacology, 
McGill Univ - Jewish General Hosp, Montreal, QC, 
Canada. 
5771 — A289 Vitreous Biomarker Changes 
in the Progression from Nonproliferative to 
Proliferative Diabetic Retinopathy. Stephanie M. 
Ecker, A.O. Igbre, J.C. Hines, B.M. Glaser. Ocular 
Proteomics, The National Retina Institute, Towson, 
MD.*CR 
5772 — A290 Intravitreal Anti-vegf Therapy 
Blocks Inflammatory Cell Infiltration And 
Re-entry Into The Circulation In Retinal 
Angiogenesis. Shintaro Nakao1, M. Arima1, K. 
Ishikawa1, R. Kohno1, S. Kawahara1, M. Miyazaki1, 
S. Yoshida1, H. Enaida1, T. Kono2, T. Ishibashi1. 
1Department of Ophthalmology, Kyushu University, 
Fukuoka, Japan; 2Ophthalmology, Fukuoka 
University Chikushi Hospital, Chikushino, Japan. 
5773 — A291 Vascular Alteration And Lipids 
Accumulation In The Retina And Choroid Of 
Non-insulin-dependent Diabetic Goto-Kakizaki 
Rats. Elvire Vaucher1A, M. Pouliot1A, T.M. 
Boutin1A, O. Fontaine1A, R. Couture1B. AOptometry, 
BPhysiology, 1University of Montreal, Montreal, QC, 
Canada. 
5774 — A292 Endothelial Mesenchymal 
Transition in Human Diabetic Epiretinal Fibrosis. 
Ray Gariano1, L.L. Zheng2. 1Ophthalmology, Scripps 
Clinic, La Jolla, CA; 2Ophthalmology, Stanford 
University School of Medicine, Palo Alto, CA. 
5775 — A293 Similarities and differences of 
Bevacizumab and Ranibizumab in microvascular 
retinal endothelial cells. Gabriele E. Lang, H.L. 
Deissler. Department of Ophthalmology, University 
of Ulm, Ulm, Germany.*CR 
5776 — A294 Vulnerability Of The Retinal 
Microvasculature To Oxidative Stress: Ion 
Channel-dependent Mechanisms. Atsuko 
Nakaizumi1A, M. Fukumoto1A, D.G. Puro1A,1B. 
AOphthalmology & Visual Sciences, BMolecular & 
Integrative Physiology, 1University of Michigan, Ann 
Arbor, MI. 
5777 — A295 The Anti-inflammatory Receptor 
GPR109A Regulates Angiopoeitin-like-4 
(ANGPTL4) Expression in Retina: Potential New 
Link Between Regulation of Inflammatory and 
Angiogenic Signaling Mechanisms in Diabetic 
Retina. Deeksha Gambhir, S. Ananth, R. Veeranan-
Karmegam, J.P. Gnana Prakasam, V. Ganapathy, 
P.M. Martin. Biochemistry and Molecular Biology, 
Georgia Health Sciences University, Augusta, GA. 
5778 — A296 VEGF
165
B Prevents Tight 
Junctional Re-organisation In Retinal Pigmented 
Epithelial Cells Induced by VEGF
165
. Nikita Ved1, 
J.W. Bainbridge2, D.O. Bates1. 1School of Physiology 
and Pharmacology, University of Bristol, Bristol, 
United Kingdom; 2UCL Institute of Ophthalmology, 
London, United Kingdom. T 
5779 — A297 VEGF-A But Not PlGF Impairs 
Barrier Function Of Retinal Endothelial Cells. 
Heidrun L. Deissler, G.E. Lang. Department of 
Ophthalmology, University of Ulm Medical School, 
Ulm, Germany.*CR 
5780 — A298 Semaphorin 3A Promotes 
Vascular Leakage in Diabetic Retinopathy. Agustin 
Cerani, N. Tetreault, F. Binet, F. Rezende, N. Sitaras, 
E. Lapalme, S. Favret, F. Guimont-Desrochers, S. 
Lesage, P. Sapieha. Research Centre, Maisonneuve-
Rosemont Hospital, Montreal, QC, Canada. T 
5781 — A299 Adult Endothelial Progenitor Cell 
Populations: Functional Differences in Diabetic 
Retinopathy. Sergio Caballero, Jr.1, S. Hazra1, 
A. Bhatwadekar1, S. Li Calzi1, L.J. Paradisio2, L. 
Miller2, T.S. Kern3, M.B. Grant1. 1Pharmacology/
Therapeutics, University of Florida, Gainesville, FL; 
2America Stem Cell, Inc., Helotes, TX; 3Department 





















*Refer to Program Number in the Commercial Relationships (CR) Index for Disclosures   –   f Refer to Program Number in the Clinical Trial (CT) Registration Index  –   T Travel Grant Awardee
5797 — A351 Significant Compliance 
Improvement For Patients Lying Postoperatively 
In “Face-down-position” After Vitrectomy And 
Gas Tamponade. Henrik F. Schaefer, P. Singh, 
M. Koss, K. Frank. Retina department, Johann 
Wolfgang Goethe-University, Frankfurt am Main, 
Germany.*CR 
5798 — A352 The Effect Of Retinal 
Detachment On Retinal Oxygenation. 
Alexander Kyhnel, III1, S. Traustason1, J. Hajari1, 
J. Kiilgaard1, E. Stefánsson2, M. La cour1. 
1Ophtalmology, Glostrup University Hospital, 
Glostrup, Denmark; 2Department of Ophtalmology, 
Landspitali University Hospital, Reykjavík, Iceland. 
5799 — A353 Pockets of Subretinal Fluid 
after Retinal Reattachment Surgery: New 
Insights with SD-OCT. John B. Miller1, R.C. 
Rao2, N. Choudhry1, D.M. Wu3, G.K. Shah4, 
D. Vavvas1, S. Mukai1, D. Eliott1. 1Harvard 
Department of Ophthalmology, Massachusetts Eye 
and Ear Infirmary, Boston, MA; 2Department of 
Ophthalmology and Visual Sciences, Washington 
University School of Medicine/The Retina Institute, 
St. Louis, MO; 3Doheny Eye Institute, University 
of Southern California, Los Angeles, CA; 4Barnes 
Retina Institute, Town and Country, MO. 
5800 — A354 Macular Effects of Silicone Oil 
Tamponade: Optical Coherence Tomography 
Findings During and After Silicone Oil 
Removal. Danielle M. Lo, L. Olmos, A.A. Fawzi. 
Ophthalmology, Doheny Eye Institute, Keck School 
of Medicine, University of Southern Ca, CA. 
5801 — A355 Association between Fundus 
Autofluorescence with foveal microstructure 
and visual outcome after successful surgical 
detachment repair. Seung-Young Yu, J-S. Han, 
K-Y. Kim, H-W. Kwak. Ophthalmology, Kyung Hee 
University, Seoul, Republic of Korea. 
5802 — A356 Foveal Architectural Changes 
in Rhegmatogenous Retinal Detachment as 
Detected by Intraoperative Optical Coherence 
Tomography. Matthew P. Ohr, S. Srivastava, P. 
Kaiser, G. Smith, J.P. Ehlers. Ophthalmology, 
Cleveland Clinic, Cleveland, OH. 
5803 — A357 Investigation Of Subretinal 
Fibrosis In Rhegmatous Retinal Detachment 
With Spectral Domain Optical Coherence 
Tomography. Ping Hou, X. Mai, J. Zheng, H. Chen, 
W. Chen. Joint Shantou International Eye Center, 
Shantou, China. 
5804 — A358 Autofluorescence Image Intensity 
Segmentation And Analysis Of Macular 
Geometry Indices Against Microperimetry And 
Sdoct Ultra Structural Findings In Patients With 
Successfully Repaired Rhegmatogeneous Retinal 
Detachments. Marco F. Vieira1, M. Falcao2, P. 
Brito1, A. Sousa1, P. Faria1, N. Gomes1, E. Brandão1, 
F. Falcão-Reis1. 1Ophthalmology, Hospital S. Joao 
Porto, Porto, Portugal; 2Ophthalmology, Hospital S 
Joao, Porto, Portugal. 
5782 — A300 Loss of Neuronal Support to 
the Bone Marrow BM Promotes Increased 
Generation Of (C-C Motif) Receptor 2+ (CCR2+) 
Monocytes And Reduced Endothelial Progenitors 
Cells (EPC): Implications For Diabetic 
Retinopathy (DR) Pathogenesis. Maria B. Grant1, 
A. Bhatwadekar1, P. Hu2, S. Hazra1, S. Caballero1, 
S. Mohr3A, S.F. Abcouwer4, D.R. Saban5, T. Chan-
Ling6, J.V. Busik3B. 1Pharmacology and Therapeutics, 
University of Florida, Gainesville, FL; 2Department 
of Anatomy, University of Sydney, Camperdown, 
Australia; ADepartment of Physiology, BPhysiology, 
3Michigan State University, East Lansing, MI; 
4Ophthalmology & Visual Science, Univ of Michigan 
Kellog Eye Ctr, Ann Arbor, MI; 5Schepens Eye 
Research Institute, Harvard Medical School, Boston, 
MA; 6Anatomy, University of Sydney, Sydney, 
Australia. 
5783 — A301 Caspase-14: A Novel Caspase 
with Potential Role in Diabetic Retinopathy. 
Sylvia Megyerdi1A, S. Ahmad1A, S. Hsu1A, Z. Gurel2, 
E.S. Shin2, N. Sheibani2, M. Al-Shabrawey1A,1B. 
AOral Biology and Anatomy, BOphthalmology, 
1Georgia Health Sciences University, Augusta, GA; 
2Ophthalmology and Visual Sciences, University of 
Wisconsin, Madison, WI. 
Hall B/C A338-A370




5784 — A338 Primary Repair of 
Rhegmatogenous Retinal Detachment with 
23-Gauge Transconjonctival Vitrectomy. Ricardo 
Valdes1, O. Ramirez1, F. Ochoa2, J. Trujillo2. 1Clinica 
Ver Bien, Pereira, Risaralda, Colombia; 2Clinica Ver 
Bien, Armenia, Quindio, Colombia. 
5785 — A339 Two-Step Pneumatic Retinopexy 
with Intravitreal Gas Injection Followed 
by Next Day Laser Treatment for Repair of 
Rhegmatogenous Retinal Detachment. Oscar 
C. Kuruvilla, K. Kahook, H. Gao. Ophthalmology, 
Henry Ford Hospital, Detroit, MI. 
5786 — A340 The Outcome of vitrectomy for 
chronic diabetic tractional retinal detachment. 
Muneera A. Abunajma1, H.N. Al-Shamsi2, H. Al-
Dhibi2, N.G. Ghazi2. 1Ophthalmology Residency 
Program, King Saud University, Riyadh, Saudi 
Arabia; 2Vitroretina, King Khaled Eye Specialist 
Hospital, Riyadh, Saudi Arabia. 
5787 — A341 Evaluation of Retinectomy in 
the Treatment of Severe Retinal Detachment. 
Thais S. Mendes1, A.M. Gomes2, H.V. Passos1, 
A. Baptistella1. 1Ophthalmology, Suel Abujamra 
Institute, Sao Paulo, Brazil; 2Ophthalmology, 
University of Sao Paulo, Sao Paulo, Brazil. 
5788 — A342 Influence Of Intraocular 
Tamponade On Unintentional Retinal 
Displacement After Standard Vitrectomy 
For Reghmatogenous Retinal Detachment. 
Giovanni Fogliato, M. Codenotti, G. Maestranzi, 
U. De Benedetto, L. Iuliano, G. Querques, M. 
Prati, A. Ramoni, F. Bandello. Department of 
Ophthalmology, University Scientific Institute San 
Raffaele, Milan, Italy.*CR 
5789 — A343 Determining the Effect 
of Low-dose Isotretinoin on Proliferative 
Vitreoretinopathy. Nikolas J. London1, R.S. 
Kaiser1, R.A. Alshareef1, M. Khuthaila1, V.A. 
London2, O.P. Gupta1, J. Hsu1, J.F. Vander1,2, M.J. 
Spirn1, C.D. Regillo1. 1Retina Service, Wills Eye 
Institute, Philadelphia, PA; 2Family Dermatology, 
Philadelphia, PA. f 
5790 — A344 Sustained-release Intravitreal 
Dexamethasone As A Surgical Adjuvant In The 
Repair Of Complicated Retinal Detachment 
With Proliferative Vitreoretinopathy. Ryan W. 
Shultz, S. Bakri, R. Iezzi. Ophthalmology, Mayo 
Clinic, Rochester, MN. 
5791 — A345 Triamcinolone-Assisted Internal 
Limiting Membrane Peeling During Primary 
Rhegmatogenous Retinal Detachment Repair 
Reduces Postoperative Macular Pucker 
Formation. Rajesh C. Rao1, K.J. Blinder2, G.K. 
Shah2. 1Ophthalmology and Visual Sciences, 
Washington University School of Medicine, The 
Retina Institute, Saint Louis, MO; 2The Retina 
Institute, Saint Louis, MO. 
5792 — A346 Siluron 2000 Novel-Generation 
Silicone Oil: Proof of Concept and One 
Year Clinical Results. Theodor Stappler1, L. 
Konstantinidis1, D.S. Wong2. 1St Paul’s Eye Unit, 
Royal Liverpool University Hospital, Liverpool, 
United Kingdom; 2The Eye Institute, The University 
of Hong Kong, Hong Kong. 
5793 — A347 Air as Tamponade for Retinal 
Detachments. Aranzazu Mateo Montoya1, 
M.D. de Smet2. 1Clinique de Montchoisi 
(Lausanne, Switzerland), Lausanne, Switzerland; 
2Ophthalmology, Clinique de Montchoisi, Lausanne, 
Switzerland. 
5794 — A348 Extramacular-hole Drainage 
Of Subretinal Fluid In Macular Hole Retinal 
Detachment. Ji Eun E. Lee, H. Jeon, I. Byon, S. 
Park, B. Oum. Ophthalmology, Pusan National 
Univ Hospital, Busan, Republic of Korea. 
5795 — A349 Hole Position In Rhegmatogenous 
Retinal Detachment: A Analysis Of Mustard, 
A Retrospective Interventional Case Series Of 
4325 Participants In Relation To The Lincoff-
rules”. Ulrich Thelen1, H. Gerding2. 1Private 
Practice, Munster, Germany; 2Clinic Pallas, Olten, 
Switzerland. 
5796 — A350 Retinal Detachment from 
Guttering also a Problem after Vitrectomy. 
Milad Hakimbashi1, P. Amini1, A. Khatibi1, M.H. 
Goldbaum2. 1Ophthalmology, Univ of California, 
San Diego, La Jolla, CA; 2Ophthalmology, Univ of 
California-San Diego, La Jolla, CA. 
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5805 — A359 Predictive Oct Findings To Pre- 
And Postoperative Visual Acuity In Macular-off 
Rhegmatogenous Retinal Detachment. Yukitoshi 
Shimoda, S. Kishi. Department of Ophthalmology, 
Gunma Univ School of Med, Maebashi City, Japan. 
5806 — A360 Retinal Cell Layer Measurements 
in Patients After Successful Macula-off Retinal 
Detachment Repair and in Healthy Controls 
using a new OCT Sub-segmentation Algorithm. 
Marcel N. Menke1, J.H. Kowal2, P. Dufour2, U.E. 
Wolf-Schnurrbusch1, L. Ceklic1, S. Wolf1. 1Dept 
of Ophthalmology, University of Bern, Bern, 
Switzerland; 2Ophthalmic Technologies, ARTORG 
Center, Bern, Switzerland. 
5807 — A361 Foveal Thickness After Surgery 
In Eyes With Retinal Detachment. gaku 
terauchi1, C.S. Matsumoto2,3, E. Watanabe2, K. 
Shinoda2, H. Matsumoto3, T. Kondo4,5, A. Mizota2. 
1Ophthalmology, Teikyo University School of 
Medicine, Tokyo, Japan; 2Ophthalmology, Teikyo 
University, Itabashi-ku, Japan; 3Matsumoto Eye 
Clinic, Tokushima, Japan; 4Teikyo University, Tokyo, 
Japan; 5Ophthalmology, University Of West Verginia, 
Morgantown, WV. 
5808 — A362 Retinal Detachment Caused 
By Giant Retinal Tears: Etiologies, Techniques 
and Outcomes. Marco A. Gonzalez, H. Flynn. 
Ophthalmology, Bascom Palmer Eye Institute, 
Miami, FL. 
5809 — A363 Prognosis Factors Of 
Rhegmatogenous Retinal Detachments Associated 
With Giant Tear. Mounir Benzerroug1, B. 
Chanaoui2, O. Genevois2, G. Brasseur2, S. Milazzo1, 
M. Muraine2. 1Ophthalmology, Amiens University 
Hospital, Amiens, France; 2Ophthalmology, Rouen 
University Hospital, Rouen, France. 
5810 — A364 Retinal Detachment after 
Resident-performed Cataract Surgery. Tidarat 
Prechanond, M. Lee, M.L. Trinidad, A. Khatibi, T.C. 
Porco, A. Naseri, J.M. Stewart. Ophthalmology, 
University of California, San Francisco, San 
Francisco, CA. 
5811 — A365 Characteristics and Outcomes of 
Rhegmategenous Retinal Detachment in Stickler 
Syndrome at a Tertiary Eye Care Center in Saudi 
Arabia. Saeed T. Alshahrani1A, S. Alrashaed1B, N.G. 
Ghazi1B. AOphthalmology, BVitreo/Retinal, 1King 
Khaled Eye Specialist Hospital, Riyadh, Saudi 
Arabia. 
5812 — A366 Retinal Detachment In Coats’ 
Disease In Infants. Emmanuel L. Bui Quoc1, 
G. Dethorey1, E. Costantini2, I. Ingster-Moati3. 
1Ophthalmology, Hospital Robert Debre, Montrouge, 
France; 2Service 5, CHNO des 15-20, Paris, France; 
3Ophthalmology, Univ Paris 7 Diderot, Hopital 
Necker, Paris, France. 
5813 — A367 Use of Silicone Oil for Complex 
Retinal Detachment in Pediatric Population. 
Krishnapriya kalyam1, P. Emani2, D. Shah2, 
K. Gorukanti1, M.A. Zarbin3, N. Bhagat4. 
1Ophthalmology, Robert Wood Johnson Medical 
School, Piscataway, NJ; 2Ophthalmology, New 
Jersey Medical School, Newark, NJ; 3Ophthalmology 
& Visual Science, UMDNJ-New Jersey Medical 
School, Newark, NJ; 4Ophthalmology, IOVS-New 
Jersey Med School, Newark, NJ. 
5814 — A368 Outcomes and Complications of 
Silicone Oil Use in Pediatric Eyes for Complex 
Retinal Detachment Repair After Open Globe 
Injuries. Dipal P. Shah, P. Kalyam, P. Emami-
Naeini, M. Zarbin, N. Bhagat. The Institute of 
Ophthalmology & Visual Science, New Jersey 
Medical School, Newark, NJ. 
5815 — A369 Outcomes of Optic Nerve Pit-
related Maculopathy: a Case Series from the 
Wills Eye Institute. Adiel G. Smith, R.E. Shah, J. 
Hsu, G.C. Brown, C.D. Regillo, A. Sivalingum, J.I. 
Maguire, M.J. Spirn. Ophthalmology, Wills Eye 
Institute, Philadelphia, PA. 
5816 — A370 Coats disease in Saudi 
Arabia. Abdullah A. Alqahtani1, N.G. Ghazi2. 
1Ophthalmology, Dammam University, Dhahran, 
Saudi Arabia; 2Retina, KKESH, Riyadh, Saudi 
Arabia. 
Hall B/C A437-A469






5817 — A437 Laser Mediated Activation 
Of Human Retinal Pigment Epithelial (rpe) 
Cells And Concomitant Release Of Matrix 
Metalloproteinases (mmps). JinJun Zhang, A. 
Hussain, J. Marshall. GENETIC, UCL Institute of 
Opthalmology, London, United Kingdom. 
5818 — A438 In vivo Retinal Laser Lesion 
Formation with Simultaneous Adaptive 
Optics Enhanced Confocal Scanning Laser 
Ophthalmoscope (AOcSLO) and Spectral Domain 
Optical Coherence Imaging (AO-SDOCT). 
Ginger M. Pocock1,2, J.W. Oliver1, C.A. Harbert1, 
G.D. Noojin1, K.J. Schuster1, A. Shingledecker1, D.J. 
Stolarksi1. 1Air Force Research Laboratory, Fort 
Sam Houston, TX; 2Biomedical Engineering, The 
University of Texas at Austin, Austin, TX. 
5819 — A439 PASCAL(PAttern SCAnning 
Laser) Photocoagulator: Evolution Of Size 
In Photocoagulation Scars. Cyril Temstet, F. 
Fajnkuchen, V. Sarda, C. Khamari, S. Nghiem-
Buffet, R. Nicolau, T. Grenet, G. Chaine. Department 
of Ophthalmology, Avicenne Hospital, Paris XIII 
University, Bobigny, France. 
Thursday – Posters – 5805 – 5827
5820 — A440 Laser Titration Algorithm For 
Minimally-traumatic, Sub-visible And Sub-lethal 
Retinal Phototherapies. Daniel Lavinsky1A,1B, C. 
Sramek2, Y. Mandel1A,1B, P. Huie1A, D.V. Palanker1A,1B. 
AOphthalmology, BHansen Experimental Physics 
Laboratory, 1Stanford University, Stanford, CA; 
2Topcon Medical Laser Systems, Santa Clara, 
CA.*CR 
5821 — A441 Development Of A Simulated 
Model For Battlefield Retinal Laser Injury. 
Sher A. Aslam1, M. Singh1, P. Charbel Issa1, W. 
Davies1, M. McClements1, R. Scott2, R.E. MacLaren1. 
1Nuffield Laboratory of Ophthalmology, University 
of Oxford, Oxford, United Kingdom; 2Royal Centre 
for Defence Medicine Institute of Research & 
Development, Birmingham, United Kingdom. 
5822 — A442 The Pattern Scan Yellow Laser: 
Evaluation Of Efficacy And Safety. Kaori 
Nishikawa, M. Nozaki, T. Mizutani, M. Yoshida, Y. 
Ogura. Department of Ophthalmology, Nagoya City 
Univ Medical School, Nagoya, Japan. 
5823 — A443 Image Guided Navigated 
Retinal Laser Treatments Using Multiple 
Image Modalities. Igor Kozak1, J. Chhablani2, 
G. Barteselli1, D-U.G. Bartsch3, W.R. Freeman4. 
1Ophthalmology, University of California San Diego, 
La Jolla, CA; 2Ophthalmology, Shiley Eye Center, 
UCSD, La Jolla, CA; 3Ophthalmology, Univ of 
California-San Diego, La Jolla, CA; 4Ophthalmology, 
UCSD Jacobs Retina Center, La Jolla, CA.*CR 
5824 — A444 Nd-yag Laser Arteriotomy For 
Central Retinal Artery Occlusion (crao). Clayton 
Scanlon1, M. Currie1, A. Grant2, E.N. Cetin1, L. 
Akduman1. 1Ophthalmology, Saint Louis University 
Eye Institute, Saint Louis, MO; 2Ophthalmology, 
Washington University, Saint Louis, MO.*CR 
5825 — A445 Effects of LMP7 Subunit 
Knockout Immunoproteasome on the Laser-
Induced Chorioretinal Neovascular Model 
in Mice. Justin C. Kohl1, A.A. Rageh1, D.A. 
Ferrington1A, S.R. Montezuma1A. AOphthalmology, 
1University of Minnesota, Minneapolis, MN. 
5826 — A446 Impact of Endothelium-
specific NFκ-B Signaling on Choroidal 
Neovascularization. Souska Zandi1,2, S. Nakao3, D. 
Sun4, R. Schmidt-Ullrich5, A. Schering1, F. Hafezi2, 
A. Hafezi-Moghadam1. 1Radiology, Brigham and 
Women’s Hospital, Harvard Medical School, Boston, 
MA; 2Ophthalmology, Geneva University Hospitals, 
Geneva, Switzerland; 3Ophthalmology, Kyushu 
University, Fukuoka, Japan; 4Ophthalmology, The 
Second Hosp of Harbin Med Univ, Harbin, China; 
5Signal Transduction in Tumor Cells, Max-Delbrück-
Center for Molecular Medicine, Berlin, Germany. 
5827 — A447 An Angiogenic Role Of 
Adrenomedullin In Choroidal Neovascularization. 
Susumu Sakimoto1, M. Kamei1, H. Kidoya2, H. 
Naito2, N. Matsumura1, M. Suzuki1, H. Sakaguchi1, 
N. Takakura2, K. Nishida1. 1Ophthalmology, Osaka 
University Graduate School of Medicine, Suita, 
Japan; 2Signal Transduction, Research Institute for 
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5843 — A463 Adipose derived Mesenchymal 
stem cells partially rescue the Mitomycin C 
treated ARPE19 from cell death in co-culture. 
Jose-Carlos Pastor, A.K. Singh, G.K. Srivastava, 
D. Rodríguez, M. García-Gutierrez. IOBA-Campus 
Miguel Delibes, University of Valladolid, Valladolid, 
Spain. 
5844 — A464 Repeated Ab-Externo 
Catheterization of the Sub-retinal Space Using 
a Microcatheter for Targeted Delivery of a 
Cell Therapy Product in a Pig Model. Marc D. 
de Smet1, S. Wyse2, M. Vezina2, S. Conston3, C. 
Sachs4, S.H. Popma4. 1Ophthalmology, Clinique de 
Montchoisi, Lausanne, Switzerland; 2Preclinical 
Services, Charles River Laboratories, Montreal, QC, 
Canada; 3iScience Interventional, Menlo Park, CA; 
4Janssen Pharmaceuticals Companies of Johnson & 
Johnson, Radnor, PA.*CR 
5845 — A465 Correlation Of The Detection 
Of Blood Flow In An RPE-choroid Graft 
With Phase-resolved Doppler OFDI, With The 
Revascularization Steps Found On SD-OCT. 
Elsbeth J. Van Zeeburg1,2, B. Braaf2, M.G. Cereda1, 
J.C. van Meurs1,3, J.F. de Boer4,2. 1The Rotterdam Eye 
Hospital, Rotterdam, The Netherlands; 2Rotterdam 
Ophthalmic Institute, Rotterdam, The Netherlands; 
3Erasmus MC, Universtiy Medical Center, 
Rotterdam, The Netherlands; 4: Institute for Lasers, 
Life and Biophotonics Amsterdam, Department of 
Physics and Astronomy, VU University, Amsterdam, 
The Netherlands.*CR 
5846 — A466 Case Series of Central Serous 
Chorioretinopathy (CSR) Treated with the Novel 
Navilas Navigated Laser System. Ravi Menghani, 
S. Lu. Ophthalmology, UCI Gavin Herbert Eye 
Institute, Orange, CA. 
5847 — A467 Efficient Transfection and 
Genomic Integration of the PEDF Gene into a 
Limited Number of Primary IPE Cells. Gabriele 
Thumann, N. Harmening, A. Dobias, S. Johnen. 
Department of Ophthalmology, RWTH Aachen 
University, Aachen, Germany. 
5848 — A468 Autologous Bruch’s Membrane 
Rotation As A Potential Adjunct To Retinal 
Pigment Epithelium Cell Replacement Therapy 
For Age Related Macular Degeneration. Mandeep 
S. Singh1,2, E.J. Lee2, H.E. Jones2, B. Ahmed2, 
I.M. Andolina2, P.M. Munro2, K.L. Grieve3, G.W. 
Aylward2, A.M. Sillito2, R.E. MacLaren1,2. 1University 
of Oxford & Oxford Eye Hospital NIHR Biomedical 
Research Centre, Oxford, United Kingdom; 2UCL 
Institute of Ophthalmology & Moorfields Eye 
Hospital NIHR Biomedical Research Centre, 
London, United Kingdom; 3Faculty of Life Sciences, 
University of Manchester, Manchester, United 
Kingdom. 
5828 — A448 Implication of GPx4 in Choroidal 
Neovascularization. Murilo F. Roggia1, T. Ueta1, 
I. Hirotaka2, T. Inoue1, Y. Tamaki1, Y. Yanagi1. 
1Ophthalmology, University of Tokyo, Tokyo, Japan; 
2Pharmaceutical Sciences, Kitasato University, 
Tokyo, Japan. 
5829 — A449 Different Mechanisms in 
Regulation of Laser Induced CNV by Arresten. 
Sudhakar A. Yakkanti1, V. Gunda2, R.K. Verma2, C.S. 
Boosani2. 1Genetics/ Retinal Cell Signaling, Boys 
Town Natl Res Hospital, Omaha, NE; 2Genetics, 
Boys Town Nt’l Research Hosp, Omaha, NE. 
5830 — A450 Topical NPD1 Promotes 
Microglia Ramification in Experimental CNV. 
Kristopher G. Sheets1A, W.C. Gordon1B, N.G. 
Bazan1B. ANeuroscience Center, BOphthalmology & 
Neuroscience Center, 1LSU Health Sciences Center, 
New Orleans, LA. 
5831 — A451 Selective Cre/lox Flt-1 Ablation In 
RPE Induces CNV: A Novel Transgenic Murine 
CNV Model. Ling Luo1,2, T. Olsen1, X. Zhang1, S. 
Das1, H. Uehara1, N. Singh1, T. Miya1, B. Archer1, 
Y.Z. Le3, B.K. Ambati1. 1Moran Eye Center, Salt Lake 
City, UT; 2Department of Ophthalmology, The 306th 
Hospital of PLA, Beijing, China; 3Department of 
Medicine and Harold Hamm Oklahoma Diabetes 
Center, University of Oklahoma Health Sciences 
Center, Oklahoma City, OK. 
5832 — A452 Ikk2 Inhibition Attenuates The 
Laser Induced Choroidal Neovascularization. 
Qiutang Li, H. Lu, W. Wang, Q. Lu, H.J. Kaplan. 
Ophthal & Vis Science, University of Louisville, 
Louisville, KY. 
5833 — A453 Inhibitory Effect oF CXCR4 
Inhibitor (AMD3100) Combined with Anti-
VEGF Antibody on Laser-induce Experimental 
Choroidal Neovascularization. Wenqiu wang, F. 
Wang, X. Sun. Shanghai Key Laboratory of Ocular 
Fundus, Shanghai First People’s Hospital, Shanghai, 
China. 
5834 — A454 Proton Beam Irradiation for 
Choroidal Neovascularization: Long-term 
Prevalence of Radiation Retinopathy. Rachel M. 
Huckfeldt, E. Shildkrot, A. Lane, E. Gragoudas, 
J.W. Miller. Retina Service, Department of 
Ophthalmology, Massachusetts Eye and Ear 
Infirmary and Harvard Medical School, Boston, MA. 
5835 — A455 Long Term Results of 
Photodynamic Therapy in Patients With 
Choroidal Neovascularization Secondary to Age 
Related Macular Degeneration. Anuj Chawla1, 
J.T. Thompson2, R.J. Sjaarda2. 1Ophthalmology, 
University of Maryland, Baltimore, MD; 
2Ophthalmology, Retina Specialist, Baltimore, 
MD.*CR 
5836 — A456 Functional Recovery After 
Experimental RPE Debridement, mfERG 
Studies in a Porcine Model. Jens F. Kiilgaard1,2, 
N. Sørensen2, M.V. Kyhn2, N. Lassota3, J.U. Prause3, 
M.D. de la Cour2. 1Dept of Ophthalmology, 
Rigshospitalet, Copenhagen, Denmark; 2Dept. 
of Ophthalmology, Glostrup Copenhagen Univ. 
Hospital, Glostrup, Denmark; 3Eye Pathology Inst, 
Copenhangen University, Copenhagen, Denmark. 
5837 — A457 RPE Tears: An in silico 
Perspective. Garth G. Whelan, A. Shirinifard, 
J.A. Glazier. Physics, Biocomplexity Institute, 
Bloomington, IN. 
5838 — A458 Transplantation of Human ESC-
derived RPE into Rodent Models of Retinal 
Degeneration. Madalena Carido1, Y. Zhu1, B. 
Benkner2, T. Kurth1, T. Munch2, E. Tanaka1, M. 
Ader1. 1Center for Regenerative Therapies Dresden, 
Dresden, Germany; 2Werner Reichardt Center for 
Integrative Neuroscience, Tubingen, Germany. 
5839 — A459 Transplantation of Human 
Embryonic Stem Cell-Derived Retinal Cells into 
the Subretinal Space of a Non-Human Primate. 
Jennifer R. Chao1A, D.A. Lamba2, T. Klesert1, K. 
Sternhagen1A, R. Taylor1A, A. Yanagida1A, M. Neitz1A, 
J. Neitz3, R.K. Wang1B, T.A. Reh1C. AOphthalmology, 
BBioengineering, CDept of Biological Structure, 
1University of Washington, Seattle, WA; 2Buck 
Institute for Research on Aging, Novato, CA; 
3Ophthalmology, Univ of Washington, Medical 
School, Seattle, WA.*CR 
5840 — A460 Characteristics Of Rat Iris 
Pigment Epithelial Cells Cultured On Modified 
Expanded-polytetrafluroethylene (ePTFE) 
Substrates. Shen Nian1A, C.M. Sheridan2, V. Kearns2, 
R. Williams2, D. Wong1A, K. Vasilev3, A. Bachhuka3, 
A.C. Lo1A,1B, W.W. Lai1A. AEye Institute, BResearch 
Centre of Heart, Brain, Hormone and Healthy 
Aging, 1The University of Hong Kong, Hong Kong, 
Hong Kong; 2Eye and Vision Science, University of 
Liverpool, Liverpool, United Kingdom; 3Mawson 
Institute and School of Advanced Manufacturing, 
University of South Australia, Mawson Lakes, 
Australia. 
5841 — A461 Cell-based Therapy In A Mouse 
Model Of Leber Congenital Amaurosis. Yi-Sheng 
Chang1,2, W. McIntosh Ambrose1, C. Lin1, H. Qian1, T. 
Li1, T. Cogliati1, A. Swaroop1. 1National Eye Institute, 
National Institutes of Health, Bethesda, MD; 
2Department of Ophthalmology, National Cheng 
Kung University, Tainan, Taiwan. 
5842 — A462 Long-term Outcome Following 
270-degree Retinotomy And Autologous 
Retinal Pigment Epithelium Choroid Graft In 
Patients With Neovascular Age-related Macular 
Degeneration. Gernot Roessler, A.W. Weinberger, T. 
Hirsch, N. Plange, B.A. Mazinani, P. Walter. Dept of 
Ophthalmology, RWTH Aachen University, Aachen, 
Germany. 
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5849 — A469 Ips-derived Rpe Demonstrate 
Both Trophic Rescue And Functional 
Phagocytosis Of Photoreceptor Outer Segments 
Following Implantation In Diseased Rat Eyes. 
David F. Friedlander1A, P.D. Westenskow1A, T. 
Kurihara1A, J. Wang1B, A.L. Dorsey1A, S. Bravo1A, G. 
Siuzdak1B, M. Friedlander1A. ACell Biology, BCenter 
for Metabolomics, 1The Scripps Research Institute, 
La Jolla, CA. 
Hall B/C A470-A512




5850 — A470 The Utility of Large Spot 
Binocular Indirect Laser Delivery for Peripheral 
Photocoagulation Therapy in Children. Saranya 
C. Balasubramaniam, B.G. Mohney, G.M. Bang, 
T.P. Link, J.S. Pulido. Mayo Clinic, Rochester, 
MN. f 
5851 — A471 Earlier Laser Treatment Of 
Retinopathy of Prematurity Could Reduce 
Need For Vitrectomy. Joo Eun Lee1, S. Jea2, I. 
Yun3. 1Ophthalmology, Haeundae Paik Hospital, 
Inje University, Busan, Republic of Korea; 
2Ophthalmology, GM St. Mary’s Eye Center, Busan, 
Republic of Korea; 3Ophthalmology, Busan Paik 
Hospital, Inje University College of Medicine, 
Busan, Republic of Korea. 
5852 — A472 Late Occurrence of Narrow 
Angles and Angle Closure Glaucoma in Patients 
with Treated Retinopathy of Prematurity. Paul 
Baciu1, T.N. Szymarek2, C.S. Teitelbaum3,4, W.W. 
Merriam3,4, S.W. Merriam3,4, J.S. Weizer2, J.D. 
Stein2, S.M. Archer2, S.E. Moroi2. 1University 
of Michigan Medical School, Ann Arbor, MI; 
2Ophthalmology & Visual Sciences, Univ of 
Michigan-Kellogg Eye Ctr, Ann Arbor, MI; 
3Department of Ophthalmology, SUNY Upstate 
Medical University, Syracuse, NY; 4Crouse 
Hospital, Syracuse, NY. 
5853 — A473 Long-term Follow-up Of The 
Adults With Retinopathy Of Prematurity Who 
Received Photocoagulation And Cryopexy 
Treatments. Hiroki Kaneko1,2, C. Fujioka1, R. 
Furuhashi1. 1Ophthalmology, Yokkaichi Municipal 
Hospital, Yokkaichi, Japan; 2Ophtahlmology, 
Nagoya University Graduate School of Medicine, 
Nagoya, Japan. 
5854 — A474 Refractive Error and Ocular 
Biometry in Patients with a History of 
Retinopathy of Prematurity. Susan E. Yanni1, 
J.N. Leffler2, E.E. Birch1,3. 1Retina Foundation of 
the Southwest, Dallas, TX; 2Children’s Eye Care 
of North Texas, Plano, TX; 3Ophthalmology, 
University of Texas Southwestern Medical Center, 
Dallas, TX. T 
5855 — A475 Anti-vegf In Rop Treatment - 5,5 
Years Of Experience. Susana M. teixeira1A,1B, C.M. 
Santos1A, F.C. Silva1A, G. Pires1A, R. Barroso1A. 
AOphthalmology, BOphthalmology Department, 
1Hospital Professor Doutor Fernando Fonseca, 
Lisbon, Portugal. 
5856 — A476 Anti-VEGF Agents in 
Retinopathy of Prematurity (ROP): Results of 
a Utilization Survey and Recommendations for 
the Consent Process. Kamiar Mireskandari, M. 
Collins, N. Najm-Tehrani. Dept of Ophthalmology 
& Vis Sci, Hospital for Sick Children, Toronto, ON, 
Canada. 
5857 — A477 Comparison of Short Term 
Outcomes After Intravitreal Bevacizumab 
Versus Ranibizumab in the Treatment of Stage 3 
Retinopathy of Prematurity. Jose Luis Guerrero-
Naranjo1, F. Schoonewolff2, J.J. Fromow-Guerra3, 
V. Morales-Canton4, G. Garcia-Aguirre5, H. 
Quiroz-Mercado6, M.A. Martinez-Castellanos7. 
1Retina, Asoc Para Evitar la Ceguera en Mexico, 
Mexico City, Mexico; 2Retina, Asoc Para Evitar 
la Ceguera en Mexico, Mexico, Mexico; 3Retina, 
Association Para Evitar la Ceguera, Mexico City, 
Mexico; 4Retina, Assoc para Evitar la Ceguera, 
Mexico, Mexico; 5Retina, Asoc Para Evitar la 
Ceguera, Mexico City, Mexico; 6Ophthalmology, 
Denver Health Medical Center, Denver, CO; 7Retina 
and Vitreous, Asociacion Para Evitar la Ceguera, 
Mexico, Mexico. f 
5858 — A478 Structural Outcome Of 
Intravitreal Injection Of Bevacizumab For 
Type I Rop Compared To Conventional Laser 
Treatment. Antonio Baldascino1A, D. Lepore1A, 
F. Molle1A, P. Papacci1B, C. Giannantonio1B, V. 
Purcaro1B, L. Orazi1A, P. Perrini1A, A. Molisso1B, 
C. Romagnoli1B. AOphthalmology, BPediatrics, 
1Catholic University of the Sacred Heart, Rome, 
Italy. f 
5859 — A479 Evaluation of the Effects of 
Intravitreal Injection of Bevacizumab on 
Controlateral Eye Treated with Conventional 
Laser Photoablation. Fernando Molle1A, D. 
Lepore1A, A. Baldascino1A, P. Perrini1A, L. Orazi1A, 
M.M. Pagliara1A, V. Purcaro1B, C. Giannatonio1B, 
P. Papacci1B, C. Romagnoli1B. AOphthalmology, 
BPediatrics, 1Catholic University of the Sacred 
Heart, Rome, Italy. f 
5860 — A480 Fluorangiographic Study of 
Retinal and Choroideal Vasculature in a Preterm 
Population. Domenico Lepore, M.M. Pagliara, 
A. Baldascino, L. Orazi, S. Luceri, P. Perrini, G. 
D’Amico, C. Angora, F. Lafranceschina, F. Molle. 
Ophthalmology, Catholic University of the Sacred 
Heart, Rome, Italy. 
Thursday – Posters – 5849 – 5866
5861 — A481 Fluorescein angiographic 
findings in spontaneously-regressing stage 1 or 
2 retinopathy of prematurity. Andrea Portilla 
Demichelis1, F. Schoonewolff2, M.F. Chiang3, R. 
Bollens4, H. Winninghoff4, J. Hernandez-Vargas1, 
V. Morales-Canton5, M. Martinez Castellanos1, 
A.I. Ortiz6. 1Asociacion para Evitar la Ceguera en 
Mexico, IAP., Col. Barrio San Lucas, Coyoacan, 
Mexico; 2Retina, Asoc Para Evitar la Ceguera en 
Mexico, Mexico, Mexico; 3Ophthalmology and 
Medical Informatics, Casey Eye Institute, Oregon 
Health & Science University, Portland, OR; 
4Pomona College, Claremont, CA; 5Retina, Assoc 
para Evitar la Ceguera, Mexico, Mexico; 6Retina- 
Col San Lucas Coyoacan, APEC, Mexico City, 
Mexico.*CR 
5862 — A482 Lack of peripheral retinal 
vascularization after infancy in Retinopathy of 
Prematurity (ROP) and Incontinentia Pigmenti 
(IP). William S. Tasman. Ophthalmology, Wills Eye 
Institute, Philadelphia, PA. 
5863 — A483 Fluorescein Angiography 
Macular Abnormalities Assessed by Optical 
Coherence Tomography in Retinopathy of 
Prematurity. Fernando Schoonewolff1, V.E. 
Giordano2, V. Morales-Canton3, R.V. Chan4, H. 
Quiroz-Mercado5, M.A. Martinez-Castellanos6. 
1Retina, Asociación Para Evitar la Ceguera en 
México, Mexico, Mexico; 2Retina, Asoc Para Evitar 
la Ceguera en Mexico, Distrito Federal, Mexico; 
3Retina, Assoc para Evitar la Ceguera, Mexico, 
Mexico; 4Ophthalmology, Weill Cornell Medical 
College, New York, NY; 5Ophthalmology, Denver 
Health Medical Center, Denver, CO; 6Retina and 
Vitreous, Asociacion Para Evitar la Ceguera, 
Mexico, Mexico. f 
5864 — A484 New method of analysis of 
tortuosity of retinal vessels in Retinopathy 
of Prematurity. Alfredo reibaldi1, A. Scuderi1, 
A. Longo1, L.M. Franco1, A. Russo1, F. Munno1, 
V. Villari2, A. Cantavenera1, M. Reibaldi1. 
1Ophthalmology, University of Catania, Catania, 
Italy; 2Institute for Physical and Chemical 
Processes, CNR-IPCF, Messina, Italy. 
5865 — A485 Plus Disease Diagnosis In 
Retinopathy Of Prematurity: Vascular Tortuosity 
As A Function Of Distance From Optic Disc 
Center. Katie M. Keck1A, J. Kalpathy-Cramer2, E. 
Ataer-Cansizoglu3, S. You3, D. Erdogmus3, M.F. 
Chiang1A,1B. AOphthalmology, BMedical Informatics, 
1Oregon Health & Science University, Portland, 
OR; 2Radiology, Massachusetts General Hospital, 
Boston, MA; 3Electrical and Computer Engineering, 
Northeastern University, Boston, MA.*CR 
5866 — A486 Aggressive posterior retinopathy 
of prematurity: Quantitative analysis of vascular 
features. Rany Woo1, R.V. Chan2, M. Martinez-
Perez3, M.F. Chiang4. 1Yale School of Medicine, 
New Haven, CT; 2Ophthalmology, Weill Cornell 
Medical College, New York, NY; 3Department of 
Computer Science, Institute of Research in Applied 
Mathematics and Systems, UNAM, Mexico City, 
Mexico; 4Ophthalmology and Medical Informatics, 
Casey Eye Institute, Oregon Health & Science 
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5881 — A501 Telemedicine Screening for 
Retinopathy of Prematurity (ROP): Three 
years experience in Ontario, Canada. Nasrin N. 
Tehrani. Ophthalmology, The Hospital for Sick 
Children, Toronto, ON, Canada. 
5882 — A502 Arginase 2 Deficiency Limits 
Microglia/Macrophage Activation and Prevents 
Hyperoxia-induced Vascular Injury in the Mouse 
Retina. Jutamas Suwanpradid1A, Z. Xu1A, S.P. 
Narayanan1A, R.W. Caldwell1B, R.B. Caldwell1A,2. 
AVascular Biology Center, BDepartment of 
Pharmacology and Toxicology, 1Georgia Health 
Sciences University, Augusta, GA; 2VA Medical 
Center, Augusta, GA. 
5883 — A503 Genetic Deletion or 
Pharmacological Inhibition of Aldose Reductase 
Protects the Retina in a Mouse Model of 
Ischemia-induced Retinopathy. Zhongjie Fu1A, 
S-Y. Li1A, S. Chung1B,1C, D. Wong1A, A.C. Lo1A,1C. AEye 
Institute, BAnatomy, CResearch Center of Heart, 
Brain, Hormone and Healthy Aging, 1The University 
of Hong Kong, Hong Kong, Hong Kong. 
5884 — A504 Systemic Safety After Intravitreal 
Bevacizumab Injection In Newborn Rabbit Eyes. 
Wei-Chi Wu, C-C. Lai. Ophthalmology, Chang Gung 
Memorial Hosp, Taoyuan, Taiwan. 
5885 — A505 Spectral Domain Optical 
Coherence Tomography (SDOCT) Findings in 
a Mouse Model of Retinopathy of Prematurity. 
Felix Y. Chau1A, O.J. Mezu-Ndubuisi1B, N.M. Reddy1B, 
J. Wanek1A, P-Y. Teng1A, N.P. Blair1A, S.P. Reddy1B, 
M. Shahidi1A. AOphthalmology & Visual Sciences, 
BPediatrics, 1University of Illinois at Chicago - UIC, 
Chicago, IL. 
5886 — A506 Dark Rearing (DR) as a means of 
mimicking ‘Physiological Hypoxia’: A rationale 
for non-invasive treatment of Retinopathy of 
Prematurity. Samuel J. Adamson1, P. Kozulin2, R. 
Maccarone3, S. Yun1, P. Hu1, S. Bisti3, J. Provis2, M.C. 
Madigan4, J. McColm1, T. Chan-Ling1. 1Department 
of Anatomy & Histology, The University of Sydney, 
Sydney, Australia; 2ARC Centre of Excellence In 
Vision Science, Australian National University, 
Canberra, Australia; 3Biomedical & Science 
Technology, University of L’Aquila, L’Aquila, Italy; 
4School of Optometry & Vision Science, University 
of NSW, Sydney, Australia. 
5887 — A507 Role of the Krebs Cycle 
Metabolites in Retinal Angiogenesis: Implication 
of α-KG and its Receptor GPR99. Francois 
Duhamel1, S. Tremblay1, K. Zaniolo1, P. Sapieha2, 
S. Chemtob3. 1Pharmacology, Ste-Justine Hospital 
Research Center, Montreal, QC, Canada; 
2Ophthalmology, University of Montreal, Montreal, 
QC, Canada; 3Pediatrics & Pharmacology, Research 
Ctr/Hosp Ste Justine, Montreal, QC, Canada. 
5867 — A487 Outcome of Laser Treatment 
of AP-ROP in Extremely Premature Infants. 
Glen A. Gole1,2, D.J. Gunn1, D. Cartwright3. 
1Ophthalmology, Royal Childrens Hospital, 
Brisbane, Australia; 2Paediatrics and Child Health, 
University of Queensland, Brisbane, Australia; 
3Neonatology, Royal Brisbane and Women’s 
Hospital, Brisbane, Australia. 
5868 — A488 New Insights in Retinal Vascular 
Morphology in Neonates with Congenital Heart 
Disease. Axel Orozco-Hernandez1, F. Schoonewolff1, 
J. Mercado2, R. Chan3, V. Morales-Canton1, G. 
Garcia-Aguirre1, M. Martinez-Castellanos1. 1Retina, 
APEC, Mexico City, Mexico; 2Neonatal Intensive 
Care Unit, Instituto de Salud del Estado de Mexico, 
Toluca, Mexico; 3Retina, New York Presbyterian 
Hospital Weill Cornell Medical College, New York, 
NY. 
5869 — A489 Evaluating The Association 
Of Autonomic Drug Use In The Development 
and Severity Of Retinopathy Of Prematurity. 
Mohamed A. Hussein, D.K. Coats, H. Khan, E. 
Paysse, P. Steinkuller, L. Kong. Ophthalmology, 
Baylor College of medicine, Houston, TX. 
5870 — A490 Analysis of Postnatal Weight 
Gain for the Prediction of Severity of 
Retinopathy of Prematurity. Patricia Buttke. 
Ophthalmology, San Antonio Military Medical 
Center, San Antonio, TX. 
5871 — A491 Swedrop - A National Quality 
Register For Retinopathy Of Prematurity 
- Makes It Possible To Improve Screening 
Criteria For Rop In Sweden. Gerd Holmstrom1, 
A. Hellstrom2, P. Jakobsson3, P. Lundgren4, 
K. Tornqvist5, A. Wallin6. 1Neuroscience, 
ophthalmology, Uppsala University, Uppsala, 
Sweden; 2Section of Pediatric Ophthalmology, The 
Queen Silvia Children’s Hospital, Sahlgrenska 
Academy, University of Gothenburg, Sweden; 
3Ophthalmology, Linkoping University, Linkoping, 
Sweden; 4Ophthalmology, Norrland’s University 
Hospital, Umea, Sweden; 5Ophthalmology, 
Lund University Hospital, Lund, Sweden; 
6Ophthalmology, St Eriks Eye Hospital, Stockholm, 
Sweden. 
5872 — A492 Improving The Fit In Logistic 
Regression Models Of Retinopathy Of 
Prematurity: The Square Of Birth Weight As A 
New Covariate Of Risk. Simon Dulku1, C.N. Igwe1, 
R.L. Holder2, L. Butler1. 1Birmingham & Midland 
Eye Centre, City Hospital, Birmingham, United 
Kingdom; 2Department of Primary Care, University 
of Birmingham, Birmingham, United Kingdom. 
5873 — A493 Macular Pigment Imaging in 
Infants and Children Using the RetCam. Paul S. 
Bernstein1, M. Sharifzadeh2A, A. Liu1, I. Ermakov2A, 
K. Nelson1, X. Sheng2B, C. Panish1, B. Carlstrom1, 
R.O. Hoffman1, W. Gellermann2A. 1Ophthal and 
Visual Sciences, Univ of Utah/Moran Eye Center, 
Salt Lake City, UT; APhysics, BPediatrics, 2Univ of 
Utah, Salt Lake City, UT.*CR 
5867 – 5887 – Thursday – Posters
5874 — A494 Description Of A Technique 
To Make Stereo Ocular Images And Retina 
Angiograms Using The Retcam Ii In Pediatric 
Patients. Victoria Gonzalez1, F. Schoonewolff2, 
V. Morales-Canton3, M.A. Martinez-Castellanos4. 
1ophthalmology, Asociacion Para Evitar la Ceguera, 
Mexico, D.F., Mexico; 2Retina, Asoc Para Evitar 
la Ceguera en Mexico, Mexico, Mexico; 3Retina, 
Assoc para Evitar la Ceguera, Mexico, Mexico; 
4Retina and Vitreous, Asociacion Para Evitar la 
Ceguera, Mexico, Mexico. T 
5875 — A495 Influence of Foveal Photoreceptor 
Sub-Elements On Visual Acuity In Premature 
Infants With And Without Retinopathy Of 
Prematurity. Anand Vinekar1A, K. Avadhani1A, 
M. Sivakumar1A, M. Kurian1, P. Mahendradas1, 
S. Braganza1A, R. Shetty1, B. Shetty1. APediatric 
Retina, 1Narayana Nethralaya PG Institute of 
Ophthalmology, Bangalore, India. 
5876 — A496 Digital Imaging Identification Of 
Skip Lesions In Laser Treatment Of Retinopathy 
Of Prematurity. Robison V. Chan1, K.B. Kang1, A. 
Orlin1, M.F. Chiang2, T.C. Lee3. 1Ophthalmology, 
Weill Cornell Medical College, New York, NY; 
2Ophthalmology and Medical Informatics, Casey 
Eye Institute, Oregon Health & Science University, 
Portland, OR; 3Ophthalmology, Childrens Hospital 
Los Angeles, Los Angeles, CA.*CR 
5877 — A497 Comparison of 
Neurodevelopmental Outcomes In Two 
Retinopathy of Prematurity (ROP) Cohorts: 
Standard vs. Revised Oxygen Saturation 
Protocol Groups. Tamara J. Lee1, J. Bernardo1, C. 
Sonnie2, G. Hoppe2, J.E. Sears2. 1Ophthalmology, 
Cleveland Clinic Lerner College of Medicine, 
Cleveland, OH; 2Cole Eye Institute, Cleveland 
Clinic, Cleveland, OH. T 
5878 — A498 Lower Target Oxygen Saturation 
And Rop. Julio A. Urrets-Zavalia1, N. Crim1, E.G. 
Knoll1,2A, M.E. Forniez-Paz1, R. Monti1, E. Collino2B, 
E. Esposito1, C.E. Gilbert3, H.M. Serra4. 1University 
Clinic R Fabiola/Ophthalmol, Universidad Catolica 
de Cordoba, Cordoba, Argentina; AOphthalmology, 
BNeonatology, 2Hospital Materno Neonatal Ramon 
Carrillo, Cordoba, Argentina; 3ICEH / CRU / ITD, 
London Sch of Hygiene & Tropical Med, London, 
United Kingdom; 4Bioquimica Clinica, CIBICI, Fac 
ultad de Cs Quimicas UNC, Cordoba, Argentina. 
5879 — A499 Clinical Characteristics Of 
Retinopathy Of Prematurity In Infants Born 
Before 25 Weeks’ Gestation In A Korean Single 
Neonatal Intensive Care Unit. Mingui Kong1A, 
E. Kim1B, Y. Chang1B, S. Kim1A. AOphthalmology, 
BPediatrics, 1Samsung Medical Center, Seoul, 
Republic of Korea. 
5880 — A500 Screening for ROP:16 years 
experience. Lorenzo Orazi, D. Lepore, A. 
Baldascino, S. Luceri, P. Perrini, G. D’Amico, 
M.M. Pagliara, F. Molle. Ophthalmology, Catholic 
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5888 — A508 Decreased IGF1 Expression 
Associated with Avascular Retina in Model of 
Retinopathy of Prematurity. Yanchao Jiang1, 
B. Numpang2, B. Yu2, H. Wang1, G. Smith1, M. 
McCloskey1, S. Patel2, R. DiGeronimo2, M. Hartnett1, 
R. Lane2. 1Ophthalmology, John Moran Eye Center, 
The University of Utah, Salt Lake City, UT; 
2Division of Neonatology, The University of Utah, 
Salt Lake City, UT. 
5889 — A509 A Novel Allosteric Modulator 
of the IL-1 Receptor Prevents the Development 
of Oxygen-Induced Retinopathy. Jose C. 
Rivera1,2, N. Sitaras2, D. Hamel1, A. Madaan1, J-C. 
Honore1, B. Noueihed1, M. Blais2, C. Quiniou1, 
P. Sapieha2, S. Chemtob1,2. 1Pediatrics, Ophthal, 
Pharmacology, Hopital Sainte-Justine/Montreal 
University, Montreal, QC, Canada; 2Ophthalmology, 
Maisonneuve-Rosemont Hospital, Montreal, QC, 
Canada. 
5890 — A510 A Novel Model Of Retinopathy 
Of Prematurity In Normobaric Hyperoxic 
Conditions With Fewer Oxygen Supply In The 
Rat. Umut Karaca1, T. Ozgurtas2A, A.H. Durukan2B, 
F.N. Aydın2A, M. Ozler2C, S. Tekin2D, E.U. Bagriacik3. 
1Ophthalmology, Isparta Military Hospital, 
Isparta, Turkey; ABiochemistry, BOphthalmology, 
CPhysiology, DSchool of Medicine, 2Gulhane Military 
Medical Academy, Ankara, Turkey; 3Immunology, 
Gazi Univercity of Medicine, Ankara, Turkey. 
5891 — A511 Nitric Oxide and Signal Loss in the 
“ROP Rat” Retina. Tara L. Favazza1, G. DeWalt2, 
N. Zhang1,3, R.M. Hansen1,3, A.B. Fulton1,3, W.D. 
Eldred2, J.D. Akula1,3. 1Ophthalmology, Children’s 
Hospital Boston, Boston, MA; 2Biology, Boston 
University, Boston, MA; 3Ophthalmology, Harvard 
Medical School, Boston, MA. 
5892 — A512 The Retina and Refractive 
Outcome in the Rat Model of ROP. Nan 
Zhang1,2, T.L. Favazza1, A. Baglieri1, A.B. Fulton1,2, 
R.M. Hansen1,2, P.M. Iuvone3, J.D. Akula1,2. 
1Ophthalmology, Children’s Hospital Boston, Boston, 
MA; 2Ophthalmology, Harvard Medical School, 
Boston, MA; 3Ophthalmology and Pharmacology, 
Emory University School of Medicine, Atlanta, GA. 
Hall B/C A572-A606
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5893 — A572 Gene Expression and 
Immunogenicity of induced Pluripotent Stem 
Cell-Derived Retinal Pigment Epithelial Cells. 
Hiroyuki Kamao1,2, M. Mandai1, A. Suga1, J. Kiryu2, 
M. Takahashi1. 1Laboratory for Retinal Regeneration, 
RIKEN Ctr for Dvlpmntl Biology, Kobe, Japan; 
2Ophthalmology, Kawasaki medical school, 
Okayama, Japan. 
Thursday – Posters – 5888 – 5907
5894 — A573 Manipulation Of Gene Expression 
In Orbital Adipose-derived Mesenchymal Stem 
Cells From Retinoblastoma Patients Using 
Lentiviral Vectors. David M. Wu1, J. Aparicio2, 
A. DiConti3, T.C. Lee4. 1Doheny Eye Institute, 
University of Southern California, Los Angeles, CA; 
2Ophthalmology, Children’s Hospital Los Angeles, 
Los Angeles, CA; 3Ophthalmology, Children’s 
Hospital Of Los Angeles, Los Angeles, CA; 
4Ophthalmology, Childrens Hospital Los Angeles, 
Los Angeles, CA. 
5895 — A574 VEGF Induces Neural and 
Astrocytic Differentiation and Angiogenesis in 
Bone Marrow-derived Stem Cells and Promotes 
Microglia Conversion Following Mobilization 
With GM-CSF. Revital B. Avraham Lubin1, T. 
Sadikov1, N. Askenasy2, N. Goldenberg Cohen1,3. 
1The Krieger Eye Research, Sackler Faculty of 
Medicine, Tel Aviv University, Petach Tikva, Israel; 
2Frankel Laboratory, Center for Stem Cell Research, 
Petach Tikva, Israel; 3Department of Pediatric 
Ophthalmology, Schneider Children’s Medical 
Center of Israel, Petach Tikva, Israel. 
5896 — A575 Retinal Pigment Epithelial 
(RPE) Cell Conditioned Medium Contains 
Factors Responsible for Increased RPE Cell 
Differentiation from Human Embryonic Stem 
Cells. Jamie Hsiung, D. Zhu, D.R. Hinton. University 
of Southern CA Doheny Eye Institute, Los Angeles, 
CA. 
5897 — A576 Optimizing Retinal Progenitor 
Differentiation of hESC - Effect of RPE Co-
Culture. Magdalene J. Seiler1, D. Ferguson1, G. 
Nistor2, S. Rana1, I. Turovets3, J. Almodovar1, J. 
Taylor1, N.A. Turovets3, H.S. Keirstead1. 1Anatomy & 
Neurobiol/Reeve-Irvine Res Ctr, Univ of California, 
Irvine, Irvine, CA; 2California Stem Cell Inc., 
Irvine, CA; 3International Stem Cell Corporation, 
Oceanside, CA.*CR 
5898 — A577 Growth and Organization of 
Human iPS Cell-Derived Retinal Cell Types on 
a Biocompatible Membrane. Jessica M. Martin1, 
J. Phillips1, L.S. Wright1, C. Johnson2, N. Radtke3, 
D.M. Gamm1. 1University of Wisconsin - Madison, 
Madison, WI; 2Cook Biotech, West Lafayette, IN; 
3University of Louisville, Louisville, KY.*CR 
5899 — A578 Enhanced Progenitor Cell 
Integration and Differentiation Following 
Transplantation on to PLGA Polymer 
Construct. Brandon M. Menke1A, V.B. Joshi1B, A. 
Wongrakpanich1B, K.R. Anfinson1A, M.R. Streb1A, 
M.E. Eyestone1A, A.K. Salem1B, B.A. Tucker1A. 
AOphthalmology, BPharmacy, 1University of Iowa, 
Iowa City, IA. 
5900 — A579 Transfer of mRNA and 
Micro-RNA by Embryonic Stem Cell-Derived 
Microvesicles Induces Gene Expression Changes 
in Retinal Progenitor Müller Cells. Diana 
Katsman, D.R. Demin, D.B. Farber. Ophthalmology, 
University of California, Los Angeles, JSEI, Los 
Angeles, CA. T 
5901 — A580 Characterization Of Human 
Retinal Progenitor Cells. Petr Y. Baranov1, G.B. 
Melo2, M.J. Young3. 1Schepens Eye Research 
Institute, Boston, MA; 2Ophthalmology, Federal Univ 
of Sao Paulo/UNIFESP, Aracaju, Brazil; 3Schepens 
Eye Research Inst, Harvard Medical School, Boston, 
MA. 
5902 — A581 Transdifferention And Molecular 
Characterization Of Bone Marrow-derived 
Progenitors In A Coculture system. Stephanie 
G. Lecaude, I. Mathivanan, S. Wolf, V. Enzmann. 
Department of Ophthalmology, University of Bern, 
Bern, Switzerland. 
5903 — A582 Visual Cycle Machinery in Human 
Induced Pluripotent Stem Cell-Derived RPE. 
Alberto Muniz1, M.L. Plamper2, B.S. Betts3, A.J. 
Johnson2, H-C.H. Wang2. 1Ocular Trauma, National 
Research Council / USAISR, Fort Sam Houston, TX; 
2Ocular Trauma, US Army Inst of Surgical Research, 
Fort Sam Houston, TX; 3Biology, University of Texas 
at San Antonio, San Antonio, TX. 
5904 — A583 Transcriptional Regulation of 
Retinal Fate Determination from Human Induced 
Pluripotent Stem Cells. Akshayalakshmi Sridhar1, 
M.M. Steward1, M. Gupta1, J.S. Meyer1,2. 1Biology, 
Indiana Univ Purdue Univ Indianapolis, Indianapolis, 
IN; 2Center for Regenerative Biology and Medicine, 
Department of Medical and Molecular Genetics, 
Indiana University Stark Neurosciences Research 
Institute, Indianapolis, IN. 
5905 — A584 In vitro Differentiation of Human 
Induced Pluripotent Stem Cells Towards Retinal 
Photoreceptors. Carla B. Mellough1A, E. Sernagor1B, 
D.H. Steel2, M. Lako1A. AInstitute of Genetic 
Medicine, BSchool of Neurology, Neurobiology and 
Psychiatry, 1University of Newcastle Upon Tyne, 
Newcastle, United Kingdom; 2Sunderland Eye 
Infirmary, Sunderland, United Kingdom. 
5906 — A585 Functional Comparison Of RPE 
Cultures Expanded From Differentiated Human 
iPS Cells And Prenatal Eye Tissue. Ruchira 
Singh1A, W. Shen1A, X. Guo1A, E.T. Perez1A, D. Kuai1A, 
L.S. Wright1, B. Pattnaik1B, D.M. Gamm1C. AWaisman 
Center, BDepts. of Ophthalmology and Visual 
Sciences and Pediatrics, Eye Research Institute, 
CDept. of Ophthalmology and Visual Sciences and 
Eye Research Institute, 1University of Wisconsin, 
Madison, WI. 
5907 — A586 Soluble Factors Secreted by 
Fibroblast Feeder Cells Induce Retinal Pigment 
Epithelium Differentiation from Human 
Pluripotent Stem Cells. Alexandra Mikhailova1,2, 
H. Hongisto1,2, H. Vaajasaari1,2, S. Narkilahti1,2, 
R. Suuronen2,3, T. Ilmarinen1,2, H. Skottman1,2. 
1University of Tampere, Institute of Biomedical 
Technology, Tampere, Finland; 2Institute of 
Biosciences and Medical Technology, Tampere, 
Finland; 3Tampere University Hospital, Department 
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5922 — A601 Embryonic Stem Cell Derived 
Retinal Pigment Epithelium Stem Cell 
Transplant: Survival And Lack Of Tumor 
Formation In Athymic Nude Rats. Bruno Diniz, 
Sr.1,2, R. Ribeiro1, R. Brant1, Y. Hu1,3, L. Liu1, P. 
Thomas1, B. Thomas1, D. Hinton1,4, M. Humayun1. 
1Doheny Eye Institute, University of Southern 
California, Los Angeles, CA; 2Ophthalmology, 
Universidade Federal de São Paulo, São Paulo, 
Brazil; 3Department of Ophthalmology, Peking 
University Third Hospital, Beijing, China; 4Keck 
School of Medicine, Los Angeles, CA. 
5923 — A602 Comparison of Barrier Properties 
of RPE Derived from Two Human Embryonic 
Stem Cell Lines to the Properties of Human 
Fetal RPE. Shaomin Peng1A,2, G. Gan1A, C. Qiu1B, 
L. Li1A, R.A. Adelman1C, L.J. Rizzolo1A. ASurgery/
Ophthalmology, BCell biology, COphthalmology, 
1Yale University, New Haven, CT; 2Ophthalmology, 
2nd Hospital of Harbin Medical University, Harbin, 
China. 
5924 — A603 Polarized Human Embryonic 
Stem Cell-Derived RPE Maintains its Monolayer 
Integrity and Function after Long-term in vitro 
Culture. Danhong Zhu1, D.O. Clegg2, D.R. Hinton3. 
1Doheny Eye Institute/Pathology, Univ of Southern 
California, Los Angeles, CA; 2Bioscience II, Univ 
of California-Santa Barbara, Santa Barbara, CA; 
3Pathology, Keck School of Medicine USC, Los 
Angeles, CA. 
5925 — A604 Reciprocal Modulation Of 
Wnt Signaling Promotes Enhanced Retinal 
Regeneration Following Selective Retinal Cell 
Ablation In Zebrafish. Jeff S. Mumm, J. Ariga. 
Cellular Biology & Anatomy, Georgia Health 
Sciences University, Augusta, GA.*CR 
5926 — A605 Injury of the Adult Zebrafish 
Retina Induces Expression of Purinergic 
Receptors and Ecto-nucleotidases that Control In 
Vivo Cell Proliferation. Ariadna G. Battista1, M.P. 
Faillace1,2. 1Laboratorio de Neurociencias, Piso 7, 
Universided de Buenos Aires Facultad de Medicina, 
Buenos Aires, Argentina; 2Instituto de Química y 
Fisicoquímica Biológicas (IQUIFIB), Buenos Aires, 
Argentina. 
5927 — A606 HB-EGF is a Master Regulator 
of Müller Glia Dedifferentiation and Retina 
Regeneration. Jin Wan, D.J. Goldman. Molecular 
& Behav Neurosc Inst, University of Michigan, Ann 
Arbor, MI. 
5908 – 5927 – Thursday – Posters
5908 — A587 Engraft Of Hyaluronic Acid-based 
Hydrogel Loaded Mesenchymal Stem Cell Into 
The Vitreous Body Of The Ischemic Rat Retina. 
Su-Ja Oh1A, J. Lee1A, J. Shin1A, C. Yeum1B, G. Chae1B, 
M-H. Chun1A. ADepartment of Anatomy, BInstitute 
of Hansen’s Disease, 1Coll of Med Catholic Univ of 
Korea, Seoul, Republic of Korea. 
5909 — A588 Characterization Of Human 
Induced Pluripotent Stem Cells Derived Neural 
Progenitor Cells. Wei Kong1, N. Yang2, X. Li2. 
1Ophthalmology, the Fourth People’s Hospital of 
Shenyang City, Shenyang, China; 2Ophthalmology, 
the 4th Affiliated Hospital of China Medical 
University, Shenyang, China. 
5910 — A589 Directing Virus-free Human 
Induced Pluripotent Stem Cells To Differentiate 
Into Retinal Cells. Xiufeng Zhong1, C. Hampton1, 
T. Park2, D.M. Gamm3, E. Zambidis2, V. Canto-
Soler1. 1Wilmer Eye Inst, Johns Hopkins Univ Sch, 
Baltimore, MD; 2Institute for Cell Engineering, 
Johns Hopkins Univ Sch, Baltimore, MD; 3Stem 
Cell Research Program at Waisman Center and 
Ophthalmology and Visual Sciences, University of 
Wisconsin-Madison, Madison, WI. 
5911 — A590 BDNF and DNA Demethylation 
Increase Expression of Pluripotent and Retinal 
Neuronal Genes in ImM10 Müller Glia-Derived 
Retinal Stem Cells. Deborah C. Otteson1, J. 
Phillips2, T.D. Petkova1. 1Optometry, University of 
Houston, Houston, TX; 2University of Wisconsin, 
Madison, WI. 
5912 — A591 Transcriptomic Comparison of 
RPE Derived from Two Human Embryonic Stem 
Cell Lines with Human Fetal RPE. Lawrence J. 
Rizzolo1A, G. Gan1A, S. Peng1A,2, T.A. Van Zyl1A, L.S. 
Ediriwickrema1A, H. An1B, M. Zhong1B, C. Qiu1B, R.A. 
Adelman1C. ASurgery/Ophthalmology, BCell Biology, 
COphthalmology, 1Yale Univ Sch of Med, New 
Haven, CT; 2Ophthalmology, 2nd Hospital of Harbin 
Medical University, Harbin, China. 
5913 — A592 Retinal Differentiation Of 
Human Es Cells Maintained In Chemically 
Defined, Xeno-free E8 Culture Medium. Kyle 
Wallace1, A. Gerner2, J. Martin2, Z. Hou3, D.M. 
Gamm2A. 1Waisman Center, University of Wisconsin, 
Madison, WI; AWaisman Center, Department of 
Ophthalmology, Eye Research Institute, 2University 
of Wisconsin Madison, Madison, WI; 3Morgridge 
Institute for Research, Madison, WI. 
5914 — A593 Microparticles in Differentiation 
of Retinal Pigment Epithelial Cells from Human 
Pluripotent Stem Cells. Anni E. Sorkio1,2, T.H. 
Ilmarinen1,2, J.S. Loo3, H.T. Skottman1,2. 1Institute 
of Biomedical Technology, University of Tampere, 
Tampere, Finland; 2Institute of Biosciences and 
Medical Technology, Tampere, Finland; 3School 
of Materials Science and Engineering, Nanyang 
Technological University, Singapore, Singapore. 
5915 — A594 Transfection of IGF-1 and 
IGFBPL-1 in Neuronal Progenitor Cells 
from Human Persistent Fetal Vascular for 
Neuroprotection. Jie Ma1, C. Guo1, G. Chen2, 
D. Cyr1, K. Lashkari1,3. 1Schepens Eye Research 
Institute, Boston, MA; 2The Second Xiangya 
Hospital, Central South University, Changsha, 
China; 3Massachusetts Eye & Ear Infirmary, Boston, 
MA. T 
5916 — A595 Evaluation of Matrigel 
Degradation by MMP Secretion of hESC-RPE. 
Kenrick Kuwahara, D. Zhu, M. Humayun, D. Hinton, 
A.K. Ahuja. Doheny Eye Institute, Los Angeles, CA. 
5917 — A596 Surface Substrates Affect The 
Behavior And Survival Of Müller Glia Derived 
Stem Cells. Gisela Velez, A. Roy. Ophthalmology, 
University of Massachusetts Medical School, 
Weston, MA. 
5918 — A597 Effects Of Clinically Relevant 
Agents On Human Retinal Progenitor Cells 
(hrpcs) In Culture: A Pre-clinical Cytotoxicity 
Study. Jing Yang, H. Klassen. Gavin Herbert Eye 
Institute, Department of Ophthalmology, University 
of California Irvine, Irvine, CA. 
5919 — A598 New Approach To Harvest 
Retinal Neuron-like Cells From Weri-rb1 Cancer 
Stem Cells. Jian Ge, H. Hu, F. Deng, M. Chen, X. 
Sun. Glaucoma, Zhongshan Ophthalmic Center, 
Guangzhou, China. 
5920 — A599 Evaluation of hESC-Derived 
Retinal Pigment Epithelial Cells Cultured as a 
Monolayer on Polymer Substrate Transplanted 
in RCS Rats. Padmaja B. Thomas1, B.B. Thomas1A, 
L. Liu2,3, Y. Hu1,4, D. Zhu5, E. Barron1, D.O. Clegg6, 
D.R. Hinton7, M.S. Humayun8. AOphthalmology, 
1Doheny Eye Institute-USC, Los Angeles, CA; 
2Cell and Neurobiology, University of Southern 
Califormia, Los Angeles, CA; 3Ophthalmology, 
Chang Gung Memorial Hospital, Taoyuan, Taiwan; 
4Ophthalmology, Peking University Third Hospital, 
Beijing, China; 5Pathology/Doheny Eye Inst, 
Univ of Southern California, Los Angeles, CA; 
6Bioscience II, Center for Stem Cell Biology and 
Engineering- UCSB, Santa Barbara, CA; 7Pathology, 
Keck School of Medicine USC, Los Angeles, CA; 
8Ophthalmology, Doheny Eye Institute - USC, Los 
Angeles, CA. 
5921 — A600 Activated Omental Stromal Cells 
Protect Against Light-Induced Retinal Injury. 
Evan B. Price1A,2A, P. Bu1B,2A, P. Sethupathi2B, E.B. 
Stubbs, Jr.1B,2A, J.I. Perlman1A,2A. ASurgery, BResearch, 
1Edward Hines, Jr. VA Hospital, Hines, IL; 
AOphthalmology, BMicrobiology and Immunology, 
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5928 — A153 Long-term Efficacy of 
Endoscopic Cyclophotocoagulation Combined 
with Cataract Surgery. Carter N. Kirk1, T.Q. 
Kirk2, S.H. Kirk3. 1Georgetown University School 
of Medicine, Washington, DC; 2Ophthalmology, 
Allegheny General Hospital, Pittsburgh, PA; 
3Ophthalmology, Kirk Eye Center, River Forest, IL. 
5929 — A154 Trabectome™ Outcomes in 
Patients of African Decent. Ninita H. Brown1, 
L.S. Jones2. 1Ophthalmology, Howard University, 
Washington, DC; 2Ophthalmology, Howard 
University Hospital, Washington, DC. 
5930 — A155 The Trabectome - First European 
Clinical Results and Subgroup Analysis. Matthias 
Neuburger, C. van Oterendorp, T. Wecker, D. 
Boehringer, T. Reinhard, J.F. Jordan. University 
Eye Hospital, Freiburg, Germany. 
5931 — A156 Trabectome Results In Eyes 
With Low Preoperative IOP. Xuejing Chen, K. 
Kaplowitz, N. Loewen. Ophthalmology, Yale School 
of Medicine, New Haven, CT.*CR 
5932 — A157 Characteristics and Outcomes 
of Eyes with Neovascular Glaucoma (NVG) that 
Underwent Combined Pars Plana Vitrectomy 
(PPV) and Baerveldt Glaucoma Shunt 
Procedure. Christopher W. Seery1, C. Seery2, 
P. Emami-Naeimi2, A. Kolomeyer2, M. Zarbin2, 
R. Fetchner2, N. Bhagat2. 1UMDNJ/ Bucknell 
University, Florham Park, NJ; 2UMDNJ, Newark, 
NJ. 
5933 — A158 A Comparison Of Post-operative 
Outcomes Of Glaucoma Surgeries Performed 
By Residents Vs. Attending Physicians. Camila 
Zangalli, R. Clifford, L. Gupta, M. Hsieh, G.L. 
Spaeth, M. Ali. Glaucoma Service, Wills Eye 
Institute, Philadelphia, PA. 
5934 — A159 Comparison of Visual Acuity 
and Intraocular Pressure Outcomes of Surgical 
Versus Medical Management of Neovascular 
Glaucoma. Tahsin Choudhury, S.T. Ali, P.J. Maris, 
L.A. Al-Aswad. Department of Ophthalmology, 
Columbia University Medical Center, New York, 
NY. 
5935 — A160 A Prospective Study of Phakic 
vs Pseudophakic Eyes After Phacoemulsification 
in Trabeculectomy for Open-Angle Glaucoma. 
Yuji Takihara1, M. Inatani2, M. Iwao1, M. Kawai3, 
T. Inoue1, K. Iwao4, H. Tanihara1. 1Ophthal 
& Vis Science, Kumamoto Univ Sch of Med, 
Kumamoto, Japan; 2Department of Ophthalmology, 
University of Fukui, Fukui, Japan; 3Ophthalmology, 
Asahikawa Medical College, Asahikawa, Japan; 
4Ophthalmology, Saga University, Saga City, 
Japan. f 
5936 — A161 Time Course Of Induced 
Astigmatism After Canaloplasty. Anselm G. 
Junemann1, J. Schlomberg1, F.K. Horn1, R. Rejdak2, 
F.E. Kruse1, M.C. Moelle1. 1Ophthalmology, 
University of Erlangen Nurnberg, Erlangen, 
Germany; 2General Ophthalmology, Medical 
University of Lublin, Lublin, Poland. 
5937 — A162 Postoperative Hypotony With 
Good Visual Function And Without Macular 
Edema. Kellie A. Moore, A.L. Jamil, R.P. Mills. 
Glaucoma Consultants Northwest, Seattle, WA. 
5938 — A163 Combined Trabectome 
Phacoemulsification versus Phacoemulsification 
Alone in Open Angle Glaucoma. Ani 
Khondkaryan, B.A. Francis. Ophthalmology, 
Doheny Eye Institute, Los Angeles, CA.*CR 
5939 — A164 A Comparison Of Intraocular 
Pressure Reduction After Selective Laser 
Trabeculoplasty With The Co-administration Of 
Loteprednol Versus None. Ronald L. Rebenitsch1A, 
N.R. Binder1A, A. Jani1, K. Pikey1A. AOphthalmology, 
1University of Missouri-Kansas City, Kansas City, 
MO. 
5940 — A165 Mitomycin-C Deep Sclerectomy 
With Injectable Cross-Linked Hyaluronic Acid 
Implant: 3-Year Report Of An Ongoing Case 
Series. Paolo Bettin, M. Fiori, C. Ciampi, F. Di 
Matteo, F. Bandello. Ophthalmology, University 
Scientific Institute San Raffaele, Milan, Italy.*CR 
5941 — A166 Efficacy Of Glaucoma Surgical 
Procedures: A Systematic Review And 
Metanalysis. Luciano Quaranta1, I. Floriani2, I. 
Riva1, G. Gambirasio1, I. De Simone2, E. Rulli2, E. 
Biagioli2, S. Credidio2. 1Ophthalmology-Glaucoma 
Unit, University of Brescia, Brescia, Italy; 
2Laboratory of Clinical Trials, Istituto di ricerche 
farmacologiche «Mario Negri», Milan, Italy. 
5942 — A167 Faster Visual Recovery Following 
Ex-press Than Trabeculectomy: Results Of A 
Prospective Rct. Delan Jinapriya1, L. Beltran-
Agullo2A, Y.P. Jin2A,2B, L.D. Wagschal3, G.E. Trope2A, 
Y.M. Buys2A. 1Ophthalmology, Queen’s University, 
Kingston, ON, Canada; AOphthalmology and Vision 
Sciences, BDalla Lana School of Public Health, 
2University of Toronto, Toronto, ON, Canada; 
3Ophthalmology, Shaare Zedek Medical Center, 
Jerusalem, Israel. f 
5943 — A168 To Report On Long-term 
Comparative Outcomes For Mitomycin C 
Augmented Needle Revisions For Failing Deep 
Sclerectomies And Trabeculectomies. Antigoni 
Koukkoulli, F. Musa, N. Anand. Huddersfield Royal 
Infirmary, NHS, Huddersfield, United Kingdom. 
5944 — A169 Progression Rate Before and 
After Trabeculectomy. Jimena Schmidt1, S. 
Araneda1, E. Abusleme1, C. Perez1, E. Maul D.1, E. 
Maul F.1, A. Gerhard1, C. Trigo2. 1Ophthalmology 
Department, Catholic University of Chile, Santiago, 
Chile; 2Ophthalmology Department, Sotero del Rio 
Hospital, Santiago, Chile. 
Thursday – Posters – 5928 – 5952
5945 — A170 Success Rates And Risk 
Factors For Failure Of Bleb Needling Post 
Trabeculectomy. Andrew Toren1, S. Kulkarni2, L. 
Shuba1, M. Nicolela1. 1Ophthalmology & Visual 
Sciences, Dalhousie University, Halifax, NS, 
Canada; 2Ophthalmology, University of Ottawa, 
Ottawa, ON, Canada. 
5946 — A171 Effect of Phacoemulsification 
on IOP Control in Glaucoma Patients- PACG, 
POAG and Operated Trabeculectomies. 
Paromita Dutta, R. Sihota, R. Saxena, S. Phuljhele. 
Ophthalmology, RP Centre, AIIMS, New Delhi, 
India. 
5947 — A172 Reconstruction of Non-
functional Trabeculectomy Bleb Using Silicone 
Sponge Wrapped with Amniotic Membrane 
for Refractory Glaucoma. Akihiko Tawara, N. 
Miyamoto, T. Nagata, S. Ishibashi, Y. Harada, N. 
Tou. Department of Ophthalmology, Univ of Occup 
& Environ Hlth, Japan, Kitakyushu, Japan. 
5948 — A173 Outcome And Structural 
Evolution Of Mytomycin Assisted 
Trabeculectomy In Inflammatory Glaucoma. 
Friederike Mackensen1, B.C. Dobner1, A.B. Knoll1, 
A.F. Scheuerle2, K. Rohrschneider2. 1Department of 
Ophthalmology, Interdisciplinary Uveitis Center, 
University of Heidelberg, Heidelberg, Germany; 
2Department of Ophthalmology, University of 
Heidelberg, Heidelberg, Germany.*CR 
5949 — A174 Comparing the Effect of 
Descemet Stripping Automated Endothelial 
Keratoplasty (DSAEK) versus Penetrating 
Keratoplasty (PKP) on Intraocular Pressure 
(IOP) Control in Glaucomatous Eyes. John 
W. Anderson, N. Wang, N. Bell, A. Chuang, R. 
Feldman. UTHealth- Houston, Houston, TX. 
5950 — A175 Impact of Trabeculectomy 
Surgery on Global Visual Field Indices Using 
Data from Advanced Glaucoma Intervention 
Study (AGIS). Linda Zhang, D.C. Musch, L.M. 
Niziol, J.D. Stein. Ophthalmology, University of 
Michigan, Ann Arbor, MI. 
5951 — A176 Single Digit Intraocular Pressure 
In Post Trabeculectomy Patients And Its Effects 
On Visual Field Progression. Ana C. Toro1, C. 
Fernandez1, G. Hernandez2. 1Ophthalmology, 
University of Puerto Rico, San Juan, PR; 
2Ophthalmology, Hospital Metropolitano, San Juan, 
PR. 
5952 — A177 The Effects Of Trabeculectomy 
On Visual Field Progression Rates In Glaucoma. 
Aachal Kotecha1, R.A. Russell1,2, J.C. Clarke3, P.T. 
Khaw1, Moorflow Study Group. 1NIHR BRC for 
Ophthalmology, UCL Institute of Ophthalmology 
and Moorfields Eye Hospital, London, United 
Kingdom; 2Optometry and Visual Science, The City 
University, London, United Kingdom; 3Glaucoma, 
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5969 — A194 Baseline Intraocular Pressure 
Strongly Predicts Response to Selective Laser 
Trabeculoplasty for Open Angle Glaucoma. 
J D. Nussdorf1, A C. Janot1, D.W. Hanson1, P.J. 
DeMarco2. 1Department of Ophthalmology, 
Ochsner Clinic Foundation, New Orleans, LA; 
2Psychological and Brain Sciences, University of 
Louisville, Louisville, KY. 
5970 — A195 Laser Surgery in the United 
Kingdom. Gordon Bowler1, H. Saedon2, R. 
Thomas3, W. Chan4. 1Ophthalmology, Princess 
Royal University Hospital, Orpington, United 
Kingdom; 2Ophthalmology, University 
Hospitals Coventry Warwickshire & Warwick 
Medical School, Coventry, United Kingdom; 
3Ophthalmology, Croydon University Hospital, 
Croydon, United Kingdom; 4Ophthalmology, Great 
Ormond Street Hospital, London, United Kingdom. 
5971 — A196 Repeat SLT In Comprehensive 
Ophthalmology Practices. Jeffrey D. Henderer1A, 
E.S. Yung1A, A. Johnston1A, S.K. Luminais1A, 
R. Sherry1A, J.P. Gaughan1B. AOphthalmology, 
BEpidemiology and Biostatistics, 1Temple 
University, Philadelphia, PA. 
5972 — A197 Quantification of Short-
Term Endothelial Cell Loss and Intraocular 
Pressure Reduction Following Laser Peripheral 
Iridotomy. Gabriela C. Barretto1, L. Trancoso1, M. 
Cota2, L. Biteli1, T. S Prata1. 1Glaucoma, Hospital 
Medicina dos Olhos, Sao Paulo, Brazil; 2Glaucoma, 
Complexo Hospital Padre Bento, Sao Paulo, Brazil. 
5973 — A198 Efficacy of Transscleral Diode 
Laser Cyclophotocoagulation on Neovascular 
Glaucoma: Vein Occlusion versus Proliferative 
Diabetic Retinopathy. Neha Sangal1, A. Anchala1, 
T.D. Patrianakos1,2. 1University of Chicago, 
Chicago, IL; 2John H. Stroger Jr. Hospital of Cook 
County, Chicago, IL. 
5974 — A199 Effectiveness of Selective Laser 
Trabeculoplasty with Regard to Influence of 
Pseudophakia and Prostaglandin Analogues. 
Cornelia Hirn, M. Toeteberg-Harms, G. Bauer, S. 
Zehnder, D. Lindegger, J. Funk. Ophthalmology, 
University Hospital Zurich, Zurich, Switzerland. 
5975 — A200 Change in Lens Vault after Laser 
Iridotomy in Asian Indian Eyes with Angle 
Closure. Dhawal Haria1, R. Sasikumar2, S. A V2, 
D.A. Rao2, R. Balu2, N. K P2. 1ophthalmology, 
Narayana Nethralaya Super Speciality Eye hospital, 
Bangalore, India; 2ophthalmology, Narayana 
Nethralaya Super Speciality Eye hospital and Post 
Graduate institute of ophthalmology, Bangalore, 
India. 
5976 — A201 Effectiveness of Selective Laser 
Trabeculoplasty on Pigmentary Glaucoma. 
Claire Scemama Timsit, E. Blumen Ohana, J. 
Akesbi, E. Bluwol, A. Labbe, O. Laplace, J. 
Nordmann. Department #75, CHNO 15/20, Paris, 
France. 
5953 — A178 The Influence Of Scleral Flap 
Thickness, Shape, Suture Number And Position 
On Pressure Change And Aqueous Flow 
Direction In A New Trabeculectomy Model. Amir 
Samsudin1,2, S. Brocchini2,3, P.T. Khaw2, I. Eames4. 
1University of Malaya, Kuala Lumpur, Malaysia; 
2NIHR Biomedical Research Centre, Moorfields 
Eye Hospital and UCL Institute of Ophthalmology, 
London, United Kingdom; 3UCL School of 
Pharmacy, London, United Kingdom; 4UCL 
Department of Mechanical Engineering, London, 
United Kingdom. 
5954 — A179 Outcomes Of Combined 
Glaucoma And Cataract Surgery: Comparison 
Of Non-penetrating Deep Sclerectomy Vs 
Trabeculectomy. Johannes Keller, A. Saint-
Jean, M. Figueras Roca, C. Larena Gómez, E. 
Millà Griñó. Ophthalmology, Hospital Clinic de 
Barcelona, Barcelona, Spain. 
5955 — A180 Eyes With Occludable Angles 
Despite Patent Iridotomy: How Efficient Is Laser 
Iridoplasty In These Cases? Vitor G. Prado1, 
P.A. Moreno1,2, E.D. Almeida, Jr.1, A.S. Sousa1, T.S. 
Prata1,2. 1Ophthalmology, Federal University of São 
Paulo, São Paulo, Brazil; 2Hospital Medicina dos 
Olhos, São Paulo, Brazil. 
5956 — A181 Short-Term Efficacy of Selective 
Laser Trabeculoplasty in Primary Angle Closure 
Disease - Results of a Randomized Controlled 
Trial. Arun Kumar Narayanaswamy1, S.A. 
Perera2A, C. Ho2A, C.K. Leung3, D.V. Istiantoro4, 
M.E. Nongpiur1, H.M. Htoon1, T.T. Wong1,2, 
D. Goh2A, T. Aung1,2. 1Glaucoma, Singapore 
Eye Research Institute, Singapore, Singapore; 
AGlaucoma, 2Singapore National Eye Centre, 
Singapore, Singapore; 3Glaucoma, Department 
of Ophthalmology and Visual Sciences,Chinese 
University of Hong Kong, Hong Kong, Hong 
Kong; 4Glaucoma, Jakarta Eye Center, Jakarta, 
Indonesia.*CR, f T 
5957 — A182 Excimer Laser Trabeculostomy 
(ELT) combined with Phacoemulsification 
and Lens Implantation: 5 Year Post-OP 
Observations. Ulrich F. Giers1, L. Kleineberg1, R.P. 
Stodtmeister2, M.S. Berlin3, L.E. Pillunat4. 1Detmold 
Eye Clinic, Detmold, Germany; 2Ophthalmology, 
University Hospital Carl Gustav Carus, Rodalben, 
Germany; 3Ophthalmology, Glaucoma Inst 
of Beverly Hills, Los Angeles, CA; 4Dept of 
Ophthalmology, University of Dresden, Dresden, 
Germany. f 
5958 — A183 Selective Laser Trabeculoplasty 
Promotes Phagocytosis In Cultured Trabecular 
Meshwork Cells. Grayson A. Roumeliotis, D. 
Kagain, C.M. Hutnik. Ivey Eye Institute, Schulich 
Sch of Med & Dentistry, London, ON, Canada. 
5959 — A184 Primary and Repeat Selective 
Laser Trabeculoplasty in Pseudophakic 
Eyes: 2 year follow-up. Tamara L. Berezina1, 
A.S. Khouri1, B.A. Maltzman1, K. Shah2, R.D. 
Fechtner1. 1Ophthalmology, UMDNJ-New Jersey 
Medical School, Newark, NJ; 2Drexel University, 
Philadelphia, PA. 
5960 — A185 Intraocular Pressure Reduction 
After Repeated Selective Laser Trabeculoplasty 
(slt). Marcelo N. Ayala, E. Chen. St Erik Eye 
Hospital, Stockholm, Sweden. f 
5961 — A186 The Effectiveness of Selective 
Laser Trabeculoplasty on Eyes of Different 
Corneal Thicknesses. Joseph A. Donnelly1, E. 
Miglino2, L.F. Jindra3. 1Albert Einstein College of 
Medicine, Bronx, NY; 2Floral Park Opthalmology, 
Floral Park, NY; 3Ophthalmology, Columbia 
University, Floral Park, NY.*CR 
5962 — A187 Transscleral Micropulse Diode 
Laser Cyclophotocoagulation as Effective 
Adjunctive Treatment prior to Glaucoma 
Surgery. Maria Cecilia D. Aquino1, A. Tan1, S. 
Loon1, P.T. Chew1,2. 1Ophthalmology, National 
University Hospital, National University Health 
System, Singapore, Singapore; 2Ophthalmology, 
National University of Singapore, Singapore, 
Singapore. 
5963 — A188 Predictive Factors Of Selective 
Laser Trabeculoplasty Success In Medically 
Uncontrolled Glaucoma. Ulrich Brandlhuber, K. 
Sekura, A. Neubauer, C. Hirneiss. Department of 
Ophthalmology, Ludwig-Maximilians-University, 
Munich, Germany. f 
5964 — A189 Predictive Factors of Selective 
Laser Trabeculoplasty (SLT) Outcome in Open-
Angle Glaucoma Patients. Mamta Shah, B. 
Eliassi-Rad. Department of Ophthalmology, Boston 
University School of Medicine, Boston, MA. 
5965 — A190 Selective Laser Trabeculoplasty 
Energy Dose Response - Long Term Results. 
Larissa A. Gregory, T.L. Berezina, S. Prasertsit, 
R.D. Fechtner, A.S. Khouri. Ophthalmology, 
UMDNJ - New Jersey Medical School, Newark, NJ. 
5966 — A191 The Cost Effectiveness And 
Duration Of Effectiveness Of SLT As Primary 
And Secondary Therapy Relative To Medications 
In The Treatment Of Primary Open Angle 
Glaucoma. Ernesto D. Golez, III1, T.A. Shazly2, A. 
Porta3, F. Ferentini3, M.A. Latina4. 1Ophthalmology, 
Massachusetts Eye and Ear Infirmary, Reading, 
MA; 2Ophthalmology, MEEI / HMS, Reading, MA; 
3Ophthalmology, Eye Unit, Ospedale “C. Cantu”, 
Abbiategrasso, Italy; 4Reading Health Center, 
Reading, MA.*CR 
5967 — A192 Subsequent Slt Can Be Effective 
After Initially Less Responsive Slt: 4 Year 
Follow-up. Albert S. Khouri1, T.L. Berezina1, 
B. Maltzman2, K. Shah3, R.D. Fechtner1. 
1Ophthalmology, UMDNJ - New Jersey Med 
Sch, Newark, NJ; 2Ophthalmology, Hudson Eye 
Physicians and Sugeons, Jersey City, NJ; 3Drexel 
University, Philadelphia, PA. 
5968 — A193 Selective Laser Trabeculoplasty: 
12 Years Follow Up. Audrey Giocanti-Auregan, Y. 
Lachkar. Ophthalmology, St Joseph, Paris, France. 
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5977 — A202 A Qualitative and Quantitative 
Analysis of Filtering Blebs with Optical 
Coherence Tomography in Patients after 
Primary Trabeculectomy. Pietro E. Napoli, I. 
Zucca, M. Fossarello. Eye Clinic, University of 
Cagliari, Cagliari, Italy. 
5978 — A203 Anterior Segment OCT in Eyes 
with Cyclodialysis after Trabectome Glaucoma 
Surgery. Robert M. Knape, F.E. Sayyad, M.R. 
Banitt. Ophthalmology, Bascom Palmer Eye 
Institute, University of Miami, Miami, FL. 
5979 — A204 Analysis of Bleb Morphology 
after Trabeculectomy with Anterior Segment 
Module Spectralis Ocular Coherence 
Tomography (SD-OCT). Sara Bochicchio, L. 
de Polo, M. Blini, G. Staurenghi. Dpt of Clinical 
Science, Eye Clinic Sacco Hospital, Milano, 
Italy.*CR 
5980 — A205 Filtration Bleb-associated Tear 
Film Sign Demonstrated by Three Dimensional 
Anterior Segment Optical Coherence 
Tomography (3D AS-OCT). Sachi Kojima, T. 
Inoue, T. Kawaji, U. Kuroda, K-I. Nakashima, 
R. Matsumura, H. Tanihara. Deparment of 
Ophthalmology and Visual Science, Kumamoto 
University Graduate School of Medical Sciences, 
Kumamoto, Japan. 
5981 — A206 Scanning Electron Microscopy 
Findings In Rabbit Eyes Undergoing Ultrasonic 
Cyclocoagulation. Florent Aptel1,2, A. Béglé3, T. 
Charrel2,3, C. Lafon2, J-Y. Chapelon2, P. Denis4, 
F. Romano3. 1Grenoble University Hospital, 
Grenoble, France; 2Inserm U1032, Lyon, France; 
3EyeTechCare, Rillieux la Pape, France; 4Croix-
Rousse University Hospital, Lyon, France.*CR 
5982 — A207 The Effects Of Combined 
Endoscopic Cyclophotocoagulation (ECP) 
And Phacoemulsification In The Treatment Of 
Mild to Moderate Glaucoma. Michael J. Siegel1, 
W-S. Shieh2, O.S. Faridi3, C.K. Gupta4, M.S. 
Juzych1, M.E. Citron5, M.J. Siegel5, L.I. Siegel5. 
1Ophthalmology, Kresge Eye Institute, Detroit, 
MI; 2School of Medicine, Wayne State University, 
Detroit, MI; 3Ophthalmology, William Beaumont 
Hospital, Royal Oak, MI; 4Ophthalmology, 
Beaumont, Bloomfield Hills, MI; 5Glaucoma Center 
of Michigan, Southfield, MI. 
Hall B/C D804-D848




5983 — D804 Analysis of the Role of ZEB1 
in the Pathogenesis of Posterior Polymorphous 
Corneal Dystrophy. Vivek S. Yellore1, R.K. 
Gangalum2, S.A. Rayner1, C.K. Nguyen1, Z. Jing3, 
S.P. Bhat4, A.J. Aldave5. 1Jules Stein Eye Institute, 
Univ of California-Los Angeles, Los Angeles, 
CA; 2Ophthalmology, Jules Stein Eye Institute, 
UCLA, Los Angeles, CA; 3Jules Stein Eye Institute, 
University of California, Los Angeles, Los Angeles, 
CA; 4Ophthalmology, Jules Stein Eye Institute 
UCLA, Los Angeles, CA; 5Cornea Service, CHS/
UCLA, Los Angeles, CA. 
5984 — D805 Posterior Polymorphous 
Dystrophy: A Proposed Mechanism for Associated 
High Myopia. Sharel C. Ongchin, A. Weiss. 
Ophthalmology, University of Washington, Seattle, 
WA. 
5985 — D806 Oxidative Stress and Protective 
Proteins in Fuchs Endothelial Corneal Dystrophy. 
Yutaka Kaneko, S. Saraswathy, R.E. Smith, N.A. Rao. 
Ophthalmology, Doheny Eye Institute, Los Angeles, 
CA. 
5986 — D807 Surgical Management and 
Outcomes of Patients with Concurrent Fuchs’ 
Corneal Endothelial Dystrophy and Keratoconus 
- A Multi-Center Case Series. Charles S. 
Bouchard1, S. Vira1, U. Abugo1, B. Sperling2, S. 
Basti3, S.B. Hannush2. 1Ophthalmology, Loyola 
University Chicago, Maywood, IL; 2Cornea Service, 
Wills Eye Institute Cornea Service, Langhorne, PA; 
3Ophthalmology, NWestern Univ Feinberg Sch of 
Med, Willowbrook, IL. 
5987 — D808 Genetic screen of African-
Americans with Fuchs endothelial corneal 
dystrophy. Natalie A. Afshari1, M.A. Minear2, J. 
Rimmler2, E. Balajonda1, S. Watson2, M.A. Hauser3, 
R R. Allingham1, G.K. Klintworth4, Y-J. Li2, S.G. 
Gregory2. 1Ophthalmology, Duke University Eye 
Center, Durham, NC; 2Duke Center for Human 
Genetics, Durham, NC; 3Ophthalmology & 
Medicine, Duke Univ Medical Center, Durham, 
NC; 4Pathol Ophthal, Duke Univ Medical Center, 
Morrisville, NC. 
5988 — D809 Successful Culture Of Human 
Corneal Endothelial Cells Isolated From Patients 
With Fuchs Endothelial Corneal Dystrophy. 
Marie-Claude Perron1, K. Zaniolo2, C. Bostan1, O. 
Rochette Drouin2, A. Deschambeault2, I. Brunette1,3, 
S. Proulx2. 1Maisonneuve-Rosemont Hospital 
Research Center, Montreal, QC, Canada; 2Centre 
LOEX de l’Université Laval, Génie tissulaire 
et régénération; Centre de recherche FRSQ du 
CHA universitaire de Québec and Department of 
ophthalmology and ORL, Laval University, Quebec, 
QC, Canada; 3Department of ophthalmology, 
University of Montreal, Montreal, QC, Canada. 
Thursday – Posters – 5977 – 5995
5989 — D810 Relationship between Central 
and Peripheral Corneal Thickness in Fuchs 
Endothelial Dystrophy. Daniel Repp1A, D. Hodge1B, 
K. Baratz1A, J. McLaren1A, K. Kittleson1A, S. Patel1A. 
AOphthalmology, BHealth Sciences Research, 1Mayo 
Clinic, Rochester, MN. T 
5990 — D811 Regional variability in endothelial 
cell density in Fuchs Endothelial Corneal 
Dystrophy; An HRT3 Study. Christina R. 
Prescott, P. Hamrah, U. Jurkunas. Ophthalmology, 
Massachusetts Eye and Ear Infirmary, Boston, MA. 
5991 — D812 Differential Modes of Cell Death 
in Mouse Models of Fuchs Dystrophy Harboring 
Homozygous L450W and Q455K Mutations in the 
Col8a2 Gene. Huan Meng1, M. Matthaei2, A.S. Jun3. 
1Ophthalmology, Anterior Segment, Johns Hopkins 
Wilmer Eye Institute, Baltimore, MD; 2Anterior 
Segment / Cornea, The Wilmer Eye Inst, Johns 
Hopkins Univ, Baltimore, MD; 3Ophthal-Smith 5011, 
Johns Hopkins Wilmer Eye Inst, Baltimore, MD. 
5992 — D813 Reconstruction of a Corneal 
Endothelium Using Cells From Patients With 
Fuchs Endothelial Corneal Dystrophy. Stephanie 
Proulx1, M. Haydari2, B. Goyer1, O. Roy1, S. 
Laprise1, O. Rochette Drouin1, I. Brunette2. 1Centre 
LOEX de l’Université Laval, Génie tissulaire 
et régénération; Centre de recherche FRSQ du 
CHA universitaire de Québec and Département 
d’ophtalmologie, Université Laval, Quebec, QC, 
Canada; 2Département d’ophtalmologie, Université 
de Montréal and Centre de Recherche de l’Hôpital 
Maisonneuve-Rosemont, Montréal, QC, Canada. 
5993 — D814 Sulforaphane Decreases 
Endothelial Cell Apoptosis in Fuchs Endothelial 
Corneal Dystrophy: A Novel Treatment. Alireza 
Ziaei, U.V. Jurkunas. Schepens Eye Research 
Institute, Massachusetts Eye and Ear, Department of 
Ophthalmology, Harvard Medical School, Boston, 
MA. 
5994 — D815 Fabricating Bioengineered 
Corneal Endothelial Cell Sheet Through 
Chitosan-polycaprolactone-blended Membranes. 
Tsung-Jen Wang1,2, I-J. Wang3,4, T-H. Young2. 
1Department of Ophthalmology, Taipei Medical 
University Hospital, Taiepi, Taiwan; 2Institute of 
Biomedical Engineering,, College of Medicine and 
College of Engineering, National Taiwan University, 
Taiepi, Taiwan; 3Department of Ophthalmology, 
National Taiwan University Hospital, Taiepi, Taiwan; 
4Department of Ophthalmology, National Taiwan 
University College of Medicine, Taipei, Taiwan. 
5995 — D816 Evaluating the Use of Statins 
in the Establishment of a Corneal Endothelial 
Protective Phenotype. Guadalupe Villarreal, Jr., T. 
Schmedt, R. Pineda, U.V. Jurkunas. Department of 
Ophthalmology, Massachusetts Eye & Ear Infirmary, 
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6012 — D833 NF-κB is the Transcription Factor 
of FGF-2 that Causes Endothelial Mesenchymal 
Transformation in Cornea. JeongGoo Lee1,2, J M. 
Heur1,2, E.P. Kay1,2. 1Ophthalmology, University of 
Southern California, Los Angeles, CA; 2Doheny Eye 
Institute, Los Angeles, CA. 
6013 — D834 Isolation and Propagation of 
Human Corneal Endothelial Cells Using a Dual 
Media Culture System. Gary S. Peh1, K-P. Toh1, 
D. Balehosur1, H-P. Ang1, M-X. Lee1, D.T. Tan2,3, 
J. Mehta2,4. 1Singapore Eye Research Institute, 
Singapore, Singapore; 2Singapore National Eye 
Centre, Singapore, Singapore; 3Department of 
Ophthalmology, Yong Loo Lin School of Medicine, 
National University of Singapore., Singapore, 
Singapore; 4Department of Clinical Sciences, 
Duke-NUS Graduate Medical School, Singapore, 
Singapore. 
6014 — D835 Apoptosis And Viability Of 
Human Corneal Endothelial Cell Cultures 
Following Photodynamic Therapy (pdt). Tanja 
Stachon1A, J. Wang1A,2, T. Eppig1B, A. Langenbucher1B, 
B. Seitz1A, N. Szentmáry1A. ADepartment of 
Ophthalmology, BExperimental Ophthalmology, 
1Saarland University Hospital, Homburg/Saar, 
Germany; 2Department of Ophthalmology, Renmin 
Hospital of Wuhan University, Wuhan, China. 
6015 — D836 Transient Receptor Potential 
Melastatin 8 (TRPM8) Channels Mediate 
Complex Calcium Responses in Human Corneal 
Endothelial Cells. Stefan Mergler1, M. Valtink2, 
M. Sahlmüller1, P.S. Reinach3, K. Engelmann4, U. 
Pleyer1. 1Department of Ophthalmology, University 
Medicine Charite Berlin, Berlin, Germany; 
2Anatomy, TU Dresden, Dresden, Germany; 
3Biological Sciences, SUNY College of Optometry, 
New York, NY; 4Ophthalmology, Klinikum 
Chemnitz, Chemnitz, Germany.*CR 
6016 — D837 System to High-Throughput Drug 
Screening with Corneal Endothelial Survival 
Effect against ER and Oxidative Stress. Eun Chul 
Kim, H. Meng, M. Matthaei, G. Bonfadini, A.S. Jun. 
Ophthalmology, Wilmer Eye Institute, Baltimore, 
MD. 
6017 — D838 Corneal Endothelial Cell 
Migration and Proliferation Enhanced by Rho 
Kinase (ROCK) Inhibitors and Statins. Landon 
C. Meekins, N. Rosado-Adames, R. Maddala, D.L. 
Epstein, V. Rao, N.A. Afshari. Ophthalmology, Duke 
University Eye Center, Durham, NC. 
6018 — D839 Study of Effect of Donor Age 
and Death Enucleation Time on in-vitro Culture 
of Human Corneal Endothelial Cells. Himi 
Singh1A, R. Tandon1A, S. Mohanty1B, A. Kumar1A. 
AOphthalmology,Dr.R.P. Centre for Ophthalmic 
Sciences, BStem Cell Facility, 1All India Institute of 
Medical Sciences, New Delhi, India. 
5996 — D817 Kinetics of Intracellular Pro-
Apoptotic Bax Protein Inducing Cell Death 
in Corneal Endothelial Cells. Marko Pastak1A, 
B.B. Singer1A, A. Kovtun2, M. Czugala1A, B. 
Seitz3, M. Epple2, K-P. Steuhl1B, S. Ergün1A, T.A. 
Fuchsluger1A,4. AInstitute of Anatomy, BDepartment 
of Ophthalmology, 1Essen University Hospital, 
Essen, Germany; 2Institute of Inorganic Chemistry, 
University of Duisburg Essen, Essen, Germany; 
3Department of Ophthalmology, Saarland University 
Hospital, Homburg/Saar, Germany; 4Department 
of Ophthalmology, Düsseldorf University Hospital, 
Düsseldorf, Germany. 
5997 — D818 Cell cycle CDK1 expression profile 
of Human Corneal Endothelial Cells (HCECs). 
Aboulghassem Shahdadfar, J. Navaratnam, J.K. 
Slettedal, L. Lillevold, S. Boye, M.C. Moe, L.K. 
Drolsum, B. Nicolaissen. Center for Eye Research, 
Department of Ophthalmology, Oslo University 
Hospital and University of Oslo, Norway. 
5998 — D819 Viral Vectors For Gene Transfer 
To Corneal Endothelial Cells. Thomas A. 
Fuchsluger1,2, U.V. Jurkunas3, A. Kazlauskas4, R. 
Dana5. 1Department of Ophthalmology, Heinrich-
Heine-University Duesseldorf, Duesseldorf, 
Germany; 2Department of Ophthalmology, Schepens 
Eye Research Institute, Massachusetts Eye and Ear 
Infirmary, Harvard Medical School, Boston, MA; 
3Dept of Ophthalmology/Harvard Med Sch, Mass 
Eye&Ear Infirmary; Schepens Eye Res, Boston, MA; 
4Ophthalmology, Schepens Eye Res Inst/ Harvard, 
Boston, MA; 5MEEI/SERI Harvard Ophthalmology, 
Boston, MA.*CR 
5999 — D820 Rock Inhibitor Eye Drops 
Accelerate Corneal Endothelium Wound Healing 
In A Primate Model. Naoki Okumura1,2, N. 
Koizumi1,2, M. Ueno2, Y. Sakamoto1, H. Takahashi1, 
K. Yamasaki1, R. Torii3, J. Hamuro2, S. Kinoshita2. 
1Biomedical Engineering, Doshisha University, 
Kyotanabe, Japan; 2Ophthalmology, Kyoto 
Prefectural Univ of Med, Kyoto, Japan; 3Research 
Center for Animal Life Science, Shiga University, 
Otsu, Japan. 
6000 — D821 Culture of Human Corneal 
Endothelial Cells (HCECs) for therapeutic 
purposes. Jesintha Navaratnam1A, J.K. Slettedal1A, 
E. Gulliksen1A, S. Boye1, M.C. Moe1A, L. Drolsum1A, 
B. Nicolaissen1A, A. Shahdadfar1A. ACenter for Eye 
Research, 1Oslo University Hospital, Oslo, Norway. 
6001 — D822 Increased Proliferation and 
Replicative Lifespan of Isolated Human 
Corneal Endothelial Cells with L-Ascorbic acid 
2-phosphate. Satoru Yamagami1,2, N. Shima1, M. 
Kimoto2, M. Yamaguchi2. 1Ophthalmology, University 
of Tokyo Graduate School of Medicine, Bunkyo-ku, 
Japan; 2Foundation for Biomedical Research and 
Innovation, Kobe, Japan. 
6002 — D823 Evaluation Of Cytotoxicity 
Of Bevacizumab On VEGF-enriched Corneal 
Endothelial Cells. Carolee M. Cutler Peck, R. 
Rusovici, S. Grover, K V. Chalam. Ophthalmology, 
University of Florida College of Medicine, 
Jacksonville, FL. 
6003 — D824 In Vitro Expansion Of Corneal 
Endothelial Cells On Biomimetic Substrates. 
Rachelle Palchesko1,2, J.L. Funderburgh1, A. 
Feinberg2. 1Ophthalmology, University of Pittsburgh 
School of Medicine, Pittsburgh, PA; 2Biomedical 
Engineering, Carnegie Mellon University, Pittsburgh, 
PA. 
6004 — D825 Lentivirus Mediated Interference 
With the ZO-1/ZONAB Pathway Induces 
Cell Cycle Progression in Human Corneal 
Endothelial Cells. Daniel Kampik1,2, M. Basche1, 
A. Georgiadis1, U.F. Luhmann1, A.J. Smith1, F. 
Larkin2, R.R. Ali1. 1Department of Genetics, UCL 
Institute of Ophthalmology, London, United 
Kingdom; 2Moorfields Eye Hospital, London, United 
Kingdom. T 
6005 — D826 Functional Study of SLC4A11 in 
HEK293 cells. Diego G. Ogando1, S.S. Jalimarada1, 
E.N. Vithana2, J.A. Bonanno1. 1School of Optometry, 
Indiana University, Bloomington, IN; 2Singapore Eye 
Research Institute, Singapore, Singapore. 
6006 — D827 Functional Characterization of 
the Zebrafish Corneal Endothelium. J M. Heur1A, 
S. Jiao1A, G. Crump1B. AOphthalmology, BCell and 
Neurobiology, 1University of Southern California, 
Los Angeles, CA. 
6007 — D828 Notch Inhibitor DAPT Blocks 
Fibroblastic Transformation of Corneal 
Endothelium. Cheng Li, F. Dong, W. Li, Z. Liu. 
Eye Inst & Affiliated Xiamen Eye Ctr, Xiamen, 
China. T 
6008 — D829 Over-representation Preliminary 
Analysis Between Expressed Genes In Corneal 
Endothelium And Mesenchymal Stem Cells. 
Jorge E. Valdez1,2, J. Zavala2, V. Treviño3, E. 
Martínez3. 1Dean’s Office, Tecnologico de Monterrey 
School of Medicine, Monterrey, Mexico; 2Cátedra 
de Oftalmología - Tecnológico de Monterrey, 
Monterrey, Mexico; 3Cátedra de Bioinformática - 
Tecnológico de Monterrey, Monterrey, Mexico. 
6009 — D830 CD147 Expression Required for 
Lactate Transporters MCT1 and MCT4 in Rabbit 
Corneal Endothelium. Shimin Li, T.T. Nguyen, J.A. 
Bonanno. School of Optometry, Indiana University, 
Bloomington, IN. 
6010 — D831 Cultivation of Human Corneal 
Endothelial Cells on a Pericellular Matrix 
Prepared from Human Decidua-Derived 
Mesenchymal Cells. Ryohei Numata1, N. 
Okumura1, M. Nakahara1, M. Ueno2, S. Kinoshita2, 
Y. Kanemura3, Y. Sasai4, N. Koizumi1. 1Biomedical 
Engineering,Faculty of Life and Medical 
Sciences, Doshisha University, Kyotanabe, Japan; 
2Ophthalmology, Kyoto Prefectural Univ of Med, 
Kyoto, Japan; 3Division of Regenerative Medicine, 
Institute for Clinical Research Osaka National 
Hospital, National Hospital Organization, Osaka, 
Japan; 4Center for Developmental Biology, Riken, 
Kobe, Japan. 
6011 — D832 The Role Of DJ-1 In Nrf2-
regulated Antioxidant Defense In Human Corneal 
Endothelial Cells. Cailing Liu, T. Schmedt, U. 
Jurkunas. Schepens / Massachusetts Eye and Ear, 
Harvard Medical School, Boston, MA. 
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6019 — D840 Enhanced Survival and 
Expansion of Bovine Corneal Endothelial 
Progenitors using Accutase. Wing Yan Yu1A, C.M. 
Sheridan2, I. Grierson2, A.C. Lo1A,1B, D. Wong1A,1B. 
AEye Institute, BResearch Centre of Heart, Brain, 
Hormone and Healthy Aging, 1The University of 
Hong Kong, Hong Kong, Hong Kong; 2Department 
of Eye and Vision Science, University of Liverpool, 
Liverpool, United Kingdom.*CR 
6020 — D841 Cytotoxicity of Ganciclovir on 
Cultured Human Corneal Endothelial Cells. 
Young Joo Shin1, J. Koh2, T. Chung3, J. Hyon4, 
W. Wee4. 1Ophthalmology, Hallym University 
College of Medicine, Seoul, Republic of Korea; 
2Ophthalmology, Chosun University School 
of Medicine, Kwangju, Republic of Korea; 
3Ophthalmology, Samsung Medical Center, 
Sungkyunkwan University School of Medicine, 
Seoul, Republic of Korea; 4Ophthalmology, Seoul 
National University College of Medicine, Seoul, 
Republic of Korea. 
6021 — D842 Cytoplasmic Localization Of 
P120ctn And N-cadherin In Ex Vivo Expansion Of 
Human Corneal Endothelial Cells On Amniotic 
Membrane. Ray J. Tsai1, R.Y. Tsai2. 1Ophthalmology, 
Taipei Eye Center/Taipei Medical University, Taipei, 
Taiwan; 2Ophthalmology, Taipei Eye Center, Taipei, 
Taiwan.*CR 
6022 — D843 Idiopathic Multifocal Pigmented 
Plaques on the Corneal Endothelium. Liwu G. 
Chen1,2, P.T. Finger2,1. 1Ophthalmology, New York 
University, New York, NY; 2Ophthalmic Oncology, 
New York Eye Cancer Center, New York, NY. 
6023 — D844 Endothelial Keratoplasty: The 
Relationship Between Six Month Postoperative 
Endothelial Cell Density And Graft Survival. 
Asem A. Alqudah1A, M.A. Terry1B, M. Straiko1A, M. 
Greiner1A, D. Davis-Boozer2. ACornea, BCorneal 
Services, 1Devers Eye Institute, Portland, OR; 2Lions 
Eye Bank of Oregon, Portland, OR.*CR 
6024 — D845 Effect Of Air Fill Pressure And 
Graft Thickness On Interface Fluid Dispersion In 
An Oct Model Of Descemets Stripping Automated 
Endothelial Keratoplasty. Maninder S. Bhogal, 
B.D. Allan. Cornea and External diseases, Moorfields 
Eye Hospital, London, United Kingdom. 
6025 — D846 Corneal Endothelial Reserve 
and Corneal Endothelial Reserve Factor for 
Intraocular Surgeries. Fernando C. Abib1A, D.S. 
Abib1B. AAnatomy, BAnesthesiology, 1Federal 
University of Parana, Curitiba, Brazil.*CR 
6026 — D847 Long-Term Endothelial 
Cell Density with Phakic Foldable Iris-
Claw Intraocular Lens (Veriflex®). Natalie 
Kaplan1, H. Dick2, W. Sekundo3, N. Pfeiffer1, U. 
Vossmerbaeumer1. 1Department of Ophthalmology, 
Mainz University Medical Center, Mainz, Germany; 
2Department of Ophthalmology, Ruhr University 
Bochum, Bochum, Germany; 3Department of 
Ophthalmology, Marburg University Medical Center, 
Marburg, Germany. 
6027 — D848 Improvement Of Endothelial 
Keratoplasty Lamellar Dissection By Combined 
Use Of Femtosecond And Excimer Lasers. 
Liem Trinh1A,1B, B. Saubaméa2,3A, F. Auclin1A,1B, A. 
Denoyer1A,4, R. Lai-Kuen3A, M. El Hamdaoui1A,1B, A. 
Labbé1A,4, M-C. Despiau1C, F. Brignole-Baudouin4,3B, 
C. Baudouin1A,4. AOphthalmology III, BClinical 
Investigation Center (CIC) 503, CPharmacy, 
1Quinze-Vingts National Hospital, Paris, France; 
2INSERM U705, UMR CNRS 8206, Paris, France; 
APlateau Technique d’Imagerie Cellulaire et 
Moléculaire, BToxicology, 3Faculty of Biological 
and Pharmacological Sciences, University of Paris 
5 René Descartes, Paris, France; 4Vision Institute, 
UMRS 968, University Pierre et Marie Curie Paris 6, 
Paris, France. 
Hall B/C D849-D896






6028 — D849 Main indications for admission 
to a corneal transplant program in Mexico: 
Analysis of the National Transplant Registry. 
Jose A. Claros1, A.J. Ramirez-Miranda1, R. Vargas1, 
A. Navas1, A. Gomez1, A. Jimenez-Corona2, E.O. 
Graue1. 1Cornea And Refractive Surgery, Instituto 
de Oftalmologia Conde de Valenciana, Mexico 
City, Mexico; 2Instituto Nacional de Salud Publica, 
Cuernavaca, Mexico. 
6029 — D850 Evolution of Corneal 
Transplantation in the Province of Quebec 
from 2000 to 2011. Louis-Pierre Gauvin 
Meunier1, J. Lapointe1, M-È. Choronzey2, S. 
Dubuc3, M. Germain3, M. Mabon1,4, I. Brunette1,2. 
1Ophthalmology, University of Montreal, Montreal, 
QC, Canada; 2Maisonneuve–Rosemont Hospital 
Research Center, Montreal, QC, Canada; 3Héma-
Québec, Québec, QC, Canada; 4Quebec Eye Bank, 
Montreal, QC, Canada. 
6030 — D851 Average Waiting Time before 
Keratoplasty and Possible Variation of this 
Deadline According to the Seasons: Retrospective 
Study about 318 cases and 10 Years of Follow-
up. Jean-Marc Perone, A. Agapie, O. Guechi, 
O. Gheorghe, I. Botez, P-J. Bertaux, A. Ferte. 
Ophthalmology, Regional Hospital Center of Metz 
Bon Secours, Metz, France. 
6031 — D852 Comparison Of Single Versus 
Multiple Field Endothelial Cell Counts Of 
Donor Corneas Using A Large Field Specular 
Microscope. Bennie H. Jeng1, B. Iliakis2, C. 
Ulrickson2. 1Ophthalmology, University of California 
San Francisco, San Francisco, CA; 2SightLife, 
Seattle, WA. 
6032 — D853 European Study On Reliability 
Assessment Of Endothelial Cell Count In Eye 
Banks: The Eurokeratotest Study. Gilles Thuret1A,2, 
Z. He2, N. Campolmi1A,2, B. Ha Thi2, J. Dumollard1B, 
M. Peoc’h1B, N. Delesalle3, A. Bernard2, P. Gain1A,2. 
AOphthalmology, BPathology, 1University Hospital 
of St-Etienne, Saint-Etienne, France; 2Corneal Graft 
Biology, Engineering and Imaging Laboratory, 
EA2521, Federative Institute of Research, Faculty 
of Medicine, Jean Monnet University, Saint-Etienne, 
France; 3The French Health Products Agency 
(Afssaps), Saint-Denis, France. 
6033 — D854 Reasons for not harvesting 
corneas in the Hospital São Paulo Eye Bank. Joyce 
Tsuchiya, V. Yamada, F.E. Hirai, M. Coelho, C.B. 
Adán, É.H. Sato. Ophthalmology, UNIFESP, Sao 
Paulo, Brazil. 
6034 — D855 Restriction Of Donor Cornea 
Post-Mortem Time To 24 Hours Does Not Lead 
To Further Improvement Of Allograft Quality. 
Anja K. Gruenert, K. Rosenbaum, G. Geerling, 
T.A. Fuchsluger. Department of Ophthalmology, 
Heinrich Heine University Duesseldorf, Duesseldorf, 
Germany. 
6035 — D856 Downs Syndrome Donor Tissue: 
Suitability and Outcomes of Stromal Replacement 
Corneal Transplantation. Syed Mahmood A. Shah1, 
M. Moshirfar2, M. Mifflin2, Y. Khalifa1,2. 1Flaum Eye 
Institute, University of Rochester Medical Center, 
Rochester, NY; 2Moran Eye Center, University of 
Utah, Salt Lake City, UT. 
6036 — D857 Preparation and Evaluation of 
Decellularized Porcine Cornea. Jemin J. Chae1, Q. 
Lu1, J. Choi1, Q. Guo1, O.D. Schein2, J.H. Elisseeff1. 
1Biomedical Engineering, Johns Hopkins University, 
Baltimore, MD; 2Ophthalmology, Johns Hopkins 
Wilmer Eye Inst, Baltimore, MD. 
6037 — D858 Cross-linked Variants Of A Novel 
Semi-synthetic Collagen Substitute For The 
Reconstruction Of The Surface. Corinna Petsch1, 
U. Schlotzer-Schrehardt2, M. Frey3, F.E. Kruse4, B. 
Bachmann1. 1Ophthalmology, University Hospital 
Erlangen, Erlangen, Germany; 2Department of 
Ophthalmology, University of Erlangen-Nürnberg, 
Erlangen, Germany; 3RESORBA Wundversorgung 
GmbH & Co. KG, Nuremberg, Germany; 
4Department of Ophthalmology, University of 
Erlangen Nurnberg, Erlangen, Germany.*CR T 
6038 — D859 A Biocornea Of Fish Scales - First 
Results Of A Research Model. T. H. Van Essen1, C 
C. Lin2, H.J. Lai2, A.K. Hussain1, M.J. Jager1, G.P. 
Luyten1. 1Department of Ophthalmology, Leiden 
University Medical Center, Leiden, The Netherlands; 
2Department of Research, Aeon Astron Europe B.V., 
Leiden, The Netherlands.*CR 
6039 — D860 Investigation for the Possibility 
of Using Polymer Hydrogels as a Device for 
Cultivation and Transplantation of Corneal 
Epithelial Cells. Toru Matsunaga1,2, Y. Watanabe1,2, 
T. Sato1,2, T. Funaki1, A. Matsuda1, N. Ebihara1, A. 
Murakami1. 1Dept of Ophthalmology, Juntendo Univ 
School of Med, Bunkyo-Ku, Japan; 2Research and 
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6058 — D879 Femtosecond Laser-Assisted 
Mushroom Configuration Penetrating 
Keratoplasty And Deep Anterior Lamellar 
Keratoplasty In Advanced Keratoconus. Simon 
S. Fung1, F. Aiello2,1, A. Iovieno1, C. Nucci2, V. 
Maurino1. 1Cornea and External Disease Service, 
Moorfields Eye Hospital, London, United Kingdom; 
2Department of Biopathology, Ophthalmology Unit, 
University of Rome Tor Vergata, Rome, Italy. 
6059 — D880 Femtosecond Laser Assisted 
Keratoplasty: Comparing Full and Partial-
thickness Cut Wound Burst Pressure and 
Endothelial Cell Loss Across a Variety of Wound 
Patterns. Kamden R. Kopani1, M.A. Page2, J.D. 
Holiman3, D. Davis-Boozer3, C. Stoeger3, W.D. 
Chamberlain1. 1Ophthalmology, Casey Eye Institute, 
Portland, OR; 2Ophthalmology, University of 
Minnesota, Minneapolis, MN; 3Lions Eye Bank of 
Oregon, Portland, OR. 
6060 — D881 Optical Functional Properties 
Of The Osteo-odonto-keratoprosthesis (ookp). 
Richard M. Lee1, G. Ong1, J. White1, F. Lam1, C.S. 
Liu1, C.C. Hull2. 1Ophthalmology, Sussex Eye 
Hospital, Sussex Eye Hospital, United Kingdom; 
2Optometry & Visual Science, City University, 
London, United Kingdom. 
6061 — D882 In Vitro Effect of Microbial 
Infection on Candidate Biomaterials for Osteo-
Odontoid Keratoprosthesis Skirt. Jodhbir S. 
Mehta1A, X. Tan1B, A. Riau2, A. Tan3, R.W. Beuerman2, 
D. Tan1A, K. Khor2. ACornea Refractive Tissue 
Engineering, BTissue Engineering, 1SNEC / SERI, 
Singapore, Singapore; 2Tissue Engineering, SERI, 
Singapore, Singapore; 3Cornea, SNEC, Singapore, 
Singapore. 
6062 — D883 Field of View of Modified Osteo-
Odonto Keratoprosthesis. Victor M. Hernandez1A,2, 
C. de Freitas1A, G.C. Falcinelli1B, Y. Sawatari3, V. 
Perez1B, D. Sathiah3, F. Manns1A,2, E.C. Alfonso1B, 
J-M.A. Parel1B,1A. AOphthalmic Biophysics Center, 
BDepartment of Ophthalmology, 1Bascom Palmer 
Eye Institute, Miami, FL; 2Department of Biomedical 
Engineering, Biomedical Optics and Laser 
Laboratory, University of Miami, Coral Gables, FL; 
3Department of Maxillofacial Surgery, University of 
Miami Miller School of Medicine, Miami, FL. 
6063 — D884 Poly(ethylene glycol diacrylate) 
- Poly(2-hydroxyethyl methacrylate) (PEGDA-
PHEMA) Based Keratoprosthesis. Amelia L. 
Zellander1, M. Makhsous2, M. Cho1. 1Bioengineering, 
University of Illinois at Chicago, Chicago, IL; 
2Physical Therapy and Human Movement Sciences, 
Orthopaedic Surgery and Physical Medicine, 
Northwestern University, Chicago, IL.*CR 
6064 — D885 Boston Type 1 Keratoprosthesis: 
Microbial Colonization and Antibacterial 
Resistance. Elie P. Eid1A, M-C. Robert1A, P. Saint-
Antoine1B, M. Harissi-Dagher1A. AOphthalmology, 
BMicrobiology, 1Centre Hospitalier de l’Université de 
Montréal (CHUM), Hôpital Notre-Dame, Montréal, 
QC, Canada. 
6040 — D861 Reduced Hem- And 
Lymphangiogenesis Into A Fishscale-derived 
Collagen Scaffold Used As Biological Artificial 
Cornea (BioCornea). Deniz Hos1, F. Bock1, B. 
Regenfuss1, J. Onderka2, C.C. Lin3, H.J. Lai4, 
C. Cursiefen1. 1Department of Ophthalmology, 
University of Cologne, Cologne, Germany; 
2Department of Ophthalmology, University of 
Erlangen-Nuremberg, Erlangen, Germany; 3Aeon 
Astron Corp., Tapei, Taiwan; 4Aeon Astron Europe 
B.V., Leiden, The Netherlands.*CR 
6041 — D862 Autologous Tragal Perichondrium 
Transplantation in Refractory Necrotizing 
Scleritis. Jae Chan Kim, H. Koo, J. Kim. 
Ophthalmology, Chung-Ang Univ. Hospital, Seoul, 
Republic of Korea. 
6042 — D863 The Fate Of Collagen-based 
Hydrogels As Corneal Substitutes In “High Risk” 
Graft Recipients. Lucia Kuffova1, R. Fordyce1, 
M. Robertson1, M. Griffith2, J-I. Ahn3, K. Merrett4, 
R.L. Hendricks5, J.V. Forrester1. 1Department of 
Ophthalmology, University of Aberdeen, Aberdeen, 
United Kingdom; 2Integrative Regenerative Medicine 
Centre, Linköping University, Linköping, Sweden; 
3Department of Ophthalmology, University of 
Ottawa Eye Institute, Ottawa, ON, Canada; 4GMP 
Laboratories, Linköping University Hospital, 
Linköping, Sweden; 5Department of Ophthalmology, 
University of Pittsburgh School of Medicine, 
Pittsburgh, PA.*CR 
6043 — D864 Therapeutic Keratoplasty 
Using Cryo-preserved Human Cornea For The 
Urgent Treatment Of Perforated Cornea Due To 
Infectious Keratitis. Hyung-Joon Kim, J-H. Lee. 
Department of Ophthalmology, Daegu Catholic Univ 
Hospital, Daegu, Republic of Korea. 
6044 — D865 Corneal Patch Grafts: A Review 
of the Indications, Techniques, And Success 
Rates. Gabriel Schaab, C. Clavell, H. Goyal. 
Ophthalmology, SUNY Downstate, Brooklyn, NY. 
6045 — D866 Cosmetic And Refractive Results 
Of Lamellar Grafts In Corneal Dermoids. Fasika 
A. Woreta, A. Vedula, D. Goldman, R. Forster. 
Ophthalmology, Bascom Palmer Eye Institute, 
Miami, FL. 
6046 — D867 Repair of Acute Perforated 
Cornea with Modified Conjunctival Flap, Tissue 
Adhesive and Bandage Contact Lens. Naomi V. 
Odell, T.T. Shen. Ophthalmology, University of 
Washington, Seattle, WA. 
6047 — D868 Endothelial Graft Failure 
after Contralateral Autologous Corneal 
Transplantation. Jaime D. Martinez, A. Galor, V.L. 
Perez, C.L. Karp, S.H. Yoo, E.C. Alfonso. Bascom 
Palmer Eye Institute, Miami, FL. T 
6048 — D869 Risk Factors for Endothelial 
Cell Loss after Corneal Transplantation. 
Vincent M. Borderie1A, J. Bullet1A, O. Touzeau1A, 
P. Goldschmidt1B, L. Laroche1A. AOphthalmology, 
BLaboratory, 1CHNO des Quinze-Vingts, Paris, 
France. 
6049 — D870 Graft Failure And Intraocular 
Pressure Control After Keratoplasty In 
Iridocorneal Endothelial Syndrome. Desmond T. 
Quek1,2, S. Han1,3, T. Wong1,2, D. Tan1,2, J. Mehta1,2. 
1Singapore National Eye Center, Singapore, 
Singapore; 2Singapore Eye Research Institute, 
Singapore, Singapore; 3Ophthalmology, Samsung 
Medical Centre, Sungkyunkwan University, Korea, 
Republic of Korea. 
6050 — D871 Corneal Transplant Surgery in 
Mucolipidosis IV-- A Clinico-pathologic Review. 
Chelsea Lefebvre, K. Juechter, D. Husney, L. Han, 
S. Jain, G. Zaidman. Ophthalmology, New York 
Medical College, Valhalla, NY. 
6051 — D872 A Study On Recurrent 
Corneal Stromal Dystrophies: Fifteen Years Of 
Penetrating Keratoplasty. Tenley N. Bower, B.F. 
Fernandes, D. Cheema, J. Deschenes, P.T. Logan, 
M.N. Burnier, Jr. McGill University, Montreal, QC, 
Canada. 
6052 — D873 Clinical Outcomes Of Surgical 
Intervention For Stromal Corneal Dystrophies. 
Jagadesh C. Reddy, C.J. Rapuano, K.M. 
Hammersmith, P.K. Nagra. Cornea Service, Wills 
Eye Institute, Philadelphia, PA. 
6053 — D874 Long-Term Outcome of Corneal 
Transplant Surgery in Pediatric Patients 
with Keratoconus. Anna Djougarian1,2, G.W. 
Zaidman1,2. 1New York Medical College, Valhalla, 
NY; 2Ophthalmology, Westchester Medical Center, 
Valhalla, NY. 
6054 — D875 Spontaneous wound dehiscence 
after removal of combined penetrating 
keratoplasty suture. Retrospective study about 
71 cases. Oualid Guechi, J-M. Perone, A. Agapie, 
O. Gheorghe, A. Ferte, I. Botez, P-J. Bertaux. 
Ophthalmology, Regional Hospital Center of Metz 
Bon-Secours, Metz, France. 
6055 — D876 Impact Of Early Vs. Late Suture 
Removal On Astigmatism And Visual Acuity In 
Femtosecond Laser Keratoplasty. Payam Morgan, 
K. Lin, M. Wade, A. Pirouzian, S. Garg, M. Farid, R. 
Gaster, R. Steinert. Department of Ophthalmology, 
Gavin Herbert Eye Institute, UC Irvine, Irvine, CA. 
6056 — D877 Results Of Excimer Laser 
Penetrating Keratoplasty In Aphakic Eyes. Kouris 
Ninios, P. Matoula, N. Szentmary, F. Schirra, B. 
Seitz. Department of Ophthalmology, University of 
Saarland, Homburg, Germany. 
6057 — D878 Update on the Outcome of 
Femtosecond Laser Penetrating Keratoplasty 
Performed with a Zig-Zag Incision. Garrick Chak, 
M. Wade, K.Y. Lin, M. Farid, S. Garg, R.F. Steinert. 
Ophthalmology, Gavin Herbert Eye Institute, UC 
Irvine, Irvine, CA.*CR T 
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6065 — D886 Light-induced Maculopathy 
After Keratoprosthesis Surgery - True Or False? 
Borja Salvador Culla1, I. Behlau1, R.R. Sayegh1, F. 
Delori2, C.H. Dohlman1. 1Cornea - Keratoprosthesis, 
Massachusetts Eye & Ear Infirmary, Boston, MA; 
2Schepens Eye Research Institute, Boston, MA. 
6066 — D887 Outcomes following Boston 
Keratoprosthesis Type I Implantation in Aniridia 
Patients: The University of Montreal Experience. 
Salima I. Hassanaly, J. Talajic, M. Harissi-Dagher. 
University of Montreal, Montreal, QC, Canada. 
6067 — D888 Prospective Evaluation of the 
International Boston Keratoprosthesis Project 
in Ethiopia. Roberto Pineda, II1, A. Cruzat1, I. 
Behlau1, Y. Tilahun2, J. Ament1, C. Dohlman1. 
1Ophthalmology, Mass Eye & Ear Infirmary, Boston, 
MA; 2Ophthalmology, Menelick II Hospital, Addis 
Ababa, Ethiopia. 
6068 — D889 Retroprosthetic Membrane 
Thickness and Risk of Melt in Patients with Type 
I Boston Keratoprosthesis. Kavitha R. Sivaraman, 
J.H. Hou, N. Allemann, J. De la Cruz, M.S. Cortina. 
Department of Ophthalmology, University of Illinois 
Eye & Ear Infirmary, Chicago, IL. 
6069 — D890 Results of the Boston 
keratoprosthesis type 1 larger backplate. Anita 
Shukla1, A. Cruzat1, J-C. Abad2, C.H. Dohlman1, K.A. 
Colby1. 1Ophthalmology, Massachusetts Eye & Ear 
Infirmary, Boston, MA; 2Ophthalmology, Clinica 
Oftalmica de Medellin, Medellin, Colombia. 
6070 — D891 The Boston Type I 
Keratoprosthesis: The Weill Cornell Experience. 
Michael A. Klufas, K.K. Yin, N.M. Radcliffe, R.V. 
Chan, S. Kiss, D.J. D’Amico, J.B. Ciralsky, M.I. 
Rosenblatt, K.C. Sippel, C.E. Starr. Department of 
Ophthalmology, Weill Cornell Medical College, New 
York, NY. 
6071 — D892 Long-term Follow-up Of 
Implanted Boston Type I Keratoprosthesis 
And Angle Structural Changes Using Anterior 
Segment Optical Coherence Tomography. Cynthia 
X. Qian1A, S. Hassanaly1B, M. Harissi-Dagher1B. 
AOphthalmology, BMedicine, 1University of 
Montreal, Montreal, QC, Canada. 
6072 — D893 Cross-linking Donor Corneas 
for the Boston Keratoprosthesis: A Method 
of Increasing Resistance to Collagenolytic 
Degradation. Samer N. Arafat1,2, A.N. Shukla1, 
C.H. Dohlman1, J. Chodosh1, J.B. Ciolino1. 
1Massachusetts Eye and Ear Infirmary, Department 
of Ophthalmology, Harvard Medical School, 
Boston, MA; 2Schepens Eye Research Institute, 
Massachusetts Eye and Ear Infirmary, Department of 
Ophthalmology, Harvard Medical School, Boston, 
MA. 
6073 — D894 Argon Laser Iridoplasty for Optic 
Obstruction in Boston Keratoprosthesis. Joann 
J. Kang, A.A. Aref, N. Allemann, M.S. Cortina, J. 
de la Cruz. Ophthalmology and Visual Sciences, 
University of Illinois at Chicago, Chicago, IL. 
6074 — D895 Monitoring Of Glaucoma After 
The Implantation Of A Keratoprosthesis. Riccardo 
Scotto1, M. Papadia2A, A. Bagnis2B, A. Macrì3, C.E. 
Traverso2C. 1Ophthalmology, DiNOG, University 
of Genoa, Genova, Italy; ADi NOG, BEye Clinic, 
CClinica Oculistica - Di NOG, 2University of Genova, 
Genova, Italy; 3Azienda Ospedaliera Universitaria 
San Martino, Genova, Italy. 
6075 — D896 A Prospective Trial Comparing 
Scleral Pneumotonometry to Goldmann 
Applanation Tonometry. Sara L. Duke, U. Abugo, 
S. Patel. Ophthalmology, Loyola University Medical 
Center, Maywood, IL. 
Hall B/C D897-D947




6076 — D897 Effect of Contact Lens Solutions 
on the Antimicrobial Efficacy of Human Tear 
Proteins during Lens Disinfection. Bianca L. 
Price1A, P.B. Morgan1B, C. Maldonado-Codina1B, 
C.B. Dobson1A. AFaculty of Life Sciences, BEurolens 
Research, Faculty of Life Sciences, 1University of 
Manchester, Manchester, United Kingdom.*CR 
6077 — D898 Effects Of Multi-purpose 
Solutions On The Viability And Encystment Of 
Clinical Isolates Of Acanthamoeba Determined 
By Flow Cytometry. Masaki Imayasu1, K.T. 
Tchedre1, H D. Cavanagh2. 1R&D Center, Menicon 
Co Ltd, Kasugai, Japan; 2Ophthalmology, Univ 
Texas Southwestern Med Ctr, Dallas, TX.*CR 
6078 — D899 Evaluation Of Commercially 
Available Novel Multipurpose Contact Lens 
Care Solutions Effect On Membrane-associated 
Mucin Expression In The Rat Cornea. 
Kissaou T. Tchedre1, M. Imayasu1, Y. Hori2, H D. 
Cavanagh3. 1R&D and Innovation Center, Menicon 
LTD, Kasugai, Japan; 2Ophthalmology, Toho 
University Sakura Medical Center, Sakura, Japan; 
3Ophthalmology, Univ Texas Southwestern Med 
Ctr, Dallas, TX.*CR 
6079 — D900 Comparison of Disinfection 
Efficacies of Four Contact Lens Care 
Regimens Against Pseudomonas aeruginosa 
on Orthokeratology Lenses. Yoshie Itou1A, N. 
Miyata1A, T. Kawagoe2, M. Nobuhisa2, E. Okada1. 
AOkada Eye Clinic, 1Okada Eye Clinic, Yokohama, 
Japan; 2Department of Ophthalmology and Visual 
Science, Yokohama City University, Yokohama, 
Japan. 
6080 — D901 Evaluation of Acanthamoeba 
Encystment for a Novel One-Step Hydrogen 
Peroxide Disinfecting Solution and Comparator 
Peroxide Disinfecting Solutions. Shawn C. Lynch, 
C.J. Kovacs, J.G. Carr, M.A. Dehmler, K.A. Millard, 
M.J. Schoene, S.F. Groemminger, T.W. Morris. 
Bausch & Lomb, Rochester, NY.*CR 
Thursday – Posters – 6065 – 6089
6081 — D902 Antimicrobial Properties Of 
Selenium Covalently Incorporated Into The 
Polymer Of Contact Lens Case Material. Ted 
W. Reid1A, P. Tran1A, C. Jarvis1A, J. Thomas1A, 
K. Tran1A, T. Mosley2, R. Hanes3, A. Hamood1B. 
AOphthal & Visual Science, BMicrobiology, 1Texas 
Tech University Health Sciences Center, Lubbock, 
TX; 2Selenium Ltd., Lubbock, TX; 3Selenium Ltd., 
Austin, TX.*CR 
6082 — D903 Comparison of Biocidal Efficacy 
of Hydrogen Peroxide Disinfecting Systems and 
Total Peroxide Exposure Values. Jenilee Kilbury, 
K.A. Millard, S.F. Groemminger, E. Xia. Vision Care 
R&D, Bausch + Lomb Inc., Rochester, NY.*CR 
6083 — D904 Regimen Testing of a Novel One-
Step Hydrogen Peroxide Disinfecting Solution 
and Comparators with Soft Contact Lenses and 
Ocular Clinical Isolates. Jessica M. Burger, T.H. 
Bassage, A.J. Principe, D. McGrath, P.A. Walsh, 
T.W. Morris. Microbiology, Bausch & Lomb, Inc., 
Rochester, NY.*CR 
6084 — D905 Pharmacodynamic Analysis 
of Hydrogen Peroxide Solution Disinfection 
Efficacy in One-Step Peroxide Neutralizing 
Lens Cases. Timothy W. Morris, D.W. Cordero, D. 
McGrath, S.F. Groemminger, K.A. Millard. Bausch 
& Lomb, Inc, Rochester, NY.*CR 
6085 — D906 Antimicrobial Efficacy of 
Melimine Covalently Bound to Contact Lenses. 
Debarun Dutta1,2, N. Cole1,2, M. Willcox1,2. 1Brien 
Holden Vision Institute, Sydney, Australia; 2School 
of Optometry and Vision Science, University of 
New South Wales, Sydney, Australia. 
6086 — D907 Organo-Selenium Coated 
Contact Lenses: Effect Upon Bacterial Biofilm 
Attachment. Phat Tran1A, A. Hamood1B, C. 
Jarvis1C, J. Thomas1C, B. Lackey1C, T. Mosley2, 
T. Reid1C. AOphthalmology and Visual Sciences, 
BMicrobiology, COphthalmology, 1Texas Tech 
University Health Sciences Center, Lubbock, TX; 
2Selenium Ltd., Lubbock, TX.*CR 
6087 — D908 Non-Cultivatable Bacterial 
Biofilm Communities in Used Contact Lens 
Cases. Judith L. Flanagan1, M. Allgeier2, M.D. 
Willcox3, P. Hugenholtz4. 1Brien Holden Vision 
Institute, Sydney, Australia; 2Joint Genome Institute, 
Walnut Creek, CA; 3Brien Holden Vision Institute, 
Univ of New South Wales, Sydney, Australia; 
4Australian Centre for Ecogenomics, School of 
Chemistry and Molecular Biosciences & Institute 
for Mol, University of Queensland, Queensland, 
Australia. 
6088 — D909 Evaluation of Antimicrobial 
Activity and Cytotoxicity of Diamidine as 
a Disinfectant. Bandarage M. Bandara, R.S. 
Bandara, D. Wu, H. Zhu, S. Franz, M.D. Willcox. 
Brien Holden Vision Institute, UNSW, Sydney, 
Australia. 
6089 — D910 Membrane Permeability Of 
Staphylococcus Aureus Aggregates Exposed To 
Contact Lens Care Solutions. David J. McCanna, 
L.W. Jones. CCLR-School of Optometry, University 
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6108 — D929 Corneal Nerve Morphology In 
Soft And Orthokeratology Contact Lens Wear. 
Edward Lum, B. Golebiowski, H.A. Swarbrick. 
Sch of Optometry/Vision Sci, Univ of New South 
Wales, Sydney, Australia.*CR 
6109 — D930 Design and Development 
of an In Vitro Tear Replenishment System. 
Saman Mohammadi, M. Gorbet. Systems Design 
Engineering, University of Waterloo, Waterloo, ON, 
Canada. 
6110 — D931 Evaluation of Contact Lens 
Image Stability and Predicted logMAR Image 
Resolution as Lenses Dehydrate. Rosa H. Lee, 
A.C. Kingston, G. Richardson. Product Design 
Group, Bausch + Lomb, Rochester, NY.*CR 
6111 — D932 Interfacial Interactions Of 
Cationic And Anionic Artificial Tears With Ionic 
Hydrogel Contact Lens Surface. Muhammad 
Abdulrazik1, S. Benita2. 1Ophthalmology/Innovative 
Interventions, East Jerusalem Biomedical 
Institute, East Jerusalem, Palestine; 2Institute of 
Drug Research, Hebrew University of Jerusalem, 
Jerusalem, Israel.*CR 
6112 — D933 Contact Lens/Contact 
Lens solution Combinations Determine the 
Inflammatory Changes on the Ocular Surface: 
A Laser In Vivo Confocal Microscopy Study. 
Bernardo M. Cavalcanti1, A. Cruzat2, Y. Qazi3A, 
N. Baniasadi4, M. Trinidad3B, A. Watts3C, D. 
Critser5A, C. Leahy3C, C.W. Sindt5B, P. Hamrah1. 
1Cornea/Ophthalmology, Harvard Medical School/
MEEI, Boston, MA; 2Cornea / Ophthalmology, 
Harvard Medical Sch/MEEI, Boston, MA; 
AOphthalmology, BCornea Research, CContact Lens, 
3Massachusetts Eye and Ear Infirmary, Boston, MA; 
4Cornea/Ophthalmology, MA Eye & Ear Infirm/
Harvard Med Sch, Boston, MA; AContact Lens, 
BOphthalmology, 5University of Iowa, Iowa City, 
IA.*CR, f 
6113 — D934 Stress Induced Frictional 
Transitions in Cross-Linked Surface Gels. 
Thomas E. Angelini1, A.C. Dunn1, J.M. Uruena1, 
H.A. Ketelson2, W G. Sawyer1A. AMechanical and 
Aerospace Eng, 1University of Florida, Gainesville, 
FL; 2R & D, Alcon Research Ltd, Fort Worth, 
TX.*CR 
6114 — D935 Surface Mechanical and 
Tribological Properties of Silicone Hydrogels 
Measured by Atomic Force Microscopy. 
Alexander Rudy1, Y. Huo1, S.S. Perry1, H.A. 
Ketelson2. 1Materials Science and Engineering, 
University of Florida, Gainesville, FL; 2R & D, 
Alcon Research Ltd, Fort Worth, TX.*CR 
6115 — D936 Surface Segregation of Chemical 
Moieties in Silicone Hydrogels. Scott S. Perry1, C. 
Argenbright1, Y. Huo1, H.A. Ketelson2. 1Materials 
Science and Engineering, University of Florida, 
Gainesville, FL; 2R & D, Alcon Research Ltd, Fort 
Worth, TX.*CR 
6116 — D937 Surface Characterization of 
Dailies Contact Lens Material. James W. Davis, 
H.A. Ketelson. R & D, Alcon Research Ltd, Fort 
Worth, TX.*CR 
6090 – 6116 – Thursday – Posters
6090 — D911 Comparison Of Two Dual-
disinfection Systems For Ocular Comfort, 
Corneal Staining And Corneal Infiltrative 
Events. Daniel Tilia1, P. Lazon De La Jara1,2, N. 
Peng1, H. Zhu1, M.D. Willcox1,2, B.A. Holden3,2. 
1Brien Holden Vision Institute, Sydney, Australia; 
2School of Optometry and Vision Science, 
University of NSW, Sydney, Australia; 3Brien 
Holden Vision Institute, Vision Cooperative 
Research Centre, Sydney, Australia.*CR, f 
6091 — D912 Ocular Cytotoxic Potential 
Assessment Of Contact Lens Care Solutions 
And Evidence For A Useful Rinse Step With 
Unpreserved Solution. Melody Dutot1A, J. Vincent2, 
I. Fabre2, C. Grasmick2, R. Fagon1B, P. Rat3. 
AToxicology, BResearch&Development, 1YSLAB, 
Paris, France; 2Direction des Laboratoires et des 
Contrôles, Agence Française de Sécurité Sanitaire 
des Produits de Santé, Vendargues, France; 3Chimie-
Toxicologie Analytique et Cellulaire (EA 4463), 
Université Paris Descartes, Sorbonne Paris Cité, 
Faculté de Pharmacie, Paris, France.*CR 
6092 — D913 Morning Cleaning or 
Replacement of Lenses Reduces Complications 
with Extended Wear of Contact Lenses. Jerome 
Ozkan1A, M.D. Willcox2, P. Lazon De La Jara1, V.M. 
Rathi3, B.A. Holden4. AClinical Research & Trials 
Centre, 1Brien Holden Vision Institute, Sydney, 
Australia; 2Brien Holden Vision Institute, Univ 
of New South Wales, Sydney, Australia; 3Cornea, 
Contact lens, Refractive Surgery, LV Prasad Eye 
Institute, Banjara Hills, Hyderabad, India; 4Brien 
Holden Vision Institute, Vision Cooperative 
Research Centre, Sydney, Australia. f 
6093 — D914 Qualitative and Quantitative 
Lubricity of Experimental Contact Lenses. 
Robert C. Tucker, B. Quinter, D. Patel, J. Pruitt, J. 
Nelson. R&D, Alcon, Johns Creek, GA.*CR 
6094 — D915 Effect of Soft Contact Lens 
Storage Solutions on Lens Wettability In-Vitro. 
Raied Fagehi, A. Tomlinson, V. Manahilov. Vision 
Sciences, Glasgow Caledonian University, Glasgow, 
United Kingdom. 
6095 — D916 Robust Contact Lens Lubricity 
using Surface Gels. W. G. Sawyer1, A.C. Dunn1, 
J.M. Uruena1, H.A. Ketelson2. 1Mechanical and 
Aerospace Eng, University of Florida, Gainesville, 
FL; 2R & D, Alcon Research Ltd, Fort Worth, 
TX.*CR 
6096 — D917 Improving The Wettability Of 
Silicone Hydrogel Contact Lenses. Alonzo Cook, 
M. Skinner, J. Li, C. Loose, K. Schultz, Z. Zhang. 
Semprus BioSciences, Cambridge, MA.*CR 
6097 — D918 Proteoglycan 4 (lubricin) 
Enhances the Wettability Of Model Conventional 
And Silicone Hydrogel Contact Lenses. Lakshman 
N. Subbaraman1, T.A. Schmidt2, H. Sheardown1. 
1Chemical Engineering, McMaster University, 
Hamilton, ON, Canada; 2Biomedical Engineering, 
University of Calgary, Calgary, AB, Canada. 
6098 — D919 Estimating in-vivo Contact Lens 
Wettability Through Tear Film Hydrodynamics. 
Jalaiah P. Varikooty1A, N.J. Keir1A, T.L. Simpson1B. 
ACCLR, School of Optometry, BSchool of 
Optometry, 1University of Waterloo, Waterloo, ON, 
Canada. 
6099 — D920 Hyaluronan Release from 
Contact Lenses in vitro and in vivo. Krista M. 
Fridman, C.A. Scheuer, S. Su, L. Zhang, S.E. Burke. 
Bausch + Lomb, Rochester, NY.*CR, f 
6100 — D921 Solute Release From Soft-
contact-lens Hydrogels. Csaba Kotsmar, T. 
Nadolski, N. Taylor, K. Yeh, C.J. Radke. Chemical & 
Biomolecular Eng, Univ of California at Berkeley, 
Berkeley, CA.*CR 
6101 — D922 Ocular Delivery Of Ketotifen 
Fumarate By Silicone Hydrogel And 
Conventional Hydrogel Contact Lens Materials. 
Anthony Soluri, A. Hui, L. Jones. Centre for Contact 
Lens Research, University of Waterloo, Waterloo, 
ON, Canada. 
6102 — D923 Development of a Drug released 
Soft Contact Lens that Releases Antibiotics in 
a Sustained Manner. Shinichiro Kobayakawa1, 
T. Matsunaga2, K. Kakisu1, Y. Yamazaki2, T. Sato2, 
T. Tochikubo1. 11st Dept of Ophthalmology, Toho 
University, Tokyo, Japan; 2SEED Co Ltd, Kounosu-
shi, Japan.*CR 
6103 — D924 Surface versus Bulk Absorption 
of a Diblock Copolymer on/in Silicone Hydrogels. 
Yuchen Huo1, S.S. Perry1, H.A. Ketelson2. 1Materials 
Science and Engineering, University of Florida, 
Gainesville, FL; 2R & D, Alcon Research Ltd, Fort 
Worth, TX.*CR 
6104 — D925 Understanding Lens Shape 
Dynamics During Off-Eye Dehydration of 
Contact Lens Materials with Varying Water 
Content. Ian G. Cox, R.H. Lee. Vision Care, 
Bausch + Lomb, Rochester, NY.*CR 
6105 — D926 Oxygen Diffusion Behind 
Modern Scleral Rigid Gas Permeable Contact 
Lenses. Sofia C. Peixoto-de-Matos1, V. Compañ2, S. 
Moya2, J. Jorge1, J.M. Gonzalez-Meijome1. 1Center 
of Physics, University of Minho, Braga, Portugal; 
2Applied Thermodynamics, Universidad Politécnica 
de Valencia, Valencia, Spain.*CR 
6106 — D927 Rapid Measurement of Tear 
Oxygen Tension Underneath Soft Contact 
Lenses by Frequency-Domain Phosphorimetry. 
Sangly P. Srinivas1, G. Guidoboni2, L. Carichino2, 
Y. Jiang1, J.A. Bonanno1. 1Optometry, Indiana 
University, Bloomington, IN; 2Mathematics, IUPUI, 
Indianapolis, IN. 
6107 — D928 Surface Characterization of a 
Water Gradient Silicone Hydrogel Contact Lens 
(delefilcon A). John Pruitt, Y. Qiu, S. Thekveli, R. 
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6117 — D938 Evaluation of In Vitro 
Cytotoxicity Assays for Contact Lens Multi-
Purpose Solutions. Mercedes Salvador-Silva1A, 
L.C. Huang1A, C.H. Powell1B, L. Hoong1B, R.M. 
Yetemian1A. AR&D - Biological Sciences, BCorneal 
R&D, 1Abbott Medical Optics (AMO), Santa Ana, 
CA.*CR 
6118 — D939 Cytotoxic and Inflammatory 
Effects of Contact Lens Multipurpose Solutions 
on Human Corneal Epithelial Cells. Nir 
Erdinest1A, Y. Grosman1A, R. Harari1A, H. Ovadia1B, 
A. Solomon1B. AOphthalmology, BNeurology, 
1Hadassah Hebrew University Medical Center, 
Jerusalem, Israel. 
6119 — D940 The Impact of Intermittent Air 
Exposure on the Deposition of Lipids on Silicone 
Hydrogel and Conventional Hydrogel Contact 
Lens Materials. Holly I. Lorentz, M. Heynen, W. 
Khan, D. Trieu, L. Jones. Centre for Contact Lens 
Research, University of Waterloo, Waterloo, ON, 
Canada.*CR 
6120 — D941 Clinical Performance and “ex-
vivo” Dehydration of Silicone Hydrogel Contact 
Lenses with Two New Multipurpose Solutions. 
Jose Manuel Gonzalez-Meijome, A. da Silva, D. 
Lopes-Ferreira, H. Neves, A. Queiros Pereira. 
Center of Physics-Optometry, University of Minho, 
Braga, Portugal.*CR 
6121 — D942 In Vitro Dehydration of Daily 
Disposable and Silicone Hydrogel Contact Lens 
Materials. Hendrik Walther, L. Subbaraman, 
L.W. Jones. CCLR, University of Waterloo, ON, 
Canada.*CR 
6122 — D943 Differential Surface Friction 
Analysis of Silicone Hydrogel Contact Lenses 
Treated with Block Co-Polymer Multi-
Purpose Solutions. Peter Maziarz, III1, X. Liu2, 
C.P. Lusignan2, M.M. Merchea3. 1Research & 
Development, Bausch + Lomb, Brockport, NY; 
2Research & Development, Bausch + Lomb, 
Rochester, NY; 3Bausch & Lomb, Rochester, 
NY.*CR 
6123 — D944 Differential Contact Angle 
and Protein/Lipid Deposition Profiles On a 
Novel Daily Disposable Contact Lens Material. 
Mohinder M. Merchea, P.S. Harmon, E.P. Maziarz, 
X.M. Liu. Bausch + Lomb, Rochester, NY.*CR 
6124 — D945 Study Of Novel Chitosan-coated 
Contact Lens As An Equivalent Substrate For 
The Therapeutic Delivery Of Rabbit Limbal 
Epithelium. Xiao-Wei Tan, D. Tan, R.W. Beuerman, 
J.S. Mehta. Singaopore Eye Research Institute, 
Singapore Eye Research Institute, Singapore, 
Singapore. 
6125 — D946 Measuring The Kinetics 
and Activity of Adsorbed Proteins: In Vitro 
Lysozyme Deposited Onto Contact Lenses Over 
Short Time Periods. Brad Hall1A, L. Jones1A, J.A. 
Forrest1B. ASchool of Optometry, BDepartment of 
Physics ＆ Astronomy, 1University of Waterloo, 
Waterloo, ON, Canada. 
6126 — D947 Regenerated Cellulose Hydrogels 
with High Optical Transparency and Mechanical 
Strength for Corneal Applications. Marcia W. 
Patchan1, J. Graham1,2, Z. Xia1, J. Maranchi1, 
J. Elisseeff2,3, O.D. Schein3, M. Trexler1. 1Milton 
Eisenhower Research Center, Johns Hopkins 
University Applied Physics Lab, Laurel, MD; 
2Biomedical Engineering, Johns Hopkins 
University, Baltimore, MD; 3Ophthalmology, Johns 
Hopkins Wilmer Eye Inst, Baltimore, MD.*CR 
Hall B/C D987-D1021
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6127 — D987 Serratamolide as a novel 
hemolytic factor produced by Serratia 
marcescens. Robert M. Shanks1A, N.A. Stella1A, 
R.M. Lahr1A, S. Wang1B, T. Veverka2, R.P. Kowalski3, 
X. Liu1B. AOphthalmology, BChemistry, 1University 
of Pittsburgh, Pittsburgh, PA; 2Biology, Bucknell 
University, Lewisburg, PA; 3Ophthalmology, 
University of Pittsburgh, Pittsburgh, PA, Pittsburgh, 
PA. 
6128 — D988 Pseudomonas aeruginosa Small 
Protease (PASP), a Keratitis Virulence Factor. 
Richard J. O’Callaghan, A. Tang, M. Marquart, 
A. Caballero. Dept of Microbiology, Univ of 
Mississippi Med Ctr, Jackson, MS. 
6129 — D989 Cxcl1 Contributes To Host 
Resistance Following Pseudomonas Aeruginosa 
Corneal Infection But Not To Herpes Simplex 
Virus Type 1. Katie M. Hudson1A, D.J. Carr1A,1B. 
AOphthalmology, BMicrobiology and Immunology, 
1University of Oklahoma Health Sciences Center, 
Oklahoma City, OK. 
6130 — D990 Vasoactive Intestinal Peptide 
Regulates Toll-like Receptors in the Infected 
Cornea. Xiaoyu Jiang, S.A. McClellan, R.P. Barrett, 
E.A. Berger, Y. Zhang, L.D. Hazlett. Department of 
Anatomy and Cell Biology, Wayne State University 
School of Medicine, Detroit, MI. 
6131 — D991 mTOR Inhibition has Similar 
Effects to Treatment with Substance P in the 
Cornea of Pseudomonas aeruginosa-Infected 
BALB/c Mice. Megan E. Foldenauer, S. McClellan, 
R. Barrett, L. Hazlett. Anatomy & Cell Biology, 
Wayne State University - School of Medicine, 
Detroit, MI. 
6132 — D992 Pseudomonas aeruginosa 
Keratitis: Pathogen Genotype Impacts Clinical 
Presentation and Outcomes. Durga S. Borkar1, 
S.M. Fleiszig2, D.J. Evans2, C. Leong2, P. Lalitha3, 
M. Srinivasan3, T.M. Lietman1, N.R. Acharya1. 1F. I. 
Proctor Foundation, University of California, San 
Francisco, San Francisco, CA; 2School of Optometry, 
University of California, Berkeley, Berkeley, CA; 
3Aravind Eye Hospital, Madurai, India. 
Thursday – Posters – 6117 – 6140
6133 — D993 Virulence factors in Pseudomonas 
aeruginosa keratitis. Henri Sueke1A, J. Shankar1B, 
T. Neal1B, S. Aldwinckle1A, C. Winstanley2, S. Tuft3, 
S.B. Kaye1A, Microbiology Ophthalmic Group. 
AOphthalmology, BMicrobiology, 1Royal Liverpool 
University Hospital, Liverpool, United Kingdom; 
2Microbiology, University of Liverpool, Liverpool, 
United Kingdom; 3Ophthalmology, Moorfields Eye 
Hospital, London, United Kingdom. T 
6134 — D994 The Role Of Dendritic Cells 
In Flagellin-induced Protection Against 
Pseudomonas Aeruginosa Keratitis. Nan Gao, F-S. 
Yu. Ophthalmology, Wayne State Univ/Kresge Eye 
Inst, Detroit, MI. 
6135 — D995 Characterization Of Pseudomonas 
Aeruginosa Type Three Secretory System (TTSS) 
Effector Molecules (Exo U/S/T) From Human 
Corneal Ulcer. Jeganathan lakshmi priya1, R. 
Sivaganesa Karthikeyan1, N. Venkatesh Prajna1, E. 
Pearlman2, A. Rietsch3, P. Lalitha1. 1Microbiology, 
Aravind Medical Research Foundation, Madurai, 
India; 2Ophthalmology and Visual Sciences, Case 
Western Reserve University, Cleveland, OH; 3Dept. 
of Molecular Biology and Microbiology, Case 
western Reserve university, Cleveland, OH. 
6136 — D996 Interactions of Pseudomonas 
aeruginosa with human corneal fibroblasts 
in vitro.. Ahmad Elsahn1,2, C. Heath1, M. 
Christodoulides1, P. Hossain1,2. 1Infection, 
Inflammation & Immunity, University of 
Southampton, Southampton, United Kingdom; 
2Eye Unit, University Hospital Southampton NHS 
Foundation Trust, Southampton, United Kingdom. 
6137 — D997 Vasoactive Intestinal Peptide 
Modulates Growth Factors and their Receptors in 
Normal and Infected Cornea. Sharon A. McClellan, 
X. Jiang, R.P. Barrett, Y. Zhang, M.E. Foldenauer, 
L.D. Hazlett. Anatomy & Cell Biology, Wayne State 
Univ School of Med, Detroit, MI. 
6138 — D998 Staphylococcus aureus Protease 
Activity and Ocular Virulence. Armando R. 
Caballero, A. Tang, R. O’Callaghan. Microbiology, 
Univ of Mississippi Med Ctr, Jackson, MS. 
6139 — D999 Genotypic Characterization 
of Staphylococcus aureus isolates from Eyes 
with Keratitis. Takashi Suzuki, S. Hayashi, Y. 
Ohashi. Department of Ophthalmology, Ehime 
University,Graduate School of Medicine, Toon-shi, 
Japan.*CR 
6140 — D1000 Molelcular Characterization of 
Virulence Genes Associated with MRSA Keratitis 
isolates. Jorge Maestre1A, E. Perez1B, M. Diaz1B, E. 
Alfonso1A, D. Miller1A. AOphthalmology, BBascom 
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6155 — D1015 Efficacious Clinical 
Outcome of an Ophthalmic Formulation of 
Phosphatidylserine- binding Monoclonal 
Antibody in a Rabbit Model of Acute HSV-1 
Keratitis. Christian Clement1A, H.W. Thompson1B, 
P.S. Bhattacharjee2, H.E. McFerrin, Jr.2, W.J. 
Lukiw3, K. Corbin-Lickfett4A, C.J. Empig5, K. 
Schlunegger4, J.M. Hill1A. AOphthalmology, BSchool 
of Public Health, 1LSUHSC, New Orleans, LA; 
2Biology, Xavier University of Louisiana, New 
Orleans, LA; 3Neuroscience & Ophthalmology, 
Lousiana State Univ Hlth Sci Ctr, New Orleans, LA; 
AOphthalmology, 4Peregrine Pharmaceuticals, Inc., 
Tustin, CA; 5Peregrine Pharmaceuticals Inc., Tustin, 
CA.*CR 
6156 — D1016 The Role of Natural Killer (NK) 
Cells in the Control of Acute HSV-1 Infection. 
Jared E. Knickelbein, A.J. St. Leger, R.L. Hendricks. 
Department of Ophthalmology, University of 
Pittsburgh, Pittsburgh, PA. 
6157 — D1017 Mistyping of Human 
Adenovirus Type 19 Associated with Epidemic 
Keratoconjunctivitis. Xiaohong Zhou1, C.M. 
Robinson1, J. Rajaiya1, D. Seto2, M.S. Jones3, D.W. 
Dyer4, J. Chodosh1. 1Ophthalmology, Mass Eye and 
Ear - Harvard Medical School, Boston, MA; 2School 
of Systems Biology, George Mason University, 
Manassas, VA; 3Viral and Rickettsial Disease 
Laboratory, California Department of Public Health, 
Richmond, CA; 4Microbiology and Immunology, 
University of Oklahoma Health Science Center, 
Oklahoma City, OK.*CR 
6158 — D1018 Apoptosis and Expression of 
Antiviral Response Genes during Ocular HSV-1 
Infection in TNFR1 or TNFR2 Knockout Mice. 
Wen Chen, M. Zhang, J. Covar, N. Zhang, S.S. 
Atherton. Cellular Biology and Anatomy, GHSU, 
Augusta, GA. T 
6159 — D1019 Treatment of VZV-induced 
Chronic Pain in a Rat Model of Post-Herpetic 
Neuralgia Using Replication Defective HSV-1 
Expressing the Tonal Modulator Proenkephalin. 
Paul R. Kinchington1, M.B. Yee1, M. Zhang2, W.F. 
Goins2. 1Ophthalmology/Mol Micro & Genetics, 
Univ of Pittsburgh Eye & Ear Inst, Pittsburgh, 
PA; 2Mol Micro & Genetics, Univ of Pittsburgh, 
Pittsburgh, PA. 
6160 — D1020 Neutralizing Kc (cxcl1) 
Ameliorates Recurrent Hsk. Patrick M. Stuart, D. 
West. Ophthalmology, St Louis University, St Louis, 
MO. 
6161 — D1021 Non-professional Phagocytosis 
Can Play A Role In Herpesvirus Entry Into 
Ocular Cells. Deepak Shukla, V. Tiwari. Ophthal/
Visual Sciences, University of Illinois at Chicago, 
Chicago, IL. 
6141 — D1001 Involvement of Corneal 
Epithelial Cells in the T
H
17 Response in an In 
Vitro Bacterial Inflammation Model. Isabel 
Arranz-Valsero1,2, U. Schulze3, L. Contreras-
Ruiz1,2, L. Garcia-Posadas1,2, A. Lopez-Garcia1,2, 
F. Paulsen3,4, Y. Diebold1,2. 1Ocular Surface Group, 
IOBA-University of Valladolid, Valladolid, Spain; 
2Networking Research Center on Bioengineering, 
Biomaterials and Nanomedicine (CIBER-BBN), 
Valladolid, Spain; 3Department of Anatomy and Cell 
Biology, Martin Luther University Halle/Wittenberg, 
Halle/Saale, Germany; 4Department of Anatomy II, 
Friedrich Alexander University Erlangen/Nuremberg, 
Erlangen, Germany. 
6142 — D1002 Role of Antimicrobial Peptides 
in the Defense against F.solani keratitis. Satya Sree 
N. Kolar, H. Baidouri, A. McDermott. University of 
Houston College of Optometry, Houston, TX. 
6143 — D1003 Reprogramming Inducted by 
TLR2/4 Agonists Regulates Corneal Immune 
Responses to Fungal Infection. Xinyi Wu, J. 
Wang, L. Wang, Y. Li. Ophthal QiLu Hosp/Ophthal, 
Shandong University, Jinan, Shandong, China. 
6144 — D1004 Analysis of Acanthamoeba cysts 
isolated from contact lenses with the Raman 
spectroscopy microscope. Pablo L. Goldschmidt1A, 
D. Di Cave2, S. Degorge1A, D. Benallaoua1A, E. 
Borsali1A, A. Le Bouter1A, L. Batellier1A, V. Borderie1B, 
L. Laroche1B, C. Chaumeil1B. ALaboratoire, BService 
5, 1Quinze Vingts Nt’l Ophtalmologic Ctr, Paris, 
France; 2Dept. of Public Health and Cell Biology, 
University of Rome Tor Vergata, Rome, Italy. 
6145 — D1005 Acanthamoeba Associated 
Microbial Communities. Darlene Miller1, J. 
Maestre-Mesa1, M. Diaz1, E. Perez1, V. Shestopalov1, 
R. Van Gelder2, E.C. Alfonso1. 1Bascom Palmer Eye 
Institute, Univ of Miami Miller Sch of Med, Miami, 
FL; 2Ophthalmology, Univ of Washington School of 
Medicine, Seattle, WA. 
6146 — D1006 Experimental Induction of 
Acute Acanthamoeba castellanii Keratitis in Cats. 
Eric C. Ledbetter1A, E.C. da Silva1A, L. Dong1B, S.P. 
McDonough1B. AClinical Sciences, BBiomedical 
Sciences, 1Cornell University, Ithaca, NY.*CR 
6147 — D1007 The Herpes Simplex Virus 
Type 1 Latency Associated Transcript Inhibits 
Phenotypic and Functional Maturation of 
Dendritic Cells. Lbachir BenMohamed, A.A. 
Chentoufi, X. Dervillez, G. Dasgupta, C. Nguyen, 
K.K. Kabbara, S.L. Wechsler, A.B. Nesburn. Gavin 
Herbert Eye Institute, Univ of California-Irvine, 
Irvine, CA. 
6148 — D1008 Gene Transfer Of Hsv1-specific 
Meganuclease To The Murine Cornea Using 
Electroporation. Antoine Rousseau1,2, A. Ergani2, 
E.E. Gabison3, M. Corral3, N. Huot2, M. Gailledrat4, 
C. Desseaux4, B. Chapellier, Jr.3, P. Roy5, M. 
Labetoulle1,2. 1Ophthalmology, Hopital Bicetre, 
South Paris University, Le Kremlin Bicetre, France; 
2Laboratoire de Virologie Moléculaire et Structurale, 
Centre National de la Recherche Scientifique, Gif-
sur-Yvette, France; 3Institut de la Vision, Paris, 
France; 4Cellectis Therapeutics, Paris, France; 5OPIA 
Technologies SAS, Paris, France.*CR 
6149 — D1009 Bilateral Herpetic 
Keratoconjunctivitis in Cancer Patients. Elvia 
Canseco1, J. Modak2, A. Kingham2, V. Arevalo2, S.K. 
Kim2. 1Ophthalmology, UT Houston Health Science 
Center (UTHSC), Houston, TX; 2Ophthalmology 
Section/Head and Neck Surgery, UT MD Anderson 
Cancer Center, Houston, TX. T 
6150 — D1010 Hsv1-specific Meganuclease 
May Reduce Ocular Infection In A Mouse Model 
Of Herpes Keratitis. Marc Labetoulle1,2, E.E. 
Gabison3,4, N. Huot2, A. Rousseau1, S. Barradeau5, C. 
Mahiet5, M. Gailledrat6, C. Desseaux6, B. Chapelier4, 
A. Ergani2. 1Ophthalmology, Hopital Bicetre, South 
Paris University, Le Kremlin Bicetre, France; 2Cnrs, 
upr 3296, Laboratoire de Virologie Moleculaire 
et Structurale, Gif sur Yvette, France; 3Hopital 
Bichat AP-HP Cornea, Fondation A de Rothschild, 
Paris, France; 4Institut de la Vision, Paris, France; 
5Genomic Vision, Bagneux, France; 6Cellectis 
therapeutics SAS, Paris, France.*CR 
6151 — D1011 CD8+ T Cells Inhibit Viral 
Replication but Become a Source of VEGF 
Expression During Corneal Herpes Simplex 
Type I Infection. Christopher D. Conrady1, M. 
Zheng2, D.U. Stone2, D.J. Carr1,2. 1Microbiology 
and Immunology, Univ of Oklahoma Hlth Sci Ctr, 
Oklahoma City, OK; 2Ophthalmology, University of 
Oklahoma, University of Oklahoma/Oklahoma City, 
OK. T 
6152 — D1012 Protective Asymptomatic 
Human Leukocyte Antigen (HLA)-A*0201-
Restricted CD8+ Cytotoxic T-Lymphocyte 
Epitopes Identified from Herpes Simplex Virus 
Glycoprotein B. Anthony B. Nesburn1, X. Dervillez1, 
A.A. Chentoufi1, G. Dasgupta1, K.W. Kabbara1, 
M.C. Villacres2, C. Nguyen1, S.L. Wechsler1, L. 
BenMohamed1. 1Gavin Herbert Eye Institute, 
University of California, Irvine, Irvine, CA; 
2University of Southern California, Los Angeles, CA. 
6153 — D1013 Non-Muscle Myosin IIA 
Mediates HSV-1 Entry Into the Cells of the 
Human and Pig Corneas. Thessicar E. Antoine1A,1B, 
D. Shukla1A,1B. AOphthalmology and Visual Sciences, 
BMicrobiology and Immunology, 1University of 
Illinois at Chicago, Chicago, IL. 
6154 — D1014 Corneal Dendritic Cells Suppress 
Local Corneal Damage and Mediate Systemic 
Viral Dissemination in Herpes Simplex Keratitis. 
Kai Hu1, H. Ghiasi2, U. Von Andrian3, P. Hamrah1,4. 
1Ophthalmology, Massachusetts Eye & Ear Infirmary, 
Boston, MA; 2Surgery/Ophthal Research, Cedars-
Sinai Medical Center, Los Angeles, CA; 3Immune 
Disease institute, Boston, MA; 4Immue Institute 
Disease, Boston, MA. 
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6162 — D1022 Association between Atopy and 
Herpetic Eye Disease in a Hawaiian population. 
John A. Gonzales1, D. Borkar1, V. Tham2, A. Vinova2, 
E. Esterberg1, N. Acharya1. 1F.I. Proctor Foundation, 
University of California San Francisco, San 
Francisco, CA; 2Ophthalmology, Kaiser Permanente 
Honolulu, Honolulu, HI. 
6163 — D1023 Pattern of Herpetic Eye Disease 
In A Referral Centre In Milan, Northern Italy. 
Giulio Modorati, E. Miserocchi, I. Bianchi, A. 
Colucci, F. Bandello. Dept of Ophthalmology, Univ 
Hospital San Raffaele, Milan, Italy. 
6164 — D1024 Herpetic Eye Disease: 
Spectrum Of Disease At A City Hospital For 
The Underserved. Aimee R. Edell, E. Cohen. 
Ophthalmology, New York University, New York, 
NY. 
6165 — D1025 Practice Patterns in the 
Management of Anterior Herpes Simplex Virus 
Eye Disease Compared to Herpetic Eye Disease 
Study Group Findings. Tabassum F. Ali, D. Liang, 
I.U. Scott. Department of Ophthalmology, Penn State 
Milton S. Hershey Medical Center, Hershey, PA. 
6166 — D1026 Findings In Detection Of 
Herpesviridae By Real-time Polymerase Chain 
Reaction And Intraocular Antibody Production 
In A Case-series Of Anterior Uveitis. Marie-
Helene Errera1A, P. Goldschmidt1B, L. Batellier1B, S. 
Degorge1B, E. Héron1C, L. Laroche1D, J-A. Sahel1A, 
M. Westcott2, C. Chaumeil1B. AOphthalmology 
Department IV, BLaboratory, CInternal Medicine, 
DOphthalmology Department V, 1Hopital des Quinze-
Vingts, Paris, France; 2Moorfields Eye Hospital, 
London, United Kingdom. 
6167 — D1027 The Immune Response To 3 
Different Therapies In Herpetic Stromal Keratitis. 
Mauricio Cedillo Sarabia, Sr.1, R. Velasco Ramos, II1, 
S. Perez Tapia, III2, A. Babayan Sosa, IV1, O. Baca 
Lozada, V1, O. Fernández Viscaya, V1, R. Suárez 
Velasco, V1, G. Cortés Sanchez, V1, M. Navarro Pena, 
V1. 1Cornea, Fundacion Hospital de Nuestra Senora 
de la Luz, MEXICO DF, Mexico; 2Department of 
Immunology, National School of Biological Sciences 
ENCB-IPN, MEXICO DF, Mexico. 
6168 — D1028 Diagnosis of Herpetic Uveitis 
is Aided by Confocal Microscopy with the HRT 
RCM. Alexandra B. Knoll, I. Metzger, F. Mackensen. 
Ophthalmology, Interdisciplinary Uveitis Center, 
University Hospital Heidelberg, Heidelberg, 
Germany.*CR 
6169 — D1029 Clinical and epidemiolgical 
characteristics of infectious keratitis at Fundación 
Banco de Ojos “Fernando Oca del Valle” in 
Paraguay. Martin M. Nentwich1, M. Bordón2, 
D. Sánchez di Martino2, A. Ruiz Campuzano2, W. 
Martínez Torres2, S. Lichi2, M. Samudio2, N. Fariña2, 
F. Laspina2, H. Mino de Kaspar1. 1Department 
of Ophthalmology, Ludwig-Maximilians-
University, Munich, Germany; 2Fundación Banco 
de Ojos “Fernando Oca del Valle”. Instituto de 
Investigaciones en Ciencias de la Salud, Asunción, 
Paraguay. 
6170 — D1030 10 year experience of fungal 
keratitis at the University of Iowa. Gina M. 
Rogers, K.M. Goins, A.S. Kitzmann, N.A. Syed, 
M.D. Wagoner. Ophthalmology & Visual Science, 
University of Iowa, Iowa City, IA. 
6171 — D1031 Molecular Surveillance of 
Contact Lenses, Cases, and Solutions for 
the Presence of Free-Living Amoeba Among 
Patients with Infectious Keratitis. Ryan Young, 
H. Flynn, J. Maestre-Mesa, E.C. Alfonso, D. Miller. 
Ophthalmology, Bascom Palmer Eye Institute, 
Miami, FL. 
6172 — D1032 Growth Of Acanthamoeba On 
Contact Lens Storage Case Bacteria And Their 
Survival Within The Cyst Stage. Anthony Lam, 
S. Kilvington. Corneal R&D Microbiology, Abbott 
Medical Optics, Santa Ana, CA. 
6173 — D1033 Characterization Of Bacteria 
From Contact Lens Storage Cases Of Corneal 
Infiltrative Event Patients. Simon Kilvington1, J.P. 
Shovlin2, M. Nikolic1. 1Corneal R&D Microbiology, 
Abbott Medical Optics, Santa Ana, CA; 
2Northeastern Eye Institute, Scranton, PA. 
6174 — D1034 Prevalence of Positive 
Microbiology Results from Donor Cornea Tissue 
in Corneal Transplantation from 2006-2010 and 
Subsequent Clinical Outcomes. Bishoy O. Said, S. 
Garg, M. Farid, R.F. Steinert. Ophthalmology, UC 
Irvine, Irvine, CA. 
6175 — D1035 Rapid Identification of 
Microorganisms Using the Two-Photon 
Ophthalmoscope. Yinhong Qu1,2, K.E. Thomas2, 
M. Eugenia Vola2, A-C. Roch-Levecq2, Y-K. Wu1, 
T.L. Purcell2, J.F. Bille1, D.J. Schanzlin2. 1Medical 
Physics, Heidelberg University, Heidelberg, 
Germany; 2Shiley Eye Center, UCSD, La Jolla, CA. 
6176 — D1036 Reduced Corneal Inflammation 
By Birch Leave Extract In Combination With 
Sub-therapeutic Cyclosporin A. Katrin Wacker1, 
C. Gründemann2, R. Huber2, T. Reinhard1, J. 
Schwartzkopff1. 1University Eye Hospital, Freiburg, 
Germany; 2Department of Environmental Health 
Sciences, University Medical Centre, Freiburg, 
Germany.*CR 
Thursday – Posters – 6162 – 6184
6177 — D1037 Topical sCD83 Induces Graft 
Tolerance In High-risk Corneal Transplantation. 
Felix Bock1, A. Steinkasserer2, C. Cursiefen1, E. 
Zinser2. 1Department of Ophthalmology, University 
of Cologne, Cologne, Germany; 2Department of 
Dermatology, University of Erlangen, Erlangen, 
Germany. 
6178 — D1038 Effect Of Rapamycin And IL-2 
On Regulatory CD4+CD25+Foxp3+T Cells In Mice 
After Allogenic Penetrating Keratoplasty. Qihua 
Le1, X. Wang1, W. Wang1, J. Xu2. 1Ophthalmology, 
Eye & ENT Hospital of Fudan University, Shanghai, 
China; 2Ophthalmology, EYE & ENT Hospital of 
Fudan University, Shanghai, China. 
6179 — D1039 Clinical Similarities among 
Meibomitis-Related Keratoconjunctivitis, 
Phlyctenular Keratitis and Ocular Rosacea in 
Childhood. Tomo Suzuki1,2, Y. Sano1, N. Yokoi1, S. 
Kinoshita1. 1Department of Ophthalmology, Kyoto 
Prefectural University of Medicine, Kyoto, Japan; 
2Kyoto City Hospital, Kyoto, Japan. 
6180 — D1040 ICAM-1 is Necessary for 
Efficient Accumulation of CD11c+ Cells in 
Healing Corneal Epithelium. Yuan Gao1A, Z. Li1A, 
C.W. Smith1B. ALeukocyte Biology, BPed-Children’s 
Nutrition Rsrch Ctr, 1Baylor College of Medicine, 
Houston, TX. 
6181 — D1041 Expression Of Adhesion 
Molecules During Development Of Conjunctiva-
Associated Lymphoid Tissue. Uta Gehlsen1, S. 
Siebelmann1, M.E. Stern2, J.Y. Niederkorn3, P. 
Steven1. 1Ophthalmology, University Hospital 
of Cologne, Cologne, Germany; 2Biological 
Sciences, Allergan, Inc, Irvine, CA; 3Department of 
Ophthalmology, UTSouthwestern Medical Center, 
Dallas, TX.*CR 
6182 — D1042 Estrogen And Lipoxin A4 Have 
Opposing Bioactions In Driving Macrophage 
Polarization And Function. Karsten Gronert, 
D.W. Lin, Y. Wang, K.M. Hu, V. Mani, S.B. Wang. 
Vision Science, School of Optometry, University of 
California, Berkeley, Berkeley, CA. 
6183 — D1043 Peripheral Antigen Presenting 
Cells Are Differentially Distributed in Normal 
and Inflamed Murine Corneas. Albert H. Alhatem1, 
U.H. von Andrian2, P. Hamrah1,2. 1Cornea Service 
and Department of Ophthalmology, Massachusetts 
Eye and Ear Infirmary, Harvard Medical School, 
Boston, MA; 2Immune Disease Institute, Program 
in Cellular and Molecular Medicine at Children’s 
Hospital Boston, Harvard Medical School, Boston, 
MA. 
6184 — D1044 IL-17 Deletion Accelerates Onset 
and Severity of Dacryoadenitis in CD25KO mice. 
Rosa M. Corrales, F. Pelegrino, E. Volpe, D-Q. Li, 
S.C. Pflugfelder, C.S. De Paiva. Ophthalmology, 
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6201 — D1061 Therapeutic Effects of Topical 
Bacteriophage KPP12 Administration on 
Pseudomonas aeruginosa Keratitis in Mice. Ken 
Fukuda1A, W. Ishida1A, J. Uchiyama1B, T. Morita2, Y. 
Harada1A, T. Sumi1A, S. Matsuzaki1B, M. Daibata1B, A. 
Fukushima1A. AOphthalmology, BMicrobiology and 
Infection, 1Kochi Medical School, Nankoku, Japan; 
2Kochi Medical School Hospital, Nankoku, Japan. 
6202 — D1062 Effects Of Intravitreal 
Injection Of Daptomycin In An Experimental 
Rabbit Model Of Staphylococcus Aureus 
Endophthalmitis. Maher Saleh1,2, S. Lefevre2A, T. 
Bourcier2B, G. Prevost2A, D. Gaucher2B, C. Speeg-
Schatz2B, F. Jehl2A. 1Ophthalmology, Univ Hosp, 
Besancon, France; AMicrobiology, BOphthalmology, 
2Univ Hosp, Strasbourg, France. 
6203 — D1063 Safety and Efficacy of 
Ganciclovir Ophthalmic Gel for Treatment of 
Adenovirus Keratoconjunctivitis Utilizing Cell 
Culture and Animal Models. Seth P. Epstein, K.B. 
Fernandez, B.M. Carter, S.A. Abdou, N. Gadaria, 
P.A. Asbell. Ophthalmology, Mount Sinai School of 
Medicine, New York, NY.*CR 
6204 — D1064 Long-term oral Therapy 
with Ganciclovir in Patients with Posner-
Schlossman Syndrome. Manfred Zierhut, C.M. 
Deuter, D. Doycheva, B. Sobolewska. Centre for 
Ophthalmology, University of Tuebingen, Tuebingen, 
Germany. 
6205 — D1065 Treatment of Numular Keratitis 
with Intracorneal Gancyclovir. Eduardo Arenas1, 
A. Mieth2. 1ophthalmology, Santa Fe Foundation, 
BOGOTA, Colombia; 2Asocornea, Bogota, 
Colombia. 
6206 — D1066 In Vitro Effectiveness Of 
Photodynamic Therapy Against Multi-resistant 
Pathogens. Katrin Winkler1A, M. Finke1A, J. 
Wang1B, N. Szentmáry1B, T. Eppig1C, H-J. Foth2, 
D. Hüttenberger3, A. Langenbucher4A, B. Seitz4B, 
M. Bischoff1A. ADepartment of Microbiology, 
BDepartment of Ophthalmology, CExperimental 
Ophthalmology, 1Saarland University, Homburg, 
Germany; 2Physics Department, University of 
Kaiserslautern, Kaiserslautern, Germany; 3Apocare 
Pharma GmbH, Bielefeld, Germany; AExperimental 
Ophthalmology, BDepartment of Ophthalmology, 
4Saarland University, Homburg/Saar, Germany.*CR 
6207 — D1067 Efficacy of photodynamic 
antimicrobial chemotherapy on Staphylococcus 
aureus. Taiichiro Chikama1A, L.M. Akhyar1A, M. 
Shibasaki1A, T. Sasaki1A, J-A. Ko1A, Y. Kiuchi1A, T. 
Sakaguchi1B. AOphthalmology, BVirology, 1Hiroshima 
Univ Grad Sch of Biomed Sci, Minami-Ku, Japan. 
6208 — D1068 Effect of photodynamic therapy 
with methylene blue on Acanthamoeba In Vitro. 
Tsuyoshi Mito, T. Suzuki, T. Kobayashi, Y. Ohashi. 
University of Ehime, Toon, Japan. 
6185 — D1045 In Vivo Confocal Microscopy 
Of Corneal Langerhans Cells In Systemic Lupus 
Erythematosus (SLE) Without Ocular Surface 
Manifestation. Miklos D. Resch1, L. Marsovszky1, E. 
Medgyessi2, A. Balog2, L. Kovacs2, J. Nemeth1. 1Dept 
Ophthalmology, Semmelweis University, Budapest, 
Hungary; 2Rheumatology Department, University 
of Szeged, Albert Szent-Györgyi Clinical Center, 
Faculty of Medicine, Szeged, Szeged, Hungary. 
6186 — D1046 Microarray Based Ige Detection 
In Tears Of Vernal Keratoconjunctivitis Patients. 
Andrea Leonardi1A, D. Faggian1B, A. La Gloria 
Valerio1A, F. Piliego1A, L. Motterle1A, M. Plebani1B. 
ANeuroscience, Ophthalmology, BDepartment of 
Laboratory Medicine, 1University of Padova, Padova, 
Italy. 
6187 — D1047 Inhibitory Role of ICOS in 
Antigen-specific T cell-mediated Ocular Tissue 
Damage. Misao Terada1A, H. Taniguchi1B, R. 
Abe2, J. Hori1B. ADivision of Lab Animal Science, 
BOphthalmology, 1Nippon Medical School, Bunkyo-
ku, Japan; 2Research Institute for Biological Science, 
Tokyo University of Science, Noda, Japan. 
6188 — D1048 Bone Marrow Derived Dendritic 
Cells Prevent Corneal Allograft Rejection In The 
Rat. Thomas Ritter, M. Nosov, A. Ryan, O. Treacy, M. 
Cregg, G. Fahy, M. Morcos, L. O’Flynn. Medicine, 
Nt’l Univ of Ireland, Galway, Galway, Ireland. 
6189 — D1049 Corneal Inflammatory Cell (IC) 
Recruitment in Murine Allergic Conjunctivitis 
(AC): An Intravital Confocal Microscopy Study. 
Tomas Blanco, H. Lee, D.R. Saban. Ophthalmology, 
Schepens Eye Res Inst, MEE, Harvard Medical 
School, Boston, MA. T 
6190 — D1050 Etiologic Diversity Of Atypical 
And Severe Anterior Uveitis. Audrey Fel1, M. 
Bojanova2, V. Touitou1, P. Le Hoang1, F. Rozenberg2, 
B. Bodaghi1. 1Ophthalmology, Hopital la Pitié 
Salpétrière, Paris, France; 2Virology, Hopital Cochin, 
Paris, France. 
6191 — D1051 The Role of Toll-like Receptors 
in Corneal Angiogenesis. Lei Liu, J. Liu, A. Dick. 
Dept of Ophthalmology, School of Clinical Sciences, 
University of Bristol, Bristol, United Kingdom. 
Hall B/C D1052-D1077
Thursday, May 10, 2012, 8:30 AM-10:15 AM
Immunology & Microbiology / Cornea / Retina / 




6192 — D1052 In Vivo Antiviral Activity Of A 
Novel Peptide Inhibitor Of Herpes Simplex Virus 
(TAT-CdO) And The Effect Of Formulation On 
Efficacy. Curtis R. Brandt, G.G. Jose, I.V. Larsen, J. 
Gauger, E. Carballo, R. Stern, R. Brummel. Ophthal 
& Visual Sci, Univ of Wisconsin-Madison, Madison, 
WI. 
6193 — D1053 Spectrum Of Isolated 
Microorganisms And Their Antibiotic Resistance 
Pattern In Postoperative Endophthalmitis. 
Karsten U. Kortuem, Y. Yactayo-Miranda, F. 
Schwarzbach, M.M. Nentwich, M. Kernt, A. Kampik, 
H. Mino de Kaspar. Department of Ophthalmology, 
Ludwig-Maximilians-University, Muenchen, 
Germany. 
6194 — D1054 Emergence Of Pan-drug 
Resistant Pseudomonas Aeruginosa As A Cause 
Of Microbial Keratitis. Merle Fernandes1A, A. 
Pathengay2, N. Kumar1B. ACornea and Anterior 
Segment, BOcular Microbiology Service, 1L V Prasad 
Eye Institute, Visakhapatnam, India; 2Retina, Bascom 
Palmer Eye Institute, Miami, FL. 
6195 — D1055 Antibiotic Resistance Profile of 
Ocular Pathogens - An Update from the ARMOR 
2011 Surveillance Study. Wolfgang Haas1, J. 
Deane2, T.W. Morris1, D.F. Sahm2. 1Bausch & Lomb, 
Inc, Rochester, NY; 2Eurofins Medinet, Chantilly, 
VA.*CR 
6196 — D1056 Evaluation of Bacterial Flora 
after Chronic Topical Antibiotic use in Boston 
Keratoprostheses. Brett L. Shapiro, S.H. Lee, J.Y. 
Li, C. Polage, W. Smith, M.J. Mannis. UC Davis Eye 
Center, Sacramento, CA. 
6197 — D1057 Heterogeneous Vancomycin-
Intermediate Staphylococci Isolates from 
Endophthalmitis. Paulo J. Bispo1,2, D. Miller1. 
1Ophthalmology, Bascom Palmer Eye Institute, 
Miami, FL; 2Universidade Federal de São Paulo, São 
Paulo, Brazil. 
6198 — D1058 Microbiological Eradication 
Rates with BID or TID Dosing of Besifloxacin 
Ophthalmic Suspension, 0.6% in Bacterial 
Conjunctivitis Clinical Trials from 2004 - 2010. 
Kirk Bateman, T.L. Comstock, L.S. Gearinger, C.K. 
Hesje, C.M. Sanfilippo, T.W. Morris. Bausch & 
Lomb, Inc., Rochester, NY.*CR 
6199 — D1059 Moxifloxacin Superior To 
Cefuroxime In Reducing Early-phase Adherence 
Of Staphylococcus Epidermidis To Hydrophobic 
Intraocular Lenses. Fathalah Benbouzid1, S.A. 
Baillif2, F. Renaud3a, D. Hartmann3b, P. Denis1, L. 
Kodjikian1. 1Ophthalmology, Lyon Croix-Rousse 
Hospital, Lyon, France; 2Ophthalmology, Saint Roch 
Hospital, Nice, France; AMicrobiology laboratory, 
BDepartment of biomaterials and biological 
interactions, 3Claude Bernard University, Lyon I, 
Lyon, France. 
6200 — D1060 N-chlootaurine,n-monochloro-
deimethyltaurine And N,n-dichloro-
dimethyltaurine Are Safe And Effective 
Bacteriacidal Agents In Cornea Models. Barbara 
Teuchner1A, E. Schmid1A, M. Nagl1B, N. Bechrakis1A. 
AOphthalmology, BMicrobiology, 1Innsbruck Medical 
University, Innsbruck, Austria. 
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6209 — D1069 Treatment of Infectious Keratitis 
from Acanthamoeba by Corneal Crosslinking. 
Martin Berra1, G. Galperin1, G. Boscaro2, J. 
Zarate1, J. Tau1, P. Charadia3, A. Berra1. 1Lab de 
Investigaciones Oculares, Buenos Aires, Argentina; 
2BioFundus, Buenos Aires, Argentina; 3Servicio de 
Oftalmología-Htal.Clinicas, Buenos Aires, Argentina. 
6210 — D1070 In Vitro Investigation of 
Riboflavin/UVA-mediated Elimination of 
Acanthamoeba Castellanii. Karim Makdoumi1A,2, A. 
Backman1B,2, J. Mortensen1A, S. Crafoord1A,2. ADept of 
Ophthalmology, BClinical Research Center, 1Orebro 
University Hospital, Orebro, Sweden; 2School of 
Health and Medical Sciences, Orebro University, 
Orebro, Sweden. 
6211 — D1071 In Vitro Efficacy Of Amoebicidal 
Treatment Using Riboflavin/UV-A (365nm) 
Combination. Jonathan Letsch, Jr.1, A. Sauer1, 
C. Speeg-Schatz1, A. Abou-Bacar2, E. Candolfi2, 
T. Bourcier1. 1Service d’Ophtalmologie, Nouvel 
Hopital Civil, Strasbourg, France; 2Laboratoire de 
Parasitologie et de Mycologie Médicale, Hopitaux 
Universitaires de Strasbourg, Strasbourg, France. 
6212 — D1072 Biocidal Activity of a Novel One-
Step Hydrogen Peroxide Disinfecting Solution 
and Comparator Peroxide Disinfecting Solutions 
against Ocular Pathogens Including Multidrug-
Resistant Bacteria. Deborah McGrath, D.W. 
Cordero, P.A. Walsh, T.W. Morris. Microbiology, 
Bausch & Lomb, Inc., Rochester, NY.*CR 
6213 — D1073 Resistance And Growth Of 
Fusarium spp. In Contact Lens Disinfectant 
Solutions. Marina Nikolic, S. Kilvington, A. Lam, N. 
Brady. Corneal R&D Microbiology, Abbott Medical 
Optics, Santa Ana, CA. 
6214 — D1074 The Effect of Low 
Concentrations of Benzalkonium Chloride on 
Acanthamoebal survival. Elmer Y. Tu1, M.E. Shoff2, 
C.E. Joslin3. 1Ophthalmology, University of Illinois 
at Chicago, Glenview, IL; 2CDRH/OSEL/DB, FDA, 
Silver Spring, MD; 3Ophthalmology/Visual Sciences, 
University Illinois at Chicago, Chicago, IL. 
6215 — D1075 Ophthalmic Demulcents 
Associated with Acanthamoeba Encystment in 
Model Multi-Purpose Lens Care Solutions Do Not 
Cause Encystment in Model Hydrogen Peroxide 
Solutions. Joseph G. Carr, C.J. Kovacs, S.C. Lynch, 
M.A. Dehmler, K.A. Millard, M.J. Schoene, S.F. 
Groemminger, T.W. Morris. Bausch & Lomb, Inc., 
Rochester, NY.*CR 
6216 — D1076 Systemic vs. Combination 
Antiviral Therapy and Retinal Outcomes in Acute 
Retinal Necrosis. Stephanie K. cramer1, C. Flaxel1, 
S. Yeh2. 1Ophthalmology, Casey Eye Institute, 
Portland, OR; 2Ophthalmology, Emory Eye Center, 
Decatur, GA. 
Thursday – Posters – 6209 – 6226
6217 — D1077 Organo-selenium Coatings 
Inhibit Multiple Species Of Biofilm Formation On 
Different Types Of Ophthalmic Device Material. 
Kelly T. Mitchell1A, P. Tran1A, A. Arnett1A, T. Mosley2, 
R. Hanes2, C. Jarvis1A, A. Hamood1B, L. Dominguez1A, 
T. Reid1A,2. AOphthalmology, BMicrobiology and 
Immunology, 1Texas Tech University HSC, Lubbock, 
TX; 2Selenium Ltd., Austin, TX. 
Hall B/C D1078-D1087
Thursday, May 10, 2012, 8:30 AM-10:15 AM




6218 — D1078 Risk Of Cataract In Persons 
With Acquired Immune Deficiency Syndrome 
And Cytomegalovirus Retinitis. Elizabeth A. 
Sugar1,2A, A.T. Lyon3, R.A. Lewis4, D.A. Jabs5, 
M-H. Heinemann6,7, J.P. Dunn2B, J.H. Kempen8, 
Studies of Ocular Complications of AIDS Research 
Group. 1Biostatistics, Epidemiology, Bloomberg 
School of Public Health, The Johns Hopkins 
University, Baltimore, MD; AThe Sidney Kimmel 
Comprehensive Cancer Center, BOphthalmology, 
2The Johns Hopkins University School of Medicine, 
Baltimore, MD; 3Ophthalmology, Northwestern 
University, Chicago, IL; 4Ophthalmology, Medicine, 
Pediatrics, Molecular and Human Genetics, Baylor 
College of Medicine, Houston, TX; 5Ophthalmology, 
Internal Medicine, Mount Sinai School of Medicine, 
New York, NY; 6Ophthalmology, Weill Cornell 
Medical College, New York, NY; 7Opthalmic 
Oncology Service, Department of Surgery, Memorial 
Sloan Kettering Cancer Center, New York, NY; 
8Ophthalmology, Epidemiology, Center for Clinical 
Epidemiology and Biostatistics, The University of 
Pennsylvania School of Medicine, Philadelphia, 
PA.*CR 
6219 — D1079 The Best Functional Predictor 
of HIV Status in Relation to the Retinal Damage. 
Afsana Karim1A, I. Kozak1B, D-U.G. Bartsch2, H. 
Lemus3, L. Dustin4, J. Chhablani5, G. Barteselli1A, H. 
Wang1A, S.P. Azen6, W.R. Freeman7. AUCSD Jacobs 
Retina Center, BOphthalmology, 1University of 
California San Diego, La Jolla, CA; 2Ophthalmology-
Shiley Eye Ctr, Univ of California-San Diego, La 
Jolla, CA; 3Graduate School of Public Health, San 
Diego State University, san diego, CA; 4Biostatistics, 
University of Southern California, Los Angeles, CA; 
5Vitreo-Retina, Shiley Eye Center, UCSD, La Jolla, 
CA; 6Preventive Medicine, USC Keck School of 
Medicine, Los Angeles, CA; 7Ophthalmology, UCSD 
Jacobs Retina Center, La Jolla, CA. 
6220 — D1080 Non-Cytomegalovirus Related 
Ocular Opportunistic Infections in Patients With 
AIDS. Alice T. Lyon1, S. Gangaputra2, J.E. Thorne3, 
V. Vaidya4, L.T. Drye4, Longitudinal Study of Ocular 
Complications of AIDS(LSOCA) Research Group. 
1Ophthalmology, Northwestern University, Chicago, 
IL; 2Ophthal & Visual Sciences, Fundus Photograph 
Reading Ctr, Madison, WI; 3Ophthalmology, 
Johns Hopkins Wilmer Eye Inst, Baltimore, MD; 
4Epidemiology, Johns Hopkins Bloomberg School of 
Public Health, Baltimore, MD. 
6221 — D1081 Association between HIV 
Microangiopathy and Systemic Complications in 
Patients with AIDS. Yuko Iwasaki1,2, N. Yamamoto1, 
T. Kawaguchi1,2, N. Ozaki1, M. Mochizuki2, K. 
Murakami1. 1Ophthalmology, Tokyo Metropolitan 
Cancer and Infectious diseases Center Komagome 
Hospital, Tokyo, Japan; 2Ophthalmology & Visual 
Science, Tokyo Medical and Dental University, 
Tokyo, Japan. 
6222 — D1082 Analysis of Ophthalmic Surgery 
and Rates of Mixed Infection with Syphilis 
and Hepatitis in Individuals with Human 
Immunodeficiency Virus. Norio Takeda, S. Yashiro, 
Y. Nakamura, N. Yoshida. Dept of Ophthalmology, 
Hosp, Nt’l Ctr for Global Health & Med, Shinjuku-
Ku, Tokyo, Japan. 
6223 — D1083 Ocular Manifestations in HIV/
AIDS Patients with Concurrent Cryptococcal 
Meningitis. Ninani E. Coyne Kombo1, O. 
Nkomazana2, S.H. Forster1, R.A. Adelman1. 
1Ophthalmology and Visual Science, Yale University 
School of Medicine, New Haven, CT; 2University of 
Botswana School of Medicine, Gaborone, Botswana. 
6224 — D1084 Role Of Quantitative Polymerase 
Chain Reaction (qPCR) In Diagnosis Of Ocular 
Tuberculous Uveitis. Ramya N. Swamy, H. Nazari 
Khanamiri, N.A. Rao. Ophthalmology, Doheny Eye 
Institute, Los Angeles, CA. 
6225 — D1085 The Caspase-1-induced 
Pyroptotic Cell Death Pathway (Pyroptosis) 
Is Upregulated During Progression Of 
Experimental Murine Cytomegalovirus (MCMV) 
Retinitis in Mice With Retrovirus-induced 
Immunosuppression (MAIDS). Hsin Chien1, 
E.L. Blalock1, L.R. Bush1, C.I. Alston1, R.D. Dix1,2. 
1Department of Biology, Viral Immunology Center, 
Georgia State University, Atlanta, GA; 2Department 
of Ophthalmology, Emory University School of 
Medicine, Atlanta, GA. 
6226 — D1086 Murine Cytomegalovirus 
(MCMV) Downregulates Interleukin-17 via 
Increased Interleukin-10 Expression in Mice 
with Retrovirus-induced Immunuosuppression 
(MAIDS) that are Susceptible to Experimental 
Cytomegalovirus Retinitis. Emily L. Blalock1, H. 
Chien1, R.D. Dix1,2. 1Department of Biology, Viral 
Immunology Center, Georgia State University, 
Atlanta, GA; 2Department of Ophthalmology, Emory 
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6242 — D1102 Label-free LC-MSMS-based 
Differential Proteome Analysis of Vitreous from 
Autoimmune Uveitis Cases. Stefanie M. Hauck1, F. 
Hofmaier2, J. Dietter1,3, M. Blindert1, E. Kremmer4, 
M.E. Swadzba2, B. Amann2, C.A. Deeg2, M. Ueffing1,3. 
1Department of Protein Science, Helmholtz Center 
Munich, Neuherberg, Germany; 2Department for 
Veterinary Sciences, Institute of Animal Physiology, 
Munich, Germany; 3Centre for Ophthalmology, 
Institute for Ophthalmic Research, Tubingen, 
Germany; 4Institute for Molecular Immunology, 
Helmholtz Center Munich, Munich, Germany. 
6243 — D1103 Hsa-mir-let 7i Treatment 
Suppresses Tlr4 Mediated Mitochondrial 
Oxidative Stress In Giant Cell Arteritis. Narsing 
A. Rao, S. Saraswathy. Ophthalmology, Doheny Eye 
Institute, Los Angeles, CA. 
6244 — D1104 Amelioration of Experimental 
Autoimmune Uveoretinitis by Inhibiton of Toxic 
AGEs Formation. Zhenyu Dong1A,1B, N. Kitaichi2,1B, 
D. Iwata1A,1B, R. Ando1A,1B, J. Fukuhara1A,1B, A.M. 
Lennikov1A,1B, A. Kanda1A,1B, K. Noda1A,1B, S. Ohno1C, 
S. Ishida1A,1B. ADepartment of Ophthalmology, 
BLaboratory of Ocular Cell Biology and Visual 
Science, CDepartment of Ocular Inflammation 
and Immunology, 1Hokkaido University Graduate 
School of Medicine, Sapporo, Japan; 2Department 
of Ophthalmology, Health Sciences University of 
Hokkaido, Sapporo, Japan. 
6245 — D1105 Ophthalmological and 
Histological Manifestations of IgG4-Related 
Disease. Elise Philippakis, V. Touitou, C. Bloch-
Queyrat, A. Rigolet, F. Charlotte, P. LeHoang, B. 
Bodaghi. Pitie Salpetriere Hospital, Paris, France. 
6246 — D1106 Ocular Immune Pathological 
Analysis in a Murine Model of Anterior Scleritis. 
Hiroko Taniguchi1, M. Wang1, A. Nakajima2, J. Hori1. 
1Ophthalmology, Nippon Medical School, Tokyo, 
Japan; 2Rheumatology, Tokyo Metropolitan Police 
Hospital, Tokyo, Japan. 
6247 — D1107 Erythrocyte Sedimentation Rate 
and C-Reactive Protein in Anterior Uveitis. Justin 
D. Marsh, B.B. Markowitz. University of South 
Carolina, Columbia, SC. 
6248 — D1108 Antiphospholipid syndrome in 
Mexican population. Claudia Recillas-Gispert, J. 
Martinez. Ophthalmology, INCMNSZ, Mexico City, 
Mexico. 
6249 — D1109 Scleritis Associated with 
Inflammatory Bowel Disease. Maite Sainz de la 
Maza1, N. Molina1, L.A. Gonzalez-Gonzalez2, P.P. 
Doctor3, J. Tauber4, S. Foster2,5. 1Instituto Clinico 
Oftalmologia, Hospital Clinico Oftalmologia, 
Barcelona, Spain; 2Ophthalmology, Massachusetts 
Eye Research and Surgery Institution, Cambridge, 
MA; 3Ophthalmology, BayWiew Clinic, Mumbai, 
India; 4Ophthalmology, Tauber Eye Center, Kansas 
City, MO; 5Ophthalmology, Harvard Medical School, 
Boston, MA. 
6227 — D1087 Characteristics of 
Suppressor of Cytokine Signaling (SOCS)1 
and SOCS3 Expression in Response to 
Murine Cytomegalovirus (MCMV) Infection 
During Health and Retrovirus-Induced 
Immunosuppression (MAIDS). Christine I. 
Alston1, H. Chien1, E.L. Blalock1, R.D. Dix1,2. 
1Department of Biology, Viral Immunology Center, 
Georgia State University, Atlanta, GA; 2Department 
of Ophthalmology, Emory University School of 
Medicine, Atlanta, GA. 
Hall B/C D1088-D1116
Thursday, May 10, 2012, 8:30 AM-10:15 AM




6228 — D1088 Intraocular Th1/Th17 Cells 
Coexpressing IL-10: Tregs that Prevent Recurrent 
EAU? Ulrike Kaufmann, M. Diedrichs-Moehring, G. 
Wildner. Section of Immunobiology, Ophthalmology, 
Clinic of the Ludwig-Maximilians-University, 
Munich, Germany. T 
6229 — D1089 Cd4+ Foxp3+ Cd25Bright 
T Regulatory Cells Population In Ocular 
Sarcoidosis. Alexis Pinel1A, A. Mathian1B,2, M. 
Miyara1B, C. Chapelon-Abric1B, C. Parizot1C, D. 
Boutin1B, Z. Amoura1B, G. Gorochov1C, P. Lehoang1A, 
B. Bodaghi1A,3. AOphthalmology, BInternal medecine, 
CImmunology, 1CHU Pitie-Salpetriere, Paris, France; 
2INSERM UMR-S 945, Paris, France; 3U972 
INSERM, Paris, France. 
6230 — D1090 Assessment of Th1, Th2, and 
Th17 Cells in Birdshot Retinochoroidopathy. Paul 
Yang, C.S. Foster. Ophthalmology, Massachusettes 
Eye Research and Surgery Institute, Cambridge, MA. 
6231 — D1091 Regulatory T-Cells In 
Peripheral Blood of Patients With Birdshot 
Retinochoroidopathy. Sana S. Siddique1, L. 
Amorese1, L. Almulki2, A. Suelves3, C. Foster4. 
1Ophthalmology, MERSI/OIUF, Cambridge, MA; 
2Ophthalmology, Massachusetts Eye Res and Surgery 
Inst, Cambridge, MA; 3MERSI, Xirivella, Valencia, 
Spain; 4Ophthalmology, Ocular Immunol & Uveitis 
Fndtn, Cambridge, MA. 
6232 — D1092 Clinical Course of Patients 
with Behcet’s Uveoretinitis that Discontinued 
Infliximab Therapy. Tatsushi Kawaguchi1,2, Y. 
Iwasaki1,2, S. Kanda2, S. Sugita2, M. Mochizuki2. 
1Ophthalmology, Tokyo Metropolitan Komagome 
Hospital, Tokyo, Japan; 2Ophthalmology & Visual 
Science, Tokyo Medical and Dental University, 
Tokyo, Japan. 
6233 — D1093 Anti-DEC205 Mediated Delivery 
of Self-Antigen to Dendritic Cell Restores 
Tolerance in Spontaneous EAU. Koju Kamoi1, C. 
Martin-Granados1, C. Bobu1, M.E. Wikstrom2, M.A. 
Degli-Esposti2, R.M. Steinman3, J.V. Forrester1. 
1Ophthalmology, University of Aberdeen, Aberdeen, 
United Kingdom; 2Lion Eye Institute, University 
of Western Australia, Nedlands, Western Australia, 
Australia; 3Rockfeller University, New York, NY. 
6234 — D1094 Monocyte-derived Macrophages 
in EAU Resolution. Inbal Benhar1, A. London1, R.R. 
Caspi2, M. Schwartz1. 1Neurobiology, Weizmann 
Institute of Science, Rehovot, Israel; 2Laboratory 
of Immunology, National Eye Inst/NIH, Bethesda, 
MD. T 
6235 — D1095 Alpha-1 Adrenergic Stimulation 
Exacerbates Acute Ocular Inflammation Through 
A Mechanism Mediated By Transforming Growth 
Factor Beta (TGFB). Paola A. Durand1, Y. Tan2, D. 
Fatmi1, X. Xia2, E. Suarez1, V.L. Perez2, J.L. Vega1. 
1Neurology, Herbert Wertheim College of Medicine-
Florida International University, Miami, FL; 
2Ophthalmology, Bascom Palmer Eye Insitute, Miller 
School of Medicine, Miami, FL. 
6236 — D1096 Effect Of P2Y2 Deficiency On 
Experimental Autoimmune Uveitis Development. 
Laure E. Caspers1, L.J. Relvas1, R. Dewispelaere1, 
M. Makhoul2, D. Communi2, J-M. Boeynaems2, B. 
Robaye2, C. Bruyns2, F. Willermain1. 1Ophthalmology, 
Univ of Brussels-St Pierre Hosp, Brussels, Belgium; 
2Univ of Brussels-IRIBHM, Brussels, Belgium. 
6237 — D1097 Role of iC3b-CR3 interaction 
in Experimental Autoimmune Anterior Uveitis. 
Bharati Matta, P. Jha, P.S. Bora, N.S. Bora. 
Ophthalmology, Jones Eye Institute-UAMS, Little 
Rock, AR. 
6238 — D1098 Temporal Expression of miR-155 
Correlates with the initiation and Development 
of Experimental Autoimmune Uveitis (EAU). 
Bernadette Marrero, Y. Chen-Rong, C. Nagineni, C. 
Egwuagu. Immunology, NEI, Bethesda, MD. 
6239 — D1099 DAP-12, a Major 
Immunomediator, Either Promotes or Suppresses 
EAU Development. Barbara P. Vistica1, V. 
Montalvo-Reddin1, G. Shi1, L. Nugent1, L. Quigley2, 
D.W. McVicar2, I. Gery1. 1Lab of Immunology, 
National Eye Institute, Bethesda, MD; 2Cancer and 
Inflammation Program, NCI-Frederick, Frederick, 
MD. 
6240 — D1100 Inhibition of CdK5 Attenuates 
Experimental Autoimmune Uveitis. Zili Zhang1, 
X. Wu1, J. Duan1, J.T. Rosenbaum2. 1Pediatrics, 
Oregon Health & Science University, Portland, 
OR; 2Ophthalmology, Casey Eye Institute-OHSU, 
Portland, OR. 
6241 — D1101 Immunological Inhibition of 
Pigment Epithelium-Derived Factor (PEDF)? 
Charles E. Thirkill. Ocular Immunology Research 
Lab 1220 Surge III, UC Davis, Davis 95616, 
CA.*CR 




 – 10:15 am
381
*Refer to Program Number in the Commercial Relationships (CR) Index for Disclosures   –   f Refer to Program Number in the Clinical Trial (CT) Registration Index  –   T Travel Grant Awardee
6250 — D1110 Posterior Scleritis and Orbital 
Mass Associated to Positive Antineutrophil 
Cytoplasmic Autoantibodies Without Systemic 
Involvement. MarÃ a de los Angele Ramos Cadena1, 
G. Aguilar Montes1, M. Ruiz Cruz2. 1Ophthalmology, 
Hospital General Dr. Manuel Gea Gonzalez, 
Mexico City, Mexico; 2Ophthalmology, Centro 
de Investigacion de Enfermedades Infecciosas del 
Instituto Nacional de Enfermedades Respiratorias, 
Mexico City, Mexico. 
6251 — D1111 Uveitis In Patients With Diabetes 
Mellitus. Martha C. Fuentes, C.G. Sánchez-Balleza, 
M. Pedroza-Seres. Ocular Inflammation and 
Immunology, Conval, Mexico, Mexico. 
6252 — D1112 Risk Factors Associated with 
the Relapse of Uveitis in Patients with Juvenile 
Idiopathic Arthritis. Ujwala H. Baheti1, A. 
Radwan1, C. Arcinue1, R. Parikh1, A. Mohamed2, 
C. Foster1. 1Ophthalmology, Massachusetts Eye 
Research and Surgery Institution, Cambridge, MA; 
2Hyderabad Eye Research Foundation, L V Prasad 
Eye Institute, Hyderabad, India. 
6253 — D1113 Risk Factors for Loss of Visual 
Acuity among Patients with Uveitis Associated 
With Juvenile Idiopathic Arthritis: The SITE 
Study. Jennifer E. Thorne1, A. Gregory1, E. Daniel2, 
C. Foster3, D.A. Jabs4, G.A. Levy-Clarke5, R.B. 
Nussenblatt6, J.T. Rosenbaum7A, E.B. Suhler7B, 
J.H. Kempen8. 1Ophthalmology, Johns Hopkins 
Wilmer Eye Inst, Baltimore, MD; 2Ophthalmology, 
University of Pennsylvania, Philadelphia, PA; 
3Ophthalmology, Ocular Immunol & Uveitis Fndtn, 
Cambridge, MA; 4Ophthalmology, Mount Sinai 
School of Medicine, New York, NY; 5Tampa Uveitis, 
Tampa, FL; 6National Eye Inst/NIH, Bethesda, MD; 
AOphthalmology, BUveitis Clinic/Portland VAMC, 
7Casey Eye Institute-OHSU, Portland, OR; 8Ophthal-
Biostatistics & Epidemiol, Scheie Eye Inst/Univ of 
Penn, Philadelphia, PA. 
6254 — D1114 In Search Of Intraocular 
Biomarkers In Uveitis Associated With Juvenile 
Idiopathic Arthritis (jia). Viera Kalinina Ayuso1A, 
J.D. de Groot-Mijnes2, J. Dekkers1B, L. de Visser1A, 
A. Rothova1A, J.H. de Boer1A. AOphthalmology, 
BVirology, 1UMC Utrecht, Utrecht, The Netherlands; 
2Virology, Univ Medical Center Utrecht, Utrecht, The 
Netherlands. 
6255 — D1115 Dramatic Effect Of Bolus 
Cyclophosphamide In Two Severe Cases Of 
Lupus Retinopathy. Soydan Kurun, A. Locatelli, T. 
Maalouf, K. Angioi. Ophthalmology, Regional Univ 
Hosp Ctr Brabois, Nancy, France. 
6256 — D1116 Inhibition Of The Acid 
Sphingomyelinase/ceramide System Prevents 
Hallmarks Of Graves Ophthalmopathy. Melissa 
Meyer zu HÃ¶rste1,2, E. Stroeher1, Y. Zhang2, K. 
Roeck3, J. Fischer3, U. Bercher-Pfannschmidt1, 
A.K. Eckstein1, E. Gulbins2. 1Department of 
Ophthalmology, University Hospital Duisburg-
Essen, Essen, Germany; 2Department of Molecular 
Biology, University of Duisburg-Essen, Essen, 
Germany; 3Institute of Pharmacology and 
Clinical Pharmacology, University of Dueseldorf, 
Duesseldorf, Germany. 
Thursday – Posters – 6250 – 6268
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6257 — D1117 An Antimicrobial Peptide Can 
Enhance the Activity of a Fluoroquinolone in 
Reducing Colony Counts of Fluoroquinolone-
Resistant MRSA in the NZW Rabbit Keratitis 
Model. Eric G. Romanowski, K.A. Yates, F.S. 
Mah, Y J. Gordon, R.P. Kowalski. The Charles 
T. Campbell Laboratory, UPMC Eye Center, 
University of Pittsburgh, Pittsburgh, PA.*CR 
6258 — D1118 Pharmacokinetic Parameters 
Determined For A Fluoroquinolone In The Eye 
Of Rabbits And Multiple Dosage Regimens 
Prediction. Juan Carlos Rivera-Castro, Sr., J. 
Tornero-Montaño, J. Quintana-Hau, H. Figueroa-
Ponce, A. Carrillo-Guzmán, L. Urquidez-Espinoza. 
R&D, Laboratorios Sophia SA de CV, Zapopan, 
Mexico.*CR 
6259 — D1119 In Vitro Activity of ACH-
0139586, a Novel Isothiazoquinolone, 
Moxifloxacin and Gatifloxacin Against 
Clinical Isolates, Including Methicillin and 
Fluoroquinolone Resistant. Aron Shapiro1, L. 
Belen1, A. Whitlock1, D. Sahm2. 1Ora, Inc., Andover, 
MA; 2Eurofins Medinet, Chantilly, VA.*CR 
6260 — D1120 A Novel Antiviral Protein RC28. 
Naihong Yan1, F. Piraino2, X. Liu1. 1Ophthalmic 
Laboratories, Chengdu, China; 2Department of 
Ophthalmology and Visual Sciences, University of 
Wisconsin Medical School, WI. 
6261 — D1121 Clinical utility of Ophthalmic 
Antimicrobial Susceptibility Measurement 
Plate. Norihiko Tou1, R. Nejima2, Y. Ikeda3, Y. 
Hori4, K. Sasaki5, M. Sakamoto6, K. Miyata2, Y. 
Inoue3, A. Tawara1, H. Fujiwara7. 1Ophthalmology, 
Univ of Occup & Environ Health, Kitakyushu-
shi, Japan; 2Miyata Eye Hospital, Miyazaki, 
Japan; 3Department of Ophthalmology, Tottori 
Univ Faculty of Medicine, Yonago, Japan; 
4Ophthalmology, Toho University Sakura Medical 
Center, Sakura, Japan; 5Ideta Eye Hospital, 
Kumamoto, Japan; 6Ophthalmology, The Research 
Foundation for Microbial Diseases of Osaka 
University, Osaka, Japan; 7Department of Clinical 
Laboratory, Tottori University Hospital, Yonago, 
Japan. 
6262 — D1122 Prevalence and risk factors of 
methicillin-resistant Staphylococcus aureus nasal 
carriage among ophthalmology outpatients in 
Puerto Rico. Maria H. Berrocal1, V. López2, L.A. 
Acabá3, A. Acabá4. 1Ophthalmology, University of 
Puerto Rico, San Juan, PR; 2Bryn Mawr College, 
Bryn Mawr, PA; 3U. of Puerto Rico, San Juan, PR; 
4U. Puerto Rico, San Juan, PR.*CR 
6263 — D1123 A Comparative Study in the 
Clinical and Microbial Efficacy of Topical 
Besifloxocin Ophthalmic Suspension 0.6% with 
Erythromycin Ophthalmic Ointment 0.5% for 
Management of Acute Blepharitis. George John. 
VA Medical Center, Louisville, KY.*CR, f 
6264 — D1124 Effect Of Different Excipients 
In Tobramycin Sulfate Watery Solutions 
Degradation Rate. Abida Carrillo-Guzman, L. 
Torres-Pedraza, J. Tornero-Montaño, H. Figueroa-
Ponce. R & D, Laboratorios Sophia SA de CV, 
Zapopan, Mexico.*CR 
6265 — D1125 Effect of Simultaneous 
Treatment of Quinolones and Antifungal Drugs 
on Fungal-Bacterial Coculture. Diana Gabriela 
Ponce-Angulo, Jr.1A, M. Martinez-Rivera, Sr.2, V. 
Bautista-de Lucio, Sr.1A, A. Rodriguez-Tovar, Sr.2, 
C. Santacruz-Valdez, Sr.1B, A. Climent-Flores, Sr.1B, 
A. Robles-Contreras, Jr.1A, C. Diaz-Godinez, Jr.2, 
E. Felix Diaz-Parga, Jr.2, H. Mejia-Lopez, Sr.1A. 
AResearch Unit / Microbiology and Proteomics, 
BCornea service, 1Institute of Ophthalmology, 
Mexico, D.F., Mexico; 2Laboratory of Medical 
Mycology, Department of Microbiology, National 
School of Biological Sciences (IPN), Mexico, D.F., 
Mexico. 
6266 — D1126 Lacritin, a Novel Tear 
Glycoprotein, is an Effective Topical 
Antimicrobial Agent in an Animal Model. Alireza 
Hosseini1, F.A. Lattanzio, Jr.1, S.S. Samudre1, J.D. 
Sheppard, Jr.2, G.W. Laurie3, R.L. McKown4, P.B. 
Williams1. 1Physiological Sciences, Eastern Virginia 
Medical School, Norfolk, VA; 2Virginia Eye 
Consultants, Norfolk, VA; 3Cell Biology, University 
of Virginia, Charlottesville, VA; 4Integrated 
Science & Technology, James Madison University, 
Harrisonburg, VA. 
6267 — D1127 Susceptibility Of Methicillin-
resistant Staphylococci Clinical Isolates To 
Netilmicin And Other Antibiotics Commonly 
Used In Ophthalmic Therapy. Anna Rita Blanco1A, 
A. Sudano Roccaro1A, V. Papa1B, M. Mazzone1C. 
APharmaco Biology Unit - BU Pharma, BMedical 
Marketing - BU Pharma, CProduct Portfolio 
Development - BU Pharma, 1SIFI SPA, Catania, 
Italy.*CR 
6268 — D1128 Clinical Efficacy and Safety 
of Azithromycin 1.5% versus Tobramycin 0.3 
% Eye Drops in the Treatment of Children 
Bacterial Conjunctivitis. Dominique Bremond-
Gignac1, F. Chiambaretta2, H. Nezzar2, B. 
Mortemousque3, C. Speeg-Schatz4, S. Milazzo5, 
Azithromycin Study Group. 1Ophthalmology, St 
Victor Center, CHU Amiens, Picardie University, 
Amiens, France; 2Ophthalmology, CHU 
Clermont Ferrand, Clermont Ferrand, France; 
3Ophthalmology, CHU Bordeaux, Bordeaux, 
France; 4Ophthalmology, CHU Strasbourg, 
Strasbourg, France; 5Ophthalmology/Saint Victor 
Center, CHU Amiens, University Jules Verne, 
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6269 — D1129 Increased Antibiotic Resistance 
Of Ocular Surface Flora After Repeated Use 
Of Prophylactic Topical Fluoroquinolone Post 
Intravitreal Injection For Neovascular Age-
related Macular Degeneration (amd). Vivian 
T. Yin1, D. Weisbrod1,2, E. Mandelcorn1,3, C. 
Schwartz1,2, R. Kohly1,2, K. Eng1,2, W-C. Lam1,3, 
P. Kertes1,2. 1Department of Ophthalmology, 
University of Toronto, Toronto, ON, Canada; 
2Sunnybrook Health Sciences Center, Toronto, ON, 
Canada; 3Toronto Western Hospital, University 
Health Network, Toronto, ON, Canada.*CR, f 
6270 — D1130 Multicenter Comparison of 
Loteprednol 0.5% vs Prednisilone Acetate 1% 
in patients Post-Phacoemulsifaction with IOL 
implants. Carlos Buznego1, G. Perez2, W. Trattler3, 
J.A. Khell4, B. Henderson5. 1General & Surgical 
Ophthal, Center for Excellence in EyeCare, Miami, 
FL; 2Ctr for Excellence in Eye Care, Miami, FL; 
3Cornea, Center For Excellence in Eye Care, Miami, 
FL; 4Ophthalmology/Cornea, Center for Excellence 
in Eyecare, Miami, FL; 5Boston Eye Surgery and 
Laser Center, Boston, MA.*CR, f 
6271 — D1131 Prostaglandin E
2
 Sensitive 
Receptors Reduce Leukocyte Infiltration And 
Protein Exudation In Lps Induced Uveitis 
In Rats. Neil Poloso, C. Vu, D.F. Woodward. 
Biological Sciences, Allergan Inc, Irvine, CA.*CR 
6272 — D1132 Retinal Damage in Severe 
Chemical Burn and the Use of Infliximab 
Therapy. Fabiano Cade1,2, E. Paschalis1, C.V. 
Regatieri3,2, R. Dana1,3, C.H. Dohlman1. 1Cornea 
and Refractive Surgery, Massachusetts Eye & Ear 
Infirmary, Harvard Medical School, Boston, MA; 
2Ophthalmology, Federal Sao Paulo University, Sao 
Paulo, Brazil; 3Schepens Eye Research Institute, 
Harvard Medical School, Boston, MA. 
6273 — D1133 Topical Treatment With A 
Selective COX-2 Inhibitor Promotes Retinal 
Ganglion Cell Survival After Optic Nerve Crush. 
Oliver W. Gramlich1A, H.D. von Pein1B, A. Ziegler1A, 
K. Bitz1A, N. Pfeiffer1A, F.H. Grus1A. AExperimental 
Ophthalmology, BDepartment of Neuropathology, 
1University Medical Center, Mainz, Mainz, 
Germany. 
6274 — D1134 Twenty-Eight Day Microbial 
Preservative Efficacy of Loteprednol Etabonate 
Ophthalmic Ointment, 0.5%; an Unpreserved 
Ointment with Low Water Activity. Brien C. 
David, L.S. Gearinger, J. Klingensmith, H.H. 
Decory. R&D Microbiology, Bausch & Lomb, 
Rochester, NY.*CR 
6275 — D1135 A Novel Peptide from 
Adiponectin Suppresses LPS-induced Pro-
inflammatory Signaling in Macrophages by 
Inducing Interleukin-10 Expression. Huiyi Jin, 
X. Yang, X. Xu, K. Liu. Shanghai First People’s 
Hospital, Shanghai, China. 
6276 — D1136 Amelioration Of Endotoxin-
induced Uveitis Treated With An Ikb Kinase 
Inhibitor, Imd-0354 In Rats. Anton Lennikov1A, 
N. Kitaichi1A,2, K. Noda1A, R. Ando1A, Z. Dong1A, 
K. Namba1A, K. Namba1A, S. Ohno1B, S. Ishida1A. 
ALaboratory of Ocular Cell Biology and Visual 
Science, Department of Ophthalmology, 
BDepartment of Ocular Inflammation and 
Immunology, 1Hokkaido University, Sapporo, 
Japan; 2Department of ophthalmology, Health 
Sciences University of Hokkaido, Sapporo, 
Japan. T 
6277 — D1137 Lutein-rich Marigold 
Extract Induces Gene Expression Of Phase II 
Antioxidants In The PC12D Neuronal Cells. 
Seiji Miyake1A,2, N. Takahashi1A, M. Sasaki1,1A, 
S. Kobayashi2, K. Tsubota1, Y. Ozawa1,1A. 
ALaboratory of Retinal Cell Biology, 1Department 
of Ophthalmology, Keio University School of 
Medicine, Tokyo, Japan; 2Wakasa Seikatsu Co., 
Ltd., Kyoto, Japan.*CR 
6278 — D1138 Ocular and Systemic 
Pharmacokinetics of Loteprednol Etabonate Gel 
(0.5%) following Topical Ocular Administration 
to Rabbits. Shellise Glogowski, J.W. Proksch. 
Drug Metabolism & Pharmacokinetics, Global 
Pharmaceutical R&D, Bausch & Lomb, Rochester, 
NY.*CR 
6279 — D1139 Topical Application Of 
Infliximab (Remicade®) In The Treatment 
Of Corneal Caustication. Fabio Bignami1A, 
G. Ferrari1A,2, C. Giacomini1A, S. Franchini1, P. 
Rama1B. ACornea Unit - Eye Repair Lab, BOphthal-
Cornea and Ocular Surface Unit, 1San Raffaele 
Scientific Institute, Milan, Italy; 2Bietti Eye 
Foundation, Rome, Italy. 
6280 — D1140 Identification of The Anti-
Inflammatory Annexin-A1 Protein in Tears 
of Normal Subjects and Association of its 
Cleaved-Inactive Form with Active Vernal 
Keratoconjunctivitis Patients. Samia Yazid1, 
A. Leonardi2, V. Calder1, R. Flower3. 1Molecular 
Therapy, UCL, Institute of Ophthalmology, London, 
United Kingdom; 2Medicine School, University of 
Padua, Padua, Italy; 3Biochemical Pharmacology, 
QMUL, William Harvey Research Institute, 
London, United Kingdom. 
6281 — D1141 HC-HA but not High 
Molecular Weight HA Polarizes LPS-Activated 
Macrophages toward M2 Phenotype via CD44-
Mediated Suppression of TLR4 Signaling. Hua 
He1, S.C. Tseng2. 1TissueTech and Ocular Surface 
Center, Miami, FL; 2Ocular Surface Center, Ocular 
Surface Res & Educ Fndtn, Miami, FL.*CR 
6282 — D1142 Genetically Engineered 
IL-30 (IL27p28) Suppresses Experimental 
Autoimmune Uveitis. Ren-Xi Wang, C-Y. Yu, R. 
Mahdi, C. Egwuagu. Laboratory of Immunology, 
NEI, Bethesda, MD. 
6283 — D1143 Viscoelastic And Sedimentation 
Characterization Of Loteprednol Etabonate 
Ophthalmic Gel, 0.5%. Martin J. Coffey, S.R. 
Davio. Pharmaceutical Product Development, 
Bausch and Lomb, Rochester, NY.*CR 
6284 — D1144 A Novel Peptide Inhibits 
Inflammation in Endotoxin-induced Uveitis 
by Suppressing NF-kappaB and MAPK 
Signaling Pathway. Xiao lu Yang, H. Jin, X. Xu. 
Ophthalmology, Shanghai First People’s Hospital, 
Shanghai, China. 
6285 — D1145 Anti-inflammatory Effects 
Of Glucocorticoids On Endotoxin-induced 
Uveitis In Rats : Effects Of The Mode Of 
Administration. Pierre-Paul Elena, N. Cimbolini, 
S. Antonelli, H. Dubos, L. Feraille, P. Margaron. 
Iris Pharma, La Gaude, France.*CR 
6286 — D1146 Clinical Experience With 
Sustained-Release Intravitreal Corticosteroid 
Implants: A Comparison Between The 
Fluocinolone Acetonide (Retisert) And 
Dexamethasone (Ozurdex) Implants In Uveitis. 
Cheryl A. Arcinue1, C. Foster1, O. Ceron1, L. 
Almulki2. 1Uveitis and Ocular Immunology, 
Massachusetts Eye Research & Surgery Institution, 
Cambridge, MA; 2Ophthalmology, Massachusetts 
Eye Res and Surgery Inst, Cambridge, MA. 
6287 — D1147 Cytokine Levels In The Vitreous 
Fluid Of Patients With Ocular Sarcoidosis 
And Patients With Diabetic Retinopathy. Kenji 
Nagata1, K. Maruyama1, K. Yoneda1, T. Yoshimura2, 
K-H. Sonoda3, S. Kinoshita4. 1Ophthalmology, 
Kyoto Prefectural Univ of Med, Kyoto, Japan; 
2Ophthalmology, Kyushu University, Fukuoka, 
Japan; 3Ophthalmology, Yamaguchi University, 
Ube, Japan; 4Ophthalmology, Kyoto Prefectural 
Univ of Med, Kamigyo-Ku, Japan. 
6288 — D1148 Human Tears Reveal Insights 
Into Corneal Neovascularization. Nadia 
Zakaria1A,2, S. Van Grassdorff1A, K. Wouters1B, 
J. Rozema1A, N. Cools1C, V. Van Tendeloo1D, Z. 
Berneman1D, M-J. Tassignon1A. AOphthalmology, 
BStatistics, CHematology, DCenter for Cell Therapy 
and Regenerative Medicine, 1University Hospital 
Antwerp, Antwerp, Belgium; 2Center for Cell 
Therapy and Regenerative Medicine, Antwerp 
University Hospital, Antwerp, Belgium. T
6289 — D1149 Errors In Measuring VEGF 
Concentrations In The Presence Of Anti-
VEGF Antibodies By Using ELISA. Hidenori 
Takahashi1,2, Y. Fujino1,2, Y. Yanagi2. 1Ophthalmology, 
Tokyo KoseiNenkin Hospital, Tokyo, Japan; 
2Ophthalmology, University of Tokyo, Tokyo, Japan. 
6290 — D1150 BDNF and Forskolin act on 
Retinal Development in a Ganglion Cell-free 
Novel Explant System of the Chick Embryo. 
Alexander Greif, J. Wiedemann, G. Thangaraj, 
P.G. Layer. Entwicklungsbiologie, Technische 
Universitaet Darmstadt, Darmstadt, Germany. 
6291 — D1151 Tear Cytokine Profile as a 
Non-invasive Biomarker of Inflammation for 
Multicenter Clinic Trials of Ocular Surface 
Diseases. Yi Wei, K. Fernandez, N. Gadaria, P. 
Dentone, B. Pearlman, P. Asbell. Ophthalmology, 
Mount Sinai School of Med, New York, NY.*CR 
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6292 — D1152 Cytokine Profile In Active Ocular 
Toxoplasmosis. Amanda Rey Torrente, B. Molins, 
V. Llorens, L. Pelegrín, M. Mesquida, M. Figueras, 
A. Adán Civera. Ophthalmology, Hospital Clinic 
Barcelona, Barcelona, Spain. 
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6298 — 12:30 Netrin-1 Promotes Vascular 
Regeneration in a Mouse Model of Ischemic 
Retinopathy. Francois Binet1, G-S. Mawambo-
Tagne1, S. Favret1, N. Sitaras1, N. Tétreault1, A. 
Cerani1, E. Lapalme1, F. Rezende1, T. Kennedy2, P. 
Sapieha1. 1Research Center, Maisonneuve Rosemont 
Hospital, Montreal, QC, Canada; 2Montreal 
Neurological Institute, McGill University Montreal, 
QC, Canada. T 
Floridian BCD





6300 — 11:15 Decreasing Peripheral 
Hyperopia With Distance-centre Relatively-plus 
Powered Periphery Contact Lenses Reduced The 
Rate Of Progress Of Myopia: A 5 Year Vision 
Crc Study. Brien A. Holden1,2, P.R. Sankaridurg1,3, 
P. Lazon De La Jara1,3, T. Naduvilath1,3, A. Ho1,2, 
D.F. Sweeney4,3, M. Markoulli1,3, E.L. Smith, 
III5,3, J. Ge6,3, Vision CRC Myopia Clinical Study 
Group. 1Brien Holden Vision Institute, Sydney, 
Australia; 2School of Optometry and Vision 
Science, University of New South Wales, Sydney, 
Australia; 3Vision Cooperative Research Centre, 
Sydney, Australia; 4College of Health and Science, 
University of Western Sydney, Sydney, Australia; 
5College of Optometry, University of Houston, 
Houston, TX; 6Zhongshan Ophthalmic Center, 
Guangzhou, China.*CR, f 
6301 — 11:30 Impact of a Novel Silicone 
Hydrogel Material on Meibomian Gland 
Structure. Jason J. Nichols1, K.E. Osborn2, T. 
Henderson3. 1College of Optometry, University of 
Houston, Houston, TX; 2Vistakon, Columbus, OH; 
3Vistakon, Jacksonville, FL.*CR, f 
6302 — 11:45 A Novel Method Of Measuring 
Tear Evaporation Rates Using Infrared 
Thermography. Andrea Petznick1, S. Lee1, J. Tan2, 
U. Acharya2,3, E. Ng4, L. Tong5,1. 1Ocular Surface 
Research Group, Singapore Eye Research Institute, 
Singapore, Singapore; 2School of Engineering, Ngee 
Ann Polytechnic, Singapore, Singapore; 3Singapore 
Institute of Technology, University of Glasgow, 
Glasgow, United Kingdom; 4School of Mechanical 
and Aerospace Engineering, Nanyang Technological 
University, Singapore, Singapore; 5Cornea and 
External Eye Disease Service, Singapore National 
Eye Centre, Singapore, Singapore. 
6303 — 12:00 Keratoconus Detection 
by Corneal Epithelial Thickness Mapping 
with Fourier-Domain Optical Coherence 
Tomography. Yan Li1, O. Tan1, R. Brass2, J.L. 
Weiss3, D. Huang1. 1Ophthalmology, Oregon Health 
and Science University, Portland, OR; 2Albany Med 
Coll/Brass Eye Ctr, Latham, NY; 3Gordon & Weiss 
Vision Institute, San Diego, CA.*CR 
6304 — 12:15 Vitrified Collagen Gels with 
Optimized Material Properties for Repair of 
Ocular Injuries. Xiomara Calderon-Colon1, Z. 
Xia1, Q. Guo2, J.E. Tiffany1, J.P. Maranchi1, R.L. 
McCally1,3, O. Schein4, J.H. Elisseeff2,3, M.M. 
Trexler1. 1Research and Exploratory Development, 
Johns Hopkins Univ - APL, Laurel, MD; 
2Department of Biomedical Engineering, Johns 
Hopkins University, Baltimore, MD; 3The Wilmer 
Eye Institute at Johns Hopkins, Baltimore, MD; 
4Department of Ophthalmology, Johns Hopkins 
University, Batimore, MD.*CR 
6305 — 12:30 Mechanical Corneal Sculpting 
As New Technique For Refractive Surgery. 
Wolfgang Herrmann1A, S. Gebauer2, A. Dannullis1A, 
J. Schroeder1B, H. Maas2, H. Helbig1A, O. Strauss1A. 
AOphthalmology, BPathology, 1University of 
Regensburg, Regensburg, Germany; 2Gebauer 
Medizintechnik GmbH, Neuhausen, Germany.*CR 
6306 — 12:45 A Novel Method to Generate 
Precut Tissue for Descemet Membrane 
Endothelial Keratoplasty (DMEK). Bjoern O. 
Bachmann1, U. Schlötzer-Schrehardt1, M. Börgel2, 
F.E. Kruse1. 1Ophthalmology, Universityhospital 
Erlangen, Erlangen, Germany; 2Deutsche 
Gesellschaft für Gewebetransplantation (DGFG), 
Hannover, Germany. 
Room 114
Thursday, May 10, 2012, 11:15 AM-1:00 PM
Immunology & Microbiology / Eye Movements, 
Strabismus, Amblyopia & Neuro-Ophthalmology 




6307 — 11:15 The Role of Interleukin-17A in 
a Spontaneous Model of Autoimmune Uveitis 
Elicited by Retina-specific T Cells. Benjamin 
C. Chaon1A,2, R. Horai1A, J. Chen1A, C. Zárate-
Bladés1A, R. Villasmil1B, C-C. Chan1A, R.R. Caspi1A. 
ALaboratory of Immunology, BFlow Cytometry 
Core, 1National Eye Institute - NIH, Bethesda, MD; 
2Howard Hughes Medical Institute, Bethesda, MD. 
6308 — 11:30 Abundant Il-17+ T Cells 
Induced In Immunized C57bl/6 Mice Are Not 
Autoreactive. Deming Sun1, D. Liang1, A. Zuo1, H. 
Shao2, H.J. Kaplan3, H. Nian1. 1DVRC-411, Doheny 
Eye Institute, Los Angeles, CA; 2Ophthal & Visual 
Sciences, University of Lousiville, Louisville, KY; 
3Ophthal & Vis Science, University of Louisville, 
Louisville, KY. 
6309 — 11:45 Identification of a MC5r+ 
Gr-1low F4/80+ CD11b+ APC Associated with 
EAU Recovery. Darren J. Lee, A.W. Taylor. 
Ophthalmology, Boston University School of Med, 
Boston, MA. T 
Floridian A




6293 — 11:15 Tyrosinase Function Determines 
Retinal Vascular Regeneration and Retinal 
Vascular Endothelial Progenitor Cell Recruitment 
in the Oxygen-Induced Retinopathy Model. 
Robert C. Symons1, R.S. White2, B.E. O’Bryhim3. 
1Ophthalmology, Kansas University Medical 
Center, Prairie Village, KS; 2Ophthalmology, 
Kansas University Medical Center, Kansas City, 
KS; 3Ophthalmology; Molecular and Integrative 
Physiology, Univ of Kansas Medical Center, Kansas 
City, KS. 
6294 — 11:30 Tyrosinase Function Determines 
Bone Marrow and Blood Endothelial Progenitor 
Cell Numbers in Infant Mice in Normal 
Conditions and After Exposure to the Oxygen 
Induced Retinopathy Model. Bliss H. O’Bryhim1, 
R. White2, A. Symons2,1. 1Molecular & Integrative 
Physiology, Univ of Kansas Medical Center, Kansas 
City, KS; 2Ophthalmology, Univ of Kansas Medical 
Center, Prairie Village, KS. T 
6295 — 11:45 Altered Vascular Response in 
MicroRNA 132-212 Knockout Mice in the Model 
of Oxygen-Induced Retinopathy. Michael R. 
Powers1, M.H. Davies1, S.T. Magill2. 1Pediatrics 
& Ophthalmology, Casey Eye Institute-OHSU, 
Portland, OR; 2Vollum Institute-Oregon Health & 
Science University, Portland, OR. 
6296 — 12:00 Activation of the Endothelin 
System in Models of Ischemic Retinopathy. 
Chintan Patel1A, W. Zhang2, Z. Xu1A, S.P. 
Narayanan1A, N-T. Tsai1A, W. Caldwell1B, 
R.B. Caldwell1A. AVascular Biology Center, 
BPharmacology & Toxicology, 1Georgia Health 
Sciences University, Augusta, GA; 2Ophthalmology, 
The University of Texas Medical Branch, Galveston, 
TX. 
6297 — 12:15 Progressive Central 
Photoreceptor Damages and Retinal Pigment 
Epithelium Abnormalities in Oxygen Induced 
Retinopathy. Zhuo Shao1,2, J. Rivera2, T.E. 
Zhou1,2, P. Sapieha3, P. Lachapelle4, S. Chemtob5. 
1Pharmacology and Therapeutics, McGill University, 
Montreal, QC, Canada; 2Departments of Pediatrics 
and Pharmacology, Hôpital Ste Justine, Research 
Center, Montreal, QC, Canada; 3Ophthalmology, 
University of Montreal, Montreal, QC, Canada; 
4Ophthalmology, McGill U-Montreal Childrens 
Hosp, Montreal, QC, Canada; 5Pediatrics & 
Pharmacology, Research Ctr/Hosp Ste Justine, 
Montreal, QC, Canada. 
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6310 — 12:00 Thrombospondin Receptor CD47 
On T Cells And Not On The Surface Of Antigen 
Presenting Cells Is Necessary For Treg Induction 
Associated With Ocular Immune Privilege. Fayaz 
Mir, B. Turpie, S. Masli. Harvard Medical School, 
Schepens Eye Research Inst, Boston, MA. 
6311 — 12:15 ACAID Tolerogenic APC Induce 
Two Types Of CD4+ Treg Cells By Two Different 
Mechanisms. Rose Mathew, J. Stein-Streilein. 
Immunology, Schepens Eye Research Institute/
MEEI, Boston, MA. 
6312 — 12:30 In vivo Imaging of Experimental 
Autoimmune Uveitis disease progression in 
Cx
3
cr1-GFP and CD11c-YFP mice. Xiangting 
Chen1A, H.R. Chinnery2, J. Kezic3, M. Sidhu1A, C. 
Bernard1B, J.V. Forrester4, P.G. McMenamin1A. 
AAnatomy and Developmental Biology, BMonash 
Immunology and Stem Cell Laboratories, 1Monash 
University, Clayton, Australia; 2School of Medicine 
(Optometry) Deakin University, Geelong, Australia; 
3Anatomy and Developmental Biology, Monash 
University & Centre For Eye Research Australia, 
Clayton, Australia; 4Centre for Ophthalmology and 
Vision Sciences, University of Western Australia, 
Perth, Australia. 
6313 — 12:45 The Elevation Of Cd14high16+ 
Monocytes In Uveitis Patients. Diamond Ling, B. 
Liu, H.N. Sen, M. Casady, Z. Li, L. Wei, S. Jawad, 
R.B. Nussenblatt. Laboratory of Immunology, NEI, 
Bethesda, MD. 
Room 305
Thursday, May 10, 2012, 11:15 AM-1:00 PM




6314 — 11:15 Innate Immune Network in the 
Retina Activated by Optic Nerve Crush. Eldon 
E. Geisert1, J. Templeton1, J.M. Nickerson2, X. 
Wang1, M.M. Jablonski1, R.W. Williams1, T.S. Rex1. 
1Ophthalmology, Univ of Tennessee Health Sci Ctr, 
Memphis, TN; 2Ophthalmology, Emory University, 
Atlanta, GA. 
6315 — 11:30 Hmgb-1 Induces Apoptosis 
In Retinal Ganglion Cells And Intraretinal 
Inflammation By Activation Of Tlr4 And 
Cytokine Release. Maurice Schallenberg1, 
H. Melkonyan2, S. Thanos2. 1Department of 
Ophthalmology, University Hospital Essen, Essen, 
Germany; 2Institute of Experimental Ophthalmology, 
University of Muenster, Muenster, Germany. 
6316 — 11:45 Lipidomics of glaucomatous optic 
nerve tissue via MALDI Imaging. Franz H. Grus, 
N. Boehm, O.W. Gramlich, N. Pfeiffer. Experimental 
Ophthalmology, University Medical Center, Mainz, 
Germany. 
Thursday – Papers – 6310 – 6331
6317 — 12:00 Amyloid Fibril Formation By 
The Olfactomedin Domain Of Myocilin. Raquel L. 
Lieberman1A, S.D. Orwig1A, C.W. Perry1A, L.Y. Kim1B, 
K.C. Turnage1A, R. Zhang2, D. Vollrath2, I. Schmidt-
Krey1B. ASchool of Chemistry & Biochemistry, 
BSchool of Biology, 1Georgia Institute of Technology, 
Atlanta, GA; 2Department of Genetics, Stanford 
University School of Medicine, Palo Alto, CA. 
6318 — 12:15 Clusterin in Age-Related Ocular 
Exfoliation Syndrome. Jorge Ghiso1, I. Doudevski1, 
M. Cowman2, J. Liebmann3, C. Tello3, C. Teng3, 
R. Ritch3, A. Rostagno1. 1Pathology, New York 
University School of Medicine, New York, NY; 
2Chemical and Biological Sciences, Polytechnic 
Institute of New York University, New York, NY; 
3Einhorn Clinical Research Center, New York Eye 
and Ear Infirmary, New York, NY. 
6319 — 12:30 LOXL-1-Associated 
Pathomechanisms in Exfoliation Syndrome. 
Katalin Csiszar1, R. Laczko1, K. Molnarne Szauter1, 
R. Ritch2. 1John A. Burns School of Medicine, 
University of Hawaii, Honolulu, HI; 2Einhorn 
Clinical Research Center, New York Eye and Ear 
Infirmary, New York, NY. 
6320 — 12:45 Analysis Of HSP70B’ As A 
Potential Direct Target Gene Of The FOXC1 
Transcription Factor. Yoko Ito1A, F. Berry1B, M. 
Walter1A. AMedical Genetics, BSurgery, 1Univ of 
Alberta, Edmonton, AB, Canada. 
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6321 — 11:15 Retinal Circadian Clock 
Enhances GABA
A
 Receptor-Mediated Horizontal 
Cell Feedback to Cones at Night, Compared to the 
Day. Hee Joo Choi, M. Ishii, Y. Cao, A. Adelaja, C. 
Ribelayga, S.C. Mangel. Neuroscience, Ohio State 
Univ College of Medicine, Columbus, OH. 
6322 — 11:30 Optogenetic Detection of the pH 
Change Underlying Horizontal Cell-Mediated 
Lateral Inhibition. Tzu-Ming Wang, R.H. Kramer. 
Molecular and Cell Biology, UC Berkeley, Berkeley, 
CA. 
6323 — 11:45 Syntaxin-4 Is Highly Enriched 
Beneath S-cone Pedicles In The Primate Retina. 
Christian Puller, M.B. Manookin, M. Neitz, J. Neitz. 
Ophthalmology, University of Washington, Seattle, 
WA. 
6324 — 12:00 The Synaptic Basis of Rod-
Cone Pathway Interactions. Robert E. Marc, J. 
Lauritzen, B.W. Jones, C.B. Watt, J.R. Anderson. 
Ophthalmology-Sch of Med, Univ of Utah/Moran 
Eye Center, Salt Lake City, UT.*CR 
6325 — 12:15 Functional Characterization of 
Micro-connectomes in the Direction-Selective 
Circuit by Focal Laser Photolysis and Dual 
Patch Clamp. Seunghoon Lee, M. Chen, Z. Zhou. 
Ophthalmology and Visual Neuroscience, Yale 
University, New Haven, CT. 
6326 — 12:30 Dopaminergic Amacrine Cells 
Are Inhibited by Melatonin through Activation 
of MT1 and MT2 Receptors in The Mammalian 
Retina. Jie Feng1,2, C.L. Atkinson1, D-Q. Zhang1. 
1Eye Research Institute, Oakland University, 
Rochester, MI; 2Department of Physiology and 
Pathophysiology, Xi’an Jiaotong University School 
of Medicine, Xi’an, China. 
6327 — 12:45 Genetic Modulation of the Ratio 
of Cholinergic Amacrine Cells in the GCL and 
INL of the Mouse Retina. Irene E. Whitney1A,1B, M. 
Raven1A,1B, B.E. Reese1C,1B. AMolecular, Cellular, and 
Developmental Biology, BNeuroscience Research 
Institute, CPsychological and Brain Sciences, 
1University of California, Santa Barbara, CA. T 
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6328 — 11:15 Optimizing Modified Monovision 
to Improve Binocular Through-Focus Visual 
Performance. Len Zheleznyak1A, R. Sabesan1A, 
S. MacRae1B, G. Yoon1B. AThe Institute of Optics, 
BFlaum Eye Institute, 1University of Rochester, 
Rochester, NY.*CR T 
6329 — 11:30 Depth Of Focus With Induced 
Coma At Different Orientations. Christina 
Schwarz1, C. Canovas2, S. Manzanera1, P.M. 
Prieto1, H.A. Weeber2, P.A. Piers2, P. Artal1. 
1Laboratorio de Optica, Universidad de Murcia, 
Murcia, Spain; 2R&D, Abbott Medical Optics, 
Groningen, The Netherlands.*CR 
6330 — 11:45 Visual Outcomes Following 
Bilateral Implantation of a Trifocal Intraocular 
Lens. Sunil Shah1, A.L. Sheppard2, U. Bhatt2, J.S. 
Wolffsohn2. 1Midland Eye Institute, Birmingham, 
United Kingdom; 2School of Life and Health 
Sciences, Aston University, Birmingham, United 
Kingdom.*CR 
6331 — 12:00 Curvature Changing 
Accommodating IOL. Jim Schwiegerling, N. 
Savidis, S. McCafferty. Optical Sciences, University 
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6332 — 12:15 Improving Through-Focus 
Visual Performance Using Primary And 
Secondary Spherical Aberrations. Myoung Joon 
Kim1, L. Zheleznyak2A, R. Sabesan2A, S. MacRae2B, 
G. Yoon2B. 1Department of Ophthalmology, Asan 
Medical Center, Seoul, Republic of Korea; AThe 
Institute of Optics, BFlaum Eye Institute, 2University 
of Rochester, Rochester, NY.*CR 
6333 — 12:30 Visual Performance Under 
Pure Simultaneous Vision. Pablo De Gracia, C. 
Dorronsoro, A. Sanchez-Gonzalez, L. Sawides, 
S. Marcos. Instituto de Optica, CSIC, Madrid, 
Spain.*CR 
6334 — 12:45 Range of Vision Provided 
by Dual-Optic Accommodating Intraocular 
Lens. Sanjeev Kasthurirangan1, L.G. Vargas2, 
V. Bohorquez3, R. Alarcon3. 1R&D, Abbott 
Medical Optics, Milpitas, CA; 2R&D, Abbott 
Medical Optics, Santa Ana, CA; 3Department 
of Ophthalmology, ServiOftalmos, Bogota, 
Colombia.*CR, f 
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6335 — 11:15 Quantifying Symptoms of 
Diplopia. Jonathan M. Holmes, D.A. Leske, L. 
Liebermann, S.R. Hatt. Ophthalmology, Mayo Clinic, 
Rochester, MN. 
6336 — 11:30 Predictors of Surgery in Children 
With Intermittent Exotropia. Sarah R. Hatt, D.A. 
Leske, L. Liebermann, J.M. Holmes. Ophthalmology, 
Mayo Clinic, Rochester, MN. 
6337 — 11:45 Muscimol Inactivation Of The 
Cerebellar Fastigial Oculomotor Region In 
Strabismic Monkeys Changes Strabismus Angle. 
Anand C. Joshi, E. Baskin, V.E. Das. College of 
Optometry, University of Houston, Houston, TX. 
6338 — 12:00 Bilateral 8-mm Medial Rectus 
Muscle Resection As Primary Surgery For Large 
Angle Exotropia. Nikhil N. Batra, N.N. Batra, M.J. 
Greenwald. Pediatric Ophthalmology, University of 
Chicago, Chicago, IL. T 
6339 — 12:15 Horizontal Rectus Pulley 
Heterotopy Correlates With Cyclovertical 
Strabismus in Sagging Eye Syndrome. Zia 
Chaudhuri, R.A. Clark, J.L. Demer. Pediatric 
Ophthalmology & Strabismus Div, Jules Stein Eye 
Institute, UCLA, Los Angeles, CA. 
6340 — 12:30 Posterior Fixation Sutures 
Expand Binocularity In Patients With Persistent 
Paretic Or Restrictive Pathology. Steven A. 
Newman. Ophthalmology, University of Virginia, 
Charlottesville, VA. 
6341 — 12:45 Sustained IGF-I Treatment 
Improves Eye Alignment in Adult Strabismic 
Monkeys. Linda K. McLoon1, C.L. Willoughby1, 
S.P. Christiansen2, V.E. Das3, M.J. Mustari4. 
1Ophthalmology, University of Minnesota, 
Minneapolis, MN; 2Ophthalmology, Boston 
University School of Medicine, Boston, MA; 
3College of Optometry, University of Houston, 
Houston, TX; 4Ophthalmology, University of 
Washington, Seattle, WA. 
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539 Diabetes and Retinal Disease 
Moderators: Tunde Peto and Gavin S Tan
6342 — 11:15 Retinal Microvascular Signs 
and 5-year Incidence of Stroke: The Singapore 
Malay Eye Study. Carol Y. Cheung1,2A, W. Tay1, 
M. Ikram1,2A, E. Tai2B, T.Y. Wong1,2A. 1Singapore 
Eye Research Institute, Singapore, Singapore; 
ADepartment of Ophthalmology, BDepartment of 
Medicine, 2Yong Loo Lin School of Medicine, 
National University of Singapore, Singapore, 
Singapore. 
6343 — 11:30 Risk Factors Associated With 
Branch Retinal Vein Occlusion. Paula Anne 
Newman-Casey, M. Stem, N. Talwar, T. Gardner, 
J.D. Stein. Ophthalmology & Visual Sciences, 
Kellogg Eye Ctr, Univ of Michigan, Ann Arbor, MI. 
6344 — 11:45 Prevalence, Causes and Risk 
Factors for Visual Impairment in a Multi-
ethnic Asian Population with Diabetes. Gavin 
S. Tan1, Y. Zheng1A, W-L. Wong1A, M.K. Ikram2, 
E.L. Lamoureux, III3, P. Mitchell4, J.J. Wang5, 
T.Y. Wong6. ASingapore Eye Research Institute, 
1Singapore National Eye Centre, Singapore, 
Singapore; 2Singapore Eye Research Institute, 
Singapore, Singapore; 3Ophthalmology, 
University of Melbourne, Melbourne, Australia; 
4Ophthalmology, University of Sydney, Sydney, 
Australia; 5Ctr for Vision Research/Ophthalmol, 
University of Sydney, Westmead, Australia; 
6Singapore Eye Research Institute, National 
University of Singapore, Singapore, Singapore. 
6345 — 12:00 RAAB+DR - Rapid Assessment 
of Blindness Including Diabetes: Results of 
a New Population-based Survey Method in 
Chiapas (Mexico), Cape Town (South Africa), 
and Taif (Saudi Arabia). David B. Yorston1,2, 
S. Polack2, H. Kuper2, N. Cockburn3, P. Gomez4, 
M. Rabiu5. 1Tennent Institute of Ophthalmology, 
Gartnavel Hospital, Glasgow, United Kingdom; 
2London School of Hygiene & Tropical Medicine, 
International Centre for Eye Health, London, United 
Kingdom; 3University of Cape Town, Cape Town, 
South Africa; 4Instituto de la Vision Universidad 
de Montemorelos, Montemorelos, N.L., Mexico; 
5Prevention of Blindness Union, Riyadh, Saudi 
Arabia. 
6346 — 12:15 The Responsiveness of the 
National Eye Institute Visual Function 
Questionniare-25 (NEI VFQ-25) to Visual 
Acuity Gains in Diabetic Macular Edema 
Patients. Adam Turpcu1, S. Colman1, I.J. Suner2, 
N.M. Bressler3, R. Varma4, P. Lee5, C. Dolan6, J. 
Ward1, L. Yau1. 1Genentech, South San Francisco, 
CA; 2Retina Associates of Florida, Tampa, FL; 
3Ophthalmology, Wilmer Eye Institute, Baltimore, 
MD; 4Ophthalmology, USC, Doheny Eye Institute, 
Los Angeles, CA; 5Duke University Eye Center, 
Durham, NC; 6CMD Consulting, Palo Alto, 
CA.*CR, f 
6347 — 12:30 Longitudinal Changes In Retinal 
Vascular Caliber Measurements In Children 
And Its Relationship With Cardiovascular 
Risk Factors. Emil D. Kurniawan1, N. Cheung1, 
W. Tay2, C.Y. Cheung2, P. Mitchell3, S-M. 
Saw2,4, T.Y. Wong2,4. 1Centre for Eye Research 
Australia, Royal Victorian Eye and Ear Hospital, 
Melbourne, Australia; 2Singapore Eye Research 
Institute, Singapore, Singapore; 3Department of 
Ophthalmology, University of Sydney, Sydney, 
Australia; 4Department of Epidemiology and Public 
Health, Yong Loo Lin School of Medicine, National 
University of Singapore, Singapore, Singapore. 
6348 — 12:45 The 20-Year Incidence of 
Macular Holes and Associated Risk Factors: 
The Beaver Dam Eye Study. Stacy M. Meuer, 
C. Myers, R. Klein, B.E. Klein. Ophthalmology & 
Visual Sciences, University of Wisconsin-Madison, 
Madison, WI. 
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6349 — 11:15 Regional Variations In The 
Rate Of Laser Trabeculoplasty In The Medicare 
Population. Henry D. Jampel1A, S.D. Cassard1B, 
D.S. Friedman1B, H.A. Quigley1B, E.W. Gower2. 
AGlaucoma Center of Excellence, BDana Center 
for Preventive Ophthalmology, 1Johns Hopkins 
Wilmer Eye Inst, Baltimore, MD; 2Epidemiology 
and Prevention, Wake Forest School of Medicine, 
Winston-Salem, North Carolina, MD. 
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6350 — 11:30 Transient Corneal Endothelial 
Changes Associated With Selective Laser 
Trabeculoplasty. Andrew J. White1,2, A. Mukherjee1, 
I. Hanspal1, N. Sarkies1, K.R. Martin1,2, P. Shah3,4. 
1Ophthalmology, Cambridge University Teaching 
Hospitals NHS Foundation Trust, Cambridge, 
United Kingdom; 2NIHR Biomedical Research 
Centre, University of Cambridge, Cambridge, 
United Kingdom; 3Ophthalmology, NIHR BRC 
for Ophthalmology, Moorfields Eye Hospital & 
UCL Institute of Ophthalmology, London, United 
Kingdom; 4Ophthalmology, University Hospitals 
Birmingham NHS Foundation Trust, Birmingham, 
United Kingdom. 
6351 — 11:45 A Prospective Randomized 
Clinical Trial of Selective Laser Trabeculoplasty 
versus Argon Laser Trabeculoplasty in Open 
Angle Glaucoma and Ocular Hypertension 
Secondary to Pseudoexfoliation. Francie F. Si1, 
S. Kent1, C.M. Hutnik1, C.M. Birt2, K. Damji3, 
P. Harasymowycz4, W.G. Hodge1, Y.I. Pan1, A. 
Crichton5. 1Ophthalmology, University of Western 
Ontario, London, ON, Canada; 2Ophthal & Vis 
Sciences, University of Toronto, Toronto, ON, 
Canada; 3Ophthalmology, University of Alberta, 
Edmonton, AB, Canada; 4Ophthalmology, 
University of Montreal, Montreal, QC, Canada; 
5Ophthalmology, University of Calgary, Calgary, 
AB, Canada. f 
6352 — 12:00 Targeting Placental Growth 
Factor (PlGF) with an Inhibitory Monoclonal 
Antibody (5D11D4): New Therapeutic 
Approach for Glaucoma Filtration Failure. Tine 
Van Bergen1A, B. Jonckx2, S. Van de Velde1A, K. 
Hollanders1A, D. Sijnave1A, E. Vandewalle1A, L.K. 
Moons1B, J-M. Stassen2, I. Stalmans1A. ALab of 
Ophthalmology, BBiology Dept, Zoological Inst, 
1KU Leuven, Leuven, Belgium; 2ThromboGenics 
NV, Leuven, Belgium.*CR T 
6353 — 12:15 Bevacizumab Prolongs Bleb 
Survival In A Mouse Model Of Glaucoma 
Filtration Surgery By Attenuating Pro-fibrotic 
Gene Expression. Li-Fong Seet, S.N. Finger, T.T. 
Wong. Ocular Wound Healing & Therapeutics, 
Singapore Eye Research Institute, Singapore, 
Singapore. 
6354 — 12:30 The Norwich Trabeculectomy 
Study: Long-term outcomes of ‘modern’, 
‘safe-technique’, augmented, trabeculectomy. 
Have ‘traditional’ risk factors for failure been 
overcome? David C. Broadway. Department of 
Ophthalmology, Norfolk & Norwich University 
Hospital, Norwich, United Kingdom. 
6355 — 12:45 Three Year Results of the 
Ahmed Baerveldt Comparison (ABC) Study. 
Donald L. Budenz1, K. Barton2, W.J. Feuer3, J.C. 
Schiffman4, V.P. Costa5, D. Godfrey6, Y.M. Buys7, 
Ahmed Baerveldt Comparison Study Group. 
1Ophthalmology, University of North Carolina, 
Chapel Hill, NC; 2Glaucoma Service, Moorfields 
Eye Hospital, London, United Kingdom; 
3Biostatistics, Univ of Miami-Bascom Palmer, 
Miami, FL; 4Ophthalmology, Bascom Palmer Eye 
Institute, Miami, FL; 5Ophthalmology, University of 
Campinas, Sao Paulo, Brazil; 6Glaucoma Associates 
of Texas, Dallas, TX; 7Ophthalmology & Vision 
Sciences, University of Toronto, Toronto, ON, 
Canada.*CR, f 
Grand H




6356 — 11:15 Outcomes of Scleral Buckle 
Removal Combined with Prophylactic Laser 
Retinopexy. Mohammed Khuthaila1, M. Rasouli2, 
M. Spirn1, S.J. Garg1, M. Greve2, M. Tennant2, J. 
Hsu1. 1Retina, Wills Eye Institute, Philadelphia, PA; 
2Ophthalmology, University of Alberta, Edmonton, 
AB, Canada. 
6357 — 11:30 Evolution Of Partial-thickness 
Macular Folds Occurring After Vitrectomy For 
Retinal Detachment Repair. Roberto dell’Omo, 
S. Tan, F. Barca, H.M. Bijl, S.Y. Lesnik Oberstein, 
M. Mura. Vitreo-Retinal, Academic Medical 
Center, University of Amsterdam, Amsterdam, The 
Netherlands. 
6358 — 11:45 Correlation Between Pre-
Operative Spectral Domain Optical Coherence 
Tomography Features of Macula Involving 
Rhegmatogenous and Tractional Retinal 
Detachments and Post-Operative Outcomes. 
Samira Khan, M. Gendy, A.T. Lyon, M. Gill. 
Ophthalmology, Northwestern University, Chicago, 
IL. 
6359 — 12:00 Postoperative Retinal Function 
After Recent-onset Retinal Detachment In 
Relation To The Topography Of The Affected 
Quadrants. Marcos J. Rubio Caso1, M. Martin-
Baranera2, N. Vila Grane1, L. Arias Barquet1, J. 
Caminal Mitjana1, J. Catala Mora1, P. García Bru1, 
O. Pujol Goyta1, J. Arruga Ginebreda1, J. Garcia-
Arumi3. 1Ophthalmology, Hospital Universitari de 
Bellvitge, Barcelona, Spain; 2Epidemiology, Consorci 
Sanitari Integral, Barcelona, Spain; 3Ophthalmology, 
Hospital Vall d’Hebron, Barcelona, Spain. 
6360 — 12:15 Retinal MMP12/MMP13 And 
TIMP1/TIMP2 Expression In Experimental 
Murine Retinal Detachment. Colleen M. 
Cebulla1A, B. Kim1A, T. Wang1A, S. Pouly1A, M.H. 
Abdel-Rahman1B, A.J. Fischer1C. AOphthalmology, 
BOphthalmology and Division Human Genetics, 
CNeuroscience, 1Ohio State University, Columbus, 
OH. 
6361 — 12:30 Protective Role of Soluble 
FasL in Photoreceptor Cell Loss. Dimosthenis 
Mantopoulos1A, Y. Murakami2, G. Trichonas3, M.S. 
Gregory-Ksander4, D. Cestari1B, B.R. Ksander4, 
D. Vavvas1A. ARetina, BNeuro-ophthalmology, 
1Massachusetts Eye & Ear Infirmary, Harvard, 
Boston, MA; 2Department of Ophthalmology, 
Massachusettes Eye and Ear Infirmary, Boston, MA; 
3Cleveland Clinic, Cleveland, OH; 4Schepens Eye 
Research Institute, Harvard Medical School, Boston, 
MA. 
6362 — 12:45 A Mechanics Based Model 
Of A Detaching Retina. Howard F. Fine1, J.L. 
Prenner1, P.L. Bishay2, D.B. Roth1, W.J. Bottega2. 
1Ophthalmology, Robert Wood Johnson Univ Hosp, 
New Brunswick, NJ; 2Mechanical and Aerospace 
Engineering, Rutgers University, Piscataway, NJ.*CR 
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Moderator: Nathan G Congdon 
6363 — A1 Intraocular pressure and ocular 
perfusion pressure among 10-year incident 
glaucoma cases in the Age-Related Eye Disease 
Study (AREDS). Thasarat S. Vajaranant1A, J.A. 
Hallak1A,1B, C.E. Joslin1A,1B. AOphthalmology and 
Visual Sciences, BEpidemiology and Biostatistics, 
1University of Illinois at Chicago, Chicago, IL. 
6364 — A2 Evaluation of a Novel Optic Disc 
Grading Software for used in Population-based 
Studies. Yih Chung Tham1,2, C-L. Cheung1,3, T. 
Wong1,2, M. Baskaran1, J. Liu4, B-H. Lee4, J. Wang5, 
P. Mitchell5, T. Aung1,2, C-Y. Cheng1,2. 1Singapore 
Eye Research Institute (SERI), Singapore National 
Eye Centre, Singapore, Singapore; 2Department of 
Ophthalmology, Yong Loo Lin School of Medicine, 
National University of Singapore, Singapore, 
Singapore; 3Centre for Quantitative Medicine, 
Office of Clinical Sciences, Duke-NUS Graduate 
Medical School, Singapore, Singapore; 4Institute 
for Infocomm Research (I2R), Agency for Science, 
Technology and Research (A*Star), Singapore, 
Singapore; 5Department of Ophthalmology (Centre 
for Vision Research), Westmead Hospital, University 
of Sydney, Sydney, Australia. 
6365 — A3 Evaluation of Depression in Newly 
Diagnosed Patients of Glaucoma Before and After 
Starting Ocular Hypotensive Therapy. Neelima 
Aron1A, V. Arora1A, R. Sagar1B, V Sreenivas1C, A. 
Rathi1A, S. Kumar2, M. Wadhwani1A, T. Dada1A. ADr 
R P Centre for Ophthalmic Sciences, BDepartment 
of Psychiatry, CDepartment of Biostatistics, 1All 
India Institute of Medical Sciences, New- Delhi, 
India; 2Department of Ophthalmology, Government 
Medical College, Chandigarh, India. 
6366 — A4 Metabolic Syndrome and the Risk 
of Developing Normal Tension Glaucoma. Mijin 
Kim1,2, J. Jeoung1, W. Oh3, H. Choi4, M. Kim1, K. 
Park1, S. Kim5, T-W. Kim2, D. Kim1. 1Department 
of Ophthalmology, Seoul National University 
Hospital, Seoul, Republic of Korea; 2Department of 
Ophthalmology, Seoul National University Bundang 
Hospital, Seongnam, Republic of Korea; 3Kong 
Eye Clinic, Seoul, Republic of Korea; 4Department 
of Ophthalmology, Healthcare System Gangnam 
Center, Seoul National University Hospital, Seoul, 
Republic of Korea; 5Department of Ophthalmology, 
Seoul National University Boramae Hospital, Seoul, 
Republic of Korea. 
6367 — A5 Clinical Characteristic Of Normal 
Tension Glaucoma In Young Patients. Jin Young 
Rhew, K. Choi. Ophthalmology, Ewha Womans 
University School of Medicine, Seoul, Republic of 
Korea. 
6368 — A6 Relationship of Structural and 
Functional Asymmetry to Sleep Position in 
Primary Open Angle Glaucoma. Eberechi 
Nwogu1A, S. Thomas2, C. Hamill1A, I. Marcus1B, N.A. 
Loewen1C. AOphthalmology, BOphthalmology and 
Visual Science, COphthalmology & Visual Science, 
1Yale University School of Medicine, New Haven, 
CT; 2Ophthalmology, Yale School of Medicine, New 
Haven, CT. 
6369 — A7 Glaucoma Patient Day: Involving 
Patients, Improving Care, Prioritizing Research. 
Ananth C. Viswanathan1A, R. Mathew2A, S. Gillan2, 
L. Ramskold3, C. Bunce1, N. Okhravi1. AGlaucoma 
Service, 1NIHR Biomedical Research Centre 
for Ophthalmology, Moorfields Eye Hospital 
NHS Foundation Trust and UCL Institute of 
Ophthalmology, London, United Kingdom; 
AGlaucoma Service, 2Moorfields Eye Hospital NHS 
Foundation Trust, London, United Kingdom; 3UCL 
Medical School, London, United Kingdom. 
6370 — A8 Blindness Profile in Glaucoma 
patients in a Tertiary Eye-care Hospital in India. 
Dewang Angmo, Y. bhadange, V. Arora, V. Srinivas, 
A. Badduri, A. Panda, M. Wadhwani, M. Mehndi. 
Ophthalmology, Dr. R P Centre for ophthalmic 
sciences, AIIMS, New Delhi, India. 
6371 — A9 Profile of Patients Assisted During 
the 2011 World Glaucoma Week in Araguari 
- Minas Gerais - Brazil. fabia f. nogueira1, G.E. 
Carlos1, D.R. Martins1, G.R. Cunha1, M.S. Arcieri1, 
N.B. Ramos1, P.E. Rosa1, R.S. Arcieri2, R.L. Pereira1, 
E.S. Arcieri3,1. 1School of Medicine, Presidente 
Antonio Carlos University (UNIPAC), Araguari, 
Brazil; 2School of Medicine of Ribeirao Preto, 
University of São Paulo (USP), Ribeirao Preto, 
Brazil; 3Ophthalmology, University of Campinas 
(UNICAMP), Campinas, Brazil. 
6372 — A10 Distribution of Adherence to 
Intraocular Pressure Lowering Agents among 
Glaucoma Patients Is Bimodal and Robust 
to Operational Definitions of Glaucoma and 
Adherence. Jason P. Jones1A, D.S. Fong1B, E.N. 
Fang2, C.A. Mesirov1A, V.D. Patel3. AResearch & 
Evaluation, BOphthalmology, 1Kaiser Peramente, 
Pasadena, CA; 2Ophthalmology, Kaiser Peramente, 
Los Angeles, CA; 3Global Health Outcomes Strategy 
and Research, Allergan, Irvine, CA.*CR 
6373 — A11 25-Hydroxy Vitamin D Levels in 
Patients with Primary Open-Angle Glaucoma. 
Farhan F. Malik, A.Z. Mohiuddin, L.Z. Rajjoub, 
D.A. Belyea, J.R. Mathura, Jr. Ophthalmology, The 
George Washington University, Washington, DC. 
6374 — A12 Refractive Status In Patients With 
Narrow Angles. Sarah M. Simpson, D.C. Warder, 
A. Moore, I. Irrcher, D. Jinapriya. Department of 
Ophthalmology, Queen’s University, Kingston, ON, 
Canada. 
6375 — A13 Ordinal Measurement Error 
Model for Assessing Agreement Among Raters for 
Glaucoma Progression. Yun Ling1,2, R.A. Bilonick1,2, 
H. Ishikawa1,3, G. Wollstein1, J.S. Schuman1,3. 1UPMC 
Eye Center, Eye & Ear Institute, Ophthalmology 
and Visual Science Research Center, Dept. 
Ophthalmology, U. Pittsburgh School of Medicine, 
Pittsburgh, PA; 2Dept. Biostatistics, U. Pittsburgh 
Graduate School of Public Health, Pittsburgh, 
PA; 3Dept. Bioengineering, Swanson School of 
Engineering, U. Pittsburgh, Pittsburgh, PA.*CR 
6376 — A14 Intraocular Pressure and Central 
Corneal Thickness in a Multi-Ethnic Asian 
Population: The Singapore Epidemiology of Eye 
Disease (SEED) Study. Ching-Yu Cheng1A,2, T. 
Aung2,1A, Y. Zheng2, X. Li2, A.R. Anuar2, M. Chew2, 
B. Mani2, S-M. Saw1B,2, T.Y. Wong2,1A, SEED Study 
Group. ADepartment of Ophthalmology, BSaw Swee 
Hock School of Public Health, 1National University 
of Singapore, Singapore, Singapore; 2Singapore Eye 
Research Institute, Singapore, Singapore. 
6377 — A15 Evaluation Of The Impact Of 
Topical Medical Therapy on Quality Of Life 
In Newly Diagnosed Glaucoma Patients Using 
The Indian Vision Function Questionnaire 
(VFQ33). Tanuj Dada1A, V. Arora1A, S.K. Gupta1B, V. 
Sreenivas1C, P. Vashist1A, T. Agarwal1A, A. Panda1A. 
ARP Centre for Ophthalmic Sciences, BCentre for 
Community Medicine, CDepartment of Biostatistics, 
1All India Institute of Medical Sciences, New Delhi, 
India. 
6378 — A16 Risk Factors for Four-year 
Incidence of Open-angle Glaucoma: The Los 
Angeles Latino Eye Study. Xuejuan Jiang1, S. Wu1, 
M. Torres1, S.P. Azen2, B.A. Francis1, V. Chopra1, B.B. 
Nguyen1, R. Varma1, Los Angeles Latino Eye Study 
Group. 1Ophthalmology, Doheny Eye Institute, Univ. 
of Southern California, Los Angeles, CA; 2Preventive 
Medicine, USC Keck School of Medicine, Los 
Angeles, CA. 
6379 — A17 Undiagnosed And Overdiagnosed 
Glaucoma In The United States. Mark W. Swanson. 
Optometry, Univ of Alabama at Birmingham, 
Birmingham, AL. 
6380 — A18 Prevalence Of Glaucomatous Optic 
Neuropathy In A Telemedicine Population. Hana 
L. Takusagawa1, C. Sheppler1, C. VanAlstine1, S.K. 
Gardiner1A, S.L. Mansberger1. ADiscoveries In Sight 
Laboratories, 1Devers Eye Institute, Portland, OR. 
6381 — A19 Prevalence Survey of Structural 
and Functional Glaucomatous Optic Nerve 
Abnormalities in Young Chinese Adults. 
Christopher S. Sales1, M. Margeta1, L. Hsu1, T. Fu1, 
A. Fang2, M.Y. Kahook3, J. Tsui4, Young Chinese-
American Glaucoma Prevalence Study Group, S.C. 
Lin5, K. Singh1. 1Ophthalmology, Stanford, Palo Alto, 
CA; 2Ophthalmology, Washington University, St. 
Louis, MO; 3Ophthalmology, University of Colorado, 
Aurora, CO; 4Ophthalmology & Visual Sciences, 
Univ of Iowa Hospitals & Clinics, Iowa City, IA; 
5Ophthalmology, Univ of California - SF, San 
Francisco, CA. 
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6382 — A20 Epidemiology Of Glaucoma In 
Patients Presenting Retinal Vein Occlusions 
(RVOs). George Azar, M. Voigt, Z. Al-Arabi, Y. 
Lachkar. Ophthalmology, Saint Joseph Hospital 
(Paris) - Glaucoma Institute, Paris, France. 
6383 — A21 The Observed Co-prevalence Of 
Open-angle Glaucoma And Age-related Macular 
Degeneration Is Higher Than Predicted From The 
Prevalence Of Each Disease Alone. Lyne Racette, 
J.D. Rupp, A-D.T. Phan. Eugene and Marilyn Glick 
Eye Institute, Indiana University, Indianapolis, IN. 
6384 — A22 Comparison of Changes in 
Intraocular Pressure, Anterior Chamber Width, 
Lens Vault, and Iridocorneal Angle Between 
Asian and Caucasian After Phacoemulsification. 
Roland Y. Lee, T. Kasuga, G. Huang, E. Gonzalez, 
S. Bhosai, S.Y. Wang, Q.N. Cui, M. He, S.C. Lin. 
Ophthalmology, University of California, San 
Francisco, San Francisco, CA.*CR 
6385 — A23 The Association Between 
Compliance with Recommended Follow-up and 
Glaucomatous Disease Severity in a County 
Hospital Population. Yohko Murakami1, C. Ung1, 
E. Zhang1, T. Alfaro2, M.I. Seider2, K. Singh1, S.C. 
Lin2. 1Ophthalmology, Stanford University, Stanford, 
CA; 2Ophthalmology, University of California, San 
Francisco, San Francisco, CA.*CR 
6386 — A24 Systemic Illnesses In Glaucoma: 
A Possible Link Between Glaucoma And Breast 
Cancer? Felise May Barte1A, S. Mahasneh1A, B. 
Adams-Huet1B, K. Kooner1A. AOphthalmology, 
BClinical Sciences, 1University of Texas 
Southwestern Medical Center, Dallas, TX. 
6387 — A25 Variation In The Provision 
Of Services For Glaucoma, By Level Of 
Socioeconomic Development. Shaheen P. Shah, 
P. Morjaria, C. Gilbert. International Centre for 
Eye Health, London Sch of Hygiene & Trop Med, 
London, United Kingdom. 
6388 — A26 Direct Cost Of Glaucoma 
Treatment For Patients With Primary Angle 
Closure Glaucoma Over 10 Years. Kailing 
Yong1, H.M. Htoon2, D.T. Quek1, V.W. Wang3, 
E.L. Lamoureux, III4,5, T. Aung6. 1Ophthalmology, 
Singapore National Eye Centre, Singapore, 
Singapore; 2Statistics(Admin), Singapore Eye 
Research Inst, Singapore, Singapore; 3Center 
for Health Services Research, Singapore Health 
Services, Singapore; 4Ophthalmology, University of 
Melbourne, Melbourne, Australia; 5Singapore Eye 
Research Institute, Singapore National Eye Centre, 
Singapore; 6Glaucoma, Singapore National Eye 
Center, Singapore, Singapore. 
6389 — A27 How Was Glaucoma First 
Discovered? Risk Factors For Late Diagnosis. 
Federico Di Matteo, P. Bettin, M. Fiori, C. Ciampi, 
U. De Benedetto, F. Bandello. Ophthalmology, 
University Scientific Institute San Raffaele, Milan, 
Italy. 
Hall B/C A80-A98
Thursday, May 10, 2012, 11:15 AM-1:00 PM
Visual Psychophysics & Physiological Optics
543 Color Vision 
Moderator: Dora F Ventura
6390 — A80 Learning to Name Colors Altered 
by Colored Filters. Thomas Kuyk1, A. Smith1, S. 
Kumru2. 1TASC, Inc, Ft Sam Houston, TX; 2Air 
Force Research Laboratory, Ft Sam Houston, TX. 
6391 — A81 Spatio-chromatic Properties Of 
Human Trichromatic Vision. Elise W. Dees1,2, S.J. 
Gilson1, R.C. Baraas1. 1Optometry & Visual Science, 
Buskerud University College, Kongsberg, Norway; 
2Mathematical Sciences & Technology, Norwegian 
University of Life Sciences, Ås, Norway. 
6392 — A82 Chromatic Discrimination Of 
Gabor Functions: Space And Spatial Frequency 
Joint Entropy For The Human Visual System 
Estimated From Psychometric Functions. 
Vladimir A. Silveira, G.S. Souza, B.D. Gomes, 
A.R. Rodrigues, L.L. Silveira. Nucleo de Medicina 
Tropical, Universidade Federal do Para, Belem, 
Brazil. 
6393 — A83 Visuo-Spatial Memory and Color 
Vision Deficits in Patients with High-Functioning 
Autism. Elaine C. Zachi, T.L. Costa, D.R. 
Tsubota, M.T. Barboni, M.F. Costa, D.F. Ventura. 
Experimental Psychology, Universidade de Sao 
Paulo, Sao Paulo, Brazil. 
6394 — A84 Comparison of Color Vision Testing 
By Standard Ishihara Color Plates Versus iPad 
Version. Ivana V. OBRADOVIC, R. Cappelli, J.C. 
Priluck, K V. Chalam, S. Grover. Ophthalmology, 
University of Florida College of Medicine, 
Jacksonville, FL. 
6395 — A85 Color Contrast Sensitivity 
Estimated With Two Different Psychophysical 
Methods. Luiz Carlos L. Silveira1A, C.D. Perry2, 
E.C. Lacerda1B, M.M. Jacob1B, G.S. Souza1B, B.D. 
Gomes1B, M.E. Fitzgerald3. ANucleo de Medicina 
Tropical, BInstituto de Ciencias Biologicas, 
1Universidade Federal do Para, Belem, Brazil; 
2Biology, Biology Xavier University of Louisiana, 
New Orleans, LA; 3Anat & Neurobiol & Ophthalmol, 
UTHSC, Memphis, TN. 
6396 — A86 Color Discrimination Task Using 
Pseudoisochromatic Stimulus: Luminance Noise 
Variation Provides Better Sensitivity Than 
Noise Mean Luminance. Bruno D. Gomes1A, T.L. 
Carmichael2A, M.M. Jacob1A, E.C. Lacerda1A, G.S. 
Souza1A,1B, M.E. Fitzgerald3,2B, L.L. Silveira1B,1A. 
AInstituto de Ciencias Biologicas, BNucleo de 
Medicina Tropical, 1Universidade Federal do Para, 
Belem, Brazil; ANatural Science, BBiology, 2Christian 
Brothers University, Memphis, TN; 3Anat & 
Neurobiol & Ophthalmol, UTHSC, Memphis, TN. 
6397 — A87 Magno- And Dorsal Stream 
Processing Decline Slower Than Parvocellular 
Performance In Normal Aging. Maria F. 
Loureiro1, C. Mateus1, B. Oliveiros1, R. Lemos1, A. 
Reis1,2, M. Castelo-Branco1. 1Visual Neuroscience, 
IBILI-Faculty of Medicine-University of Coimbra, 
Coimbra, Portugal; 2Ophthalmology, University 
Hospital of Coimbra, Coimbra, Portugal. 
6398 — A88 Binocular Enhancement of Color 
Contrast Sensitivity. Jeff C. Rabin1, B. Stewart1, V. 
Wong1, J. Boster1, M. Ruelle1, T. Tran1, J. Gooch2, 
S. Wright2. 1Optometry, UIW Rosenberg School 
of Optometry, San Antonio, TX; 2Ophthalmology, 
USAF School Aerospace Medicine, Dayton, OH. 
6399 — A89 Pseudoisochromatic Color Vision 
Testing on an iPhone. Ami A. Shah, S. Pasadhika, J. 
Kim, M. Wang. Ophthalmology and Vision Sciences, 
University of Arizona, Tucson, AZ. 
6400 — A90 Cone Isolating Electroretinograms 
In Individuals With A Mutant Opsin Allele 
Associated With Cone Dystrophy. James A. 
Kuchenbecker1, S.H. Greenwald1, J. Carroll2A,2B, 
G.A. Fishman3,4, M.A. Genead5,3, T.B. Connor, Jr.2A, 
M. Neitz1, J. Neitz1. 1Ophthalmology, University of 
Washington, Seattle, WA; AOphthalmology, BCell 
Biology, 2Medical College of Wisconsin, Milwaukee, 
WI; 3Chicago Lighthouse for People Who Are Blind 
or Visually Impaired, Chicago, IL; 4Ophthalmology 
and Visual Sciences, University of Illinois - Chicago, 
Chicago, IL; 5The Pangere Center for Hereditary 
Retinal Diseases, Chicago, IL. 
6401 — A91 Color vision of female carriers and 
color vision deficiency subjects evaluated with the 
Cambridge Colour Test. Daniela M. Bonci1, M. 
Neitz2, J. Neitz2, M. Gualtieri1, M.T. Barboni1, T.L. 
Costa1, L.L. Silveira3, D.F. Ventura1. 1Experimental 
Psychology, University of Sao Paulo, Sao Paulo, 
Brazil; 2Ophthalmology, University of Washington, 
Seattle, WA; 3Nucleo de Medicina Tropical, 
Universidade Federal do Para, Belem, Brazil. 
6402 — A92 A Practical and Reliable Genetic 
Test of Red-Green Color Vision. Candice Davidoff, 
J. Neitz, M. Neitz. Ophthalmology, University of 
Washington, Seattle, WA.*CR T 
6403 — A93 Traumatic Cerebral 
Dyschromatopsia: Color Confusion Along a New 
Axis. Lynn D. Greenspan, J.B. Siegfried. Salus 
University, Elkins Park, PA. 
6404 — A94 A New Color Visual Function Test 
to Evaluate the Aging Changes in Normal Eyes. 
Kazuo Ichikawa1, S. Yokoyama1, Y. Tanaka2, H. 
Nakamura1, S. Tanabe3, K. Tanaka2, R. Horai3, Y. 
Kato1. 1Ophthalmology, Social Insurance Chukyo 
Hosp, Nagoya Aichi, Japan; 2Faculty of Engineering, 
Shinshu University, Nagano, Japan; 3Chukyo Eye 
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6405 — A95 Development of New Testing 
System Measuring Human Color Visual Function. 
Yoshiki Tanaka1, S. Yokoyama2, K. Ichikawa3, K. 
Tanaka1, H. Nakamura4, S. Tanabe5, R. Horai5, Y. 
Kato4. 1Faculty of Engineering, Shinshu University, 
Nagano, Japan; 2Ophthalmology, Social Insurance 
Chukyo Hosp, Nagoya, Japan; 3Ophthalmology, 
Social Insurance Chukyo Hosp, Nagoya Aichi, Japan; 
4Ophthalmology, Social Insurance Chukyo Hosp., 
Nagoya Aichi, Japan; 5Chukyo Eye Clinic, Nagoya 
Aichi, Japan. 
6406 — A96 Color Discrimination And 
Categorization Differences Between Male And 
Female. Marcelo F. Costa, S.M. Moreira, D.F. 
Ventura. Psicologia Experimental, Univ of Sao Paulo, 
Sao Paulo, Brazil. 
6407 — A97 The Relationship between Macular 
Pigment Optical Density and Retinal Straylight. 
Raymond O. Beirne. Vision Science Research Group, 
University of Ulster, Coleraine, United Kingdom. 
6408 — A98 Does Color Vision Impairment 
Correlate with Neuropsychological Losses in 
Visual Space and Object Perception Tests? 
Rosani A. Teixeira1A, A.L. Moura1B, M.F. Costa1A, A. 
Taub1C, D. Callegaro1D, D.F. Ventura2. APsychology, 
BDepartment of Psychology, CPsychiatry, DNeurology, 
1Universidade de Sao Paulo, Sao Paulo, Brazil; 
2Experimental Psychology, University of Sao Paulo, 
Sao Paulo, Brazil. 
Hall B/C A302-A337






6409 — A302 Activation of the Aldosterone/
Mineralocorticoid Receptor System and 
Protective Effects of Mineralocorticoid Receptor 
Antagonism in Retinal Ischemia- Reperfusion 
Injury. Kazuyuki Hirooka1, Y. Liu1,2, T. Fujita1, F. 
Shiraga1. 1Ophthalmology, Kagawa Univ Faculty 
of Medicine, Kita-gun, Japan; 2Ophthalmology, 
The Fourth Affiliated Hospital of China Medical 
University, Shenyang, China. 
6410 — A303 Progesterone Administration 
Effects On An Animal Model Of Retinitis 
Pigmentosa. Javier J. Araiz1, V. Sanchez-vallejo2, M. 
Flores-Bellver2, E. Arnal3, F. Romero4, M. Miranda2. 
1Ophthalmology, University of the Basque Country, 
Getxo, Vizcaya, Spain; 2Ciencias Biomédicas, 
Universidad CEU Cardenal Herrera, Valencia, 
Spain; 3Fundación Opftalmológica del Mediterraneo, 
Valencia, Spain; 4Facultad de Medicina, Universidad 
Católica de Valencia ‘San Vicente Mártir’, Valencia, 
Spain. 
6411 — A304 Neuroprotective Effects Of 
Erythropoietin In Mouse Models With Retinal 
Degeneration. Jasmin Balmer1, M. Tschopp1, M. 
Menke1, M. Gassmann2, S. Wolf1, V. Enzmann1. 
1Ophthalmology, University of Bern, Bern, 
Switzerland; 2Veterinary Physiology, University of 
Zurich, Zürich, Switzerland. 
6412 — A305 Morpholigal Differences 
And Apoptotic Rate In An Experimental 
Model Of Retinal Detachment After Systemic 
Submission Of a Dhea-analogue. Pavlina A. 
Tsoka1A, I. Charalampopoulos1B, A. Gravanis1B, 
M.K. Tsilimbaris2. ANeurology & Sense Organs, 
BPharmacology, 1University of Crete, Heraklion, 
Crete, Greece; 2Ophthalmology-Research Acct, 
University of Crete, Heraklion, Greece. 
6413 — A306 The Effect Of Ketone Bodies 
On The Synthesis Of Kynurenic Acid In Bovine 
Retinal Slices. Tomasz Zarnowski1A, M. Tulidowicz1A, 
T. Choragiewicz1A, R. Robert1A, T. Kocki1B, W. 
Turski1B. ADept of Ophthalmology, BDept of 
Pharmacology and Toxicology, 1Medical University 
Lublin, Lublin, Poland. 
6414 — A307 Neuroprotective Effects Of Sirna, 
Targeted Caspase9, And Atelocollagen Complex 
On Rat Retinal Damage Induced By Transient 
Ischemic Injury. Shinichiro Ishikawa1, A. Hirata1, J. 
Nakabayashi2, R. Iwakiri1, S. Okinami1. 1Saga Univ 
Faculty of Medicine, Saga, Japan; 2Saga Memorial 
Hospital, Saga, Japan. 
6415 — A308 Subretinal Electrical Stimulation 
Preserves Visual Acuity In Dystrophic RCS Rats. 
Vincent T. Ciavatta1,2A, M.H. Aung2B, T.S. Obertone2A, 
J.K. You1, M.T. Pardue1,2A. 1Rehab R&D Center of 
Excellence, Atlanta VA Medical Center, Decatur, GA; 
AOphthalmology, BNeuroscience, 2Emory University, 
Atlanta, GA. 
6416 — A309 Neuroprotection And 
Neurotoxicity Of The Sustained Intraocular 
Delivery Of Gdnf In Retinal Degeneration. 
Elodie Touchard1, P. Heiduschka2, M. Berdugo1, L. 
Kowalczuk1, P. Bigey3, S. Chahory4, C. Gandolphe3, 
J-C. Jeanny1, F. Behar-Cohen1. 1INSERM UMRS 
872, Paris, France; 2Univ Eye Hosp Muenster, 
Muenster, Germany; 3CNRS UMR8151, Paris, 
France; 4Ecole Nationale Vétérinaire d’Alfort, 
Maisons-Alfort, France. 
6417 — A310 Increased Susceptibility to 
Retinal Stress in Mice Lacking Sigma Receptor 
1 (σR1). Yonju Ha1A, A. Saul1B, C. Williams1C, 
E. Zorrilla2, V. Ganapathy1D, S.B. Smith1C. ACell 
Biology and Anatomy/Vision Discovery Institute, 
BOphthalmology, CCell Biology and Anatomy, 
DBiochemistry and Molecular Biology, 1Georgia 
Health Science University, Augusta, GA; 2Harold L. 
Dorris Neurological Institute, The Scripps Research 
Institute, La Jolla, CA. 
6418 — A311 Arginase2 Deficiency Reduces 
Hyperoxia-induced Retinal Neurodegeneration 
through the Regulation of Polyamine 
Metabolism. S. P. Narayanan1A, J. Suwanpradid1A, 
Z. Xu1A, T. Lemtalsi1A, N. Putluri2, A. Sreekumar2, 
R.W. Caldwell1B, R.B. Caldwell1A,3. AVascular 
Biology Center, BDepartment of Pharmacology and 
Toxicology, 1Georgia Health Science University, 
Augusta, GA; 2Department of Molecular and 
Cellular Biology, Baylor College of Medicine, 
Houston, TX; 3VA Medical Center, Augusta, 
GA. T
6419 — A312 The Protective Effects Of 
Brimonidine For ARPE-19 And Müller Cells 
Exposed To Hydroquinone In Vitro. Mohamed 
Tarek1, C.A. Ramirez2, M. Chwa2, G. Limb3, B.D. 
Kuppermann4, C.M. Kenney5. 1Ophthalmology, 
Gavin Herbert Eye Institute, Irvine, CA; 
2Ophthalmology, University of California, Irvine, 
Irvine, CA; 3Ocular Biology and Therapeutics, 
UCL Institute of Ophthalmology, London, United 
Kingdom; 4Gavin Herbert Eye Inst Dept Ophthal, 
University of California Irvine, Irvine, CA; 
5Ophthalmology, Univ of California-Irvine, Irvine, 
CA. T 
6420 — A313 Genetic Analysis of 
Photoreceptor Degeneration-induced Retinal 
Remodeling. James M. Fadool, K. Alvarez-Delfin, 
C.J. Saade. Biological Science and Program in 
Neuroscience, Florida State University, Tallahassee, 
FL. 
6421 — A314 Recombinant RdCVF Protein 
Promotes Cone Photoreceptor Survival in 
S334ter Rat. Yiwen Li, L. Luo, X. Xia, Z. Wang, 
P. Chen, R. Wen. Bascom Palmer Eye Institute, 
University of Miami, Miami, FL. 
6422 — A315 Quantum Dots As 
Neuroprotective Factor In A Model Of Retinal 
Photoreceptor Degeneration. Raul Velez-
Montoya1,2, N. Mandava1,2, C.R. Stoldt3, J.L. 
Olson1,2. 1Ophthalmology, University of Colorado 
Health and Science Center., Aurora, CO; 2Rocky 
Mountain Lions Eye Institute, Aurora, CO; 
3Mechanical Engineering, University of Colorado 
Boulder, Boulder, CO.*CR 
6423 — A316 Up-regulation Of Soluble 
Amyloid Beta And Down-regulation Of Soluble 
RAGE In The Vitreous Of Age-related Macular 
Degeneration Patients. Frances Fan1A, A. 
Montemari2, S. Rossi3, G. Parisi4, F. Lamoke1B, 
F. Facchiano3A, G. Ripandelli4, M. Bartoli1A. 
AOphthalmology, BPharmacology and Toxicology, 
1Georgia Health Sciences University, Augusta, GA; 
2Experimental Medicine and Pathology, University 
of Rome La Sapienza, Rome, Italy; AHematology 
and Oncology, 3Istituto Superiore Di Sanita, Rome, 
Italy; 4Fondazione GB Bietti, Rome, Italy. 
6424 — A317 Neuroprotectin D1 Is A 
Transcriptional Modulator Of The Birc3 
Gene That Encodes An Inhibitor Of Apoptosis 
Protein In Retinal Pigment Epithelial Cells. 
Aram Asatryan, J.M. Calandria, N.G. Bazan. 
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6425 — A318 Docosahexaenoic Acid Promotes 
Photoreceptor Survival by Activating a Retinoid 
X Receptor. Olga L. German, S. Monaco, D.L. 
Agnolazza, N.P. Rotstein, L.E. Politi. Institute for 
Biochemical Research-UNS, National Research 
Council (CONICET) of Argentina, Bahia Blanca, 
Argentina. 
6426 — A319 DHA Restores HNE And PEDF 
By Inhibiting Oxidative Damage In RPE At High 
Glucose Levels. Emma Arnal1, S. Johnsen-Soriano1, 
M. Miranda2, A. Navea1, J. Romero1,3. 1FOM, 
Valencia, Spain; 2Dpto. Ciencias Biomédicas, UCH-
CEU, Moncada, Spain; 3Facultad de Medicina, 
UCV, Valencia, Spain. 
6427 — A320 Transferrin Delivery In The Eye 
Protects Photoreceptors From Light-Induced 
Retinal Degeneration. Emilie Picard1,2, M. 
Berdugo1,2, M. El Sanharawi1, J-C. Jeanny1,2, Y. 
Courtois1,2, F.F. Behar-Cohen3. 1UMRS 872 team 
17, INSERM, paris, France; 2UMRS 872 team 
17, Université Pierre et Marie Curie et Université 
Descartes, Paris, France; 3Ophthalmology, Hotel 
Dieu de Paris, Universite Paris Descartes. INSERM 
UMRS872, Paris, France. 
6428 — A321 Iron Chelation Protects Against 
Murine Retinal Degeneration Induced Through 
Diverse Mechanisms. Joshua L. Dunaief1A, M. 
Hadziahmetovic2, D. Song3, Y. Song1B, Y. Li1B, S. 
Grieco1A, S. Chu1A, J. Connelly4, M. Spino4. AFM 
Kirby Ctr/Ophthalmology, BDept of Ophthalmology, 
1University of Pennsylvania, Philadelphia, PA; 
2FM Kirby Ctr, Scheie Eye Institute Univ of 
Penn, Philadelphia, PA; 3Dept of Ophthalmology, 
Peking Union Med College Hosp, Beijing, China; 
4ApoPharma, Inc., Toronto, ON, Canada.*CR 
6429 — A322 Iron Accumulation In Animal 
Models Of Genetic Retinal Degeneration: 
Human Transferrin As A Protector For 
Photoreceptors. Jean-Claude P. Jeanny1,2, L. 
Jonet1,2, M-H. Vesvres3, C. Sergeant3, F. Guillou4, 
F.F. Behar-Cohen1,2, C. Yves1,2, E. Picard1,2. 1UMRS 
872 team17, INSERM Centre des Cordeliers, Paris, 
France; 2UMRS 872 team 17, Université Pierre et 
Marie Curie et Université Descartes, Paris, France; 
3UMR 5084, Nuclear and Bio-environnemental 
Chemistry, CNRS, Bordeaux, France; 4UMR 
6175, Physiologie de la Reproduction et des 
Comportements, INRA, CNRS, Université de 
Tours, Paris, France. 
6430 — A323 TUDCA Prevents Microglia 
Activation In The P23H Rat Retina. Laura 
Fernandez-Sanchez1, A. Noailles1, I. Pinilla2, J. 
Martin-Nieto1, P. Lax1, N. Cuenca1. 1Physiology, 
Genetics & Microbiology, University of Alicante, 
Alicante, Spain; 2Ophthalmology, Universitary 
Hospital Lozano Blesa. Aragon Health Sciences 
Institute, Zaragoza, Spain. 
6431 — A324 Gentamicin-Induced Retinal 
Degeneration in Dutch Belted Rabbits. Omar 
Delgado, J. Demirs, S. Louie, M. Crowley, S. Poor, 
S. Hanks, C. Bigelow, Y. Zhang, B. Jaffee, S-M. 
Liao. Ophthalmology, Novartis, Cambridge, MA. 
6432 — A325 Fixation Stability and Central 
Retinal Sensitivity after Intravitreal Autologous 
Bone-Marrow Stem Cells for Hereditary Retinal 
Dystrophy. Rubens C. Siqueira1A, A. Messias1A, 
J.C. Voltarelli1B, K.V. Messias1A, R.S. Arcieri1A, R. 
Jorge1A. ARetina, BBone Marrow Transplantation, 
1Sao Paulo University, Ribeirao Preto, Brazil. f 
6433 — A326 Retinal Sheet Transplants Benefit 
Rats with Rod Degeneration, Revealed By 
Optokinetic Testing And Manganese-Enhanced 
MRI (MEMRI). Robert B. Aramant1A, M.J. 
Seiler1A, D.P. Bissig2A, R. Roberts2A, W. Qi1B, Z. 
Chen1B, S. Rana1A, J. Almodovar1A, H.S. Keirstead1A, 
B.A. Berkowitz2B. AAnatomy & Neurobiol/Reeve-
Irvine Res Ctr, BBiomedical Engineering, Beckman 
Laser Center, 1Univ of California, Irvine, Irvine, 
CA; AAnatomy and Cell Biology, BAnatomy and 
Cell Biology; Ophthalmology, 2Wayne State Univ 
School of Med, Detroit, MI.*CR 
6434 — A327 A SubmicroVolt Focal ERG 
Technique for Evaluating Macular Function in 
Stargardt/FF Dystrophy: Clinical Assessment of 
Test Reliability. Benedetto Falsini1, M. Piccardi1, 
D. Marangoni1, A. Minnella1, M. Bertelli2, S. Bisti3, 
A. Fadda4. 1Ophthalmology, Catholic University, 
Rome, Italy; 2Ophthalmology, MAGI Laboratory 
for molecular genetics in rare diseases, Rovereto, 
Trento, Italy; 3Physiology, University of L’Aquila, 
L’Aquila, Italy; 4Health and Technology, Istituto 
Superiore di Sanita, Rome, Italy. 
6435 — A328 The Expanded Clinical Spectrum 
of Enhanced S-cone Syndrome. Suzanne Yzer1,2, 
S.H. Tsang1, I.A. Barbazetto2, R. Allikmets1, 
L.A. Yannuzzi2,3. 1Ophthalmology, Columbia 
University, New York, NY; 2Vitreous Retina Macula 
Consultants NY, New York, NY; 3LuEsther T. Mertz 
Retinal Research Center, Manhattan Eye, Ear and 
Throat Institute, New York, NY. 
6436 — A329 Progressive RPE Dystrophy in 
Dutch Belt Rabbits. Meg Ramos1A, I. Raymond1A, 
C. Ghosn1B, J. Burke1B, S. Whitcup1C. ADrug Safety 
& Development, BBiological Sciences, CResearch & 
Development, 1Allergan, Inc, Irvine, CA.*CR 
6437 — A330 Retinal Degeneration and 
Microglial Activation in Mouse Models of 
Neuronal Ceroid Lipofuscinoses. Myriam Mirza1, 
C. Volz2, L. Woltering1, C. Schuller1, H. Jägle2, 
T. Langmann1. 1Institute of Human Genetics, 
University of Regensburg, Regensburg, Germany; 
2Department of Ophthalmology, University Eye 
Clinic Regensburg, Regensburg, Germany. 
6438 — A331 Modeling Photoreceptor 
Interactions in the Presence of Retinitis 
Pigmentosa. Erika T. Camacho, S. Wirkus. Divsion 
of Math and Natural Sciences, Arizona State 
University, Glendale, AZ. 
6439 — A332 Early S Cone Loss And L/m 
Cone Opsin Delocalization In The Canine Model 
Of Rpe65 Deficiency. Daniela Klein1, A. Mendes-
Madeira2, B. Lorenz1, F. Rolling2, S. Haverkamp3, 
K. Stieger1. 1Department of Ophthalmology, Justus 
Liebig University Giessen, Giessen, Germany; 
2Laboratory for Gene Therapy, University of 
Nantes, Nantes, France; 3Neuroanatomy, Max-
Planck-Institut for Brain Research, Frankfurt, 
Germany. 
6440 — A333 Degenerative Changes At The 
Rod Photoreceptor Synaptic Ribbon In Aging 
Dba2/j Mice. Michael Scholz1A, M. Fuchs1B, J. 
Atorf2, R. Enz1C, J.H. Brandstatter1D. AAnatomy 2, 
BBiology, CBiochemistry, DDepartment of Biology, 
1University of Erlangen-Nuremberg, Erlangen, 
Germany; 2Ophthalmology, University Hospital 
Erlangen, Erlangen, Germany. 
6441 — A334 Transgenic Expression of Glial 
Cell Line-Derived Neurotrophic Factor in 
Photoreceptor or RPE Delays but Does Not 
Prevent Photoreceptor Cell Death in rd10 
Mice. Masayuki Ohnaka, K. Miki, Y-Y. Gong, R. 
Stevens, T. Iwase, S.F. Hackett, P.A. Campochiaro. 
Ophthalmology and Neuroscience, Johns Hopkins 
University, Baltimore, MD. 
6442 — A335 Retinal Phenotypes in Patients 
Homozygous for the G1961E Mutation 
in the ABCA4 gene. Tomas R. Burke1, G.A. 
Fishman2, S.H. Tsang3, T. Smith1, R. Ayyagari4, 
R.K. Koenekoop5, A. Iannaccone6, F.P. Cremers7, 
C.C. Klaver, II8, R. Allikmets1. 1Ophthalmology, 
Columbia University, New York, NY; 2Chicago 
Lthouse for the Blind & Vis Impaired, Chicago, 
IL; 3Columbia Coll Phys Surg, Columbia Univ-
Harkness Eye Inst, New York, NY; 4Ophthalmology, 
University of California San Diego, La Jolla, 
CA; 5McGill Ocular Genetics Laboratory, McGill 
University Health Centre, Montreal, QC, Canada; 
6Ophthalmology/Hamilton Eye Institute, Univ 
Tennessee Health Sci Ctr, Memphis, TN; 7Human 
Genetics, Raboud Univ Nijmegen Med Ctr, 
Nijmegen, The Netherlands; 8Ophthalmology, 
Erasmus Medical Center, Rotterdam, The 
Netherlands. 
6443 — A336 Retinal Histopathology in Eyes 
from a Patient with Autosomal Dominant 
Retinitis Pigmentosa caused by the Pro23His 
Rhodopsin Mutation. Mary E. Rayborn1A, V.L. 
Bonilha1A, B.A. Bell1A, M.J. Marino1A, G.J. Pauer1A, 
C.D. Beight1A, E.I. Traboulsi1B, S.A. Hagstrom1A, 
J.G. Hollyfield1A. AOphthalmology, BCenter for 
Genetic Eye Diseases, 1Cole Eye Inst/Cleveland 
Clin Lerner Coll Med, Cleveland, OH. 
6444 — A337 Retinal Histopathology from 
a Patient with Autosomal Recessive Retinitis 
Pigmentosa caused by EYS Mutations. Meghan 
J. Marino1, V.L. Bonilha1, M.E. Rayborn1, B.A. 
Bell1, G.J. Pauer1, C.D. Beight1, J. Chiang2, E.I. 
Traboulsi1, S.A. Hagstrom1, J.G. Hollyfield1. 
1Ophthalmic Research, Cole Eye Institute, 
Cleveland Clinic, Cleveland, OH; 2Casey Eye 
Institute Molecular Diagnostics Laboratory, Oregon 
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6445 — A371 Inner Retinal Function and 
Structure in a Mouse Model (Rd9) of X-linked 
Retinitis Pigmentosa. Naheed W. Khan, A. Moncrief, 
G.W. Grahek, J.R. Heckenlively. Ophthalmology, 
Univ of Michigan-Kellogg Eye Ctr, Ann Arbor, MI. 
6446 — A372 Role of ER Stress-Induced 
Caspase7 in Retinal Degeneration of T17M 
Rhodopsin Transgenic Mice. Shreyasi Choudhury, 
M.S. Gorbatyuk. Cell Biology And Anatomy, 
University of North Texas Health Science Center, 
Fort Worth, TX. 
6447 — A373 Additional Neuroprotective 
Effects Of Proinsulin On Vision And Retinal 
Structure In The Rd10 Mouse Model Of Retinitis 
Pigmentosa. Enrique J. de la Rosa1, N. Forns2, 
M. Marchena2, A. Hernandez-Pinto1, R. Steel1, 
C. Isiegas3, E. Ayuso4, F. de Pablo1, F. Bosch4, P. 
de la Villa2. 1Cell & Molecular Medicine, Centro 
de Investigaciones Biologicas, Madrid, Spain; 
2Physiology, University of Alcala, Alcala de Henares, 
Spain; 3ProRetina Therapeutics SL, Madrid, Spain; 
4CBATEG, Universitat Autònoma de Barcelona, 
Bellaterra, Spain.*CR 
6448 — A374 Long-Term Rescue with Gene 
Therapy in a Mouse Model of Autosomal 
Dominant Retinitis Pigmentosa (ADRP). Haoyu 
Mao1A, M.S. Gorbatyuk2, B. Rossmiller1A, W.W. 
Hauswirth1B, A.S. Lewin1A. AMolecular Genetics & 
Microbiology, BMolecular Genetics & Microbiology, 
Ophthamology, 1University of Florida, Gainesville, 
FL; 2Department of Cell Biology and Anatomy, 
University of North Texas Health Science Center, 
Fort Worth, TX.*CR 
6449 — A375 Mpp3 is Required for Maintenance 
of Adherens Junctions in the Retina during Light 
Exposure. Jacobus J. Dudok1, A. Sanz Sanz1, D. 
Lundvig1, V. Sothilingam2, M. Garcia Garrido2, N. 
Tanimoto2, J. Klooster1, M. Jamrich3, M. Seeliger2, 
J. Wijnholds1. 1Neuromedical Genetics, Netherlands 
Inst for Neurosci, Amsterdam, The Netherlands; 
2Division of Ocular Degeneration, Ctr Ophthal 
Inst Ophthalmic Resrch, Tuebingen, Germany; 
3Molecular and Cellular Biology, Baylor College of 
Medicine, Houston, TX. 
6450 — A376 Altered Fractalkine Homeostasis 
In Rd10 Degenerating Mouse Retina. Marina 
Zieger1A, C. Schubert1A, P. Uhrin1B, P.K. Ahnelt1A. 
ANeurophysiology and Neuropharmacology, 
BVascular Biology and Thrombosis Research, 
1Medical University of Vienna, Vienna, Austria. 
6451 — A377 Characterization of a humanized 
Mouse-Model for X-linked Retinitis Pigmentosa 
caused by a point mutation in the Rpgr gene. Jutta 
U. Schlegel1A, D. Röll1A, M. Bergmann1B, B. Lorenz1A, 
K. Stieger1A. ADepartment of Ophthalmology, 
BDepartment of Veterinary Anatomy, 1Justus-Liebig-
University Giessen, Giessen, Germany. 
6452 — A378 A Knock-in Mouse Model of 
Human Rpgr G173R Mutation Exhibits Retinal 
Dysfunction and Reduced Rpgr Protein Levels. 
Zhijian Wu, S. Mookherjee, S. Hiriyanna, R. Rachel, 
T. Li, L. Dong, A. Swaroop, P. Colosi. NNRL, NIH/
NEI, Bethesda, MD. 
6453 — A379 ER Stress is Involved in Retinal 
Degeneration Induced by Human T17m Mutant 
Rhodopsin. Mansi M. Kunte1, S. Choudhury1, V.M. 
Shinde1, J.F. Manhiem1, M. Miura2, O.S. Gorbatyuk3, 
M.S. Gorbatyuk1. 1Cell Biology and Anatomy, UNT 
Health Science Center, Fort Worth, TX; 2Laboratory 
for Cell Recovery Mechanisms, Brain Science 
Institute, RIKEN, Tokyo, Japan; 3Department of 
Molecular Genetics and Microbiology, University of 
Florida, Gainesville, FL.*CR T 
6454 — A380 Ethanol Consumption Correlates 
with Retinal Degeneration and Vision Loss in the 
P23H Rat. Gema Esquiva1, P. Lax1, L. Fernandez-
Sanchez1, A. Noailles1, I. Pinilla2, N. Cuenca1. 
1Physiology, Genetics and Microbiology, University 
of Alicante, Alicante, Spain; 2Ophthalmology, 
Universitary Hospital Lozano Blesa, Zaragoza, 
Spain. 
6455 — A381 Proinflammatory Events in the 
P23H-1 Rat Model of Retinal Degeneration. 
Jiangyuan Gao, S. Cao, J.Z. Cui, E. To, C.Y. 
Gregory-Evans, K. Gregory-Evans, O.L. Moritz, J.A. 
Matsubara. Ophthalmology and Visual Sciences, 
University of British Columbia, Vancouver, BC, 
Canada. 
6456 — A382 Crb1 And Crb2 Controls 
Cell Division During Retina Development. 
Lucie P. Pellissier1, C.H. Alves1, D. Lundvig1, M. 
Garcia-Garrido2, V. Sothilingam2, N. tanimoto2, F. 
Richard3, A. Le Bivic3, M. Seeliger2, J. Wijnholds1. 
1Neuromedical Genetics, Netherlands Inst for 
Neurosci, Amsterdam, The Netherlands; 2Division of 
Ocular Neurodegeneration, Institute for Ophtalmic 
research, Tuebingen, Germany; 3Institut de Biologie 
du Développement de Marseille Luminy, Marseille, 
France. 
6457 — A383 Deficiency in the Pro-Apoptotic 
CHOP Protein, a UPR Downstream Marker, Does 
Not Prevent Vision Loss in T17M Rho Retina. 
Sonali R. Nashine1, A.S. Lewin2, M.S. Gorbatyuk1. 
1Cell Biology and Anatomy, University of North 
Texas Health Science Center, FortWorth, TX; 
2Molecular Genetics & Microbio, University of 
Florida, Gainesville, FL. 
6458 — A384 Effects of Chlorin e6 on Retinitis 
Pigmentosa Rhodopsin Mutants in vivo. Fernanda 
Balem1A,2, P.S. Akamine1A, G.L. Ioshimoto1B, B.V. 
Nagy1B, D.F. Ventura1B, J. Klein-Seetharaman2, D. 
Hamassaki1A. ACell and Developmental Biology, 
BExperimental Psychology, 1University of Sao Paulo, 
Sao Paulo, Brazil; 2Structural Biology, Univeristy of 
Pittsburgh, Pittsburgh, PA. 
6459 — A385 siRNA preservation in rapidly 
progressing autosomal dominant retinitis 
pigmentosa. Brian P. Rossmiller1A,2A, H. 
Mao1B,2A, A.S. Lewin1C,2B. AGenetics, BMolecular 
Genetics & Microbiology, CMolecular Genetics 
& Microbio, 1University of Florida, Gainesville, 
FL; ADepartment of Molecular Genetics and 
Microbiology, B1Department of Molecular Genetics 
and Microbiology, 2The University of Florida, 
Gainesville, FL. 
6460 — A386 Analysis of Retinal and Choroidal 
Circulation in the Early Phase of Fluorescein 
Angiography in an Abyssinian Cat Model of 
Retinitis Pigmentosa (rdAc). Christina Seide1, 
K. Narfstrom2, M.W. Seeliger1. 1Division of Ocular 
Neurodegeneration, Center for Ophtal., Inst. for 
Opht. Research, Tuebingen, Germany; 2Dept of Vet 
Med & Surgery, University of Missouri-Columbia, 
Columbia, MO. 
6461 — A387 Long-term Preservation Of Cone 
Photoreceptors By A Novel Multifunctional 
Drug In A Mouse Model Of Human Retinitis 
Pigmentosa. Bin Lin1A, K. Wang1B, M.B. Youdim2. 
AAnatomy, Eye Institute, BAnatomy, 1University of 
Hong Kong, Hong Kong, Hong Kong; 2Faculty of 
Medicine, Technion-Israel Institute of Technology, 
Haifa,, Israel. 
6462 — A388 Analysis Of Photoreceptor 
Abnormality In Gucy2d E837D/R838S Transgenic Pigs. 
Corinne Kostic1, T. King2, C. Sylvain1, S. Philippe3, 
S. Lillico2, C. Sarkis3, J. Mallet4, Y. Arsenijevic1, 
B. Whitelaw2. 1Gene Therapy & Stem Cell Biol, 
Jules-Gonin Eye Hosp, Univ Lausanne, Lausanne, 
Switzerland; 2Division of Developmental Biology, 
The Roslin Institute, University of Edinburgh, 
Scotland, United Kingdom; 3NewVectys, Paris, 
France; 4Team of Biotherapy and Biotechnology, 
CRICM, Paris, France.*CR 
Hall B/C A389-A436
Thursday, May 10, 2012, 11:15 AM-1:00 PM
Biochemistry & Molecular Biology
546 AMD Disease Mechanisms II 
Moderator: Anneke I Den Hollander 
6463 — A389 Establishing a Human AMD 
Interactome. Paul Wong1, D.A. Ferrington2, T.W. 
Olsen1,2. 1Ophthalmology, Emory University, Atlanta, 
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6464 — A390 Zinc Supplementation Affects 
Lesion Characteristics in a Spontaneous CNV 
Mouse Model. Neda Barzegar-Befroei1, T. Peto2, 
Y. Ng1, D.T. Shima1, I. Lengyel1. 1Ocular Biology 
and Therapeutics, UCL Institute of Ophthalmology, 
London, United Kingdom; 2Research & 
Development, Moorfields Eye Hospital, London, 
United Kingdom. 
6465 — A391 Inflammatory Reactions 
Complicating Exudative Age-Related Macular 
Degeneration (AMD). Alena Reznik1, C.H. Weber2, 
D.G. Telander3, L.S. Morse4, S.S. Park5, C.E. 
Thirkill6. 1UC Davis Eye Center, UC Davis Eye 
Center, Sacramento, CA; 2Eye Center, University of 
California Davis, Sacramento, CA; 3Ophthalmology, 
University of California, Davis, Sacramento, 
CA; 4Ophthalmology, Univ of California-Davis, 
Sacramento, CA; 5Ophthalmology & Vision Science, 
Univ of California Davis Eye Ctr, Sacramento, CA; 
6Research Lab 1220 Surge III, UC Davis, Davis, 
CA. T 
6466 — A392 Properdin and Malondialdehyde 
(MDA) effects on the APOE4 mouse model of 
Age-Related Macula Degeneration (AMD). Una 
L. Kelly1A, M. Groelle1A, J. Ding1A, W-C. Song2, C. 
Bowes Rickman1B. AOphthalmology, BOphthalmology 
and Cell Biology, 1Duke University Medical Center, 
Durham, NC; 2School of Medicine, University of 
Pennsylvania, Philadelphia, PA. 
6467 — A393 Pro-oxidant Properties of Human 
Retinal Melanolipofuscin in the Presence of 
Iron Ions; Comparison with Lipofuscin and 
Melanosomes. Malgorzata B. Rozanowska1, R. 
Edge2A, F. Tuna2B. 1Optom & Vis Science, Cardiff 
University, Cardiff, United Kingdom; AChemistry, 
BEPSRC National Service for EPR Spectroscopy, 
2University of Manchester, Manchester, United 
Kingdom. 
6468 — A394 Therepeutic Effects Of 
Fenofibrate On Laser-induced Choroidal 
Neovascularization. Yang Hu1A, Y. Chen2, J-X. 
Ma1B. AOUHSC BSEB 300, BHarold Hamm 
Oklahoma Diabetes Ctr, 1Univ of Oklahoma Hlth 
Sci Ctr, Oklahoma City, OK; 2Physiology, OUHSC, 
Oklahoma City, OK. 
6469 — A395 Mechanism Of All-Trans-retinal 
Toxicity: Implications For Stargardt’S Disease 
And Age-related Macular Degeneration. Yu 
Chen1A, K. Okano1A, T. Maeda1A,1B, V. Chauhan1A,2, 
M. Golczak1A, A. Maeda1A,1B, K. Palczewski1A. 
APharmacology, BOphthalmology, 1Case Western 
Reserve University School of Medicine, Cleveland, 
OH; 2Ophthalmology, Case Western Reserve 
University, Cleveland, OH. 
6470 — A396 Early Thinning Of The Retina 
Correlates With Increased Expression Of 
Immune Response Genes In The Harlequin 
Mouse. Justin G. Mayers1, K.A. Hill1, C.M. Hutnik2. 
1Biology, University of Western Ontario, London, 
ON, Canada; 2Ophthalmology, Ivey Eye Institute, 
London, ON, Canada. 
6471 — A397 Alu Rna Induced Rpe 
Degeneration Via Il18-myd88-caspase-3 
Signaling. Valeria Tarallo, Y. Hirano, B.D. Gelfand, 
N. Kerur, B.J. Fowler, J. Ambati. Ophthalmology, 
University of Kentucky, Lexington, KY.*CR 
6472 — A398 Regulation Of Choroidal 
Neovascularization By MicroRNAs. Qinbo 
Zhou, W. Anderson, R. Ufret-Vincenty, S. Wang. 
Ophthalmology, UT southwestern, Dallas, TX. 
6473 — A399 NR2E3, A Retina-specific Nuclear 
Receptor, Directly Regulates Transcription Of 
The Antioxidant Enzyme PON1. Qiong Qin, K. 
Petrukhin. Ophthalmology, Columbia University, 
New York, NY. 
6474 — A400 Microrna-335 Inhibits Sod2 
Expression And Increases Oxidant-induced 
Rpe Cell Injury. Haijiang Lin1A, B.F. Godley1B. 
AOphthalmology, BOphthal & Visual Sciences, 
1Univ of Texas Medical Branch, Galveston, TX. 
6475 — A401 The Inflammatory Response To 
Immune Complex Formation In The Retina. 
Salome Murinello1A, A.J. Lotery1B, V. Perry1A, 
J.L. Teeling1A. ACenter for Biological Sciences, 
BFaculty of Medicine, 1University of Southampton, 
Southampton, United Kingdom. 
6476 — A402 Elucidating the correlation 
between the levels of Macular Xanthophylls and 
A2E In Normal Indian Donor Eyes. Srinivasan 
Senthilkumari1, R. Ranjith Kumar1, A. Kotnala2, T. 
Velpandian2. 1Department of Ocular Pharmacology, 
Aravind Medical Research Foundation, Madurai, 
India; 2Department of Ocular Pharmacology & 
Pharmacy, All India Institute of Medical Sciences, 
New Delhi, India. 
6477 — A403 Linking Retinoids To Clinical 
Patterns Of Amd. Zsolt Ablonczy1, D. Higbee1, 
A.M. Hanneken2, K.L. Schey3, Y. Koutalos1, R.K. 
Crouch1. 1Ophthalmology, Medical University of 
South Carolina, Charleston, SC; 2Molec & Exp 
Med, The Scripps Research Institute, La Jolla, CA; 
3Biochemistry, Vanderbilt University, Nashville, 
TN. 
6478 — A404 Quantification Of CEP By LC 
MS/MS. Geeng-Fu Jang1, L. Zhang1, L. Hong2, 
H. Wang2, R.G. Salomon2, J.W. Crabb1,2. 1Cole 
Eye Institute, Cleveland Clinic, Cleveland, OH; 
2Department of Chemistry, Case Western Reserve 
University, Cleveland, OH.*CR 
6479 — A405 Cigarette Smoke Triggers 
Excessive Complement Activation in Human 
RPE Cells: Involvement of Nrf2 signaling. Lei 
Wang, K. Naoshi, K.B. Ebrahimi, M.D. Canol, 
J.T. Handa. Ophthalmology, Johns Hopkins Univ., 
School of Medicine, Baltimore, MD. 
6480 — A406 Correlation of Renal Function 
and C-reactive Protein, with Disease Severity 
and Progression In Eyes with Dry AMD. Mathew 
K. George, C.A. Garcia Filho, Z. Yehoshua, G. 
Gregori, W. Feuer, P.J. Rosenfeld. Bascom Palmer 
Eye Institute, Univ of Miami Miller Sch of Med, 
Miami, FL.*CR, f 
6481 — A407 Amyloid-β Peptide Induces 
Angiogenesis In The Adult Zebrafish Retina. 
Khomthorn P. Cunvong1A, D. Cameron1B. AGraduate 
College of Biomedical Sciences, BCollege of 
Optometry, 1Western University of Health Sciences, 
Pomona, CA. 
6482 — A408 Intense Physiological Light 
Upregulates VEGF and Promotes Choroidal 
Neovascularization via PGC-1α/ERR-α Pathway. 
Takashi Ueta1, T. Inoue1, K. Yuda1, T. Furukawa2, 
Y. Yanagi1, Y. Tamaki1. 1Ophthalmology, Univ 
of Tokyo, School of Med, Bunkyo-ku, Japan; 
2Department of Developmental Biology, Osaka 
Bioscience Institute, Suita, Osaka, Japan. 
6483 — A409 Genetic Association of Glucose 
Transporter Type 1 Variants with Age-Related 
Macular Degeneration and its Direct Interaction 
with Complement Factor H at the Protein 
Level. Elod Kortvely1, A.I. Den Hollander2, M. 
Gorza3, V. Cipriani4, J.R. Yates4,5, C. Hayward6, 
A.F. Wright6, S. Fauser7, C.C. Hoyng2, M. 
Ueffing8,3. 1Centre for Ophthalmology, University 
of Tuebingen, Tuebingen, Germany; 2Department 
of Ophthalmology, Radboud University Nijmegen, 
Medical Centre, Nijmegen, The Netherlands; 
3Research Unit for Protein Science, Helmholtz 
Zentrum München, German Research Center for 
Environmental Health, Neuherberg, Germany; 
4Institute of Ophthalmology, University College, 
London, London, United Kingdom; 5Department 
of Medical Genetics, University of Cambridge, 
Cambridge, United Kingdom; 6Institute of Genetics 
and Molecular Medicine, MRC Human Genetics 
Unit, Edinburgh, United Kingdom; 7University Eye 
Hospital Cologne, Cologne, Germany; 8Institute 
for Ophthalmic Research, University Eye Hospital, 
Tuebingen, Germany. 
6484 — A410 On the Origin of Proteins in 
Human Bruch’s Membrane and Drusen. Theo 
G. Gorgels1, J.C. Booij1, S. Kaing1, I. Lengyel2, 
A.A. Bergen1. 1Molecular Ophthalmogenetics, 
Netherlands Inst Neuroscience, Amsterdam, The 
Netherlands; 2Ocular Biology and Therapeutics, 
UCL Institute of Ophthalmology, London, United 
Kingdom. 
6485 — A411 Can Environmental Enrichment 
(EE) Prevent the Rodent Light-Induced 
Retinopathy (LIR)? Yasmin Kerouch1, K. 
Rousseau1, M. Gauvin1, M. Quaddoumi2, A. Polosa1, 
P. Lachapelle1. 1Ophthalmology and Neurology-
Neurosurgery, McGill University-Montreal 
Children’s Hospital Research Institute, Montreal, 
QC, Canada; 2Department of Applied Therapeutics, 



















*Refer to Program Number in the Commercial Relationships (CR) Index for Disclosures   –   f Refer to Program Number in the Clinical Trial (CT) Registration Index  –   T Travel Grant Awardee
6486 – 6507 – Thursday – Posters
6486 — A412 Characterisation Of The 
Large Macromolecular MMP Complex Of 
Human Bruch’s Membrane With Respect To 
Stability, Activation And Effects Of Ginseng 
Compounds. Yong Dol Shin1, J. Seok2, C. Sim3, 
M. Kang2, H. Shim2, Y. Lee2, A. Hussain4. 1Jeonbuk 
National University, Jeonju-si, Republic of Korea; 
2GBioMix, Jeonju-si, Republic of Korea; 3Korean 
Atomic Energy Research Institute, Dae Jeon, 
Republic of Korea; 4Division of Molecular Therapy, 
UCL Institute of Ophthalmology, London, United 
Kingdom.*CR 
6487 — A413 The oxysterol, 
27-hydroxycholesterol, disrupts Estrogen 
Receptor and Liver X Receptor signaling in 
Retinal Pigment Epithelial Cells. Bhanu C. 
Dasari, O. Ghribi. Pharmacology Physiology & 
Therapeutics, Univ of North Dakota, Grand Forks, 
ND. 
6488 — A414 Translational diffusion of 
ranibizumab and bevacizumab as measured by 
Fluorescence Recovery after Photobleaching 
(FRAP). Nishanthan Srikantha1A, K. Suhling1B, 
T. Jackson1A. AOphthalmology, BPhysics, 1Kings 
College London, London, United Kingdom. 
6489 — A415 Identifying the Roles of 
Interferon-Gamma Inducible Chemokines 
in Progression of Age-related Macular 
Degeneration (AMD). Syeda F. Absar1, D. Cyr1, 
A.D. Proia2, M.T. Malik1, P. Bex1, K. Lashkari1. 
1Schepens Eye Research Institute, Massachusetts 
Eye and Ear, Department of Opthalmology, Harvard 
Medical School, Boston, MA; 2Department of 
Pathology, Duke University Medical Center, 
Durham, NC. 
6490 — A416 Low Doses Of Proteasome 
Inhibitors Protect Against Oxidative Injuries Via 
Ppar(α)-dependent Pathway In Arpe-19 Cells. 
Shengzhou Wu, L. Sun, J. Cai, J. Qu. School of 
Optometry and Ophthalmology, Wenzhou Medical 
College, Wenzhou, China. 
6491 — A417 Reactive Oxygen Species 
and P2X
7 
receptors are critical for Alu RNA 
induced RPE degeneration caused by NLRP3 
inflammasome. Nagaraj kerur, V. Tarallo, Y. 
Hirano, B.D. Gelfand, S. Dridi, B.J. Fowler, S. 
Bogdanovich, J. Baffi, M.E. Kleinman, J. Ambati. 
Ophthalmology and Visual Sciences, University of 
Kentucky, Lexington, KY.*CR 
6492 — A418 8-CPT-2-O-Me-cAMP, a Rap1 
activator, suppress laser-induced CNV in Mice. 
Eiichi Nishimura1,2, M. McCloskey1, Y. Jiang1, G.W. 
Smith1, H. Wang1, E.S. Wittchen3, R. Koide2, M.E. 
Hartnett1. 1Ophthalmology, John A Moran Eye Ctr, 
Univ of Utah, Salt Lake City, UT; 2Ophthalmology, 
Showa University, School of Medicine, Tokyo, 
Japan; 3Cell and Developmental Biology, University 
of North Carolina, Chapel Hill, NC. 
6493 — A419 Impaired Vision in the DNA 
Double-Strand Break Repair Polµ-mutant 
Mouse. Noemi L. Alvarez-Lindo1, J. Baleriola1, 
J.M. Sanmartin1, T. Suarez1, G. Terrados2, B. 
Escudero3, A. Bernad3, L. Blanco2, P. de la Villa4, 
E. de la Rosa1. 1Cellular and molecular medicine, 
Centro de Investigaciones Biologicas-CSIC, 
Madrid, Spain; 2Centro de Biologia Molecular 
CSIC-UAM, Madrid, Spain; 3Centro de Nacional 
de Investigaciones Cardiovasculares, Madrid, 
Spain; 4Physiology, University of Alcala, Alcala de 
Henares, Spain. 
6494 — A420 Ginseng Mediated Improvement 
In The Hydraulic Conductivity Of Human 
Bruch’s Membrane: Potential For Preventive 
Therapy In AMD. Cheul Muu Sim1, J. Seok2, M. 
Kang2, Y. Shin3, H. Shim2, Y. Lee2, A. Hussain4. 
1Neutron Science Department, Korea Atomic 
Energy Research Institute, Daejeon, Republic of 
Korea; 2GBioMix, Jeonju, Republic of Korea; 
3Physics, JeonBuk University, Jeonju, Republic 
of Korea; 4Division of Molecular Therapy, UCL 
Institute of Ophthalmology, London, United 
Kingdom.*CR 
6495 — A421 The Kinetics of Retinal Gene 
Expression Profile of Ccl2/Cx3cr1 Double 
Deficient Mice on rd8 Background. De Fen 
Shen1, Y. Wang1, K. Jin2, J. Tuo1, M. Xiang2, C-C. 
Chan1. 1Laboratory of Immunology, National Eye 
Inst/NIH, Bethesda, MD; 2Center for Advanced 
Biotechnology and Medicine, University of 
Medicine and Dentistry of New Jersey, Piscataway, 
NJ. 
6496 — A422 Oxidative Stress Causes 
Activation of the ERK Signaling Pathway in 
Cultured Human Retinal Pigment Epithelial 
Cells. Piyush C. Kothary, M. Crofoot, A-M. Nae, N. 
Lpes, T. Patel, N.B. Shah, N. Shah, C. Yang, M.A. 
Del Monte. Ophthalmology, Univ of Michigan-
Kellogg Eye Ctr, Ann Arbor, MI. 
6497 — A423 A2E Induces Interleukin-1ß 
Production in ARPE-19 Cells via Activation 
of the Inflammasome. Owen A. Anderson, A. 
Finkelstein, D.T. Shima. Institute of Ophthalmology, 
University College London, London, United 
Kingdom. 
6498 — A424 Understanding The Mechanism 
Behind Enhancing Survival Of Photoreceptors 
In Culture And Regulation Of Photoreceptor 
Metabolism. Ken Lindsay1A, T.A. Reh1B, J.B. 
Hurley1A, D. Lamba1B, J. Gust1B. ABiochemistry, 
BBiological Structure, 1University of Washington, 
Seattle, WA. 
6499 — A425 Interactions Between 
Apolipoprotein E Isoforms, Hepatic Lipase, 
and Lipoprotein Lipase In The Retinal Pigment 
Epithelium. Kimberly A. Toops, J. Xu, A. 
Lakkaraju. Ophthalmology and Visual Sciences, 
University of Wisconsin - Madison, Madison, WI. 
6500 — A426 Effect Of Divalent Metal 
Chelation On The MMP System And 
Transport Characteristics Of Human Bruch’s 
Membrane. Yunhee Lee1, A. Hussain2, J. Marshall2. 
1Ophthalmology, King’s College London, Lambeth 
Palace Rd, London, United Kingdom; 2Division of 
Molecular Therapy, UCL Institute of Ophthalmology, 
London, United Kingdom. 
6501 — A427 ARMS2 A69S Associated 
Alternative Splicing and Differential Gene 
Expression in Human RPE/Choroid. S. Scott 
Whitmore, T.A. Braun, T.E. Scheetz, A. Khanna, L.M. 
Affatigato, E.M. Stone, R.F. Mullins. Ophthalmology 
and Visual Sciences, University of Iowa, Iowa City, 
IA. 
6502 — A428 Diet Can Influence Human Retinal 
n-3/n-6 VLC-PUFA Ratios. Aihua Liu1, R. Terry1, 
K. Nelson1, X. Sheng2, P.S. Bernstein1. 1Ophthal & 
Visual Sci, Univ of Utah/Moran Eye Center, Salt 
Lake City, UT; 2Department of Pediatrics, Univ of 
Utah/Department of Pediatrics, Salt Lake City, UT. 
6503 — A429 Differential gene expression 
of RPE cells in Cfh transgenic mice. Cynthia 
X. Wang, K. Zhang, B. Aredo, R. Ufret-Vincenty. 
Ophthalmology, UTSW Medical Center, Dallas, TX. 
6504 — A430 Reticular Fundus 
Autofluorescence (FAF) In The Evolution Of 
Geographic Atrophy (GA) In A Rat Model Of 
RPE Toxicity. Shelley R. Boyd, X. Zhao, H. Wang, N. 
Pankova, D. Baek, R. Hillier, T. Liang, F. Altomare. 
Ophthalmology & Vision Sciences, University 
of Toronto, St Michael’s Hospital & Li Ka Shing 
Knowledge Inst, ON, Canada. 
6505 — A431 Modifications Of Glycoproteins 
In The Bruch’S Membrane Via Glycolaldehyde 
Or Nitration: A Model For Aging And 
Inflammation. Mai T. Thao1, J.P. Dillon2A, E.R. 
Gaillard2B. 1Chemistry and Biochemistry, Northern 
Illinois University, Sycamore, IL; AChemistry and 
Biochemistry, BChemistry & Biochemistry, 2Northern 
Illinois University, DeKalb, IL. 
6506 — A432 AAV-Mediated Nrf2 Gene 
Replacement in the Nrf2 Knockout Mouse. 
Katharine J. Liang, K.T. Woodard, R.J. Samulski. 
Gene Therapy Center, The Univ of North Carolina 
Chapel Hill, Chapel HIll, NC. 
6507 — A433 Arms2 In/del Polymorphism 
Predicts Response To Intra Vitreal Anti-vegf 
Therapy For Choroidal Neovascular Age-related 
Macular Degeneration (amd). Alan J. Franklin1, 
M.F. Shuler2, S. Gupta3, J. Myers3, W.B. Lauten1. 
1Retina Specialty Institute, Mobile, AL; 2Retina 
Specialty Institute, Panama City, FL; 3Retina 
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6508 — A434 Conditional Knock-Out of Ran-
binding protein 2 (RanBP2)/Nucleoporin 358 
(NUP358) in the Retinal Pigment Epithelium 
Results in the Activation of Membrane to Nuclear 
Signaling Pathways and Hallmark Features of 
Age-Related Macular Degeneration (AMD). Paulo 
A. Ferreira1, A. Saha1, E. Haque1, Y-Z. Le2, M. Webb1. 
1Ophthalmology, Duke University Medical Center, 
Durham, NC; 2Medicine, Univ of Oklahoma Hlth Sci 
Ctr, Oklahoma City, OK. 
6509 — A435 Image Registration Reveals Sites 
of Injury from Mitochondrial Oxidative Stress 
in the Retinal Pigment Epithelium. Alfred S. 
Lewin1A, M.P. Krebs2, S. Soo1A, K. Jones1A, H. Mao1B, 
W.W. Hauswirth3. AMolecular Genetics & Microbio, 
BMolecular Genetics & Microbiology, 1University of 
Florida, Gainesville, FL; 2The Jackson Laboratory, 
Bar Harbor, ME; 3Dept of Ophthalmology, Univ of 
Florida Coll of Medicine, Gainesville, FL.*CR 
6510 — A436 Genetically-related Inflammatory 
Priming and Failing Retinal Maintenance 
Predispose to Age-Related Retinal Degeneration 
in Mice. Debarshi Mustafi1A, H. Kohno1A, K. 
Palczewski1A, T. Maeda1B. APharmacology, BOphthal 
& Visual Sciences, 1Case Western Reserve 
University, Cleveland, OH. 
Hall B/C A513-A539




6511 — A513 Associations Between Early 
Signs Of Age-related Macular Degeneration 
(AMD) And Risk Of AMD In The Fellow Eye In 
Patients With Unilateral AMD. Mariko Sasaki1,2, 
R. Kawasaki2, A. Uchida1, T. Koto1, H. Mochimaru1, 
H. Shinoda1, T.Y. Wong2,3, K. Tsubota1, Y. Ozawa1. 
1Department of Ophthalmology, Keio University, 
Tokyo, Japan; 2Centre for Eye Research Australia, 
Royal Victorian Eye and Ear Hospital, Department 
of Ophthalmology, Melbourne University, Victoria, 
Australia; 3Singapore Eye Research Institute, 
National University of Singapore, Singapore, 
Singapore.*CR 
6512 — A514 Initial Clinical Experience 
With RetnaGene AMDTm, A Genetic Test 
For Prediction Of CNV. Briana L. Sawyer1, 
D.Y. Harrison1, L. Perlee2, P.S. Bernstein1. 
1Ophthalmolgy, John A. Moran Eye Center, Salt 
Lake City, UT; 2Sequenom, Inc, San Diego, 
CA.*CR 
6513 — A515 Genetics And Prevention Of 
Blindness: Risk Factors Associated With Age-
related Macular Degeneration In A Brazilian 
Population. Priscila H. Rim1A, A.P. Marques-de-
Faria1B, L.A. Magna1B. AOphthalmology, BMedical 
genetics, 1Univ Estadual de Campinas, Campinas, 
Brazil. 
6514 — A516 Do Ultraviolet Radiations 
Induce Earlier Aged Ocular Pathologies Among 
Mountaineer Guides? Hussam El Chehab1, C. 
Dot2, J. Blein3, J. Herry4, J. Giraud1, F. Maÿ1, J. 
Renard1. 1Department of Ophthalmology, Val de 
Grace Military Hospital, Paris, France; 2Desgnettes 
Military Hospital, Lyon, France; 3Ophthalmologist, 
Chamonix Mont-Blanc, France; 4Ecole Nationale de 
Ski et d’Alpinisme, Chamonix Mont-Blanc, France. 
f 
6515 — A517 Impact Of Visceral Fat, Serum 
Leptin Levels And High-sensitive Crp Levels 
On The Pathogenesis Of Age-related Macular 
Degeneration. Paulina Haas1, K. Kubista1, W. 
Krugluger2, J. Huber3, S. Binder1. 1Ophthalmology, 
Rudolf Foundation Clinic, Vienna, Austria; 
2Institute for Laboratory Medicine/ SMZ-East, 
Vienna, Austria; 3Gynecology, Medical University 
of Vienna, Vienna, Austria. f T 
6516 — A518 Correlation of Osteoporosis 
and Incidence of Skin Cancers and AMD grade 
in the Irish Nun Eye Study Population. Evelyn 
Moore1, V. Silvestri2, M. Stevenson3A, G. Silvestri3B. 
1Ophthalmology, Royal Group Hospital, Belfast, 
United Kingdom; 2Ophthalmology, Royal Hospital 
Trust, Belfast, United Kingdom; ACentre for Public 
Health, BCentre for Vision and Vascular Science, 
3Queen’s University, Belfast, United Kingdom. 
6517 — A519 Plasma Homocysteine And 
Extracellular Soluble Receptor For Advanced 
Glycation End Products (esRage) In Aqueous 
Humor Of Patients With Age-related Macular 
Degeneration. Pinio Matoula1A,1B, K. Ninios1A, N. 
Szentmary1A, R. Obeid1B, B. Seitz1A. ADepartment 
of Ophthalmology, B2Department of Clinical 
Chemistry and Laboratory Medicine, 1University of 
Saarland, Homburg, Germany. 
6518 — A520 Visual Impairments In Age-
related Macular Degeneration To Process 
Spatial Frequencies During Natural Scene 
Categorization. Ruxandra Hera1, B. Musel2, S. 
Chokron3, C. Chiquet1, J. Romanet1, J. Le Bas1,4, 
P. Carole2. 1Ophthalmology, Hospital Albert 
Michallon, Grenoble, France; 2Laboratoire de 
Psychologie et Neurocognition, CNRS UMR 5105, 
Grenoble, France; 3Fondation Ophtalmologique 
Rothschild, Unité Fonctionnelle Vision et 
Cognition, Paris, France; 4Université Joseph Fourier 
- Institut des Neurosciences, INSERM U836, 
Grenoble, France. 
6519 — A521 Contrast Sensitivity As A 
Predictor Of Central Field Loss. Jennifer Wallis1, 
P.J. Bex2, L. Lesmes2, T.S. Wallis2, M. Jackson1. 
1Vision Rehabilitation, Harvard Medical School/
Massachusetts Eye and Ear Infirmary, Boston, MA; 
2Schepens Eye Research Institute, Harvard Medical 
School, Boston, MA. 
6520 — A522 A Canadian Registry Of Lucentis 
Treatment To Collect Effectiveness And Safety 
Data In Patients With Neovascular Age-related 
Macular Degeneration Over 36 Months (LENS): 
Findings From A 12-month Interim Analysis. 
Sebastien Olivier1, A. Charbonneau2, M. Giunta3, 
P. Saurel4, M. Bense5, B. Rehel6, F. De Takacsy7, 
R. Li7. 1Ophthalmology, Hopital Maisonneuve-
Rosemont, Montreal, QC, Canada; 2Polyclinique 
de Trois-Rivières, Trois-Rivières, QC, Canada; 
3Université de Sherbrooke, Sherbrooke, QC, 
Canada; 4Clinique ChirurgiVision, Drummondville, 
QC, Canada; 5Health Sciences Centre-Eye Clinic 
St-John’s, St-John’s, NL, Canada; 6Everest Clinical 
Research Services, Inc., Markham, ON, Canada; 
7Novartis Pharmaceuticals Canada Inc., Dorval, QC, 
Canada.*CR 
6521 — A523 The Impact Of Anti-vegf 
Treatment On Vision-related Quality Of Life 
In Age-related Macular Degeneration Outside 
Clinical Trials. Robert P. Finger1, J.B. Hassell1, 
F. Abedi1, M.C. Gillies2, J.E. Keeffe1, R.H. 
Guymer1. 1Centre for Eye Research Australia, 
Melbourne, Australia; 2Save Sight Institute, Sydney, 
Australia.*CR 
6522 — A524 Outcome Study of Treating 
Neovascular Age-related Macular Degeneration: 
Preliminary Results. Margriet I. van der Reis1, 
M. Elshout1, Y. de Jong - Hesse2, E.C. La Heij3, 
P.J. Ringens2, F. Hendrikse1, C.A. Webers1, J.S. 
Schouten1. 1Ophthalmology, University Eye 
Clinic Maastricht, Maastricht, The Netherlands; 
2Ophthalmology, VU University Medical Center, 
Amsterdam, The Netherlands; 3Ophthalmology, 
University Medical Center Utrecht, Utrecht, The 
Netherlands. 
6523 — A525 Spectral Domain Optical 
Coherence Tomography Treatment Guidance 
Of Monthly Follow-up Of Patients With 
Exudative Age-Related Macular Degeneration. 
Roberto Gallego-Pinazo1, E. Sanz-Marco1, S. 
Martínez-Castillo1, R. Dolz-Marco1, J. Arévalo2,3, 
M. Díaz-Llopis1,4. 1Ophthalmology, University 
and Polytechnic Hospital La Fe, Valencia, Spain; 
2Retina, Wilmer Eye Institute. Johns Hopkins 
University School of Medicine, Baltimore, MD; 
3King Khaled Eye Specialist Hospital, Riyhad, 
Saudi Arabia; 4Faculty of Medicine, University of 
Valencia, Valencia, Spain.*CR 
6524 — A526 A Review Of The Indications For 
And Subsequent Visual, Anatomic And Safety 
Results After Switching From One Anti-VEGF 
Therapy Agents To Another In AMD Patients. 
Jennifer A. Day, S. Dev. VitreoRetinal Surgery, PA, 
Minneapolis, MN. T 
6525 — A527 One year’s treatment with 
intravitreal Ranibizumab (lucentis®) and 
Verteporfin PDT
Rf 
Combination Therapy at 
Month 2 for Neovascular Age-related Macular 
Degeneration (AMD). Eric Fourmaux, M. 
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6526 — A528 Clinical Features Of 
Self-resolving Sub-foveal Choroidal 
Neovascularisation in ‘Wet’ Age Related Macular 
Degeneration. Sharmin Badiei1,2, N. Patel2, S. 
Walker2. 1ophthalmology, William Harvey Hospital 
NHS trust, Ashford, United Kingdom; 2Medical 
Retina Department, Medical Retina Department, 
East Kent Hospitals University Foundation NHS 
Trust, Canterbury, Kent, Kent, United Kingdom. 
6527 — A529 Novel Methods to Enhance 
Reading Ability in Patients with Macular 
Disease. Anthony Fernandes1, D. Roth1, A. Shah1, 
H. Fine1, J. Prenner1, W. Feuer2. 1Ophthalmology, 
Robert Wood Johnson Medical School, New 
Brunswick, NJ; 2Bascom Palmer Eye Institute of the 
University of Miami School of Medicine, Miami, 
FL.*CR 
6528 — A530 A French Version Of Skread To 
Identify Reading Difficulties Related To Central 
Scotoma. Anne Catherine Scherlen1, G. Faure2, 
M. Goldschmidt3, D. Raffort1, F. Vital-Durand4, 
C. Miege1. 1R&D Optics Low Vision, Essilor 
International, Paris, France; 2Hospital La Timone, 
Low Vision Clinic, Marseille, France; 3Low Vision 
Rehabilitation, Pully, Switzerland; 4SBRI, Inserm U 
846, Université Lyon1, Lyon, France.*CR 
6529 — A531 Optical Coherence Tomography 
Hyperreflective Foci Increase in Quantity 
and Central Foveal Density in Intermediate 
Age-related Macular Degeneration. Rachelle 
O’Connell1, F.A. Folgar1, J.G. Christenbury1, 
S.J. Chiu1A, S. Farsiu1B, C.A. Toth2. ABiomedical 
Engineering, BOphthal & Biomed Engineering, 
1Duke University, Durham, NC; 2Ophthalmology, 
Duke Univ Eye Center, Durham, NC.*CR, f 
6530 — A532 Hyporeflective Wedge-Shaped 
Band in Geographic Atrophy Secondary to 
Age-Related Macular Degeneration: An Under-
reported Finding. Jordi M. Mones, M. Biarnes, 
F.M. Trindade. Centro Medico Teknon, Institut de la 
Macula de la Retina, Barcelona, Spain. 
6531 — A533 Optical Coherence Tomography 
Characterization of Apparent Foveal Swelling 
in Patients with Foveal Sparing Secondary 
to Geographic Atrophy. Fabio M. Trindade, J. 
Mones, M. Biarnes. Institut de la Macula i de la 
Retina, Barcelona, Spain. 
6532 — A534 Reproducibility of Fundus 
Autofluorescence Patterns in Geographic 
Atrophy Secondary to Age-Related Macular 
Degeneration. Marc Biarnes, J. Mones, F.M. 
Trindade. Institut de la macula i de la retina, 
Barcelona, Spain. 
6533 — A535 Multimodal Functional And 
Structural Assessment Of Geographic Atrophy. 
Athanasios Panorgias, R.J. Zawadzki, A.G. 
Capps, A.A. Hunter, III, L.S. Morse, J.S. Werner. 
Ophthalmology and Vision Science, University of 
California Davis, Sacramento, CA. 
6534 — A536 Evaluation of Peripheral 
Fundusautofluorescence Changes in Patients 
with Wet ARMD: The OTELLO Study. Anita 
Zenger1A, M.B. Rougier, III2, P.E. Stanga3, S. 
Schmitz-Valckenberg4, L. Reznicek5, U.E. Wolf-
Schnurrbusch1B,1A. ABern Photographic Reading 
Centre, BOphthalmology, 1University Bern, Bern, 
Switzerland; 2Service d Ophtalmologie, CHU-
Bordeaux Univ de Bordeaux, Bordeaux, France; 
3Vitreoretinal Unit, Manchester Royal Eye Hospital, 
Manchester, United Kingdom; 4Ophthalmology, 
University of Bonn, Bonn, Germany; 5Department 
of Ophthalmology, Ludwig-Maximilians-University, 
Munich, Germany.*CR 
6535 — A537 Significance of Small Dense 
Particles During Treatment of Exudative Age-
related Macular Degeneration. Randhir Chavan, 
S. Panneerselvam, N. Narendran, Y.C. Yang. 
Ophthalmology, Royal Wolverhampton Hospitals 
NHS Trust, Wolverhampton, United Kingdom. 
6536 — A538 Bilateral Multifocal 
Electroretinogram Changes After Nanosecond 
Laser In Subjects With Early Age-related 
Macular Degeneration. Chi D. Luu, K. 
Brassington, G. Makeyeva, R.H. Guymer. Macular 
Research Unit, Centre for Eye Research Australia, 
East Melbourne, Australia. f 
6537 — A539 Within-visit And Between-visit 
Repeatability Of The Diagnosys Full-field 
Stimulus Threshold (D-FST) When Measuring 
Rod Sensitivity In Patients With Atrophic 
Age-related Macular Degeneration (ARMD). 
Martin Klein1, D.G. Birch1,2, J. Chandler3, J. 
Koester3, H. Hughes3, A. Reaves3, R. Kubota3. 1Rose 
Silverthorne Ret. Degen. Lab, Retina Foundation 
of the Southwest, Dallas, TX; 2Ophthalmology, 
UT Southwestern Medical Center, Dallas, TX; 
3Acucela, Inc., Seattle, WA.*CR, f 
Hall B/C A540-A571
Thursday, May 10, 2012, 11:15 AM-1:00 PM
Retinal Cell Biology / Visual Neurophysiology
548 Retina and RPE Cell Biology 
Moderator: Peter F Hitchcock 
6538 — A540 Neuropeptide Y Protects Retinal 
Neural Cells From Glutamate-induced Toxicity 
Through The Activation Of NPY Y
5
 Receptor. Ana 
Santos-Carvalho1,2, A.F. Ambrósio3, C. Cavadas1,2. 
1Center for Neuroscience and Cell Biology, 
University of Coimbra, Coimbra, Portugal; 2Faculty 
of Pharmacy, University of Coimbra, Coimbra, 
Portugal; 3Center of Ophthalmology and Vision 
Sciences, IBILI, Faculty of Medicine, University of 
Coimbra, Coimbra, Portugal. 
6539 — A541 NMDA-induced Calcium 
Dynamics Are Altered In Retinas Of Adult Mice 
Deficient In The Neural Cell Adhesion Molecule 
(NCAM). Jeremy A. Murphy1A, B.A. Daniels1B, B.C. 
Chauhan1C, W.H. Baldridge1B. ARetina and Optic 
Nerve Research Laboratory, Ophthalmology & 
Visual Sciences, BRetina and Optic Nerve Research 
Laboratory, Ophthalmology & Visual Sciences, 
Anatomy & Neurobiology, CRetina and Optic Nerve 
Research Lab, Ophthalmology & Visual Sciences, 
Physiology & Biophysics, 1Dalhousie University, 
Halifax, NS, Canada. 
6540 — A542 Involovement of P2X7 receptor 
and therapeutic efficacy of Brilliant Blue G in 
a mouse model of subretinal hemorrhage. Shoji 
Notomi1A, T. Hisatomi1A, A. Takeda1A, Y. Ikeda1B, H. 
Enaida1A, T. Ishibashi, Sr.2. AOphthalmology, BDept 
of Ophthalmology, 1Kyushu University, Fukuoka, 
Japan; 2Department of Ophthalmology, Kyushu 
University, Higashi-ku, Japan. 
6541 — A543 Changes In P2X Receptor 
Activity During Retinal Degeneration. Aleksandra 
Polosukhina, A. Noblet, I. Tochitsky, R.H. Kramer. 
UC Berkeley, Berkeley, CA. 
6542 — A544 Localization & Physiology of 
L-type Ca2+ Channels in Human RPE. Qin 
Wan, V. Raghuram, R. Li, J. Adijanto, R. Fariss, A. 
Maminishkis, S.S. Miller. NEI/NIH, Bethesda, MD. 
6543 — A545 Intercellular Ca2+ Wave 
Propagation In Human Retinal Pigment 
Epithelium Cells Induced By Mechanical 
Stimulation. Amna E. Abu Khamidakh1,2, K. 
Juuti-Uusitalo3,2, K. Larsson3,2, H. Skottman3,2, J. 
Hyttinen1,2. 1Department of Biomedical Engineering, 
Tampere University of Technology, Tampere, 
Finland; 2BioMediTech, Tampere, Finland; 3Institute 
of Biomedical Technology, University of Tampere, 
Tampere, Finland. T 
6545 — A547 Alpha 2 adrenergic agonist 
receptor in chick retina. Gabriella V. Costa1,1A, M.K. 
Shigetomi1,1B, R. Fleming1,1A, V.V. Oliveira1,1A, A.A. 
Costa1,1B, P. Gardino1,1A, A.M. Dantas1,1A. AInstitute 
of Biophysics Carlos Chagas Filho, BDepartment 
of Ophthalmology, 1Federal University of Rio de 
Janeiro, Rio de Janeiro, Brazil. 
6546 — A548 Angiotensin II upregulates MCP-
1 Expression through the NF-κB Pathway in 
Human Retinal Pigment Epithelium. Maria E. 
Marin Castano, M. Pons. Ophthalmology, Bascom 
Palmer Eye Institute, Miami, FL. 
6547 — A549 Expression and Localization of 
Serotonin Receptors in the Mouse Retina. Mark E. 
Pennesi, J.W. Stoddard, K.V. Michaels, E.D. Blum, 
A. Maricle, P.J. Francis. Ophthalmology, Casey Eye 
Institute - OHSU, Portland, OR. 
6548 — A550 Loss of Hfe Leads to Progression 
of Tumor Phenotype in Primary Retinal Pigment 
Epithelial Cells. Jaya Pranava Gnana Prakasam1A, 
R. Veeranan-Karmegam1A, V. Coothankandaswamy1A, 
S.K. Reddy1A, P.M. Martin1A, M. Thangaraju1A, 
S.B. Smith1B, V. Ganapathy1A. ABiochemistry and 
Molecular Biology, BCellular Biology and Anatomy, 




 – 1:00 pm
397
*Refer to Program Number in the Commercial Relationships (CR) Index for Disclosures   –   f Refer to Program Number in the Clinical Trial (CT) Registration Index  –   T Travel Grant Awardee
Thursday – Posters – 6549 – 6571
6549 — A551 Therapeutic Inhibition Of 
Retinoblastoma By Nanoceria. Kathryn E. 
Klump1A, S.V. Kiosseva1B, S. Seal2, M.A. Dyer3,4, J.F. 
McGinnis1A,1B. AOklahoma Center for Neuroscience, 
BDepartment of Ophthalmology, 1University of 
Oklahoma Health Sciences Center, Oklahoma City, 
OK; 2Mechanical Materials Aerospace Engineering, 
Nanoscience, and Technology Center, University 
of Central Florida, Orlando, FL; 3Department of 
Developmental Neurobiology, St. Jude’s Childrens 
Research Hospital, Memphis, TN; 4Howard Hughes 
Medical Institute, Chevy Chase, MD.*CR T 
6550 — A552 Inhibition of Protein Glycosylation 
by Tunicamycin Induces Shortening and 
Disorganization of Rod Outer Segments and 
Photoreceptor Degeneration in Mouse. Lauren N. 
Correa, Y. Li, Z. Wang, P. Chen, Y. Li, B.L. Lam, R. 
Wen. Bascom Palmer Eye Institute, University of 
Miami, Miami, FL. 
6551 — A553 Absorption Of Spio Nanoparticles 
Using Different Media On Arpe-19 And Hcec Cell 
Cultures. Gustavo T. Grottone1, R.R. Loureiro2, J. 
Couvre2, L. Gamarra3, P. Cristovam1, J.P. Gomes2. 
1Ophthalmology, UNIFESP/Santa Casa de Santos, 
Santos, Brazil; 2Ophthalmology, UNIFESP, Santos, 
Brazil; 3Oncology, Instituto Israelita de Pesquisas 
Albert Einstein, São Paulo, Brazil. 
6552 — A554 Secretion Of VEGF From 
Polarized RPE By Tnf-a Or Thrombin. Hiroto 
Terasaki1A, M. Shirasawa1A, N. Arimura1A, S. 
Sonoda1B, T. Sakamoto1B. AOphthalmology, 
BDepartment of Ophthalmology, 1Kagoshima 
University, Kagoshima, Japan. 
6553 — A555 CEP290 is Required for 
Photoreceptor Ciliogenesis and Ventricular 
Ependymal Cilia Function. Erin Yamamoto1, R. 
Rachel1, M. Dewanjee1, J. Munasinghe2, T. Li1, L. 
Dong1, A. Swaroop1. 1Neurobiol-Neurodegenrtn & 
Repair, NEI, Bethesda, MD; 2NINDS, Bethesda, MD. 
6554 — A556 Rapid Photoreceptor 
Degeneration Occurs In Zebrafish arl13b Mutants 
Following Suppression Of Pcp Signaling. Brian 
D. Perkins, L. Dudinsky. Biology, Texas A & M 
University, College Station, TX. 
6555 — A557 Role of Melanoregulin in 
Phagocytosis Dependent Synchronicity of 
Lysosomal Proteins. Jennifer Brancato, A. Bragin, 
F. Stefano, K. Boesze-Battaglia. Biochemistry, 
University of Pennsylvania, Philadelphia, PA. 
6556 — A558 Effect of Storage Temperature 
on the Viability of Cultured Retinal Pigment 
Epithelial Cells. Lara Pasovic1A, J.R. Eidet1A, 
P. Aabel1A, T. Lyberg1A, X. Chen2, T.P. Utheim1B. 
ACenter for Clinical Research, BDepartment of 
Ophthalmology, 1Oslo University Hospital, Oslo, 
Norway; 2SynsLaser Kirurgi Oslo/Tromsø, Oslo, 
Norway.*CR 
6557 — A559 Expression And Regulatory 
Sites Of Melanopsin Gene In Rabbit Retina At 
Different Ages. Maria M. De Lira, II, L.J. Alvarez, 
A. Martínez, M. Aguirre-Ramírez, J.A. Pérez-León. 
Quimico-Biologicas, UACJ, Juarez, Mexico. 
6558 — A560 Immunolocalization and Age-
related Gene Expression Changes of Complement 
Factor H in the Posterior Pole of the Mouse Eye. 
Sharon L. Oltjen, Z. Smit-McBride, L.M. Hjelmeland. 
Ophthalmology, University of California-Davis, 
Davis, CA. 
6559 — A561 Changes In The Expression 
Of Genes Related To Oxidative Stress In Rd1 
Mice. Violeta Sanchez-vallejo1, M. Flores-Bellver1, 
R. Álvarez-Nölting1, S. Johnsen-Soriano2, M. 
Miranda1, F. Romero Gómez2,3. 1Physiology, Univ 
CEU Cardenal Herrera, Valencia, Spain; 2Fundación 
Oftalmológica del Mediterráneo, Valencia, Spain; 
3Universidad Católica ´San Vicente Mártir´, Valencia, 
Spain. 
6560 — A562 The Cysteine Prodrug L-2-
Oxothiazolidine-4-Carboxylic Acid (OTC) Elicits 
Potent Antioxidant and Anti-inflammatory 
Effects in RPE: Relevance to Treatment of 
Age-Related Macular Degeneration. Wanwisa 
Promsote1A, S. Ananth1A, R. Veeranan-Karmegam1A, 
N. Lambert1B, C-C. Chan2, V. Ganapathy1A, P.M. 
Martin1A. ABiochemistry and Molecular Biology, 
BPharmacology and Toxicology, 1Georgia 
Health Sciences University, Augusta, GA; 
2Immunopathology Section, National Eye Institute, 
Bethesda, MD. 
6561 — A563 Cigarette Smoke Induces 
Endoplasmic Reticulum (ER) Stress in Retinal 
Pigment Epithelial (RPE) Cells. Marisol d. 
Cano1, L. Wang1, J. Wan1, J.T. Handa2. 1Wilmer Eye 
Institute/Ophthalmology, Johns Hopkins University, 
Baltimore, MD; 2Johns Hopkins Wilmer Eye Inst, 
Baltimore, MD. 
6562 — A564 Whole Number And Spatial 
Distribution Of The Pou4f Family Of 
Transcription Factors In The Adult Rat Retina. 
Francisco M. Nadal-Nicolas1,2, M. Jimemez-Lopez2, 
M. Salinas-Navarro2, L. Nieto-Lopez2, A. Ortin-
Martinez1,2, C. Galindo-Romero2, M. Sanchez-
Migallon2, P. Sobrado-Calvo2, M. Vidal-Sanz2, M. 
Agudo-Barriuso1. 1Unidad de Investigación, Hospital 
Universitario Virgen de la Arrixaca, Murcia, Spain; 
2Dpto Oftalmologia, Universidad de Murcia, Murcia, 
Spain. T 
6563 — A565 Bovine Collagen as a Substratum 
for Subretinal Transplantation of Pigment 
Epithelial Cells. Anne C. Rieck, A.K. Salz, S. Johnen, 
P. Walter, G. Thumann. Ophthalmology, RWTH 
Aachen University, Aachen, Germany. 
6564 — A566 The miR-183/96/182 Cluster 
Is Essential For Normal Functions Of The 
Retina And Other Sensory Organs. Shunbin 
Xu, S. Lumayag, C. Haldin, C. Cowan, B. Kovacs. 
Ophthalmology, Rush University Medical Center, 
Chicago, IL. 
6565 — A567 Putative Role for Melanoregulin 
(Mreg) in Bisretinoid Lipofuscin Degradation 
in the Retinal Pigment Epithelium (RPE). Laura 
S. Frost1, J.R. Sparrow2, F.P. Stefano1, K. Boesze-
Battaglia1. 1School of Dental Medicine, University 
of Pennsylvania, Philadelphia, PA; 2Department of 
Ophthalmology, Columbia University, New York, 
NY. 
6566 — A568 Subretinal gene therapy in 
Bbs1 mice. Arlene V. Drack, S. Bhattarai, S. Seo, 
D. Gratie, E.M. Stone, R. Mullins, V. Sheffield. 
Ophthalmology, Univ of Iowa Hospitals, Iowa City, 
IA. 
6567 — A569 The Influence of Substrate 
Elastic Modulus on Retinal Pigment Epithelial 
Cell Phagocytosis. Kieran S. Boochoon1A, J.T. 
Davis1B, J.C. Manarang1C, A.M. McDermott1A,1C, 
W.J. Foster1B,2. ABiology & Biochemistry, BPhysics, 
COptometry & Vision Science, 1University of 
Houston, Houston, TX; 2Ophthalmology, Weill-
Cornell Medical College, Houston, TX. 
6568 — A570 Synergistic interaction of Tubby 
and Tubby-like Protein 1 (Tulp1). Gabriela 
S. Alvarado, N.B. Caberoy, Y. Zhou, W. Li. 
Ophthalmology, Bascom Palmer Eye Inst, Univ of 
Miami, Miami, FL. 
6569 — A571 Delivery of Multifunctional 
Collagen Constructs for Retinal Stem Cell 
Transplantation via Lens Sparing Pars Plana 
Vitrectomy. Hari Jayaram1,2, M.F. Jones2, P.B. 
Cottrill2, K. Eastlake2, R.A. Brown3, P.T. Khaw1,2, 
D.G. Charteris1, A. Limb2. 1NIHR Biomedical 
Research Centre for Ophthalmology, London, 
United Kingdom; 2Ocular Biology & Therapeutics, 
UCL Institute of Ophthalmology, London, United 
Kingdom; 3UCL Institute of Orthopaedics & 
Musculoskeletal Science, London, United Kingdom. 
Hall B/C A208-A255
Thursday, May 10, 2012, 11:15 AM-1:00 PM
Glaucoma / Anatomy & Pathology / Retina 






6570 — A208 Exogenous PACAP Acts as a 
Retinoprotective Agent and a Modulator on 
Microglia/Macrophages Status in Mice NMDA-
induced Retinal Injury Model. Yoshihiro Wada1A,1B, 
T. Nakamachi1B, K. Endo1A,1B, T. Seki1A,1B, S. Shioda1B, 
R. Koide1A. ADepartment of Ophthalmology, 
BDepartment of Anatomy, 1Showa University School 
of Medicine, Tokyo, Japan. 
6571 — A209 Increased Neuro-retinal Injury 
After Intraocular Pressure Elevation In 
Xenomitochondrial Mice And Compensation 
By Oxphos Complex IV. Ian A. Trounce1, N. Van 
Bergen1, G. Kong1, V. Chrysostomou1, C.A. Pinkert2, 
J.G. Crowston1. 1Center for Eye Research Australia, 
University of Melbourne, Melbourne, Australia; 
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6572 — A210 Elevated Intraocular Pressure 
Increases Serine Protease Levels In The Retina 
And Promotes Retinal Ganglion Cell Loss. 
Shravan K. Chintala, X. Zhang, M. Cheng. Eye 
Research Institute, Oakland University, Rochester, 
MI. 
6573 — A211 The Cdk5 Inhibitor, Roscovitine, 
Protects Retinal Neurons From Chemical Anoxia, 
In Vitro, And Excitotoxicity, In Vivo. John P. 
Wood, T. Mammone, G. Chidlow, R.J. Casson. 
Ophthalmic Research Laboratories, S Australian 
Institute of Ophthalmology, Adelaide, Australia. 
6574 — A212 Neuroprotective Effects of 
Epigallocatechin-3-gallate against N-methyl-D-
aspartate Induced Excitotoxicity in Rat Retina. 
Libin Jiang, F. Chen, N. Wang. Eye Center, Beijing 
Tongren Hospital, Beijing, China. 
6575 — A213 Evaluation of Neuroprotective 
Effect of Celastrol in Optic Nerve Crush Model. 
Haksu Kyung, J.M. Kwong, J. Caprioli, N. Piri. Dept 
of Ophthalmology, Jules Stein Eye Institute, Los 
Angeles, CA. 
6576 — A214 Evidence Supporting An 
Association Between Expression Of Major 
Histocompatibility Complex II Expression By 
Microglia And Optic Nerve Degeneration During 
Experimental Glaucoma. Glyn Chidlow, A. 
Ebneter, J.P. Wood, R. Casson. Ophthalmic Research 
Laboratories, SA Institute of Ophthalmology, 
Adelaide, Australia. 
6577 — A215 Down Regulation of BM88 after 
Optic Nerve Crush. Ahad M. Siddiqui, T.F. Sabljic, 
A.K. Ball. Pathology and Molecular Medicine, 
McMaster University, Hamilton, ON, Canada. 
6578 — A216 Effects Of 24S-hydroxycholesterol 
On Primary Glial Müller Cells. New Insights 
On Müller Cells Function And Cholesterol 
Homeostasis In The Retina. Cynthia Fourgeux1, 
L. Martine1, L. Leclere1, B. Buteau1, A. Bron2, C-G. 
Catherine2, L. Bretillon1. 1INRA, University of 
Burgundy, Eye, Nutrition & Cell Signalling Res 
Grp, Dijon, France; 2Department of Ophtalmology, 
University Hospital, Dijon, France. 
6579 — A217 Neuroprotective Effect of 
Resveratrol after Optic Nerve Transection. 
SeokHwan Kim1, J. Park2, M. Kim2, M. Kim3, 
D. Kim2, J. Jeoung2, T-W. Kim4, K. Park2. 
1Ophthalmology, Boramae Hospital, Seoul, Republic 
of Korea; 2Ophthalmology, Seoul National University 
Hospital, Seoul, Republic of Korea; 3Ophthalmology, 
Seoul National University Bundang Hospital, Kyung-
gi, Republic of Korea; 4Ophthalmology, Seoul 
National University Bundang Hospital, Seongnam, 
Republic of Korea. 
6580 — A218 Effects of Retinal Lasers on 
Retinal Ganglion Cell Survival After Optic Nerve 
Crush. O’Sam Shibeeb, J.P. Wood, R.J. Casson, G. 
Chidlow. Ophthalmology, University of Adelaide, 
Ophthalmic Research Laboratories, Adelaide, 
Australia, Australia. 
6581 — A219 Royal jelly Peptide Promotes 
Retinal Ganglion Cell Survival in Experimental 
Model of Glaucoma Through Up-regulating 
BDNF and GDNF. Jihong Wu, X. Sun, S. Zhang. 
Eye & ENT Hospital, Fudan University, Shanghai, 
China. 
6582 — A220 SIRT1 Mediated Mitochondrial 
Biogenesis for The Protection of RGC-5 Cell 
During Oxidative Stress. Qian Fan, S. Chen, J. Ge, 
X. Zhang. Zhongshan Ophthalmic Center, Sun Yat-
sen University, Guangzhou, China. 
6583 — A221 Valproate Exerts Pleiotropic 
Neuroprotective Effects on Retinal Ganglion 
Cells in vivo Through Epigenetic Modulation in 
an Experimental Model of Glaucoma. Shenghai 
Zhang, X. Sun, J. Wu. Eye & ENT Hospital, Fudan 
University, Shanghai, China. 
6584 — A222 Acid Sphigomylelinase Plays a 
Role in IR-induced Retinal Degeneration. Jie 
Fan1A, B.X. Wu1B, Y.A. Hannun1B, C.E. Crosson1C. 
AOphthalmology-Storm Eye Inst, BBiochemistry and 
Molecular Biology, COphthalmology, 1Medical Univ 
of South Carolina, Charleston, SC. 
6585 — A223 Soluble IL-6R and 
Neuroprotection of Retinal Ganglion Cells in 
Glaucoma. Heather M. Cathcart, R.M. Sappington. 
Vanderbilt Eye Institute, Vanderbilt Univ Medical 
Center, Nashville, TN. T 
6586 — A224 Etanercept, A Widely Used 
Inhibitor Of Tumor Necrosis Factor-α (tnf-α), 
Prevents Retinal Ganglion Cell Loss In A Rat 
Model Of Glaucoma. Miin Roh1, Y. Zhang1, Y. 
Murakami1, A. Thanos1, D.G. Vavvas1, L. Benowitz2, 
J.W. Miller1. 1Ophthalmology, MEEI, Angiogenesis 
Lab, Boston, MA; 2Neuroscience, Laboratories for 
Neuroscience Research in Neurosurgery, F.M. Kirby 
Neurobiology Center, Children’s Hospital Boston, 
MA. 
6587 — A225 α2-adrenergic Receptor Agonist 
Restores Mitochondrial Transcription Factor A 
And Oxidative Phosphorylation, And Protects 
Retinal Ganglion Cells Against Retinal Ischemic 
Injury. Won-Kyu Ju1A, D. Lee1A,2, K-Y. Kim1B, Y. 
Noh1A, R.N. Weinreb1A. AHamilton Glaucoma Center, 
BNeuroscience, 1Univ of California San Diego, 
La Jolla, CA; 2Ophthalmology, Chonbuk National 
University, Jeonju, Republic of Korea. 
6588 — A226 Oncostatin M Protects Retinal 
Ganglion Cells in an Optic Nerve Crush Mouse 
Model. Xin Xia1,2, Y. Li1, Z. Wang1, L. Luo1, R. 
Wen1. 1Bascom Palmer Eye Institute, University of 
Miami, Miami, FL; 2Department of Ophthalmology, 
Shanghai First People’s Hospital, Jiaotong 
University, Shanghai, China. 
6589 — A227 Is Abeta Implicated in 
Brimonidine Effect on Reducing RGC Apoptosis 
in Ocular Hypertensive Model? Shereen Nizari1, 
L. Guo1, E.M. Normando2, M. Cordeiro2. 1Glaucoma 
& Retinal Neurodegnrtn Res Grp, UCL Institute 
of Ophthalmology, London, United Kingdom; 
2Glaucoma & Retinal Neurodegnrtn Res Grp, UCL 
Inst Ophthal & Western Eye Hsp London, London, 
United Kingdom.*CR 
6590 — A228 Adenosine A3 receptor agonist 
inhibits retinal ganglion cell apoptosis. Joana M. 
Galvao1,2, L. Guo1, A.R. Santiago2, A.F. Ambrosio2, 
M. Cordeiro3. 1Glaucoma & Retinal Neurodegnrtn 
Res Grp, UCL Institute of Ophthalmology, London, 
United Kingdom; 2Centre of Ophthalmology and 
Vision Sciences, IBILI, Faculty of Medicine, 
University of Coimbra, Portugal; 3Glaucoma & 
Retinal Neurodegnrtn Res Grp, UCL Inst Ophthal 
& Western Eye Hsp London, London, United 
Kingdom.*CR 
6591 — A229 Effect Of γ- Synuclein Antibody 
On Rgc5 And Mitochondrial Apoptosis Pathways. 
Corina Wilding, K. Bell, F. Grus, N. Pfeiffer. 
Experimental Ophthalmology, Mainz, Germany. 
6592 — A230 Down Regulation Of 14-3-3 Ab 
In Glaucoma Patients Could Lead To Loss Of 
Protective Effects. Katharina Bell, C. Wilding, N. 
Pfeiffer, F.H. Grus. Experimental Ophthalmology, 
Medical Centre Univesity of Mainz, Mainz, 
Germany. 
6593 — A231 The TRPV1 Response to Stress of 
Retinal Ganglion Cells. Nicholas J. Ward, K.W. Ho, 
T.N. Sidorova, D.J. Calkins. Ophthal & Vis Sciences, 
Vanderbilt Eye Institute, Nashville, TN. 
6594 — A232 Stretch-activated IL-3 Release 
From Retinal Ganglion Cells Is Protective 
And Involves The P2X7 Receptor. Jason C. 
Lim1A, W. Lu1A, J.M. Beckel1A, M. Buell1A, J. Xia1A, 
E.J. Macarak1A, A.M. Laties1B, C.H. Mitchell1A,1C. 
AAnatomy and Cell Biology, BOphthalmology, 
CPhysiology, 1University of Pennsylvania, 
Philadelphia, PA. 
6595 — A233 Retinal Ganglion Cell Synapse 
Loss In A Mouse Model Of Ocular Hypertension. 
Yvonne Ou1A, E.R. Lopez1A, D.W. Sretavan1B, E.M. 
Ullian1B. AOphthalmology, BOphthalmology and 
Physiology, 1University of California, San Francisco, 
San Francisco, CA. 
6596 — A234 ShH10, A Novel Müller Glia 
Cell-specific AAV Vector, Expressing GDNF 
Promotes Retinal Ganglion Cell Survival 
Following Neuronal Injury In Thy1-YFP Mice. 
Chendong Pan1, L. Guo1, S. Gu1, T.W. Chalberg, Jr.2, 
D. Schaffer3, J.G. Flannery3, A.M. Demetriades1. 
1Glaucoma Research Laboratory, Dyson Institute, 
Weill Medical College of Cornell University, 
New York, NY; 2Avalanche Biotechnologies, Inc, 
Redwood City, CA; 3Helen Wills Neuroscience 
Institute, University of California, Berkeley, 
Berkeley, CA.*CR 
6597 — A235 Membrane Attack Complex 
Induces Apoptosis In Retinal Ganglion Cells In 
Chronic Ocular Hypertension Model. Purushottam 
Jha, V.V. Lyzogubov, P.S. Bora, N.S. Bora. 
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6598 — A236 Differential Expression of CCL5 
Receptors in Acute and Chronic Murine Models 
of Glaucoma. Amanda C. Rehorn1A, D.S. Duncan1A, 
M. Stanford1A, G. Davis1B, R.M. Sappington1A. 
AVanderbilt Eye Institute, BInterdisciplinary Graduate 
Program, 1Vanderbilt University Medical Center, 
Nashville, TN. 
6599 — A237 Alpha-1 Adrenergic Receptor 
Stimulation Induces Ocular Disease via TGF-
Beta-Mediated Mechanisms. Jose L. Vega1A, 
I. Agoulnik1B, S. Masli2, F. Mir2, D. Chen2, W. 
Bowden1B, Y. Quiang2, E. Suarez3, P. Durand1A,2. 
ADepartment of Neurology, BDepartment of Cell 
Biology and Pharmacology, 1Herbert Wertheim 
College of Medicine, Miami, FL; 2Ophthalmology, 
Schepens Eye Research Institute, Boston, MA; 
3Department of Biology, Florida International 
University, Miami, FL.*CR 
6600 — A238 TRPV Subunit Interactions 
in the Rodent Retina: Implications for 
Neurodegeneration in Glaucoma. Tatiana N. 
Sidorova, D.J. Calkins. Ophthalmology/Vis Sci, 
Vanderbilt University Med Ctr, Nashville, TN. 
6601 — A239 Slit2 Delays The Death Of Retinal 
Ganglion Cells After Optic Nerve Crush Injury. 
Thomas F. Sabljic, A. Ball. Pathology & Molecular 
Medicine, McMaster University, Hamilton, ON, 
Canada. 
6602 — A240 Subtype- and Location- 
Dependent Degeneration of Retinal Ganglion 
Cells in a Mouse Model of Ocular Hypertension. 
Liang Feng1, Y. Zhao2A, M. Yoshida2B, S. Lindstrom1, 
T.S. Kim2B, J. Cang2B, J.B. Troy2A, X. Liu1. 
1Ophthalmology, Northwestern University, Chicago, 
IL; ABiomedical Engineering, BNeurobiology, 
2Northwestern University, Evanston, IL. 
6603 — A241 Mechanosensitive Channels In 
Isolated Rat Retina Ganglion Cells: Response To 
Strain From Within Neurons. Jingsheng Xia1A, 
J.C. Lim1A, W. Lu1A, J.M. Beckel1A, A.M. Laties1B, 
C.H. Mitchell1A,1C. AAnatomy and Cell Biology, 
BOphthalmology, CPhysiology, 1University of 
Pennsylvania, Philadelphia, PA. 
6604 — A242 Retinal ganglion cell morphology 
is not affected by chronic experimental glaucoma 
in mice selectively expressing Yellow Fluorescent 
Protein. Giedrius Kalesnykas1, E. Oglesby2, F. 
Cone2, M. Steinhart2, M. Pease2, H. Quigley2. 
1Ophthalmology, University of Eastern Finland, 
Kuopio, Finland; 2Ophthalmology, Johns Hopkins 
School of Med, Baltimore, MD. 
6605 — A243 Assessment of Retinal Ganglion 
Cell Complex with Optical Coherent Tomography 
(OCT) in the Diagnosis of Glaucoma. Armine 
Kazaryan, L. Obvintseva. Agency of Med & Biol-
Hosp #83, Federal State Inst of Ministry of Hlth, 
Moscow, Russian Federation. 
6606 — A244 Alteration Of Lymphocyte 
Levels In An Autoimmune Model Of Retinal 
Ganglion Cell Loss. Sandra Kuehn1, R. Noristani1, 
M. Kuehn1, J. Schiwek2, F. Grus2, B. Dick1, S. 
Joachim1. 1Experimental Eye Research Institute, 
Ruhr University, Bochum, Germany; 2Experimental 
Ophthalmology, University Medical Center, Mainz, 
Germany. 
6607 — A245 Variable Retinal Ganglion Cell 
Loss in Experimental Glaucoma. T. Michael Nork, 
C. Kim, R.J. Dashek, E.A. Hennes-Beean, J.N. Ver 
Hoeve. Ophthalmology and Visual Sciences, Univ of 
Wisconsin-Madison, Madison, WI. 
6608 — A246 Axonal Subtypes in Normal and 
Glaucomatous Retinas. Ye Zhou1, X. Zhao2, S. 
Williams2, W. Kong3, X. Huang2,1. 1Department of 
Biomedical Engineering, College of Engineering, 
University of Miami, Miami, FL; 2Bascom Palmer 
Eye Institute, Miller School of Medicine, University 
of Miami, Miami, FL; 3ShenYang No.4 Hospital, 
ShengYang, China. 
6609 — A247 Aquaporins in glaucoma eyes. 
Thuy Linh Tran1, T. Bek2, M.D. de La Cour3, S. 
Nielsen4, J.U. Prause1, S. Hamann3, S. Heegaard1,3. 
1Dept. of Neuroscience & Pharmacology, University 
of Copenhagen, Copenhagen, Denmark; 2Dept of 
Ophthalmology, Aarhus University Hospital, Aarhus 
C, Denmark; 3Dept. of Ophthalmology, Glostrup 
University Hospital, Copenhagen, Denmark; 4Dept. 
of Biomedicin, University of Aarhus, Aarhus, 
Denmark. 
6610 — A248 Pre-degenerative Astrocyte 
Modifications in the Optic Projection of 
Glaucomatous Mice. Caroline C. Benoist1, J.D. 
Dapper1, S.D. Crish2, D.J. Calkins1. 1Ophthalmology, 
Vanderbilt Univ Medical Center, Nashville, TN; 
2Pharmaceutical Sciences, Northeastern Ohio Univ 
College of Med, Rootstown, OH. 
6611 — A249 Stress-Induced Upregulation and 
Translocation of TRPV1 in Retinal Astrocytes. 
Karen W. Ho, D.J. Calkins. Ophthalmology, 
Vanderbilt University, Nashville, TN. 
6612 — A250 Enhancement Of Stem Cell 
Integration Into The Retina By Modulating 
Glial Reactivity In An In-vitro Stem Cell 
Transplantation Model. Alessia Tassoni1, N.D. 
Bull1, K.R. Martin1,2. 1Clinical Neurosciences, 
Centre for Brain Repair, University of Cambridge, 
Cambridge, United Kingdom; 2Department of 
Ophtalmology, University of Cambridge, United 
Kingdom.*CR T 
6613 — A251 Brinzolomide Has Positive 
Effect on Retinal Function and Structure in 
Normotensive Glaucomatous Canine Eyes. Sinisa 
D. Grozdanic1, E. Hernandez-Merino1,2, H. Kecova1,2, 
R.H. Kardon1,2. 1Center for Prevention and Treatment 
of Vision Loss, Dept of Veterans Affairs - Iowa City, 
Iowa City, IA; 2Department of Ophthalmology and 
Visual Sciences, University of Iowa, Iowa City, IA. 
6614 — A252 Is Transforming Growth Factor 
Beta 2 (TGF-β2) An Inducer Of Cross-Linked 
Actin Networks (CLANs) In Cultured Optic 
Nerve Head Cells (ONH)? Laura M. Currie1, N. 
Pollock1, L. Paraoan1, A.F. Clark2, I. Grierson1. 
1Eye and Vision Science, University of Liverpool, 
Liverpool, United Kingdom; 2Cell Biology & 
Anatomy, University of North Texas HSC, Fort 
Worth, TX.*CR 
6615 — A253 TLR-4 Innate Immune 
Differential Response To Three Dietary Fatty 
Acids Challenged With Low Molecular Weight 
Hyaluronic Acid, a TLR-4 Ligand. Algis 
Grybauskas1, E. Wagner1, R. Burdi1, L. Walker1, P.A. 
Knepper1,2. 1Ophthalmology and Visual Sciences, 
University of Illinois at Chicago, Chicago, IL; 
2Ophthalmology, Northwestern University Medical 
School, Chicago, IL. 
6616 — A254 Hemopexin: An Inhibitor for 
Hyaluronidase-2. Robert A. Burdi1, E. Wagner1, 
L. Walker1, A. Grybauskas1, R.D. McCarty1, J.P. 
Mayer1, P.A. Knepper1,2. 1Ophthalmology and Visual 
Sciences, University of Illinois at Chicago, Chicago, 
IL; 2Ophthalmology, Northwestern University 
Medical School, Chicago, IL. 
6617 — A255 Effect Of Coenzyme Q10 
On Mitochondrial Fission And Cellular ATP 
Reduction In Purified Rat Optic Nerve Head 
Astrocytes Exposed To Hydrogen Peroxide. You 
Hyun Noh1, K-Y. Kim2, R.N. Weinreb1, W-K. Ju1. 
1Hamilton Glaucoma Center and Department of 
Ophthalmology, University of California, San Diego, 
La Jolla, CA; 2National Center for Microscopy and 
Imaging Research and Department of Neuroscience, 
University of California, San Diego School of 
Medicine, La Jolla, CA. 
Hall B/C A607-A640




6618 — A607 In Vivo and In Vitro MRI of the 
Uvea in Pseudophakic Human Eyes. Susan A. 
Strenk1, B.S. Tjan2, L. Werner3, N. Mamalis3, L.M. 
Strenk4, K.L. Lu5. 1MRI Research, Inc, Middleburg 
Heights, OH; 2Psychology, University of Southern 
California, Los Angeles, CA; 3Ophthalmology, 
University of Utah/Moran Eye Center, Salt Lake 
City, UT; 4MRI Research Inc, Middleburg Heights, 
OH; 5Ophthalmology, University of Southern 
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6636 — A625 Continuous Intraocular 
Pressure Measurements During Small Incision 
Phacoemulsification Surgery In Porcine Eyes. 
Seung Youn Jea1, M. Son1, T. Baek1, J. Lee2. 
1Ophthalmology, GM St. Mary’ eye center, Busan, 
Republic of Korea; 2Ophthalmology, Haeundae 
Paik Hospital, Inje University College of Medicine, 
Busan, Republic of Korea. 
6637 — A626 Silicone Sleeve Polishing Of 
Posterior Capsule, A Safe And Costless I/A 
Technique. Jean-Marie Giraud1, H. El Chehab1, 
J-R. Fenolland1, M. Francoz1, D. Sendon1, F. El 
Asri1, C. Denier1, C. Dot2, F. May1, J-P. Renard1. 
1Ophtalmologie, Hopital d’Instruction des Armees 
du Val de Grace, Paris, France; 2Ophtalmologie, 
Hopital d’Instruction des Armees Desgenettes, 
Lyon, France. 
6638 — A627 Intracameral Anesthesia For 
Cataract Surgery, A Population-based Study 
On Patient Satisfaction And Outcome. Inger M. 
Westborg1, E. Mönestam2. 1Ophthalmology, Eye 
Clinic, Sunderby Hospital, Lulea, Sweden; 2Clinical 
Sci & Ophthal, UMEA University, Umea, Sweden. 
6639 — A628 Corneal Astigmatism And Its 
Correction With The Toric Intraocular Lens And 
Peripheral Corneal Relaxing Incisions. Li Wang, 
D.D. Koch, M.P. Weikert, R. Jenkins. Cullen Eye 
Institute, Dept Ophthalmology, Baylor College of 
Medicine, Houston, TX. 
6640 — A629 Viscoat Versus Visthesia During 
Phacoemulsification Cataract Surgery: Corneal 
And Foveal Changes. Marilita M. Moschos1A, 
E.P. Chatziralli1A, T.N. Sergentanis1B, I. Ladas1A. 
A1st Department of Ophthalmology, BDepartment 
of Epidemiology and Biostatistics, 1University of 
Athens, Athens, Greece. 
6641 — A630 Comparison of Keratometric 
Cylinder with Aphakic Refractive Cylinder. Tom 
D. Padrick. WaveTec Vision Systems, Aliso Viejo, 
CA.*CR 
6642 — A631 A Comparative Study 
of Phacoemulsification With the OZil-
Intelligent Phaco(IP) handpiece and OZil 
handpiece:retrospective clinical study. Yoshinao 
Setoguchi1, H. Ito1, H. Nakanishi1, K. Kuroda1, K. 
Amemiya1, M. Taniguchi1, Y. Okamoto1, A. Ootani1, 
Y. Tanaka2. 1Japanese Red Cross Wakayama 
Medical Center, Wakayama, Japan; 2Tanaka Eye 
Clinic, Wakayama, Japan. 
6643 — A632 Balancing the Small Angle 
Domain (Acuity) and the Large Angle Domain 
(Straylight) of the Point-Spread-Function for 
Cataract Surgery. Thomas J. Van Den Berg1, 
I.J. van der Meulen2. 1Ophthalmic Research, 
Netherlands Inst for Neurosci, Royal Acad, 
Amsterdam, The Netherlands; 2Ophthalmology, 
Academic Medical Center, Amsterdam, The 
Netherlands.*CR, f 
6619 – 6643 – Thursday – Posters
6619 — A608 Aravind Pseudoexfoliation 
Study (APEX) I: Intraoperative Results. 
Alan L. Robin1,2, R. Venkatesh1, A. Haripriya1, 
C. Shivakumar1, V Prabhu1, M. Sekhar1, B. 
Talwar1, P. Sathyan1, D. Ramakrishnan1. 1Aravind 
Eye Hospitals and Post Graduate Institute of 
Ophthalmology, Madurai, India; 2Ophthalmology 
and International Health, Johns Hopkins University, 
Baltimore, MD. f 
6620 — A609 Evaluation of Femtosecond 
Laser-Assisted Clear Cornea Cataract Surgery. 
Milan P. Ranka1, M.Y. Cho1, S. Dimitriou2, J. 
Datseris3, A. Kanellopoulos1,4. 1Ophthalmology, 
New York University, New York, NY; 2RealEyes 
Center, Munich, Germany; 3OMMA Eye Center, 
Athens, Greece; 4Laser Vision Institute.gr, Athens, 
Greece. 
6621 — A610 Reduced Laser Pulse Width 
Improves Cutting Efficiency in Laser Refractive 
Cataract Surgery. Simone Schneider1A, H. Uy2, 
K. Edwards1A, T. Olmstead1B, V. Teuma1B, S. Bott1B. 
AClinical and Regulatory Affairs, BResearch & 
Development, 1LensAR, Orlando, FL; 2Asian Eye 
Institute, Makati, Philippines.*CR, f 
6622 — A611 Morphology of Femtosecond 
Intrastromal Arcuate Incisions. Perry S. Binder1, 
B. Gray2A, M. Brownell2B, J. Martiz, MD3, A. Gwon, 
MD4, J. Hill5. 1Gavin Herbert Dept of Ophthal, 
Univ of California, Irvine CA, San Diego, CA; 
ABiological Sciences, BR & D, 2Abbott Medical 
Optics, Santa Ana, CA; 3Cornea, International 
Refractive Consultants, Spring, TX; 4University 
of California Irvine, Newport Beach, CA; 5Abbott 
Medical Optics Inc., Santa Ana, CA.*CR 
6623 — A612 Posterior Capsule Opacification 
of a 1-piece and a 3-piece Microincision 
Intraocular Lens - 1 year Comparison. Ana 
Prinz1, B. Weingessel1, O. Findl2, P.V. Vecsei-
Marlovits1. 1Department of Ophthalmology, 
Hietzing Hospital, Vienna, Austria; 2Department of 
Ophthalmology, Hanusch Hospital, Vienna,  
Austria. f 
6624 — A613 Impact Of Cataract Density On 
Axial Length Measured With Partial Optical 
Coherence Interferometry. Nicola Cardascia, C. 
Palmisano, G. Alessio, C. Sborgia. Oftalmologia, 
Policlinico Bari, Bari, Italy. 
6625 — A614 Corneal And Total Optical 
Quality After 2.2mm Coaxial Mini-incision 
Cataract Surgery Combined With Bimanual 
Irrigation-aspiration. Corinne Dot1, H. El 
Chehab2, P. Savary1, E. Agard1, A. Malcles1, 
N. Chave1, G. Ract-Madoux1, J. Giraud1. 
1Ophthalmology, Hopital Desgenettes, Lyon Cedex 
03, France; 2Departement of Ophthalmology, 
Hospital Desgenettes, Lyon, France. 
6626 — A615 Visual Quality In Monofocal 
Lenses: Compare Primary Posterior 
Capsulorhexis Versus Yag Laser Capsulotomy. 
Sergio D. Herrera, Sr., O. Guerrero, Sr., B. Medina, 
C. Palacio, C. Mendoza, L. Arroyo. Anterior 
Segment, Hospital Foundation:, Mexico, Mexico. f 
6627 — A616 Major Breed Distribution and 
Common Histopathologic Findings in Canine 
Globes Enucleated as a Result of Glaucoma 
Following Cataract Surgery. Erin M. Scott1, D.W. 
Esson2, K.J. Fritz2, R.R. Dubielzig1. 1Pathobiological 
Sciences, UW-Madison School of Veterinary 
Medicine, Madison, WI; 2Eye Care for Animals, 
Tustin, CA. 
6628 — A617 Correlation Of Subjective 
Nuclear Sclerotic Cataract Grading And 
Intraoperative Cumulative Dispersed Energy 
During Phacoemulsification. Nakul Shekhawat1, 
A. Chomsky1,2. 1Vanderbilt University School of 
Medicine, Nashville, TN; 2VA Tennessee Valley 
Healthcare System, Nashville, TN. 
6629 — A618 Asymtomatic Capsular Bag 
Distension 10 years After Cataract Surgery, 
7 Case Reports. Eva Monestam. Clinical Sci & 
Ophthal, UMEA University, Umea, Sweden. 
6630 — A619 Objective Discrimination 
Between Operable And Non-operable Cataracts. 
Clemente Paz Filgueira1, R.F. Sanchez1, L.A. 
Issolio1, M. Vilaseca2, J. Pujol2, E.M. Colombo1. 
1Departamento de Luminotecnia, ILAV, CONICET 
- UNT, San Miguel de Tucuman, Argentina; 
2CD6-Optica i Optometria, Universitat Politecnica 
Catalunya, Terrassa, Spain.*CR 
6631 — A620 Subjective Outcomes Evaluation 
of Aspheric Diffractive and Apodized Diffractive 
Aspheric Multifocal IOLs. Dwayne K. Logan1, E. 
Sadri2. 1Cataract and Refractive Surgery, Atlantis 
Eyecare, Long Beach, CA; 2Cataract and Refractive 
Surgery, Atlantis Eyecare, Newport Beach, CA.*CR 
6632 — A621 Quantitative Evaluation Of The 
Effect Of Oral Propranolol And Sublingual 
Timolol On Hand Tremor And Its Effect On 
Surgical Performance. Using The EYESi 
Surgical Simulator. Claudia Castillo Ayometzi, A. 
Garcia Lopez, A. Babayan Sosa, A.R. Castillejos. 
Hospital Nuestra Senora de la Luz, Mexico, 
Mexico. 
6633 — A622 Postoperative Refractive 
Error After Simultaneous Vitrectomy and 
Phacoemulsification with Sulcus Fixation of 
Intraocular Lens. eok soo suh, S. LEE, J. Chun. 
department of ophthalmology, Dongguk University 
Gyeongju Hospital, Gyeongju, Republic of Korea. 
6634 — A623 Evaluation Of Subjective 
Outcomes With Two Presbyopia-correcting IOLs 
Following Phacoemulsification. Larry Katzen. 
Katzen Eye Care & Laser Ctr, Boynton Beach, 
FL.*CR 
6635 — A624 Randomized Comparison 
of a Transversal Ultrasound vs. a Torsional 
Handpiece in Phacoemulsification: A 
Contralaterally-Controlled Trial. Kerry Assil, W. 
Christian, L. Harris. Assil Eye Institute, Beverly 
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6644 — A633 Comparison of surgically-
induced astigmatism after a 2.2 mm vs. 2.6 
temporal corneal incisions in more than 2 
years follow-up. Lei Zheng, J.C. Merriam. 
Ophthalmology, Columbia Univ-Harkness Eye Inst, 
New York, NY. 
6645 — A634 Observation On Surgical Results 
Of Complicated Cataract In Patients With 
Uveitis. Patricia M. Cerqueira, F.T. da Silva, 
P.C. Carricondo, E. Olivalves, C.E. Hirata, J.H. 
Yamamoto. Ophthalmology, University of Sao 
Paulo, São Paulo, SP, Brazil. 
6646 — A635 The Effect Of Anterior 
Capsulorhexis Optic Capture Of A Sulcus 
Fixated Iol Implant On Refractive Outcome. 
Eoghan R. Millar1, K. Merchant2, D. Steel2. 1Royal 
Victoria Infirmary, Newcastle upon Tyne, United 
Kingdom; 2Sunderland Eye Infirmary, Sunderland, 
United Kingdom. 
6647 — A636 Comparison Of Visual Outcomes 
Of Toric Intraocular Lenses Implanted 
By Resident Surgeons Using Keratometry 
Measurements From An Autorefractor Or 
The IOLMaster In The Setting Of A Veterans 
Hospital. Benjamin A. Katz1, C.R. Blake2, S.W. 
Ross1. 1Ophthalmology, University of South 
Carolina, Columbia, SC; 2Ophthalmology, Dorn 
Veterans Hospital, Columbia, SC. 
6648 — A637 Iris-sutured Posterior 
Chamber Intraocular Lens : Visual Results 
And Complications About 76 Cases. Olivier 
Le Moigne, M. Muraine, O. Genevois. Rouen 
University Hospital, Rouen, France. 
6649 — A638 Customizing Near Vision In 
Patients Implanted With Light Adjustable Iols 
With An Adaptive Optics Visual Analyzer. Eloy 
A. Villegas1, G.M. Perez1, E. Alcon1, S. Mirabet1, 
I. Yago2, J. Marin2, P. Artal1. 1Laboratorio de 
Optica, Universidad de Murcia, Murcia, Spain; 
2Oftalmología, Hospital Virgen de la Arrixaca, 
Murcia, Spain.*CR 
6650 — A639 Evaluation of Aspheric 
Diffractive Multifocal and Accommodating 
Intraocular Lenses. Stuart I. Kaplan, F.C. Tyson. 
General,Contact Lenses, Ocular Disease, Cape 
Coral Eye Center, Cape Coral, FL.*CR, f 
6651 — A640 Refractive Outcomes Of 
Combined Cataract And Glaucoma Surgery 
At A VA Hospital. Christopher T. Shah1, J. Tzu2, 
A. Galor2,3, A.K. Junk2,3, C.W. See4, S.R. Wellik5,3. 
1College of Human Medicine, Michigan State 
University, Grand Rapids, MI; 2Bascom Palmer 
Eye Institute, University of Miami Miller School 
of Medicine, Miami, FL; 3Ophthalmology, Miami 
Veterans Affairs Medical Center, Miami, FL; 
4Columbia University, New York, NY; 5Bascom 
Palmer Eye Institute, University of Miami Miller 
School of Medicine, Plantation, FL. 
Thursday – Posters – 6644 – 6668
Hall B/C A641-A670




6652 — A641 Pre-Clinical Evaluation of 
Femtosecond Laser-assisted Capsulotomy in 
Cataract Surgery. James E. Hill1A, L.C. Huang1A, 
B. Gray1A, P. De Guzman1B, A. Gwon2, L.G. 
Vargas1C, M. Brownell1B. ABiological Sciences 
R&D, BR&D Equipment, CR&D, 1Abbott Medical 
Optics, Santa Ana, CA; 2University of California 
Irvine, Irvine, CA.*CR 
6653 — A642 Primary versus Secondary 
Intraocular Lens Insertion in Traumatic 
Cataract Patients at Walter Reed Army Medical 
Center. Michael P. Smith, M. Colyer, M.J. Mines, 
R. Stutzman. Ophthalmology, Walter Reed National 
Military Medical Center, Bethesda, MD. 
6654 — A643 Clinical Outcomes at a VAMC 
after the Introduction of Universal NSAID 
Therapy Perioperatively in Cataract Patients. 
Cameron C. Johnson1A, R.A. Rombola, II1B, P.J. 
Krall1A. AOphthalmology, BCollege of Medicine, 
1University of Florida, Gainesville, FL. 
6655 — A644 Corneal Suture in Cataract 
Surgery: Evaluation of Stabilization of Induced 
Astigmatism. Patrick Loriaut, G. Kaswin, 
N. Pogorzalek, N. M’Nafek, M. Labetoulle. 
Ophthalmology, Hopital Universitaire de Bicetre, 
AP-HP, Paris, France. 
6656 — A645 Sutureless transcleral Intraocular 
Lens implantation after ocular trauma. Malek 
Khouani1, D. Gaucher2, T. Bourcier3, C. Speeg4, M. 
Montard1, B.Y. Delbosc5, M. Saleh6. 1ophthalmology, 
University Hospital of Besancon, Besancon, France; 
2Ophthalmology, Hopital Civil de Strasbourg, 
Strasbourg, France; 3Ophthalmology Dept SMOH 
Pole, University Hospital, Srasburg, France; 
4ophthalmology, University Hospital, Strasbourg, 
France; 5Ophthalmology, Centre Hospitalier 
Universitaire, Besancon, France; 6Ophthalmology, 
Univ Hosp, Besancon, France. 
6657 — A646 Changes In Anterior Chamber 
Depth And Refractive Power After Cataract 
Surgery With Or Without Simultaneous Vitreous 
Surgery. Mao Kusano, E. Tsuiki, M. Uematsu, A. 
Fujikawa, T. Kumagami, K. Suzuma, T. Kitaoka. 
Ophthalmology, Nagasaki Univ School of 
Medicine, Nagasaki, Japan. 
6658 — A647 Change In Central Corneal 
Volume After Cataract Surgery. Melissa M. 
Wong1, A. Shukla2, W.M. Munir1. 1Ophthalmology, 
Boston Univ School of Med, Boston, MA; 
2Ophthalmology, Massachusetts Eye and Ear 
Infirmary, Boston, MA. 
6659 — A648 Visco-free Phacoemulsification. 
Balamurali K. Ambati, B.C. Stagg. Ophthalmology, 
John Moran Eye Center, Salt Lake City, UT. 
6660 — A649 Evaluation of In Vitro and In 
Vivo Performance of Straight and Bent 21 Gauge 
Phaco Tips in Micro-implantation Cataract 
Surgery. Don R. Nixon1, M. Steen2. 1Tri Med Laser 
Eye Center, Barrie, ON, Canada; 2Abbott Medical 
Optics, Santa Ana, CA.*CR 
6661 — A650 Central Corneal Thickness 
Related to the Volume of BSS Plus used during 
Phacoemulsification. Erin Lessner, B. Markowitz, 
K. Banks. Ophthalmology, University of South 
Carolina, Columbia, SC. 
6662 — A651 Preoperative Cataract 
Density Grading by Scheimpflug Imaging 
and its influence on operative fluidics and 
phacoemulsification energy. Jesus Arrieta-
Camacho1, V. Estefan1, A.J. Ramirez-Miranda2, E. 
Chavez Mondragon1. 1Anterior Segment, Inst de 
Oftalmologia CONVAL, Mexico City, Mexico; 
2Cornea and refractive Surgery, Instituto de 
Oftalmologia Conde de Valenciana, Mexico City, 
Mexico. 
6663 — A652 Cost-effectiveness Analysis Of 
Immediately Sequential Bilateral Cataract 
Surgery. Monali Malvankar, W. Hodge. 
Ophthalmology, University of Western Ontario, 
London, ON, Canada. 
6664 — A653 Shadowphotogrammetry of 
IOL Injectors and Clear Cornea Incision Size. 
Alejandro Arboleda1,2, E. Arrieta1, D. Nankivil1, 
M.C. Aguilar1, K. Sotolongo1, S.H. Yoo1, J-M.A. 
Parel1. 1Ophthalmic Biophysics Center, Dept. of 
Ophthalmology, Bascom Palmer Eye Institute, 
University of Miami Miller School of Medicine, 
Miami, FL; 2Biomedical Optics and Laser 
Laboratory, Dept. of Biomedical Engineering, 
University of Miami College of Engineering, Coral 
Gables, FL.*CR 
6665 — A654 Refractive Results After Cataract 
Surgery In Patients With Previous Corneal 
Refractive Surgery. Astrid Queant, A. Saad, D. 
Gatinel. Fondation A. de Rothschild, Paris, France. 
6666 — A655 Improvement in Quality of 
life following Monocular or bilateral cataract 
extraction with lens implantation in patients in 
Lima Peru. Andrea P. Dreyfuss. adeyita@stanford.
edu, Stanford School of Medicine, Stanford, CA. 
6667 — A656 Management of Retained 
Lens Fragments After Phacoemulsification: 
Comparing Visual Outcomes of Early Pars 
Plana Lensectomy versus Late Pars Plana 
Lensectomy. Gelareh Abedi1, T. Cleland2, L. 
Marouf2. 1Department of Ophthalmology, Univ of 
Texas Health Sci Center, San Antonio, TX; 2Retina 
Associates of South Texas, San Antonio, TX. 
6668 — A657 The Effect of Posterior Capsule 
Polishing on Posterior Capsule Opacification. 
Jeanie Y. Paik1, M. Shiloach2, M.S. Macsai-
Kaplan3. 1University of Chicago, Chicago, IL; 
2NorthShore Univ Health System, Glenview, IL; 
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6669 — A658 Retrospective Evaluation 
of Tecnis Multifocal (ZMA00 or ZMB00) 
and ReSTOR (SN60D1) Intraocular Lenses 
Following Phacoemulsifcation. Gabriela Perez, 
J.A. Khell, A. Kshetrapal, W. Trattler, C. Buznego, 
F. Spektor. Ctr for Excellence in Eye Care, Miami, 
FL.*CR, f 
6670 — A659 Effect Of Lens Epithelial Cell 
Aspiration On The Rotational Stability Of Toric 
Intraocular Lens. Juan Antonio De la Campa, 
L.L. Arroyo, O. Guerrero, B.A. Medina, C. Palacio. 
Fndtn Hosp Nuestra Senora de la Luz, Mexico DF, 
Mexico. 
6671 — A660 Comparison of Intraocular 
Pressure by Tonopen vs Palpation after Cataract 
Extraction. Jeffery C. Hinson, Jr. Ophthalmology, 
University of South Carolina, Columbia, SC. 
6672 — A661 Evaluation Of Photorefractive 
Keratectomy Enhancement For Optimizing 
Refractive Error In Patients With An Implanted 
Alcon Acrysof Toric Iol. Eric Liss1, G. Perez2, G. 
Lacayo3, R.B. Simon3, J.A. Khell4, W. Trattler3A, 
C. Buznego3, B. Mendelsohn3. 1FIU Herbert 
Wertheim College of Medicine, Sarasota, FL; 2Ctr 
for Excellence in Eye Care, Miami, FL; ACornea, 
3Center For Excellence in Eye Care, Miami, FL; 
4Ophthalmology/Cornea, Center for Excellence in 
Eyecare, Miami, FL. 
6673 — A662 Evaluation Of Toric IOL 
Implantation In Cataract Surgery. Ilana 
Forchheimer, A. Kanellopoulos. Ophthalmology, 
New York Univ Medical Center, New York, NY. 
6674 — A663 The Effect of Acute Heat Stress 
on Lens Epithelial Cells: A Novel Therapeutic 
Strategy for Posterior Capsule Opacification. 
Matthew Balazsi1, B.F. Fernandes2A, S. Di Cesare2A, 
S.C. Maloney2B, T.J. Granner2B, M.N. Burnier, 
Jr.2B. 1Henry C Witelson Ocular Pathol Laboratory, 
Montreal, QC, Canada; AOcular Pathology, 
BOphthalmology, 2McGill University, Montreal, QC, 
Canada.*CR 
6675 — A664 Nanosurface Properties of 
Foldable Intraocular Lenses. Eugene P. Goldberg, 
P. Martin, A. Elachachabi, H-Y. Lee, K. Mentak. 
Materials Sci & Engr, University of Florida, 
Gainesville, FL. 
6676 — A665 Development And Evaluation 
Of PNIPAAm-based Material For Injectable, 
Thermally Responsive Accommodating 
Intraocular Lenses. Robyn E. Perry, M A. Jafar 
Mazumder, S. Fitzpatrick, H. Sheardown. McMaster 
University, Hamilton, ON, Canada. 
6677 — A667 The Vitreous Membrane 
Relaxes During Accommodation: Lens And 
Extralenticular Accommodative Factors. Mary 
Ann Croft, T M. Nork, J.P. McDonald, A. Katz, P.L. 
Kaufman. Ophthalmology, Univ of Wisconsin-
Madison, Madison, WI. 
6678 — A668 Changes in Regenerated Tissue 
around a Poly(vinylpyrrolidone) Hydrogel 
Accommodative Intraocular Lens in the Rabbit 
Eye. Kyoko Miura1A, Y. Shinohara1B, S. Yokota1A, 
S. Nagasaka1A, H. Takahashi1A, M. Nakatani1B, T. 
Sunada1A. AProduct Development, IOL Group, 
Medical Operations Headquarters, BBioengineering 
Institute, 1NIDEK Co., Ltd., Gamagori, Japan. 
6679 — A669 Morgagnian Cataract Simulating 
Iris Neoplasia: Case Report. Alessandra 
Protti1, S.A. Gandolfi1, P. Mora1, L. Zografos2. 
1Ophthalmology, University of Parma, Parma, 
Italy; 2Ophthalmology, Jules-Gonin Eye Hospital, 
Lausanne, Switzerland. 
6680 — A670 The Efficacy of Soap and Water 
Versus Bleach for the Disinfection of Gonioscopy 
and Laser Lenses. Ninel Z. Gregori1, A. Abbey1, 
D. Miller2. 1Ophthalmology, Bascom Palmer Eye 
Institute, Miami, FL; 2Bascom Palmer Eye Institute, 
Univ of Miami Miller Sch of Med, Miami, FL. 
Hall B/C D701-D729




6681 — D701 Conjunctival Bacterial Flora 
And Antibiotic Resistance Patterns After Pre-
operative Application Of Topical Levofloxacin 
0.3%. Herminia Mino de Kaspar1, L.E. Hoffmann1, 
L. He2, B. Li1, M.M. Nentwich1, C. Haritoglou1, D. 
Kook1, M. Grueterich1, A. Kampik1. 1Department of 
Ophthalmology, Ludwig-Maximilians-University, 
Munich, Germany; 2Department of Ophthalmology, 
School of Medicine, Stanford University, Stanford, 
CA. 
6682 — D702 Hypertension Complicated by 
Cardiovascular Disease is an Important Risk 
Factor for the Development of Intraoperative 
Floppy Iris Syndrome. Cynthia I. Tung1, G. 
Vizzeri1, B. Lum1, T.C. Prager2, J.M. George1, O.J. 
Alsheikh1. 1Ophthalmology and Visual Sciences, 
University of Texas Medical Branch, Galveston, 
TX; 2Ophthalmology and Visual Science, University 
of Texas Health Science Center at Houston, 
Houston, TX. 
6683 — D703 Is Topical Ketorolac 
Tromethamine 0.4% Ophthalmic Solution 
Needed for Cataract Surgery? A Randomized 
Controlled Trial. Flavia G. Ticly, R.P. Lira, F.R. 
Zanetti, M. Machado, G.B. Rodrigues, C.E. Arieta. 
Ophthalmology, UNICAMP, Campinas, Brazil. f 
6684 — D704 Efficacy of Low-Concentration, 
Modified Bromfenac Ophthalmic Solution 
Administered Once Daily for Ocular 
Inflammation and Pain Associated with Cataract 
Surgery. Sharon M. Klier1, J.H. Peace2, D.F. 
Goldberg3, J.A. Gow1, T.R. McNamara1, Low-
Concentration, Modified Bromfenac Ophthalmic 
Solution Once Daily Study Group. 1ISTA 
Pharmaceuticals, Inc., Irvine, CA; 2Diabetic Eye 
Medical Clinic, Inglewood, CA; 3Wolstan Eye 
Associates, Torrance, CA.*CR, f 
6685 — D705 Efficacy and security of 
Viscoanesthesia in phacoemulsification. 
Guadalupe Marquez, F. Solorio, M. Garzón, I. 
Urrutia, E. Chávez. Anterior Segment, Instituto de 
Oftalmologia Conde de Valenciana, Mexico City, 
Mexico.*CR, f 
6686 — D706 Outcome of Cataract Surgery 
for Endogenous Uveitis without Postoperative 
Systemic Steroid Medication. Kei Takayama, S. 
Fujii, S. Ishikawa, M. Takeuchi. Department of 
Ophthalmology, National Defense Medical Collage, 
Tokorozawa, Japan. 
6687 — D707 Long Term Complications and 
Visual Outcomes of Anterior Chamber versus 
Posterior Chamber Intraocular Lens Implants 
after Phacoemulsification in Patients with 
Uveitis. Jonathan N. Kruh, A. M. Suelves, C. Foster. 
Ophthalmology, Ocular Immunology & Uveitis 
Foundation, Cambridge, MA. 
6688 — D708 Management Of Vitreal Loss 
From Posterior Capsular Rupture During 
Cataract Operation: Posterior Versus Anterior 
Vitrectomy? Chaerin Park1,2, S. Woo3, J. Hyon3, 
T. Kim3, K. Park3. 1Department of Ophthalmology, 
Seoul National University Hospital, Seoul, Republic 
of Korea; 2Seoul Artificial Eye Center, Institutes for 
Biomedical Research, Seoul National University 
Hospital, Seoul, Republic of Korea; 3Department of 
Ophthalmology, Seoul National University Bundang 
Hospital, Seongnam, Republic of Korea. 
6689 — D709 Laterality as a Risk Factor for 
Intraoperative Complications During Cataract 
Surgery. Danielle Trief1,2, P.A. Legutko3, M.K. 
Daly1,4. 1Ophthalmology, Veterans Affairs Boston 
Healthcare System, Boston, MA; 2Ophthalmology, 
Massachusetts Eye and Ear Infirmary, Boston, MA; 
3Semphonic, Novato, CA; 4Ophthalmology, Boston 
University School of Medicine, Boston, MA. 
6690 — D710 Clinical Efficacy Of Loteprednol 
Etabonate Gel 0.5% In The Treatment Of Ocular 
Inflammation And Pain After Cataract Surgery. 
Rajesh K. Rajpal1, R. Siou-Mermet2, T. Erb3A, T.L. 
Comstock3B. 1Cornea Consultants, PC, McLean, VA; 
2European Pharmaceutical Clinical Science, Bausch 
& Lomb, Montpellier, France; ABiostatistics, 
BMedical Affairs, Global Pharmaceutical, 3Bausch 
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6691 — D711 Effect of Prophylactic 
Nonsteroidal Anti-Inflammatory Drugs on 
Pseudophakic Cystoid Macular Edema in a 
Series of Patients on the Wills Eye Cataract 
and Primary Eye Care Service. Fatima K. 
Ahmad1, B. Feldman1A, L.A. Hark1B, S. Haq1B, B.E. 
Kenney1B, C.E. Callinan1B, Y. Dai2. ACornea Service, 
BDepartment of Research, 1Wills Eye Institute, 
Philadelphia, PA; 2Jefferson Medical College, 
Philadelphia, PA. 
6692 — D712 Effect of Modified Cyclosporine 
A on Lens Epithelial Cell and Corneal 
Endothelial Viability. Elizabeth A. Lutz1A, D.A. 
Wilkie1A, A.J. Gemensky-Metzler1A, H.L. Chandler1B. 
AVeterinary Clinical Sciences, BOptometry, 1The 
Ohio State University, Columbus, OH. 
6693 — D713 Evaluation Of Postoperative 
Cystoid Macular Edema Following 
Phacoemulsification with Intraoperative 
Complication Using Spectral Domain Optical 
Coherence Tomography. Visvaraja Subrayan, K. 
Khaw. Ophthalmology, University of Malaya, Kuala 
Lumpur, Malaysia. 
6694 — D714 Incidence Of Postoperative 
Complications In Infants Undergoing Bilateral 
Simultaneous, Bilateral Sequential, Or Unilateral 
Cataract Surgery. Sheela Masifi1A, E. Agabegi1A, 
B. Schnell1B, M.B. Yang1A. AAbrahmson Pediatric 
Eye Institute, Department of Ophthalmology, 
BDepartment of Biostatistics, 1Cincinnati Children’s 
Hospital Medical Center, University of Cincinnati 
College of Medicine, Cincinnati, OH. 
6695 — D715 Safety of Difluprednate 0.05% 
after Cataract Surgery in Glaucoma Patients. 
Jessica Prince-Wolfish, J. Cotliar, A. Mozayan, 
W-J. Yao, J.S. Schultz. Dept of Ophthalmology and 
Visual Sciences, Montefiore Medical Center/Albert 
Einstein, Bronx, NY.*CR 
6696 — D716 Effect Of 0,1% Diclofenac 
Ophthalmic Solution On Inflammatory Response 
And Macula Following Phacoemulsification- 
Initial Report. Jacek P. Szaflik, E. Zielinska, M. 
Wielgorski, T. Galecki, J. Szaflik. Department of 
Ophthalmology, Medical University of Warsaw, 
Warszawa, Poland. 
6697 — D717 Intraocular Pressure Response 
in Glaucoma Patients Using Difluprednate 0.5% 
Post Operatively after Phacoemulsification. 
Melissa M. Cable. Discover Vision Centers, 
Independence, MO.*CR 
6698 — D718 The Effect Of Incision Technique 
In Reducing Intraocular Pressure After Cataract 
Extraction. Jordon G. Lubahn, S.M. Reinecke, 
R.W. Bowman, S.M. Verity, P.H. Blomquist. 
Ophthalmology, Univ of TX Southwestern Med Ctr, 
Dallas, TX. 
6699 — D719 Macular Thickness And 
Morphology After Cataract Surgery With 
Intracameral Cefuroxime. Oudy Semoun, S. 
Bonnel, L. Nicolas, F. Pecha, C. Allouch, V. 
Borderie, L. Laroche. V, Centre Hospitalier National 
d’Ophtalmologie 15-20, Paris, France. 
6700 — D720 Subconjunctival Steroid 
Injection versus Steroid Eyedrops: 
Evaluation of the Inflammatory Reaction 
after Phacoemulsification. Myrthe Dieleman1A, 
R.J. Wubbels1A, P.W. de Waard1B. ARotterdam 
Ophthalmic Institute, BGlaucoma, 1Rotterdam Eye 
Hospital, Rotterdam, The Netherlands. f 
6701 — D721 Postoperative Visual Acuity 
Following Complicated Cataract Extraction 
In Uveitis. Catherine Origlieri1A, Y. Tu1, D. Chu1. 
AOphthalmology, 1The Institute of Ophthalmology 
& Visual Science, Newark, NJ. 
6702 — D722 Prophylactic use of 
Intracameral Vancomycin in Cataract Surgery: 
a Retrospective Review of one Surgeon’s 
Experience Supporting its Safety and Efficacy. 
David M. Skale, T.A. Lopez, M.E. Rauser, C. 
Manalo, E. Yoo. Ophthalmology, Loma Linda 
University, Loma Linda, CA. 
6703 — D723 Complications of 
Phacoemulsification After Repeated Intravitreal 
Injections. Michael J. Coleman, Jr., M. McDermott. 
Ophthalmology, Kresge Eye Institute, Detroit, MI. 
6704 — D724 Visual Outcomes and Macular 
Status in Diabetic Patients after Cataract 
Surgery in a Teaching Institution. Cherrie-Ann 
M. Mattis1, M. Gonzalez1, N.Z. Gregori2. 1Surgery-
Ophthalmology, Miami VA Healthcare System, 
Miami, FL; 2Ophthalmology, Bascom Palmer Eye 
Institute, Miami, FL. 
6705 — D725 The Effect of Tamsulosin 
(Flomax) on Iris Vasculature. Christopher T. 
Hood, M. Hussain, T.M. Cooney, V.M. Elner, 
R.M. Shtein. Kellogg Eye Center, University of 
Michigan, Ann Arbor, MI. 
6706 — D726 Risk Factors For Developing 
Capsular Distension Syndrome. Maged 
Nessim1A,2, P. Pandy1A, M. Tahan2, P. Good1B, A-J. 
Ghauri1. AGlaucoma Services, BVisual Sciences, 
1Birmingham & Midland Eye Centre, Birmingham, 
United Kingdom; 2Sandwell General Hospital, 
Birmingham, United Kingdom. 
6707 — D727 Intraoperative Floppy Iris 
Syndrome: An Association with Warfarin? Rasha 
I. Ali, O. Alsheikh. Ophthalmology, University of 
Texas Medical Branch, Galveston, TX. 
6708 — D728 Factors Influencing 
Retinal Image Contrast in Eyes with 
Retrodots(Reykjavik Eye Study). Kota Nagai1, 
N. Mita2A, N. Hatsusaka3A, R. Honda4, H. 
Osada2B, E. Kubo3B, H. Sasaki3C, K. Sasaki2C, F. 
Jonasson5. 1Ophthalmology, Nagai Eye Clinic, 
Ibaraki, Japan; ADepartment of Ophthalmology, 
BOphthalmology, CDiv of Vis Rsrch for Environ 
Hlth, 2Kanazawa Medical University, Uchinada, 
Japan; AOphthalmology, BDept of Ophthalmology, 
CDepartment of Ophthalmology, 3Kanazawa 
Medical University, Kahoku-gun, Japan; 
4Kanazawa medical Univercity, Uchinada, Japan; 
5Ophthalmology, Iceland University, Iceland, 
Iceland. 
Thursday – Posters – 6691 – 6715
6709 — D729 Ultrastructural Changes In The 
Crystalline Lens Of Diabetic Patients Treated 
With Panretinal Argon Laser Photocoagulation. 
Zeliha Yazar1, M. Kilic1, E. Erdemli2, F. Topal 
Celikkan2. 1Ophthalmology, Ankara Numune 
Education and Research Hospital, Ankara, Turkey; 
2Histology, Ankara University Medicine Faculty, 
Ankara, Turkey. 
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6710 — D730 A Comparison of the Outcomes 
of Resident-Performed Phacoemulsification 
in Patients on Alpha Blockers Before and 
After the Description of Floppy Iris Syndrome 
(IFIS). Asher Neren1, A. Greenberg1, E. Burstein1, 
C. Mukhopadhyay1, A. Schrier2, E. Smith1. 
1Ophthalmology, VA Medical Center Brooklyn, 
Brooklyn, NY; 2Ophthalmology, Columbia 
University Medical Center, New York, NY. 
6711 — D731 Optimization of the A Constant for 
the SRK/T Formula. Eva Nong1A, J.C. Merriam1A, 
L. Zhang1A, M. Schlesinger1B. AOphthalmology, 
BBiostatistics, 1Columbia University, New York, NY. 
6712 — D732 Ray Tracing Intraocular 
Lens Power Calculation With Measurement 
Of Anterior Segment Optical Coherence 
Tomography. Keiichiro Minami, Y. Mori, Y. 
Kataoka, S. Otani, N. Honbou, K. Miyata. Miyata 
Eye Hospital, Miyakonojo, Japan. 
6713 — D733 Determination of Endotoxin 
Concentration in Hyaluronic Acid by The Light 
Scattering Method. Taiki Oshida1, Y. Sugiura2, 
T. Asano2, T. Hirono2, M. Sawa1. 1Division of 
Ophthalmology, Department of Visual Sciences, 
Nihon University School of Medicine, Tokyo, Japan; 
2Biophotonics Section, Research & Development 
Department, Electronics & Optics Division,, Kowa 
Company, Ltd., Tokyo, Japan. 
6714 — D734 Comparison of Predicted 
Refractions to Outcome Refractions in Patients 
Undergoing Combined Macula Surgery and 
Phacoemulsification Versus Patients Undergoing 
Phacoemulsification Alone. Amilia Schrier, E. 
Gavazi, J. Kerns, S. Chang. Ophthalmology, 
Columbia University, New York, NY. f 
6715 — D735 Improvement In The 
Achievement Of Targeted Post-Operative MRSE 
With Laser Anterior Capsulotomy Matches The 
Theoretical Model. Keith H. Edwards1, W.E. Hill2, 
H.S. Uy3, S. Schneider1. 1Clinical & Regulatory 
Affairs, LensAR Inc, Orlando, FL; 2East Hill 
Ophthalmology, Mesa, AZ; 3Asian Eye Institute, 
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6716 — D736 The accuracy of intraocular lens 
formulas in children ages 2 to 18 at Children’s 
Medical Center of Dallas. Zachary Vest, S. Wang. 
Ophthalmology, UT Southwestern, Dallas, TX. 
6717 — D737 Risks Factors and Regression 
Model for Risk Calculation of Anesthesiologic 
Intervention in Routine Cataract Surgery. 
Javier Moreno-Montanes, Sr.1A, A. Sabater1A, J. 
Barrio-Barrio1A, J. Pérez-Valdivieso1B, E. Cacho-
Asenjo1B, M. García-Granero2. AOphthalmology, 
BAnesthesiology, 1Clinica Universidad de Navarra., 
Pamplona, Spain; 2Genética, Universidad de 
Navarra. Unidad de Estadística., Pamplona, Spain. 
6718 — D738 Predicting The Post-operative 
Intraocular Lens Position Using Optical 
Coherence Tomography During Cataract 
Surgery. Nino Hirnschall, S. Tatzreiter, Y-A. 
Chen, S. Amir-Asgari, O. Findl. Hanusch Hospital, 
Ophthal. Dpt., VIROS, Wien, Austria. f 
6719 — D739 Resident Cataract Surgery 
Outcomes with Toric Intraocular Lenses. Helen 
R. Moreira1A, P.B. Greenberg, MD1B. ADivision 
of Ophthalmology, BSection of Ophthalmology, 
1Providence Veterans Affairs Medical Center, 
Providence, RI. 
6720 — D740 Scheimpflug Evaluation of a 
Dual Ophthalmic Viscosurgical Device (OVD) 
Injection Technique for Cataract Surgery. Stina 
Nilsson, B. Lundgren. R&D, Abbott Medical Optics 
(AMO), Uppsala, Sweden.*CR 
6721 — D741 Vector Analysis of Induced 
Astigmatism after 2.2 mm and 2.6 mm 
Scleral Incisions. Peter Jeppesen, T.K. Olsen. 
Ophthalmology, Aarhus Univ Hospital, Aarhus, 
Denmark. 
6722 — D742 A Comparison Between 
Eyesi Internal Scoring And Human-based 
Video Scoring In Virtual Reality Cataract 
Surgery Simulation. Madeleine Selvander, P. 
Åsman. Department of Clinical Sciences Malmo, 
Ophthalmology, Lund University, Malmo, Sweden. 
6723 — D743 Relation between some IOL 
Injectors and Clear Cornea incision size in 
the rabbit model. Esdras Arrieta, D. Nankivil, 
K. Sotolongo, A. Arboleda, M.C. Aguilar, E. 
Hernandez, S. Yoo, J-M. Parel. Ophthalmic 
Biophysics Center, Dept. of Ophthalmology, 
Bascom Palmer Eye Institute, University of Miami 
Miller School of Medicine, Miami, FL.*CR 
6724 — D744 Pediatric Pseudophakic Posterior 
Capsular Opacity. Brian M. Jerkins, N.C. Kerr, 
M. Hoehn. Univ of Tennessee Hamilton Eye Inst, 
Memphis, TN. 
6725 — D745 Validity of a Miniaturised Open-
field Aberrometer with Surgical Application. 
James S. Wolffsohn1, U.K. Bhatt1, A.L. Sheppard1, 
S. Shah2, H. Dua3, T. Mihashi4, T. Yamaguchi4. 
1School of Life and Health Sciences, Aston 
University, Birmingham, United Kingdom; 
2Midland Eye Institute, Birmingham, United 
Kingdom; 3Ophthalmology, Nottingham University, 
Nottingham, United Kingdom; 4Topcon, Tokyo, 
Japan.*CR 
6726 — D746 Technical Requirements For 
Adapting A Corneal Femtosecond Laser 
Workstation To Perform A Lenticular 
Capsulotomy. Michael Brownell1A, H. Fu1A, J. 
Hill1A, P. De Guzman1, Z. Bor1A, L.G. Vargas1, A. 
Dennison1, J. Tamkin2. AR & D, 1Abbott Medical 
Optics, Santa Ana, CA; 2Imaging Insights, Santa 
Ana, CA.*CR 
6727 — D747 In Situ Modification of 
Customized IOLs using the Phase Wrapping 
Algorithm. Ruth Sahler1, J.F. Bille2, R. Aguilera3, S. 
Zhou4, D. Schanzlin5. 1Medical Physics, University 
of Heidelberg, Heidelberg, Germany; 2Physics, 
University of Heidelberg, Mannheim, Germany; 
3Aaren Scientific Inc, Ontario, CA; 4R&D, Aaren 
Scientific Inc, Irvine, CA; 5Shiley Eye Center, 
UCSD, San Diego, CA.*CR 
6728 — D748 The Objective Measure Of The 
Effects Of Caffeine And Caffeine Withdrawal On 
Microsurgical Skills Using The Eyesi Simulator 
Module For Anterior Segment Surgery. Helen 
Koenigsman, J. Troupe. University of Florida, 
Gainesville, FL. 
6729 — D749 Effects Of Cumulative Dissipated 
Energy On Postoperative Corneal Pachymetry 
In Resident Performed Cataract Surgery. Adam 
G. Chun. Ophthalmology, Univ of S Carolina, 
School of Medicine, Columbia, SC. 
6730 — D750 A Comparison of the Cataract 
Extraction Operative Times When Using a 
Posterior Chamber Monofocal Versus Toric 
Intraocular Lens as Performed by Resident 
Surgeons. Solomon W. Ross1, B.A. Katz2, B.B. 
Markowitz1. 1Ophthalmology, University of 
South Carolina, Columbia, SC; 2Ophthalmology, 
University of South Carolina, Irmo, SC. 
6731 — D751 Biometric Parameters Before 
And After Mydriasis. Jonathan Shahar, N. Fisher, 
E. Rosenfeld, S. Kurtz. Tel Aviv Medical Center, 
ophthalmology departement, Sackler faculty of 
medicine, Tel Aviv University, Tel Aviv, Israel. 
6732 — D752 The Influence Of Ophthalmology 
Resident Surgical Simulator Training On 
Post-surgical Outcomes In Cataract Surgery. 
Adebukola Adebayo, A. Devabhaktuni, D. Belyea. 
Department of Ophthalmology, George Washington 
University, Washington, DC. 
6733 — D753 Evaluation Of A Warm-up 
Effect In Resident-performed Cataract Surgery. 
Mohsin Chowdhury1, J.B. Rosenberg2A, J.G. 
Lee3, L.A. Eisen2B, A.A. Madu2A. 1Albert Einstein 
College of Medicine, Bronx, NY; ADepartment of 
Ophthalmology and Visual Sciences, BDivision of 
Critical Care Medicine, Department of Medicine, 
2Montefiore Medical Center/Albert Einstein 
College of Medicine, Bronx, NY; 3Department of 
Ophthalmology and Visual Sciences, Case Western 
Reserve University, Cleveland, OH. 
6734 — D754 Resident Phacoemulsification 
Using Two Distinct Surgical Techniques. George 
J. Parlitsis, S.A. Hussnain, R.M. St Clair, E.C. Lai, 
J.B. Ciralsky. Department of Ophthalmology, Weill 
Cornell Medical College, New York, NY. 
6735 — D755 IOL Formula Accuracy and 
Precision in Three Mono Focal Aspheric Lenses. 
Stephanie Wise1A, J. Wang2, A. Rathod2, N K. 
Wade1B. AFaculty of Medicine, BOphthalmology and 
Visual Sciences, 1University of British Columbia, 
Vancouver, BC, Canada; 2Office of Dr. N Kevin 
Wade, Vancouver, BC, Canada. 
6736 — D756 Objective evaluation of 
Ophthalmic Viscosurgical Device (OVD) removal 
using the Pentacam Scheimpflug camera. Bjorn 
Lundgren, S. Nilsson. R & D, Abbott Medical 
Optics, Uppsala, Sweden.*CR 
6737 — D757 Fluctuations in Corneal 
Curvature Limits Predictability of IOL Power 
Calculations. Sverker Norrby1, N. Hirnschall2, Y. 
Nishi3, O. Findl2. 1Pulab, Leek, The Netherlands; 
2Moorfields Eye Hospital, London, United 
Kingdom; 3Moorfields Eye HospitL, London, 
United Kingdom.*CR 
6738 — D758 Evaluation of Visual Outcomes 
with Aspheric Diffractive and Aspheric Apodized 
Diffractive Multifocal IOLs. Ehsan Sadri, D. 
Logan. Atlantis Eyecare, Newport Beach, CA.*CR 
6739 — D759 Determining Femtosecond 
Laser Parameters for Clear Corneal Incisions. 
Roger F. Steinert1, P.S. Binder1, B. Gray2, Z. Bor2, 
M. Brownell2, J. Martiz2, A. Gwon1, J. Hill2, L.G. 
Vargas2. 1Ophthalmology, Gavin Herbert Eye 
Institute, Irvine, CA; 2Biological Sciences, Abbott 
Medical Optics, Santa Ana, CA.*CR 
6740 — D760 Complication Rate and Corneal 
Endothelial Impact in Phacoemulsification 
Performed by Ophthalmology Residents at an 
Argentinian University Hospital. Enrique L. 
Nebot, Sr.1, P.R. Ruiseñor Vazquez1, L. Fernández 
Abuyé1, H. Fernández Mendy1, J.D. Galletti1, 
P. Chiaradía1, J.G. Galletti1,2. 1Ophthalmology, 
Hospital de Clinicas, University of Buenos Aires, 
Buenos Aires, Argentina; 2ECOS (Clinical Ocular 
Studies) Laboratory, Buenos Aires, Argentina. 
6741 — D761 Toric Intraocular Lenses--
The Resident Experience. Zaina Al-Mohtaseb, 
M. Weikert. Ophthalmology, Baylor College of 
Medicine, pearland, TX. 
6742 — D762 Comparison Between Objective 
And Subjective Assessment Of The Duration 
Of Cataract Surgery. Brivael Le Du1A, C. 
Temstet1A, P-R. Rothschild1A, O. Rostaqui1A, J-B. 
Daudin1A, D. Monnet, Sr.1A, S. Grabar1B, A.P. Brezin, 
Sr.1A. AHospital Eye Clinic, BBiostatistics and 
epidemiology, 1Cochin Hospital, Paris, France. 
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6743 — D763 The Benefits of Ptosis Surgery. 
Richard A. Harrad1,2, F. Kalapesi1, H. Garrott1, H. 
Herbert1, H. Richards2, L. Jenkinson2, N. Rumsey2. 
1Ophthalmology, Bristol Eye Hospital, Bristol, 
United Kingdom; 2Psychology, University of the 
West of England, Bristol, United Kingdom. 
6744 — D764 Incidence of Deprivation 
Amblyopia and Systemic Associations in 
Congenital Ptosis. August L. Stein1, A.H. Weiss2, 
J.P. Kelly3. 1Ophthalmology, University of 
Washington, Seattle, WA; 2Ophthalmology, Roger 
Johnson Vision Lab., Seattle Children’s Hospital 
/ W-7729, Seattle, WA; 3Ophthalmology W-4743, 
Seattle Children’s Hospital, Seattle, WA. 
6745 — D765 Evaluating Outcomes of 
Blepharoptosis Surgery through Validated 
Response Measures. John Brach, E. Bradley, J. 
Sloan. Mayo Clinic, Rochester, MN. 
6746 — D766 Evaluation of Modified Levator 
Plication as Compared to Frontalis Sling for 
Severe Congenital Ptosis. Abhishek Dave, M. 
Bajaj, N. Pushker, B. Chawla, M. Chandra, S. 
Ghose. Ophthalmology, Dr RP Centre, AIIMS, New 
Delhi, India. f T 
6747 — D767 Muller’s Muscle-Conjunctiva 
Resection Outcomes And Phenylephrine 
Predictability In Ptosis From Horner’s 
Syndrome. Senad Osmanovic, J. Hou, V. Aakalu, 
P. Setabutr, A.M. Putterman. Ophthalmology, 
University of Illinois at Chicago, Chicago, IL. 
6748 — D768 Characterization of Adrenergic 
Receptor Subtype Gene Expression in 
Human Müller’s Muscle using Laser-Capture 
Microdissection and Quantitative Polymerase 
Chain Reaction. Joshua H. Hou1, R. Singa1, 
S.J. Green2, S. Jain1, V.K. Aakalu1, P. Setabutr1. 
1Ophthalmology & Visual Sciences, Univ of Illinois 
Eye & Ear Infirmary, Chicago, IL; 2DNA Services 
Facility, Univ of Illinois at Chicago, Chicago, IL. 
6749 — D769 Patient-Reported Benefit from 
Botulinum Toxin Treatment for Essential 
Blepharospasm; A Comparison of Two 
Assessment Scales. Jonathan N. Hyer, H.B. Smith, 
R.M. Lee, C.A. Jones. Ophthalmology, Maidstone 
& Tunbridge Wells NHS Trust, Maidstone, United 
Kingdom. 
6750 — D770 Outcomes And Complications 
Of Eyelid Gold Weight Implantation For Facial 
Paralysis. Preeti J. Thyparampil1, S. Lee2, M. Yen1. 
1Ophthalmology, Baylor College of Medicine, 
Houston, TX; 2Ophthalmology, Cullen Eye Inst, 
Baylor Coll of Med, Houston, TX. 
6751 — D771 Modified Frontalis Sling with 
Lash Repositioning in Pediatric Ptosis Repair. 
Jacqueline K. Ng, J. Ng. Ophthalmology, Oregon 
Health and Science University, Portland, OR. 
6752 — D772 Propranolol and Infantile 
Hemangioma: A Proposed Treatment Protocol. 
Margaret E. Phillips, J.C. Fleming. ophthalmology, 
University of Tennessee, Hamilton Eye Institute, 
Memphis, TN. 
6753 — D773 Curled Lashes are Associated 
with Obstructive Sleep Apnea. Cara W. Snyder, 
Y. Enzer. Ophthalmology, Brown University, 
Providence, RI. 
6754 — D774 Soft Tissue Perineurioma Of 
The Lacrimal Gland: A Case Report. Amanda 
B. Salter1A, Y. Enzer1B, B. Aswad1C, M. Chaump1C. 
AOphthalmology, BOculoplastics, CPathology, 
1Brown University, Providence, RI. 
6755 — D775 Gelatinous And Hard 
Silicone Spheres In The Rabbit Eviscerated 
Anophthalmic Cavities. Mayumi S. Kanamura, 
S.A. Schellini. Ophthalmology, Faculdade de 
Medicina de Botucatu - UNESP, Botucatu, Brazil. 
6756 — D776 Intraoperative Mitomycin C 
To Retard Future Cicatrix Formation During 
Severe Cicatricial Lid Retraction Repair. Renelle 
Pointdujour1, J. Gutman1, C. Calderon1, P. Langer2, 
R. Shinder1. 1Ophthalmology, SUNY Downstate 
Medical Center, Brooklyn, NY; 2Ophthalmology, 
University of Medicine & Dentistry of New Jersey, 
Newark, NJ. 
6757 — D777 Repair of pediatric canalicular 
lacerations using monocanalicular Monoka stent. 
Scott W. Yeates, F. Orge. Ophthalmology, Univ 
Hosp Case Western Med Ctr, Cleveland, OH. 
6758 — D778 Method for Measuring Lacrimal 
Drainage Resistance. Milap Mehta1, J.D. Perry2. 
1Ophthalmology, Cleveland Clinic-Cole Eye Inst, 
Cleveland, OH; 2Ophthalmology, Cole Eye Institute, 
Cleveland, OH. 
6759 — D779 Cyanoacrylate Pseudo-
tarsorrhaphy: Presentation & Treatment 
Strategies. Matthew Gorski, R. Shinder. Department 
of Ophthalmology, SUNY Downstate Medical 
Center, Brooklyn, NY. 
6760 — D780 Catheter Assisted 
Conjunctivodacryocystorhinostomy (CDCR) 
for Improved Surgical Efficiency. Charlene 
H. Crockett, S. Lee, M.T. Yen. Department of 
Ophthalmology, Baylor College of Medicine, Cullen 
Eye Institute, Houston, TX. 
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6761 — D781 Retrospective Review Of Records 
From A School Based Vision Clinic Serving The 
Chicago Community. Sandra S. Block, M. Suckow, 
S. Reed. School-Based Vision Clinic, Illinois 
College of Optometry, Chicago, IL. 
6762 — D782 Refractive Error in Preschool-
Aged Children: Sydney Paediatric Eye Disease 
Study (SPEDS). Sonia Afsari1, K.A. Rose2, A. 
Pai1, J. Leone2, P. Mitchell1. 1Ophthalmology, 
University of Sydney, Sydney, Australia; 2Discipline 
of Orthoptics, University of Sydney, Lidcombe, 
Australia. 
6763 — D783 Outcomes Associated with 
Cataract Surgery in the Pediatric Medicaid 
Population. Michelle Tarver1, M.X. Repka2, 
H. Silverman3, R. Domurat3, N. Kordic3, T. 
MaCurdy3. 1CDRH/ODE/DONED, Food and 
Drug Administration, Silver Spring, MD; 
2Ophthalmology, Johns Hopkins Wilmer Eye Inst, 
Baltimore, MD; 3Acumen, LLC, Burlingame, CA. 
6764 — D784 Visual Signs And Symptoms 
Of Brain Tumours In Children. Maria L. 
Salvetat1A, C. Stocco1B, M. Zeppieri1A, F. Miani1A, E. 
Passone1B, M. Felletti1A, C. Pilotto1B, P. Brusini1A. 
AOphthalmology, BPediatrics, 1Santa Maria della 
Misericordia Hospital, Udine, Italy. 
6765 — D785 Coagulopathy and Retinal 
Hemorrhage in Pediatric Head Trauma. Aida 
Bounama1,2A, B.J. Forbes2A,1A, C.W. Christian2B,1B, J. 
Huang1A, G-S. Ying1A, K.E. Romero3, J.P. Antigua2A, 
G. Binenbaum2A. AOphthalmology, BPediatrics, 1U. 
of Pennsylvania Perelman School of Medicine, 
Philadelphia, PA; AOphthalmology, BPediatrics, 
2Children’s Hospital of Philadelphia, Philadelphia, 
PA; 3Pediatrics, University of California San Diego, 
San Diego, CA. T 
6766 — D786 Evolution Of Axial Length 
In Congenital Glaucoma. Bruno Sautiere1a, 
A. Duhamel2, A. Galet1b, J-F. Rouland1A. 
AOphthalmology, BAnesthesia, 1Huriez Hospital, 
CHRU Lille, Lille, France; 2Biostatistics unit, 
CHRU Lille, Lille, France. 
6767 — D787 Central Conreal Thickness 
and Intraocular Pressure In Moderate-Late 
Premature School Aged Children. Lina H. Raffa1, 
J. Dahlgren2, A-K. Karlsson2, M.A. Gronlund3. 
1Department of Ophthalmology, Institute of 
Neuroscience and Physiology, Gothenburg, Sweden; 
2Department of Pediatrics, Institute of Clinical 
Sciences,The Sahlgrenska Academy at the University 
of Gothenburg, Gothenburg, Sweden; 3Department 
of Ophthalmology, Institute of Neuroscience and 
Physiology, Gothenburg, Sweden. 
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6768 — D788 Access To Government-insured 
Vision Care Versus Privatized Dental Care 
Amongst Canadian Adolescents: Is Cost The 
Sole Barrier? Kunyong Xu1, G.E. Trope2A, K. 
Thavorn2B, Y-P. Jin2A,2C. 1Michael G DeGroote Sch 
of Med, McMaster University, Hamilton, ON, 
Canada; ADepartment of Ophthalmology and Vision 
Sciences, BInstitute of Health Policy, Management 
and Evaluation, CDalla Lana School of Public Health, 
2University of Toronto, Toronto, ON, Canada. 
6769 — D789 IOLunder2: Outcomes Following 
Surgery With And Without Primary Intraocular 
Lens Implantation In Children under 2years Old. 
Lola A. Solebo1,2, J.S. Rahi1,3, British Isles Congenital 
Cataract Interest Group. 1MRC Centre Epidemiology 
(Child Health), Institute Child Health, UCL, London, 
United Kingdom; 2Kingston Eye Hospital, London, 
United Kingdom; 3Moorfields Eye Hospital, London, 
United Kingdom. 
6770 — D790 Eye Injuries in US High School 
Athletes: Results of a Six-Year Epidemiologic 
Study. Andrew W. Stacey1, C.N. Czyz2, J.A. Foster2,3, 
D. Comstock4,5. 1Department of Medical Education, 
Riverside Methodist Hospital, OhioHealth, 
Columbus, OH; 2Division of Ophthalmology, Section 
Oculofacial Plastic and Reconstructive Surgery, 
Ohio University, Doctor’s Hospital, Columbus, 
OH; 3Nationwide Children’s Hospital, Columbus, 
OH; 4Center for Injury Research and Policy, The 
Research Institute at Nationwide Children’s Hospital, 
Columbus, OH; 5Division of Epidemiology, The 
Ohio State University College of Public Health, 
Columbus, OH. T 
6771 — D791 Investigation on the reading 
ability in the hyperopic children at the Nishikasai 
Inouye Pediatric Eye Clinic. Mieko tsuruoka1, 
O. Katsumi2, M. Miyata2, M. Suzuki3, Y. Aoki1, Y. 
Miyanaga1, K. Inoue4, K. Oda3. 1Nishikasai Inouye 
Eye Hospital, Tokyo, Japan; 2Nishikasai Inouye 
Pediatric Eye Clinic, Tokyo, Japan; 3Tokyo Woman’s 
Christian University, Tokyo, Japan; 4Inouye Eye 
Hospital, Tokyo, Japan. 
6772 — D792 Paediatric Ophthalmology 
Referrals: Causes Of Reduced Vision In Children 
And How Accurate Are Referrals From Family 
Practitioners? Gurjeet Jutley, D. Ho, B. Gohil, 
S. Khan, L. Dhir. Ophthalmology, Chelsea and 
Westminster, London, United Kingdom. 
6773 — D793 Clinical and electrophysiological 
findings in children with Leigh Syndrome. 
Antovan K. Seyedi Honarvar1, N. Darin2, M. 
Tulinius2, M. Andersson Grönlund1. 1Inst of 
Neuroscience and Physiology/Ophthalmology, 
Gothenburg, Sweden; 2Dept of Pediatrics, Institute of 
Clinical Sciences, Gothenburg, Sweden. 
6774 — D794 Refractive changes in children 
with Marfan Syndrome. Luisa M. Hopker, 
S.X. Wang, D.R. Weakley. Ophthalmology, UT 
Southwestern, Dallas, TX. 
6775 — D795 Consumer Digital Cameras: 
A Feasible Strategy for the Early Detection 
of Childhood Blindness. Tirth N. Patel1A, 
A.C. Mallipatna1A, A. Merchant1A, R. Battu2, K. 
Nischal3, R.W. Arnold4, V. Naresh1A, J. Matalia1B, 
H. Dimaras5A, B. Gallie5B. Aophthalmology, 
BPediatric Ophthalmology, 1Narayana Nethralaya, 
bangalore, India; 2Pediatric ophthalmology, 
Narayana Nethralaya, Bangalore, India; 3Pediatric 
Ophthalmology, Childrens Hospital of Pittsburgh, 
Pittsburgh, PA; 4Pediatric Ophthalmology and 
Strabismus, Ophthalmic Associates, Anchorage, AK; 
AHematology Oncology, BOphthalmology, 5Hospital 
for Sick Children, Toronto, ON, Canada. 
6776 — D796 Natural History And Risk Factors 
Analysis For Retinopathy Of Prematurity In 
Premature Infants In Taiwan: A Prospective 
Study At The Post Bevacizumab Era. Yi hsing 
Chen1, W-C. Wu, II2. 1Ophthalmology department, 
Chang Gung Memorial Hospital, Taoyuan county, 
Taiwan; 2Ophthalmology, Chang Gung Memorial 
Hosp, Taoyuan county, Taiwan. 
6777 — D797 Manual choroidal thickeness 
measurements in healthy children. Changes with 
ages. Diana Perez-Garcia1a, I. Pinilla2, J. Ibañez-
Alperte1b, C. Peiro1c, J. Cristobal1d, B. Jimenez-Del 
Rio1e, A. Mateo-Orobia1f. Apediatric Ophthalmology, 
Bglaucoma, Cretina Ophthalmology, Danterior 
Segment Ophthalmology, Eophthalmology, Fcornea 
Ophthalmology, 1Hcu Lozano Blesa, Zaragoza, 
Spain; 2Retina Ophthalmology, Universitary Hospital 
Lozano Blesa, Zaragoza, Spain. 
6778 — D798 The Effect Of General Anesthesia 
On Rebound Tonometry Measurements In 
Normal Eyes Of Preschool Children. Andrea M. 
Schild, M.M. Hermann, J. Fricke, A. Neugebauer, 
M. Diestelhorst. Department of Ophthalmology, 
University of Cologne, Cologne, Germany. 
6779 — D799 The Impact Of Amblyopia And 
Strabismus On Child Development And Quality 
Of Life In Young Chinese Children. Audrey Chia1, 
Y. Chan2, E. Lamoureux3, J. Thumboo4, T. Wong5, S. 
Saw2. 1Pediatric Services, Singapore National Eye 
Centre, Singapore, Singapore; 2National University 
Singapore, Singapore, Singapore; 3University of 
Melbourne, Melbourne, Australia; 4Singapore 
General Hospital, Singapore, Singapore; 5Singapore 
Eye Research Institute, Singapore, Singapore. 
6780 — D800 Sibling Motivation Cards - New 
Screening Initiative in South India for Pediatric 
Eye Disease. Brinda Muthusamy1, B. Dey2, V. 
Kannusamy2, F. Moutappa2, H-J. Park1. 1Pediatric 
Ophthalmology & Strabismus, The Wilmer Eye 
Institute, Johns Hopkins Hospital, Baltimore, MD; 
2Pediatric Ophthalmology & Strabismus, Aravind 
Eye Hospital, Pondicherry, India. 
6781 — D801 Secondary Glaucoma and 
Pediatric Traumatic Hyphema. Jeffrey SooHoo, 
E. McCourt, R. Sands Braverman, R. Enzenauer. 
Ophthalmology, University of Colorado, Aurora, CO. 
6782 — D802 Efficacy Of Probing For 
Congenital Nasolacrimal Duct Obstruction Under 
12 Months. About 443 Cases. Alice Degoumois, 
F. Mouriaux, C. Abadie-Koebele, J. Le Garrec. 
ophtalmologie, Centre Hospitalier Universitaire de 
Caen, Caen, France. 
6783 — D803 Barriers to Care Following 
Failure of Population Based Vision Screening. 
Kristin Rarey, A. Summers, J. Vaughan, L. Reznick. 
Pediatric Ophthalmology, Casey Eye Institute, 
Portland, OR. 
Hall B/C D948-D986




6784 — D948 Corneal Biomechanical 
Properties and their Change with Corneal 
UV-Riboflavin Cross-linking from 2D Flap-
Extensiometry. Sabine Kling1, H.S. Ginis2, S. 
Marcos Celestino3. 1Instituto de Optica, Consejo 
Superior de Invest Cientificas, Madrid, Spain; 
2Institute of Vision & Optics, University of Crete, 
Heraklion, Greece; 3Instituto de Optica, Consejo 
Sup de Investig Sci, Madrid, Spain. 
6785 — D949 Corneal Nerve Regeneration 
after Collagen Cross-Linking with Riboflavin in 
Rabbit Eyes. Bing Qin, Z. Dong, L. Niu, X. Zhou. 
Ophthalmology, EENT Hospital, Fudan University, 
Shanghai, China. 
6786 — D950 To Evaluate Patient Outcomes 
Following Epithelium-on CXL In Patients 
Who Received The Treatment In One Or Both 
Eyes. Roy Rubinfeld1, W. Trattler2A, G. Perez3, 
C.J. Kaiser2, A. Koreishi4, P. Majmudar5, R.J. 
Epstein5, S. Bafna6, R. Malahotra7. 1Washington 
Eye Physicians and Surgeons, Chevy Chase, MD; 
ACornea, 2Center For Excellence in Eye Care, 
Miami, FL; 3Ctr for Excellence in Eye Care, 
Miami, FL; 4Cornea Associates of Texas, Dallas, 
TX; 5Chicago Cornea, Chicago, IL; 6Cleveland Eye 
Clinic, Cleveland, OH; 7Ophthalmology Associates, 
St. Louis, MO.*CR, f 
6787 — D951 Early Results Of Laser-assisted 
Collagen Cross-linking (laser CXL) Suggest That 
Patients Achieve Better-uncorrected Acuity At 6 
Months Compared To Mechanical Debridement 
Of The Epithelium In Patients With Progressive 
Keratoconus. Yaron S. Rabinowitz, R. Gaster. 
Ophthalmology, Cornea Eye Institute, Cedars-Sinai 
Medical Center, Beverly Hills, CA. f 
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6788 — D952 Lack Of Influence Of Corneal 
Thickness On Biomechanical Waveforms And 
How That Impact In Distinguishing Candidates 
For Lasik Or Prk. Marcony R. Santhiago1,2, R. 
Ambrosio, Jr.3, W.J. Dupps, Jr.4A, D. Smadja5, E.M. 
Espana6, S.E. Wilson4B. 1Ophthalmology, Cleveland 
Clinic Foundation, Cleveland, OH; 2Ophthalmology, 
University of Sao Paulo and Rio Laser, Sao Paulo 
and Rio de Janeiro, Brazil; 3Ophthalmology, 
Instituto de Olhos Renato Ambrosio, Rio de Janeiro, 
Brazil; ACole Eye Inst and Lerner Rsch Inst, BCole 
Eye Institute, 4Cleveland Clinic, Cleveland, OH; 
5Refractive Surgery, Cole Eye Inst, Cleveland 
Clinic, Paris, France; 6Ophthalmology, Cole Eye 
Institute, Cleveland, OH. 
6789 — D953 Repeatability And Accuracy Of 
The Ocular Response Analyzer. Hana Landoulsi, 
A. Saad, N. Haddad, E. Guilbert, D. Gatinel. Ceroc, 
Ophthalmologic Rothschild Foundation, Paris, 
France. 
6790 — D954 Safety Of Genipin A Non Uv 
Crosslinking System In The Cornea. Marcel Y. 
Avila, M. Narvaez. Ophthalmology, Univ Nacional 
de Colombia, Bogota DC, Colombia. 
6791 — D955 An Experimental Evaluation Of 
Know Computer Models Of The Porcine Cornea. 
Vito Romano1, M. Angelillo2, A. Pandolfi3. 1Second 
University of Naples, Napoli, Italy; 2University 
of Salerno, Salerno, Italy; 3Politecnico of Milan, 
Milano, Italy. 
6792 — D956 Automated Measurement 
of Corneal Stromal Collagen Fiber Angular 
Distribution. Moritz Winkler1, K.R. Huxlin2, C.J. 
Murphy3, D.J. Brown1, J.V. Jester1. 1Ophthalmology, 
University of California, Irvine, Irvine, CA; 2Flaum 
Eye Institute, University of Rochester, Rochester, 
NY; 3Surgical Radiol Sci-Sch of Veterinary, Univ of 
California-Davis, Davis, CA. 
6793 — D957 Biomechanical Response of 
Paired Donor Corneas to An Air Puff: Isolated 
Cornea vs Intact Whole Globe. Kimberly 
Metzler1A, A.M. Mahmoud1A, J. Liu1A,1B, D. Lee1A, S.J. 
Shiao1C, C.J. Roberts1A,1B. ABiomedical Engineering, 
BOphthalmology, CCollege of Medicine, 1The Ohio 
State University, Columbus, OH.*CR 
6794 — D958 A Molecular-level Model For 
Swelling Pressure In The Corneal Stroma. Xi 
Cheng, P.M. Pinsky. Mechanical Engineering, 
Stanford University, Stanford, CA. 
6795 — D959 Change in Corneal Hysteresis 
over Time in Normal and Glaucomatous Eyes. 
Syed A. Hussnain1, J.B. Alsberge1, J.R. Ehrlich1, 
M. Shimmyo2, N.M. Radcliffe1. 1Ophthalmology, 
Weill Cornell Medical College, New York, NY; 
2Ophthalmology, New York Medical College, New 
York, NY.*CR T 
6796 — D960 The Role of Collagen 
Interweaving in Stromal Elasticity: A Model 
Based on the 3-D Collagen Architecture. Steven 
J. Petsche, P.M. Pinsky. Mechanical Engineering, 
Stanford University, Stanford, CA. 
6797 — D961 Changes in Corneal 
Biomechanics after Descemet Stripping 
Endothelial Keratoplasty in Fuchs’ Dystrophy. 
Richard Y. Hwang1, B. Goldhagen2, A.N. Kuo2, N.A. 
Afshari2. 1Ophthalmology, Vanderbilt University, 
Nashville, TN; 2Ophthalmology, Duke University 
Eye Center, Durham, NC. 
6798 — D962 Comparative Diagnostic 
Performance of Pentacam Scheimpflug 
Tomography and Ocular Response Analyzer 
Measurements for Subclinical Keratoconus. 
Marianella Delrivo1, J.D. Galletti2, F. Fuentes 
Bonthoux2,1, T. Pförtner1, J.G. Galletti2,1. 1ECOS 
(Clinical Ocular Studies) Laboratory, Buenos 
Aires, Argentina; 2Ophthalmology, Hospital de 
Clinicas, University of Buenos Aires, Buenos Aires, 
Argentina. 
6799 — D963 Keratoconus Diagnostic 
Model Integrating Ocular Response Analyzer 
Measurements and Corneal Topography. 
Pablo R. Ruiseñor Vazquez, Sr.1, E.L. Nebot1, F. 
Fuentes Bonthoux1,2, M. Delrivo2, T. Pförtner2, 
J.G. Galletti1,2. 1Ophthalmology, Hospital de 
Clinicas, University of Buenos Aires, Buenos 
Aires, Argentina; 2ECOS (Clinical Ocular Studies) 
Laboratory, Buenos Aires, Argentina. T 
6800 — D964 In Vivo Corneal Elasticity 
Changes After Collagen Cross-linking Using 
Supersonic Shear Wave Imaging. David Touboul1, 
T. Nguyen2, J. Aubry2, J. Gennisson2, M. Tanter2, J. 
Bercoff3, J. Colin1. 1CHU de Bordeaux, Bordeaux, 
France; 2Institut Langevin - espci, Paris, France; 
3SuperSonic Imagine, Aix-en-Provence, France.*CR 
6801 — D965 Natural history of Intacs in 
keratoconus and corneal ectasia. Jasmin R. 
Desai1, P.S. Hersh1A. AOphthalmology, 1Cornea and 
Laser Eye Institute, Teaneck, NJ. 
6802 — D966 A Simple, Inexpensive And 
Efficient Method To Measure Changes In 
Biomechanics Of The Entire Globe. Olivier 
Richoz, F. Hafezi. Ophthalmology, Geneva 
University Hospital, Geneva, Switzerland. 
6803 — D967 Biomechanical Modeling of 
the Applanation Tonometry after Refractive 
Surgery. Svetlana M. Bauer1, L.A. Karamshina1, 
A.B. Kachanov2, E.B. Voronkova1. 1Theoretical & 
Applied Mechanics, St Petersburg State University, 
St Petersburg, Russian Federation; 2St.-Petersburg 
Branch IR&TC, St Petersburg, Russian Federation. 
6804 — D968 To Evaluate The Efficacy Of 
Riboflavin As A Cyto-Protectant For Limbal 
Epithelial Cells Exposed To UV-A Radiation. 
Debashish Das1A, D Kamesh1A, S Murali1A, 
A.A. Vincent1A, R. Shetty1B, H. Matalia1B. AStem 
Cell Research Lab, BCornea and Refractive 
Surgery, 1Narayana Nethralaya Post Grad Inst of 
Ophthalmol, Bangalore, India. T 
6805 — D969 Implications of New Absorption 
and Fluorescence Measurements of Riboflavin 
for Corneal Cross-linking. Pavel Kamaev1A, R. 
Pertaub1A, M. Friedman1A, D. Muller1. AResearch, 
1Avedro, Waltham, MA.*CR 
6806 — D970 Ultrasound-enhanced 
Penetration of Topical Riboflavin into the 
Corneal Stroma. Ricardo Lamy1A, E. Chan1A, H. 
Zhang1A, V. Salgaonkar1B, C.J. Diederich1B, J.M. 
Stewart1A. AOphthalmology, BRadiation/Oncology, 
1University of California, San Francisco, San 
Francisco, CA. 
6807 — D971 Reducing Riboflavin Pre-
soaking Time In Corneal Cross-linking. Silvia 
Schumacher, J. Wernli, T. Seiler, M. Mrochen. R & 
D, IROC AG, Zurich, Switzerland.*CR 
6808 — D972 A Multifactorial Treatment 
Analysis and Algorithm for Corneal Collagen 
Crosslinking. Steven A. Greenstein, P. Hersh. 
Cornea and Laser Eye Institute- Hersh Vision 
Group, Teaneck, NJ.*CR, f 
6809 — D973 Treatment of Keratoconus Using 
Collagen Cross Linking. Vincent Imbrogno, M. 
Pihlblad. Ophthalmology, University at Buffalo/
Ross Eye Institute, Buffalo, NY. f 
6810 — D974 Thermal Safety Analysis for 
Accelerated Cross-linking with Riboflavin. Evan 
A. Sherr, P. Kamaev, M.D. Friedman, D. Muller. 
Avedro, Inc, Waltham, MA.*CR 
6811 — D975 Beam Profile Calculations To 
Increase The Volume Of Cross-linked Of Corneal 
Tissue. Michael C. Mrochen, S. Schumacher, B.C. 
Verbiest, D. Simon, T. Seiler. IROC, IROC, Zurich, 
Switzerland.*CR 
6812 — D976 High intensity Corneal Collagen 
Cross-Linking with Optimized Beam Profile. 
Anja Kissner, F. Raiskup, E. Spoerl, L. Pillunat. 
Department of Ophthalmology, University of 
Dresden, Dresden, Germany. 
6813 — D977 Rapid Collagen Photo-
crosslinking Method to Increase Cornea 
Mechanical Strength. Irene E. Kochevar1, D. 
Cherfan2, T.E. Gisel1, E.E. Verter1, R.W. Redmond1, 
S. Melki3. 1Wellman Center for Photomedicine, 
Massachusetts General Hospital, Boston, MA; 
2Medical Sciences Program, Boston University, 
Boston, MA; 3Boston Eye Group, Boston, MA.*CR 
6814 — D978 Computer Modeling Study of 
Corneal Cross-Linking with Riboflavin. Radha 
Pertaub, M.D. Friedman, W.A. Eddington, D. 
Muller. Avedro Inc., Waltham, MA.*CR 
6815 — D979 Feasibility Study Of Riboflavin 
Dosimetry Via Detection Of Riboflavin 
Fluorescence. Marc D. Friedman, R. Pertaub, D.B. 
Usher, D. Muller. Avedro, Waltham, MA.*CR 
6816 — D980 Model Of Corneal Cross-linking 
Photochemical Kinetics With Riboflavin. David 
Muller, P. Kamaev, M.D. Friedman, E. Sherr. 
Avedro, Waltham, MA.*CR 
6817 — D981 Contralateral Eye Long-term 
Follow-up Of Prophylactic High-fluence 
Collagen Cross-linking Combined With Lasik 
For High Myopia. Kathy M. Tran1, S.L. Wang1, A.J. 
Kanellopoulos1,2. 1New York University School of 
Medicine, New York, NY; 2Laservision.gr Institute, 
Athens, Greece. 
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6818 — D982 Atopy, Floppy Eyelid Syndrome, 
Obstructive Sleep Apnea Syndrome, Eye 
Rubbing And Keratoconus. Ines Tran1A, J. 
Harquel1A, A. Sauer1A, D. Gaucher1A, C. Speeg-
Schatz1A, P. Bourgin1B, T. Bourcier1A. AService 
d’Opthalmologie, BService sommeil, 1CHU de 
Strasbourg, Strasbourg, France. 
6819 — D983 Corneal Cross-linking In 
Children With Progressive Keratoconus. Beatrice 
E. Frueh, L. Muller. Ophthalmology, Univ of Bern 
Inselspital, Bern, Switzerland. 
6820 — D984 Long-term Results Of Cross-
linking Treatment For Progressive Keratoconus. 
Dan Epstein1, E. Albè2, R. Vinciguerra2, P. 
Vinciguerra2. 1Ophthalmology, Universitaets Spital 
Zurich, ZUrich, Switzerland; 2Ophthalmology, 
Istituto Clinico Humanitas, Milan, Italy. 
6821 — D985 The use of Sub-Tenon 
Ranibizumab to Control Pterygium Recurrences. 
Linda Rose, S. Rivera, J. Byrd. Surgery, University 
of New Mexico, Albuquerque, NM.*CR, f 
6822 — D986 Two-Staged Technique Using 
Mitomycin C, Amniotic Membrane, and Prokera 
for Prevention of Pterygium Recurrence After 
Pterygium Excision. Archana T. Seethala, W.M. 
Munir. Ophthalmology, Boston University Medical 
Center, Boston, MA. 
Hall B/C D1153-D1196




6823 — D1153 Coronary And Retinal 
Reactivity To Hyperoxia In Prediabetes And 
Type 2 Diabetes. Mary E. Lott1A, B. Smith1A, J.E. 
Slocomb1B, V. Shivkumar1B, K. Bettermann1B. AHeart 
and Vascular Institute, BNeurology, 1Penn State 
Milton S Hershey Med Ctr, Hershey, PA. 
6824 — D1154 Changes Of Plasma Nitrate 
Level And Ocular Blood Flow In Patients With 
Retinal Vein Occlusion After Treatments. Teruyo 
Kida, H. Oku, T. Ikeda. Ophthalmology, Osaka 
Medical College, Takatsuki, Japan. 
6825 — D1155 The Diameter Response To 
L-lactate And The Prostaglandin Analogue 
U46619 Is Different In Porcine Retinal Arterioles 
And Capillaries In Vitro. Simon M. Pedersen, T. 
Bek. Dept of Ophthalmology, Aarhus University 
Hospital, Aarhus, Denmark. 
6826 — D1156 Effect of Nitric Oxide Inhalation 
on Retinal Arteriolar Diameter in Minipigs. 
Ioannis K. Petropoulos1A, A-L. Martin1B, G. 
Mangioris1A, E. Mendrinos1A, P.C. Rimensberger1B, 
C.J. Pournaras1A. ALaboratory of Neurobiology and 
Physiology of the Retinal Circulation, Department 
of Ophthalmology, BDepartment of Pediatrics, 
1Geneva University Hospitals, Geneva, Switzerland. 
6818 – 6842 – Thursday – Posters
6827 — D1157 Topical Latanoprost Increases 
Retinal Blood Flow In The Macular Circulation. 
Naomi Niwa, T. Hattori, M. Nozaki, Y. Ogura. 
Department of Ophthalmology, Nagoya City Univ 
Medical School, Nagoya, Japan. 
6828 — D1158 Measurement of retinal blood 
flow using dual beam bi-directional Fourier 
domain Doppler OCT - comparison with laser 
Doppler velocimetry. Rene M. Werkmeister1A, 
N. Dragostinoff1A, S. Palkovits1B, R. Told1B, L. 
Schmetterer1B. AMed Physics and Biomed Eng, 
BClinical Pharmacology, 1Medical University of 
Vienna, Vienna, Austria. 
6829 — D1159 Role of Endothelin-1 in Optic 
Nerve Head Blood Flow Regulation during 
Isometric Exercise in Healthy Humans. Agnes 
Boltz1A,1B, D. Schmidl1A, M. Lasta1A, S. Kaya1A, S. 
Palkovits1A, R. Told1A, G. Fuchsjäger-Mayrl1A,1C, 
G. Garhöfer1A, L. Schmetterer1A,1B. ADepartment of 
Clinical Pharmacology, BCenter for Medical Physics 
and Biomedical Engineering, CDepartment of 
Ophthalmology and Optometry, 1Medical University 
of Vienna, Vienna, Austria. f 
6830 — D1160 Evaluation of Ultrasound-
Assisted Thrombolysis Using Nontargeted 
Ultrasound Contrast Agents in a Model of 
Retinal Vein Occlusion. Walid F. Abdallah1,2, H. 
Patel3, E. Grant3, G.J. Chader1, M.S. Humayun1. 
1Ophthalmology, Doheny Eye Institute, Los 
Angeles, CA; 2Ophthalmology, Faculty of 
Medicine, Zagazig University, Zagazig, Egypt; 
3Radiology, Keck School of Medicine, University of 
Southern California, Los Angeles, CA.*CR 
6831 — D1161 In Vivo Adaptive Optics 
Imaging Of Retinal Pericytes And Capillary 
Blood Velocity In Mice. Jesse B. Schallek1A, Y. 
Geng1A,1B, D.R. Williams1A,1C. ACenter for Visual 
Science, BThe Institute of Optics, CFlaum Eye 
Institute, 1University of Rochester, Rochester, 
NY.*CR T 
6832 — D1162 Changes in Choroidal and Optic 
Nerve Head Blood Flow Regulation During 
an Experimental Increase in Ocular Perfusion 
Pressure. Doreen Schmidl1A, A. Boltz1A,1B, S. Kaya1A, 
R.M. Werkmeister1B, N. Dragostinoff1B, M. Lasta1A, 
E. Polska1A, G. Garhofer1A, L. Schmetterer1A,1B. 
ADepartment of Clinical Pharmacology, BCenter 
for Medical Physics and Biomedical Engineering, 
1Medical University of Vienna, Vienna, Austria. f 
6833 — D1163 Retinal Blood Flow In 
Healthy Young Subjects. Gerhard Garhofer1A, 
R.M. Werkmeister1B, N. Dragostinoff1B, L. 
Schmetterer1A,1B. ADepartment of Clinical 
Pharmacology, BBiomed Engineering & Physics, 
1Medical University of Vienna, Vienna, Austria. 
6834 — D1164 Hemorheologic and 
Hemodynamic Response of Conjunctival 
Microcirculation to Acute Hypotension in 
Rabbits. Bruce I. Gaynes1, P-Y. Teng2, J.M. Wanek2, 
M. Shahidi2. 1Ophthalmology, Loyola University 
Chicago, Maywood, IL; 2Ophthalmology and Visual 
Sciences, University of Illinois, Chicago, IL. 
6835 — D1165 Evaluation Of Retinal 
Vasomotor Reactivity During Changes In 
Arterial Blood Oxygen Content. Helene Kergoat, 
C. Dutrisac, J.V. Lovasik. School of Optometry, 
University Montreal, Montreal, QC, Canada. 
6836 — D1166 Effect Of Breathing Pure 
Oxygen And A Mixture Of 92% O
2
 + 8% Co
2
 
On Flicker Induced Vasodilatation. Stefan 
Palkovits1A, M. Lasta1A, R. Told1A, G. Garhöfer1A, L. 
Schmetterer1A,1B. AClinical Pharmacology, BCenter 
for Medical Physics and Biomedical Engineering, 
1Medical University of Vienna, Vienna, Austria. f 
6837 — D1167 Quantitative Choroidal 
Blood Flow Measurement Using Doppler 
Optical Coherence Tomography With Pulse 
Synchronization. Masahiro Miura1, S. Makita2, 
T. Iwasaki1, Y. Yasuno2. 1Dept of Ophthalmology, 
Tokyo Med Univ, Ibaraki Med Ctr, Inashiki, Japan; 
2Computational Optics Group, University of 
Tsukuba, Tsukuba, Japan.*CR 
6838 — D1168 Assessment of Oxygen 
Saturation in Retinal Vessels of Normal Subjects 
and Diabetic Patients without Retinopathy using 
the Johns Hopkins Flow Oximetry System. 
Rachel E. Annam1, M.A. Ibrahim1, L. Luu2, Y.J. 
Sepah1, M.G. Bittencourt1, O. Agbedia1, H.S. 
Jang1, J. Yohannan1, J. Ramella-Roman2, Q.D. 
Nguyen3. 1Johns Hopkins University, Wilmer Eye 
Institute, Baltimore, MD; 2Biomedical Engineering, 
Catholic University of America, Washington, DC; 
3Diseases of the Retina, and Uveitis, Johns Hopkins 
Univ,Wilmer Eye Inst, Baltimore, MD. 
6839 — D1169 Bloodflow Regulation In The 
Optic Nerve Head During Prolonged Elevation 
Of The Intraocular Pressure. John V. Lovasik1, 
H. Kergoat1, M. Parent1, M.G. Quigley2. 1School of 
Optometry, University of Montreal, Montreal, QC, 
Canada; 2Department of Ophthalmology, McGill 
Univ/Univ of Montreal, Montreal, QC, Canada. 
6840 — D1170 Sphingosine 1-Phosphate (S1P) 
Elicits Constriction of Isolated Porcine Retinal 
Arterioles by Activation of the Rho/ROCK 
Pathway. Takayuki Kamiya, T. Nagaoka, T. Omae, 
I. Tanano, S. Ono, A. Yoshida. Ophthalmology, 
Asahikawa Medical University, Asahikawa, Japan. 
6841 — D1171 Homocysteine Inhibits 
Endothelial-dependent Nitric Oxide-mediated 
Dilation Of Retinal Arterioles Via Enhanced 
Superoxide Production. Taiji Nagaoka, T. Omae, 
I. Tanano, A. Yoshida. Ophthalmology, Asahikawa 
Medical University, Asahikawa, Japan. 
6842 — D1172 Basal Blood Flow And 
Autoregulation Changes Within the Optic 
Nerve Head Of Rhesus Monkey With Idiopathic 
Bilateral Optic Atrophy. Chelsea Piper1, B. 
Fortune2, G. Cull1, C.F. Burgoyne1A, G.A. Cioffi1B, L. 
Wang3. AOptic Nerve Head Research Lab, BOphthal-
Discoveries in Sight, 1Devers Eye Institute, 
Portland, OR; 2Devers Eye Institute, Legacy Health, 
Portland, OR; 3Devers Eye Institute, Legacy 




 – 1:00 pm
409
*Refer to Program Number in the Commercial Relationships (CR) Index for Disclosures   –   f Refer to Program Number in the Clinical Trial (CT) Registration Index  –   T Travel Grant Awardee
6843 — D1173 Innervation Pattern Of 
NG2 Positive Pericytes In The Rat Choroid. 
Herbert A. Reitsamer1A, A. Trost1A, B. Bogner1A, C. 
Strohmaier1A, C. Runge1A, G. Grabner1A, L. Aigner1B, 
F. Schroedl1A,1C. AOphthalmology, BMolecular 
Regenerative Medicine, CAnatomy, 1Paracelsus 
University Salzburg, Salzburg, Austria. 
6844 — D1174 Retinal Arteriolar Reactivity 
Response Characteristics Assessed Using a 
Sinusoidal Hyperoxic Provocation. Richard W. 
Cheng1A, J.A. Fisher1A, J. Duffin1A, J.G. Flanagan2, 
T. Wong3, M. Jong1B, S.R. Patel3, A. Adleman1C, 
C. Hudson4. APhysiology, BOphthalmology and 
Vision Sciences, CMedical Science, 1University of 
Toronto, Toronto, ON, Canada; 2Dept of Ophthal & 
Vision Sci, Univ of Toronto,Toronto Western Hosp, 
Toronto, ON, Canada; 3Vision Science Division, 
University Health Network, Toronto Western 
Research Institute, Toronto, ON, Canada; 4School of 
Optometry, University of Waterloo, Waterloo, ON, 
Canada.*CR 
6845 — D1175 Signaling Pathway for Porcine 
Retinal Arteriolar Constriction to PKC 
Activation: Roles of L-type Voltage-operated 
Calcium Channels, Myosin Light Chain Kinase 
and Myosin Light Chain Phosphatase. Luke B. 
Potts1, L. Kuo1,2, W. Xu2, T.W. Hein2. 1SBTM, Texas 
A&M Health Science Ctr, Temple, TX; 2Surgery, 
Scott & White Memorial Hospital, Temple, TX. 
6846 — D1176 Correlation Of Retinitis 
Pigmentosa Disease Stage With Orbital Color 
Doppler Imaging. Amani S. Albakri, E. Al-Shahwan, 
S.R. Nowilaty. Vitreoretinal Division, King Khaled 
Eye Specialist Hospital, P.O Box 7191, Riyadh 
11462, Saudi Arabia. 
6847 — D1177 Theoretical Analysis Of 
Myogenic And Metabolic Responses In Retinal 
Blood Flow Autoregulation. Julia Arciero1, A. 
Pickrell2, B. Siesky3, A. Harris3. 1Mathematics, 
Indiana University-Purdue University Indianapolis, 
Indianapolis, IN; 2St. George’s University School 
of Medicine Grenada West Indies, Great River, 
NY; 3Ophthalmology, Indiana University School of 
Medicine, Indianapolis, IN. 
6848 — D1178 The Dcx-dsRed Transgenic Rat 
As A Model To Study Pericyte Function? Andrea 
Trost1A, F. Schroedl1A,1B, B. Bogner1A, C. Strohmair1A, 
C. Runge1A, G. Grabner1A, L. Aigner1C, H.A. 
Reitsamer1A. AOphthalmology/Optometry, BAnatomy, 
CMolecular Regenerative Medicine, 1Paracelsus 
Medical University, Salzburg, Austria. 
6849 — D1179 Caffeine Affects Ocular 
Microcirculation In Young Healthy Subjects. 
Naim Terai1A, E. Spoerl1A, R.P. Stodtmeister2, 
L.E. Pillunat1B. AOphthalmology, BDept of 
Ophthalmology, 1University of Dresden, Dresden, 
Germany; 2Ophthalmology, University Hospital Carl 
Gustav Carus, Rodalben, Germany. 
6850 — D1180 The Effect Of Adenosine On 
The Optic Nerve Head Blood Flow In Rabbits. 
Clemens Strohmaier, C. Runge, B. Bogner, A. 
Trost, F. Schrödl, G. Grabner, H.A. Reitsamer. 
Ophthalmology & Optometry, Paracelsus University, 
Salzburg, Austria. 
6851 — D1181 Lower Limit of Blood Flow 
Autoregulation in Optic Nerve Head. Lin Wang, 
G.A. Cull, C. Piper, C.F. Burgoyne, B. Fortune. 
Devers Eye Institute, Legacy Research Institute, 
Portland, OR. 
6852 — D1182 Effect of Aging on the Retinal 
Arterial Stiffness in Healthy Subjects. Eiichi 
Sato, T. Nagaoka, A. Takahashi, K. Sogawa, T. 
Omae, S. Nakabayashi, A. Yoshida. Ophthalmology, 
Asahikawa Medical University, Asahikawa, Japan. 
6853 — D1183 Changes In The Blood Volume 
Of The Optic Nerve Head By Epinephrine In 
Intravitreal Infusion Solution During Vitrectomy. 
Makoto Ubuka, Y. Onoda, K. Hitani, T. Shiba, Y. 
Hori, T. Maeno. Ophthalmology, Toho Univ Sakura 
Med Ctr, Sakura, Japan. 
6854 — D1184 Dilation of Porcine Retinal 
Arterioles via a cAMP/Protein Kinase A and 
AMP-Activated Protein Kinase-Dependent 
Mechanism with Cilostazol. Ichiro Tanano, T. 
Nagaoka, T. Omae, T. Kamiya, S. Ono, A. Yoshida. 
Ophthalmology, Asahikawa Medical University, 
Asahikawa, Japan. 
6855 — D1185 Effect of Intravitreal Rho 
Kinase Inhibitors on Retinal Microcirculation 
in Cats. Takafumi yoshioka, S. Nakabayashi, T. 
Nagaoka, T. Tani, A. Yoshida. Ophthalmology, 
Asahikawa Medical University, Asahikawa, Japan. 
6856 — D1186 Interocular Vascular 
Communication Through Collateral Vessels In 
An Experimental Pig Model. Hakan Moren1, B. 
Gesslein1, P. Undren2, S. Andreasson1, M. Malmsjö1. 
1Ophthalmology, Retinal Vascular Research, 
Lund University, Lund, Sweden; 2Department of 
Neuroradiology, Skåne University Hospital, Lund, 
Sweden. 
6857 — D1187 Dorzolamide-induced 
Vasorelaxation of Porcine Ciliary Arteries is 
Mediated by Nitric Oxide. Sidse Kringelholt1, U. 
Simonsen2, T. Bek1. 1Department of Ophthalmology, 
Aarhus University Hospital, Aarhus C, Denmark; 
2Department of Biomedicine, Aarhus University, 
Aarhus C, Denmark. 
6858 — D1188 The Effect Of Galanin On 
Choroidal Blood Flow In Rabbits And Rats. 
Christian Runge, B. Bogner, C. Strohmaier, F. 
Schrödl, A. Trost, G. Grabner, H.A. Reitsamer. 
Ophthalmology and Optometry, Paracelsus 
University, Salzburg, Austria. 
6859 — D1189 Relationship between 
Subfoveal Choroidal Thickness and Choroidal 
Circulation in Response to Increased Systemic 
Blood Pressure Induced by Cold Pressure 
Test. Kenji Sogawa1, T. Nagaoka1, T. Tani1, I. 
Tanano2, T. Omae2, A. Yoshida1. 1Ophthalmology, 
Asahikawa Medical University, Asahikawa, Japan; 
2Ophthalmology, Asahikawa Medical College, 
Asahikawa, Japan. 
6860 — D1190 Retinal Blood Flow Velocity 
in Patients with Active Uveitis Using the RFI. 
Sanjay R. Kedhar1, X. Feng2, R.B. Rosen1, C. 
Samson1. 1Ophthalmology, New York Eye & Ear 
Infirmary, New York, NY; 2Ophthalmology, Beijing 
Tongren Eye Center, Beijing, China. 
6861 — D1191 Time of Collapse of 
Spontaneous Venous Pulsation. Fabrice Moret1A, 
W.A. Lagrèze1B, C.M. Poloschek1B, M. Bach1A. ASect. 
Visual Function and Electrophysiology, BSect. 
Neuroophthalmology, 1Eye Hospital, University of 
Freiburg, Freiburg, Germany. 
6862 — D1192 Manometric Investigation Of 
The Relationship Between Pulsatile Ocular 
Blood Flow And Intraocular Pressure In 
Living Human Eyes. Nikolaos Karyotakis1, H.S. 
Ginis2A, A.I. Dastiridou3, M.K. Tsilimbaris2B, I.G. 
Pallikaris4. 1Medicine School, University Of Crete, 
Heraklion, Greece; AInstitute of Vision & Optics, 
BOphthalmology-Research Acct, 2University of 
Crete, Heraklion, Greece; 3Medicine School, 
University Of Larisa, Larisa, Greece; 4School of 
Medicine, University of Crete, Heraklion - Crete, 
Greece. f 
6863 — D1193 Mechanisms of Autoregulation 
of Retinal blood flow in Response to Decreased 
Ocular Perfusion Pressure in Cats; Comparison 
of Increased Intraocular Pressure and Decreased 
Systemic Blood Pressure. Tomofumi Tani, T. 
Nagaoka, S. Nakabayashi, K. Sogawa, A. Yoshida. 
Ophthalmology, Asahikawa Medical University, 
Asahikawa, Japan. 
6864 — D1194 Optic Nerve Head Capillaries 
Blood Oxygenation Following Dynamic Exercise 
in Human. Vasile Diaconu, P. Sauvageau, V. 
Vucea. Ecole D’optometrie, University of Montreal, 
Montreal, QC, Canada. 
6865 — D1195 Age Effects on Retinal Blood 
Flow Assessed Using Spectral-Domain Optical 
Coherence Tomography Doppler. Firdaus Yusof1,2, 
F. Tayyari1, J.G. Flanagan1,3, C. Hudson1,3. 1School 
of Optometry and Vision Sciences, University of 
Waterloo, Waterloo, ON, Canada; 2Department of 
Optometry and Visual Science, International Islamic 
University of Malaysia, Bandar Indera Mahkota, 
Kuantan, Malaysia; 3Department of Ophthalmology 
and Vision Sciences, University of Toronto, 
Toronto, ON, Canada.*CR 
6866 — D1196 Effect of Slow Releasing 
Hydrogen Sulfide Donor GYY4137 on Isolated 
Bovine Ciliary Artery. Madhura S. Kulkarni1A, 
Y. Njie-Mbye1A, C.A. Opere2, M. Whiteman3, S.E. 
Ohia1B. APharmaceutical Sciences, BProvost/
Academic Affairs, 1Texas Southern University, 
Houston, TX; 2Pharmacy Sciences, Creighton 
University, Omaha, NE; 3University of Exeter, 
Peninsula Medical School, Exeter, United Kingdom. 
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6867 — D1197 Intra-arterial Chemotherapy 
for the Management of Retinoblastoma in Eyes 
with Extensive (>50%) Retinal Detachment. 
Sotiria Palioura1,2, Y. Gobin3, S.E. Brodie1,4, I. 
Dunkel5, B. Marr1, D. Abramson1. 1Ophthalmic 
Oncology Service, Memorial Sloan-Kettering 
Cancer Center, New York, NY; 2Currently, 
Department of Ophthalmology, Massachusetts Eye 
and Ear Infirmary, Harvard Medical School, Boston, 
MA; 3Division of Interventional Neuroradiology, 
Departments of Radiology, Neurosurgery and 
Neurology, Weill Cornell Medical College, New 
York Presbyterian Hospital, New York, NY; 
4Department of Ophthalmology, Mount Sinai 
School of Medicine, New York, NY; 5Department 
of Pediatrics, Memorial Sloan-Kettering Cancer 
Center, New York, NY. T 
6868 — D1198 Effects Of Zeaxanthin On 
Cell Viability Of Cultured Human Uveal 
Melanoma Cells And Normal Ocular Cells In 
Vitro. Dan-Ning Hu1A, R.B. Rosen1B, M. Chen1C, 
S.A. McCormick1C. APathology & Ophthalmology, 
BOphthalmology, CPathology, 1New York Eye & Ear 
Infirmary, New York, NY.*CR 
6869 — D1199 Intraocular Treatments 
of a New Orthotopic Primary Human 
Retinoblastoma Xenograft. Nathalie Cassoux1A, 
F. Assayag1B, O. Chouchane-Mlik1C, F. Nemati1D, A. 
Thuleau1D, J-J. Fontaine2, I. Aets1E, L. Desjardins1A, 
F. Doz1F, D. Decaudin1G. AOphthalmology, 
BLaboratory of preclinical investigation, Cdpt 
of pathology, DLab of preclinical investigation, 
EDpt oncopediatry, FDpt of oncopediatry, Glab of 
preclinical investigation, 1Institut Curie, Paris, 
France; 2Dpt pathology, Veterinary school, Maison 
Alfort, France. 
6870 — D1200 RXRG Agonist Bexarotene 
Suppresses Retinoblastoma Growth by 
Enhancing TRB1 and p53 Tumor Suppressor 
Activity. Xiaoliang L. Xu1A, R. Jia1A,2, H. Huang1A, 
W. Joseph1A, N. Zhou1A, D.H. Abramson1B, X. 
Fan2, S.C. Jhanwar1A. ADepartment of Pathology, 
BOphthalmic Oncology Service, 1Memorial 
Sloan Kettering Cancer Center, New York, NY; 
2Department of Ophthalmology, Shanghai Jiaotong 
University, Shanghai, China. 
6867 – 6884 – Thursday – Posters
6871 — D1201 The Protein Kinase C (PKC)/
Protein Kinase D (PKD)/Steroid Receptor 
Coactivator (SRC)-3 pathway is an important 
therapeutic target in Gα-mutant Uveal 
Melanomas. Vassiliki Poulaki1, S. Chew2A, B. 
He2A, V. Eedunuri3, D. Bedoya2A, M.J. Jager4, B.W. 
O’Malley2B, N. Mitsiades2A. 1Ophthalmology, VA 
Boston Healthcare System, Boston University, 
Boston, MA; AMedicine/Molecular and Cellular 
Biology, BMolecular and Cellular Biology, 2Baylor 
College of Medicine, Houston, TX; 3Adrienne 
Helis Malvin Medical Research Foundation, New 
Orleans, LA; 4Ophthalmology, Leiden University 
Med Center, Leiden, The Netherlands. 
6872 — D1202 Periocular Tissue Concentration 
of Propranolol after Delivery with a Gel-forming 
Solution. Michael B. Yang1A, J. Hao1B, H. Liu1B, 
S. Li1B. AAbrahmson Pediatric Eye Institute/
Ophthalmology, Cincinnati Children’s Hospital, 
College of Medicine, BDivision of Pharmaceutical 
Sciences/Winkle College of Pharmacy, 1University 
of Cincinnati, Cincinnati, OH.*CR 
6873 — D1203 Outcomes Of Rho-kinase 
Inhibition On The Metastatic Profile Of A Uveal 
Melanoma Cell Line. Aizhan Tapenbayeva, J. 
Lüke, M. Lüke, S. Grisanti, A. Tura. Ophthalmology, 
University of Lübeck, Lübeck, Germany. 
6874 — D1204 Nicotinamide Treatment 
Decreases Secretion of Angiogenic and 
Inflammatory Cytokines in Uveal Melanoma 
Cell Lines. Shawn C. Maloney, S. Hari, T. Granner, 
E. Antecka, C. Miyamoto, M.N. Burnier, Jr. 
Ophthalmology, McGill University, Montreal, QC, 
Canada. 
6875 — D1205 Two Years Report: New 
Experience With Ranibizumab Against 
Choroidal Melanoma. Peter E. Liggett1A, V.A. Kon 
Jara1B, G. Haffner1A. AOphthalmology, BRetina, 
1New England Retina Associates, Hamden, CT. f 
6876 — D1206 Therapeutic Efficacy By 
Targeting Correction Of Notch1-induced 
Aberrants In Uveal Tumors. Xiaolin Huang1, L. 
Wang2, H. Zhang2, R. Jia1, H. Wang2, X. Zhao1,2, G. 
Qian2, A.D. Singh3, S. Ge1, X. Fan1. 1Department of 
Ophthalmology, Ninth People’s Hospital, Shanghai 
Jiaotong University School of Medicine, Shanghai, 
P.R., China; 2Department of Biochemistry and 
Molecular Biology, Shanghai Jiaotong University 
School of Medicine, Shanghai, P.R., China; 3Cole 
Eye Institute, Cleveland, OH. 
6877 — D1207 Towards a Novel Therapy for 
Uveal Melanoma: Targeting Oncogenic Gα
q
. 
Timothy W. Corson, K. Sishtla. Glick Eye Institute, 
Department of Ophthalmology, Indiana University 
School of Medicine, Indianapolis, IN. 
6878 — D1208 Topical Timolol for the 
Treatment of Benign Vascular Periocular 
Lesions. Raymond G. Areaux, Jr., D. Yoo. 
Ophthalmology, Loyola University Chicago, 
Maywood, IL. f 
6879 — D1209 Association Of Ocular 
Findings And Preventive Therapy With Onset 
Of Cerebral Involvement In Patients With 
Primary Intraocular Lymphoma. Noriyasu 
Hashida1, K. Nakai1, N. Ohguro2, K. Nishida2. 
1Dept of Ophthalmology, Osaka University, Suita, 
Japan; 2Department of Ophthalmology, Osaka 
Koseinennkinn Hospital, Osaka, Japan. 
6880 — D1210 Syringes Design Used for 
Intravitreal Injection Influences Dosing 
Accuracy and Drug Wastage. David M. Krumholz. 
Clinical Sciences, SUNY College of Optometry, 
New York, NY. 
6881 — D1211 Precise Modeling of the Eye 
for Proton Beam Radiotherapy of Intraocular 
Tumors. Michael B. Rueegsegger1A,1B, J.H. 
Kowal1A,1B, S. Wolf1B. AARTORG Center Ophthalmic 
Technologies, BDepartment of Ophthalmology, 
1University of Bern, Bern, Switzerland. 
6882 — D1212 In Vivo Confocal Microscopy 
Study Of Conjunctival Intraepithelial Neoplasia 
Treated With Interferon-alpha2b. Hyunjoo J. 
Lee1,2A, R. Dunphy2B, M. Daly2A,1, D. Siracuse-
Lee2A,1. 1Ophthalmology, Boston Medical Center 
/ Boston University School of Medicine, Boston, 
MA; AOphthalmology, BOptometry, 2Veterans 
Affairs Boston Healthcare System, Boston, MA. 
6883 — D1213 Expression Of N-glycolyl Gm3 
In Retinoblastoma, A Promising Candidate For 
Targeted Therapies. Ana Vanesa Torbidoni, A. 
Scursoni, S. Camarero, C. Sampor, G. Chantada, 
M.T. de Davila. Hospital de Pediatri a Prof. Dr. Juan 
P. Garrahan, Capital Federal, Argentina. 
6884 — D1214 Sulindac Protects RPE Cells 
Against Oxidative Damage but Enhances the 
Killing of Retinoblastoma Cells Exposed to 
Oxidative Stress. Arunodoy Sur1A, H.M. Prentice1B, 
H. Weissbach2, J.C. Blanks1C. AIntegrative Biology 
Phd Program, Dept of Biology, BCharles E Schimdt 
College of Medicine, CCenter for Complex Systems 
& Brain Sci, 1Florida Atlantic University, Boca 
Raton, FL; 2Center For Cellular and Molecualr 
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6885 — 1:15 Modeling Wet AMD Using Patient-
Specific iPSC-Derived RPE Cells. Martin Krupa, 
X. Zhu, H. Du, J. Luo, G. Hughes, J. Zhu, X. Wei, 
P. Shaw, J. Zhao, K. Zhang. Institute for Genomic 
Medicine and Shiley Eye Center, University of 
California, San Diego, La Jolla, CA. 
6886 — 1:30 Acid Sphingomyelinase Deficiency 
Induces Age-related Degeneration In The Mouse 
Retina. Bill X. Wu1, J. Fan2, J.W. Jenkins1, Y. 
Koutalos2, R.K. Crouch2, C.E. Crosson2, M. Kono2, 
Y.A. Hannun1. 1Biochemistry and Molecular Biology, 
Medical University of South Carolina, Charleston, 
SC; 2Ophthalmology, Medical Univ of South 
Carolina, Charleston, SC. 
6887 — 1:45 Idebenone Prevents Retinal 
Pigmentepithelium (RPE) Cells from Oxidative 
Stress and Senescence. Nicole Arend, S. Koenig, 
P. Laubichler, A. Wolf, C. Haritoglou, M.W. Ulbig, 
A. Kampik, M. Kernt. Ophthalmology, Ludwig-
Maximilians-University, Munich, Germany. 
6888 — 2:00 Canine Bestrophinopathies: 
Lesion Morphology and Molecular Pathology. 
Karina E. Guziewicz1A, A.V. Cideciyan2, W.A. 
Beltran1A, B. Zangerl1A, J. Slavik1A, S. Iwabe1A, K. 
Boesze-Battaglia1B, R.F. Mullins3, S.G. Jacobson2, 
G.D. Aguirre1A. AClinical Studies, BBiochemistry, 
1University of Pennsylvania, Philadelphia, 
PA; 2Scheie Eye Institute, Philadelphia, PA; 
3Ophthalmology and Visual Sciences, University of 
Iowa, Iowa City, IA. 
6889 — 2:15 Integration, Survival and Function 
of Transplanted RPE Stem Cells into Mouse 
Models of Geographic Atrophy. C Nathaniel 
Roybal1A, S.S. Sarfare1A, C.X. Ruan1A, J. Hu1A, S. 
Habib1A, J. Kong1B, G. Fan1B, S. Nusinowitz1A, D. 
Bok1A, G.H. Travis1A. AJules Stein Eye Institute, 
BHuman Genetics, 1UCLA School of Medicine, Los 
Angeles, CA. 
6890 — 2:30 STGD3 Mutant Exerts A 
Dominant Negative Effect On Elovl4 Enzymatic 
Activity During VLC-PUFA Biosynthesis. 
Sreemathi Logan1A, M-P.G. Agbaga1B, M.D. Chan1B, 
R.S. Brush1B, R.E. Anderson1B,2. ACell Biology, 
BOpthalmology, 1University of Oklahoma HSC, 
Oklahoma City, OK; 2Dean A. McGee Eye Institute, 
Oklahoma City, OK. 
6891 — 2:45 Cell Death in rd2/rds Retina: An 
Apoptotic Process? Francois Paquet-Durand1, S. 
Bernhard-Kurz1, B. Arango-Gonzalez2A, E. Zrenner2B, 
M. Ueffing3. 1Experimental Ophthalmology, Institute 
for Ophthalmic Research, Tuebingen, Germany; 
AExperimental Ophthalmology, BInstitute for 
Ophthalmic Research, 2Centre for Ophthalmology, 
Tuebingen, Germany; 3Institute for Ophthalmic 
Research, University Eye Hospital, Tuebingen, 
Germany. 
Floridian BCD




6892 — 1:15 Patient Specific Finite Element 
Cornea Model. David Varssano1,2A, R. Asher2B, E. 
Moisseiev1,2A, A. Gefen2B. 1Ophthalmology, Tel Aviv 
Medical Center, Tel Aviv, Israel; ASackler School of 
Medicine, BDept. of Biomedical Engineering, 2Tel 
Aviv University, Tel Aviv, Israel. 
6893 — 1:30 Conservation of Arclength in 
Keratoconic and Normal Corneas with Air Puff 
Induced Deformation. Cynthia J. Roberts1A,1B, 
A.M. Mahmoud1A,1B, J. Liu1B,1A, Z. Sharalaya1C, T.F. 
Mauger1A, R.G. Lembach1A,1B, A.J. Hendershot1A, 
R. Kuennen1A, S.D. Klyce2. AOphthalmology, 
BBiomedical Engineering, CCollege of Medicine, 
1The Ohio State University, Columbus, OH; 
2Ophthalmology, Mount Sinai School of Medicine, 
New York, NY.*CR 
6894 — 1:45 A New Approach to 
Experimentally Determine Human Corneal 
Biomechanical Characteristics Using OCT 
Applied to an Anisotropic Finite Element Model. 
Wallace Chamon1A, O. Ozturk1A, D. Fahd1A, N. 
Allemann1A, J. De la Cruz1A, M.S. Cortina1A, C. 
Foster1B, D.T. Azard1A, S. Jain1A. AOphthalmology 
& Visual Sciences, BCollege of Engineering, 
1University of Illinois at Chicago, Chicago, IL. 
6895 — 2:00 Numerical analysis of the 
influence of Intraocular Pressure on the 
photorefractive keratectomy for myopia 
correction. Maria A. del Buey1,2, E. Lanchares3, 
J.A. Cristóbal1,2, B. Calvo3, F.J. Ascaso1, L. Lavilla1, 
C. Palomino4, N. Cruz1, P. Casas1. 1Ophthalmology, 
Lozano Blesa University Clinic Hospital, Zaragoza, 
Spain; 2Quiron Hospital, Zaragoza, Spain; 
3Mechanical Engineering, University of Zaragoza, 
Zaragoza, Spain; 4Ophthalmology, Quiron Hospital, 
Madrid, Spain. 
6896 — 2:15 Estimation Of Modulus Change 
After Corneal Crosslinking (cxl) Using Multiple 
Post-cxl Topographies And Inverse Finite 
Element. Abhijit Sinha Roy1, B. Fant2, K. Rocha1, 
W. Dupps, Jr.1. 1Ophthalmology, Cleveland Clinic 
Cole Eye Inst, Cleveland, OH; 2Clinical Research 
Consultants, Cincinnati, OH.*CR, f 
6897 — 2:30 Quantification of Changes in 
Optical Properties of Cornea with Stress In 
Vitro. Ashutosh Richhariya1A, V.S. Sangwan2, 
S. Punjabi3, G. Yoon1A,1B. AFlaum Eye Institute, 
BThe Institute of Optics, 1University of Rochester, 
Rochester, NY; 2Cornea & Ocular Immunology, LV 
Prasad Eye Institute, Hyderabad, India; 3Mechanical 
Engineering, Ujjain Engineering College, Ujjain, 
India. 
6898 — 2:45 Fibrin Glue Provides Structural 
Rigidity And Inhibits Folding Propensity of 
Descemet’s Membrane. Shyam S. Chaurasia1, R. 
Champakalakshmi1, R. Poh1, X.W. Tan1, D.T. Tan2, 
J.S. Mehta3. 1Tissue Engineering and Stem Cell 
Group, Singapore Eye Research Inst, Singapore, 
Singapore; 2Ophthalmology, Singapore National 
Eye Centre, Singapore, Singapore; 3Cornea 
Refractive Tissue Engineering, SNEC / SERI, 
Singapore, Singapore. 
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6899 — 1:15 Corneal Transplant Rejection In 
NIH Miniature Swine Is Associated With Donor-
recipient Mismatches In A Region Containing 
The Homologue Of The Mouse Zfp106 Gene 
Encoding The H3a Antigen. Susan M. Nicholls1A, 
L.K. Mitchard1B, R. Pong-Wong2, R. Harley1B, 
A.D. Dick1A, A.L. Archibald2, M. Bailey1B. AUnit of 
Ophthalmology, School of Clinical Sciences, BSchool 
of Veterinary Sciences, 1University of Bristol, 
Bristol, United Kingdom; 2Division of Genetics 
and Genomics, The Roslin Institute and R(D)
SVS, University of Edinburgh, Edinburgh, United 
Kingdom. 
6900 — 1:30 In Vivo Imaging Of T Cell 
Trafficking In Eyes During Spondyloarthritis. 
Ellen J. Lee1, H. Kim2, S.R. Planck1, J.T. 
Rosenbaum1, H.L. Rosenzweig1. 1Casey Eye Institute, 
Oregon Health & Science Univ, Portland, OR; 
2Ophthalmology, Inje University, Pusan, Republic of 
Korea. 
6901 — 1:45 Ifn-γ Is Critical For Disease 
Pathogenesis In A Spontaneous Mouse Model Of 
Autoimmune Uveitis. Jun Chen, R. Horai, P. Silver, 
C-C. Chan, R. Caspi. Lab of Immunology, National 
Eye Inst/NIH, Bethesda, MD. 
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6902 — 2:00 Different Subsets Of Tumor-
infiltrating Lymphocytes Correlate With 
Macrophage Influx And Monosomy 3 In Uveal 
Melanoma. Inge H. Bronkhorst1A, T. Vu1A, E.S. 
Jordanova1B, G.P. Luyten1A, S.H. van der Burg1C, 
M.J. Jager2. AOphthalmology, BPathology, CClinical 
Oncology, 1Leiden University Medical Center, 
Leiden, The Netherlands; 2Ophthalmology, Leiden 
University Med Center, Leiden, The Netherlands. 
6903 — 2:15 Il-4 Conditions Macrophage In 
Vitro and Retina In Vivo to Generate Soluble Flt-1 
Expression and Inhibit Laser-induced CNV in 
Mice. Wei-Kang wu1A, L.B. Nicholson1A, A.D. Dick1B. 
ASchool of Cellular and Molecular Medicine, BSchool 
of Clinical Sciences, 1University of Bristol, Bristol, 
United Kingdom. 
6904 — 2:30 Local Generation of Regulatory 
T Cells in the Retina. Scott W. McPherson, 
N.D. Heuss, D.S. Gregerson. Department of 
Ophthalmology, University of Minnesota, 
Minneapolis, MN. 
6905 — 2:45 Decreased Interleukin-27 
Expression is Associated with Active Uveitis 
in Behcet’s Disease. Peizeng Yang1, C. Wang1, Y. 
Tian1, Z. Ye1, A. Kijlstra2. 1Ophthal, The 1st Hosp, 
Chongqing Medical University, Chongqing, China; 
2Ophthal, University Hospital Maastricht, Maastricht, 
The Netherlands. 
Room 305




6906 — 1:15 A Role for Wnt-Frizzled Signaling 
During FGF-induced Fiber Differentiation. 
John W. McAvoy, L.J. Dawes, Y. Sugiyama, L. Wen, 
F.J. Lovicu. Ophthalmology, Save Sight Institute, 
University of Sydney, Australia. 
6907 — 1:30 ERK1/2 Signaling is Required for 
Lens Cell Survival and Fiber Cell Differentiation 
during Development. Dinesh Upadhya, L. Reneker. 
Ophthalmology, Mason Eye Institute, Columbia, 
MO. 
6908 — 1:45 Genome-wide Identification Of 
Genes And MicroRNAs Regulated By Fgf2 
During In Vitro Lens Fiber Cell Differentiation. 
Louise V. Wolf1, C.C. Gao2, K. Gueta3, N. Podduturi4, 
P.S. Zelenka2, R. Ashery-Padan3, J. Zavadil4, A. 
Cvekl1. 1Ophthalmology & Visual Sciences and 
Genetics, Albert Einstein College of Medicine, 
Bronx, NY; 2LMDB, NEI, Bethesda, MD; 3Sackler 
School of Medicine, Tel Aviv University, Tel Aviv, 
Israel; 4Langone Center, NYU, New York, NY. 
6909 — 2:00 Inhibiton Of Human 
Lens Epithelial Cell Contraction By 
Alkylphosphocholines For PCO Prophylaxis And 
Downregulation Of The PI3K Pathway. Raffael 
Liegl, M. Kernt, A. Wolf, D. Kook, C. Haritoglou, 
A. Kampik, K.H. Eibl-Lindner. Department of 
Ophthalmology, Ludwig-Maximilians-University, 
Munich, Germany. 
6910 — 2:15 A Putative Role for Histamine 
Releasing Factor in Posterior Capsule 
Opacification. I M. Wormstone1, J.K. Kular1, 
J.R. Reddan2, L.J. Dawes3. 1School of Biological 
Sciences, University of East Anglia, Norwich, United 
Kingdom; 2Biological Sciences, Oakland University, 
Rochester, MI; 3Save Sight Institute, University of 
Sydney, Sydney, Australia. 
6911 — 2:30 Cataract EPHA2 SAM Domain 
Mutations Alter Receptor Stability and Function. 
Jeong Eun Park1, A.I. Son1, R. Hua2, X. Zhang2, 
R. Zhou1. 1Department of Chemical Biology, 
Susan Lehman-Cullman Laboratory for Cancer 
Research, Ernest Mario School of Pharmacy, Rutgers 
University, Piscataway, NJ; 2McKusick-Zhang Center 
for Genetic Medicine and State Key Laboratory 
of Medical Molecular Biology, Institute of Basic 
Medical Sciences, Chinese Academy of Medical 
Science & Peking Union Medical College, Beijing, 
China. 
6912 — 2:45 Evaluation Of Doxorubicin 
Loaded Mepeg-pcl Nanoparticle For Prevention 
Of Posterior Capsular Opacification. Aditya 
Konar1, R. Guha1, S. Chowdhary1, H. Palui2A, A. 
Mishra2B, G.K. Vemuganti3, S. Basak4, T.K. Mandal2B, 
S. Hazra2A. 1IICB, Kolkata, India; AVeterinary 
Surgery & Radiology, BVeterinary Pharmacology 
& Toxicology, 2West Bengal University of Animal 
& Fishery Sciences, Kolkata, India; 3Dean, School 
of Medical Sciences, University of Hyderabad, 
Hyderabad, India; 4Eye Bank, Disha Eye Hospital, 
Barrackpore, India. 
Room 315






6913 — 1:15 Light Adaptation at Distinct 
Intensity Levels within the Photopic Regime. 
Alexandra Tikidji-Hamburyan, T.A. Münch. Centre 
for Integrative Neuroscience, University Tuebingen, 
Tuebingen, Germany. T 
6914 — 1:30 What Information Does The Eye 
Send To The Brain? Recording The Entire Visual 
Output At A Single Retinal Location. Tom Baden1A, 
P. Berens1B, M. Bethge1B, T. Euler1A. ABCCN / CIN, 
BBCCN / CIN / MPI, 1University of Tuebingen, 
Tuebingen, Germany. 
6915 — 1:45 The Morphology and Physiology of 
Blue/Green Ganglion Cells in the Rabbit Retina. 
Stephen L. Mills, L-M. Tian. Ophthalmology & 
Visual Science, Univ of Texas Houston Med Sch, 
Houston, TX. 
6916 — 2:00 Nicotinic Block Reduces Direction 
Selectivity to Moving Gratings by Increasing 
Amplitude and Shifting Phase of Null Direction 
Excitation. Mikhail Y. Lipin1, W.R. Taylor2, R.G. 
Smith3. 1Department of Biomedical Sciences, 
Colorado State University, Fort Collins, CO; 2Casey 
Eye Institute, Opthalmology, Oregon Health Sciences 
University, Portland, OR; 3Dept of Neuroscience, 
University of Pennsylvania, Philadelphia, PA. 
6917 — 2:15 Optimal Weighting of Inhibition 
and Excitation to an Off Alpha Ganglion Cell. Jan 
Homann, M.A. Freed. Neuroscience, University of 
Pennsylvania, Philadelphia, PA. 
6918 — 2:30 Developmental Characterization 
Of NMDA Receptor Expression In Identified 
Retinal Ganglion Cells Of The Mouse Retina. Ben 
Stafford1, K.Y. Wong1, J.B. Demb2. 1Ophthalmology 
and Visual Sciences, University of Michigan, Ann 
Arbor, MI; 2Ophthalmology & Visual Sciences, Yale 
University, New Haven, CT. 
6919 — 2:45 Tyrosine Kinase Fyn Regulates The 
Development Of Retinal Ganglion Cell Dendritic 
And Axonal Maturation. Ning Tian, H. Chen, P. 
Wang. Ophthalmology & Visual Science, University 
of Utah, Salt Lake City, UT. 
Palm A





6920 — 1:15 The REPAIR Study: Prospective, 
Multi-center Trial of ranibizumab in Choroidal 
Neovascularization due to Pathological Myopia 
- Interim Analysis. Adnan Tufail, REPAIR Study 
Group. Ophthalmology, Moorfields Eye Hospital, 
London, United Kingdom.*CR, f 
6921 — 1:30 Choroidal thickness associated 
with spherical equivalent in healthy young 
adults: The Raine Eye Health Study. Alexander X. 
Tan1A, H. Forward1A, C. McKnight1A, S. Yazar1A, C. 
Pennell1B, J. Mountain1B, T.L. Young2, A.W. Hewitt3, 
D.A. Mackey1A, F.K. Chen1A. ALions Eye Institute, 
BTelethon Institute for Child Health Research, 
1University of Western Australia, Perth, Australia; 
2Ophthalmology, Duke University Eye Center, 
Durham, NC; 3Department of Ophthalmology, 
Centre for Eye Research Australia, Surrey Hills, 
Australia. 
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6922 — 1:45 Pathological Myopia: A New 
Perspective on Tilted Discs Using Spectral 
Domain-Enhanced Depth Imaging Optical 
Coherence Tomography. Danielle S. Strauss1, 
K. Mukkamala2, R.F. Spaide3, L. Yannuzzi3A. 
1Department of Ophthalmology, New York 
University Medical Center, New York, NY; 
2Ophthalmology, Vitreous Retina Macula 
Consultants of New York, New York, NY; 
ADepartment of Ophthalmology, 3Vitreous Retina 
Macula Consultants NY, New York, NY. 
6923 — 2:00 Central and Peripheral 
Outer Nuclear Layer Thickness Differences 
between Myopes and Hyperopes/Emmetropes 
using Spectral Domain Optical Coherence 
Tomography. Christopher A. Clark1, A.E. Elsner2, 
T.Y. Chui3. 1School of Optometry, University of 
Indiana, Bloomington, IN; 2Optometry, Indiana 
University, Bloomington, IN; 3Optometry, Indiana 
University, Bloomington, IN. 
6924 — 2:15 Choroidal Changes in Myopic 
Eyes Affected by Choroidal Neovascularization. 
Mario R. Romano1,2, M. Rinaldi3, F. Chiosi3, 
R. dell’Omo2, F. Parmeggiani4, F. Semeraro5, 
C. Costagliola2. 1Ophthalmology, Istituto 
Clinico Humanitas, Milan, Italy; 2University of 
Molise, Campobasso, Italy; 3Ophthalmology, 
Second University of Naples, Naples, Italy; 
4Ophthalmology, university of Ferrara, Ferrara, 
Italy; 5Ophthalmology, University of Brescia, 
Brescia, Italy. 
6925 — 2:30 Peripheral Refraction During 
Accommodation In Children Treated 
By Orthokeratology. Zhi Chen, X. Zhou. 
Ophthalmology & Visual Science, Fudan University 
EENT Hospital, Shanghai, China. f 
6926 — 2:45 Association of Paired Box 6 
gene with High Myopia in Japanese. Masahiro 
Miyake1, K. Yamashiro1, H. Nakanishi1, H. 
Hayashi1, I. Nakata1, Y. Akagi-Kurashige1, A. 
Tsujikawa1, K. Ohno-Matsui2, M. Mochizuki2, N. 
Yoshimura1. 1Department of Ophthalmology, Kyoto 
University Graduate School of Medicine, Kyoto, 
Japan; 2Department of Ophthalmology, Tokyo 
Medical and Dental University Graduate School of 
Medicine, Bunkyo-Ku, Japan. 
Grand A




6927 — 1:15 Bevacizumab for Macular Edema 
in Central Retinal Vein Occlusion: A prospective, 
randomized, double-blind clinical study. David 
L. Epstein1, P.V. Algvere2, G.C. von Wendt3A, S. 
Seregard2A, A.P. Kvanta3B. 1Posterior Segment, 
St Erik Eye Hospital, Stockholm, Sweden; 
AOphthalmic Path & Oncol Svc, 2Karolinska Inst/
St Eriks Eye Hosp, Stockholm, Sweden; ADept of 
Vitreoretinal Diseases, BOphthalmology, 3St Erik’s 
Eye Hospital, Stockholm, Sweden. f 
6928 — 1:30 Long Term Evaluation of 
the Visual Prognosis in Patients Treated 
With Dexamethasone Intravitreal Implant 
(Ozurdex) for Macular Edema Due to Retinal 
Vein Occlusion. Elad Moisseiev1, M. Goldstein2, 
M. Waisbourd1, A. Barak1, A. Loewenstein3. 
1Ophthalmology, Tel Aviv Medical Center, Tel Aviv, 
Israel; 2Ophthalmology, Tel-Aviv Medical Center, 
Tel-Aviv, Israel; 3Ophthalmology, Tel-Aviv Medical 
Center, Tel Aviv, Israel.*CR T 
6929 — 1:45 Intravitrial Aflibercept Injection 
for Macular Edema in Central Retinal Vein 
Occlusion: 1-year Results of the Phase 3 
GALILEO Study. Frank G. Holz1, Y. Ogura2, J. 
Roider3, J-F. Korobelnik4, B. Stemper5, R. Vitti6, 
A.J. Berliner6, F. Hiemeyer7, R. Sandbrink5A, O. 
Zeitz8. 1Ophthalmology, University of Bonn, Bonn, 
Germany; 2Ophthalmology, Nagoya City University 
Graduate School of Medical Science, Nagoya, 
Germany; 3Klinik fur Ophthalmologie, University 
of Kiel, Kiel, Germany; 4Service d’Ophtalmologie, 
Hopital Pellegrin, Bordeaux, France; AGCD TA 
NOHI, 5Bayer HealthCare, Berlin, Germany; 
6Ophthalmology, Regeneron, Tarrytown, NY; 7Bayer 
Health Care, Berlin, Germany; 8Global Clinical 
Development, Bayer HealthCare AG, Berlin, 
Germany.*CR, f 
6930 — 2:00 Macular Edema After Uneventful 
Phacoemulsification Detected By Ocular 
Coherence Tomography (OCT). Luiz Felipe Q. 
Silveira1, G.A. Pellegrini2, M. Harasawa1, G.A. 
Carlos1, J.C. Souza3, T. Leite1, G.S. Pierozzi1, 
A.F. Bordon4. 1Retina, Hospital Oftalmologico 
de Sorocaba, Sorocaba, Brazil; 2Hospital 
Oftalmologico de Sorocaba, Indaiatuba, Brazil; 
3Retina, Hospital de Olhos de Sorocaba, Sorocaba, 
Brazil; 4Ophthalmology UNIFESP-EPM, Federal 
Univ of Sao Paulo, Sao Paulo, Brazil. 
6931 — 2:15 Clinical Classification of 
Autosomal Dominant Cystoid Macular Edema 
and Genetic Fine Mapping of the Underlying 
Defect. Nicole T. Saksens1A, M.R. Duvvari1A, K. 
Neveling1B, J.J. van Lith-Verhoeven1A,1B, M.A. van 
Driel1B, F.P. Cremers1B, A.I. Den Hollander1A,1B, 
C.C. Hoyng1A. AOphthalmology, BHuman Genetics, 
1Radboud University Nijmegen Medical Center, 
Nijmegen, The Netherlands. T 
6932 — 2:30 Incidence Of Macular Edema 
(ME) In Fingolimod (FTY720) Multiple 
Sclerosis (MS) Clinical Program. Marco A. 
Zarbin1, A. Reder2, W. Collins3, G. Francis4, 
X. Zhang4, L.Y. Kappos5, J. Cohen6. 1Inst. of 
Ophthalmology & Visual Science, UMDNJ-New 
Jersey Medical School, Newark, NJ; 2Neurology, 
University of Chicago, Chicago, IL; 3Novartis 
Pharm AG, Basel, Switzerland; 4Novartis Pharma 
AG, Basel, Switzerland; 5University of Basel, 
Basel, Switzerland; 6Neurology, Cleveland Clinic 
Foundation, Cleveland, OH.*CR, f 
6933 — 2:45 C-REALITY (Canadian Burden 
of Diabetic Macular Edema Observational 
Study). John R. Gonder1, V. Walker2, N. Zaour3, M. 
Barbeau3, L. Hemsley2, R. Li3. 1Ophthalmology, Ivey 
Eye Institute, London, ON, Canada; 2OptumInsight, 
Burlington, ON, Canada; 3Novartis Pharmaceuticals 
Canada Inc, Montreal, QC, Canada.*CR 
Grand B
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6934 — 1:15 Socioeconomic Disparity in Access 
to Eye Care Services among U.S. Adults with 
Age-related Eye Diseases Emerged during 2002 
and 2008. Xinzhi Zhang1A, P. Nair1, G. Beckles1, 
C-F. Chou2, L. Geiss1, A. Ryskulova3, J. Saaddine1A. 
AVision Health Initiative, 1CDC, Atlanta, GA; 
2Division of Diabetes Translation, CDC/Ginn Group 
Inc, Atlanta, GA; 3CDC, Hyattsville, MD. 
6935 — 1:30 Affordability of Cataract Surgery 
using the Big Mac Index. Van C. Lansingh1, M.J. 
Carter2, K.L. Winthrop3, J.M. Furtado4. 1Agency for 
the Prevention of Blindness/VISION 2020, Weston, 
FL; 2Strategic Solutions, Inc, Cody, WY; 3Casey Eye 
Institute, Portland, OR; 4Casey Eye Institute, Oregon 
Health & Science Univ, Portland, OR.*CR 
6936 — 1:45 After Multiple Rounds of Mass 
Drug Administration for Trachoma, are there 
only “Trachoma families” left? Sheila K. West1, 
B.E. Munoz1, H. Mkocha2, C. Gaydos3, T. Quinn4. 
1Ophthalmology, Johns Hopkins Wilmer Eye 
Inst, Baltimore, MD; 2Kongwa Trachoma Project, 
Kongwa, Tanzania, United Republic of; 3Department 
of Infectious Diseases, Johns Hopkins University, 
Baltimore, MD; 4National Institute of Allergy and 
Infectious diseases, National Institute of Allergy and 
Infectious diseases, NIH,, Bethesda, MD. 
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6937 — 2:00 Characteristics of Patients 
Presenting to the Emergency Department with 
Sight-Threatening Ocular Conditions. Dolly A. 
Padovani-Claudio, N. Talwar, P.P. Lee, J.D. Stein. 
Ophthalmology & Visual Sciences, Kellogg Eye 
Center, Ann Arbor, MI. 
6938 — 2:15 Prevalence of Functional 
Low Vision and Need for Annualized Eye 
Evaluation in Adult Malays and Indians Living 
in Singapore. Yingfeng Zheng1,2, C-Y. Cheng1,3, 
E.L. Lamoureux, III4,1, P. Chiang1,5, A. Anuar1,6, T. 
Aung1,3, S-M. Saw1,7, T.Y. Wong1,8. 1Singapore Eye 
Research Institute, Singapore National Eye Centre, 
Singapore, Singapore; 2State Key Laboratory of 
Ophthalmology, Zhongshan Ophthalmic Center, Sun 
Yat-sen University, Guangzhou, China; 3Department 
of Ophthalmology, Yong Loo Lin School of 
Medicine, National University of Singapore, 
Singapore, Singapore; 4Ophthalmology, University 
of Melbourne, Melbourne, Australia; 5Duke-National 
University of Singapore Graduate Medical School, 
Singapore, Singapore; 6University of Malaya Eye 
Research Centre, Faculty of Medicine, University 
of Malaya, Kuala Lumpur, Malaysia; 7Saw Swee 
Hock School of Public Health, National University 
of Singapore, Singapore, Singapore; 8Centre for 
Eye Research Australia, University of Melbourne, 
Melbourne, Australia. 
6939 — 2:30 Excess Expenditures, Excess 
Informal Care Days, and Quality of Life 
Decrements Associated with Self-Reported 
Visual Impairment and Blindness. Kevin D. 
Frick1A, L.L. Grover2, E. Wehler1. AHealth Policy and 
Management, 1Johns Hopkins Bloomberg Sch of 
Public Hlth, Baltimore, MD; 2Ophthalmology, Johns 
Hopkins Univ Wilmer Eye Inst, Baltimore, MD. 
6940 — 2:45 Lack Of Government-insured 
Annual Eye Examinations Increases The Risk Of 
Vision Problems Amongst Low-income Elderly. 
Yaping Jin1, Y.M. Buys1, J. Xiong2, G.E. Trope3. 
1Ophthalmology & Vision Sciences, University 
of Toronto, Toronto, ON, Canada; 2University of 
Waterloo, Waterloo, ON, Canada; 3Ophthal/Toronto 
Western Hosp, University Toronto, Toronto, ON, 
Canada. 
Grand D
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6941 — 1:15 Increased Immune Response 
Against Ocular Tissue After Immunization With 
An Optic Nerve Antigen. Stephanie C. Joachim1, 
O.W. Gramlich2, P. Laspas2, S. Kuehn1, H.D. von 
Pein3, B. Dick1, F.H. Grus2. 1Experimental Eye 
Research Institute, Ruhr University, Bochum, 
Germany; 2Experimental Ophthalmology, University 
Medical Center, Mainz, Germany; 3Experimental 
Ophthalmology, Department of Neuropathology, 
Mainz, Germany. 
6942 — 1:30 Retinal Ganglion Cell Loss 
Correlates With Increased IOP in MMP-9 
Knockout Mice. Behrad Garmsiri, J.V. Robertson, 
A.K. Ball, J.A. West-Mays. Pathology and Molecular 
Medicine, McMaster University, Hamilton, ON, 
Canada. T 
6943 — 1:45 Dark-phase Intraocular Pressure 
Elevation and Retinal Ganglion Cell Loss in 
Experimental Glaucoma. Jacky Man Kwong 
Kwong, N. Vo, A. Quan, H. Kyung, N. Piri, J. 
Caprioli. Ophthalmology, Jules Stein Eye Institute, 
UCLA, Los Angeles, CA. 
6944 — 2:00 Overstimulation of TRPV4 in 
vivo Induces Selective Apoptosis of Retinal 
Ganglion Cells. An Acute in vivo Experimental 
Model for Glaucoma. amber m. frye1, D. Ryskamp2, 
S. Chauhan2, A. Jo2, D. Krizaj2. 1Moran Eye 
Institute, The University of Utah, Department of 
Opthalmology & Visual Sciences, Salt Lake City, 
UT; 2ophthalmology, The University of Utah, Salt 
Lake City, UT. 
6945 — 2:15 Anti-Connective Tissue Growth 
Factor Antibody Therapy Combats Expression 
of Fibrotic Genes in Glaucoma. Deborah M. 
Wallace1A,2, A.F. Clark3, N. Oliver4, J.K. Crean1B, 
C.J. O’Brien5,6. ASchool Medicine & Medical 
Science, BSchool of Biomolecular & Biomedical 
Science, Conway Inst., 1University College Dublin, 
Dublin, Ireland; 2Dept. Of Ophthalmology, Mater 
Misericordiae University Hospital, Dublin, Ireland; 
3Cell Biology & Anatomy, University of North Texas 
HSC, Fort Worth, TX; 4FibroGen Inc, San Francisco, 
CA; 5Ophthalmology, Mater Misericordiae Univ 
Hospital, Dublin, Ireland; 6School of Medicine 
and Medical Science, University College Dublin, 
Ireland.*CR T 
6946 — 2:30 Crossed Linked Actin Networks 
are Formed in Human Trabecular Meshwork 
Cells after treatment with Latrunculin B. Paul 
Russell1A, K. Murphy1B, J.A. Wood1A, C.T. McKee1A, 
C.J. Murphy1C. ASchool of Veterinary Medicine, 
BSchool of Biomedical Engineering, CSchool of 
Medicine and School of Veterinary Medicine, 
1University of California Davis, Davis, CA. 
6947 — 2:45 Defects In Whole Cell Respiration 
In POAG Lymphoblasts. Jonathan G. 
Crowston1A, L. Sheck2, N.J. Van Bergen1B, S. Lee1, 
V. Chrysostomou3, A.L. Vincent2, I.A. Trounce4. 
ADepartment of Ophthalmology, BGlaucoma 
Research Unit, 1Centre for Eye Research Australia, 
East Melbourne, Australia; 2Ophthalmology, 
University of Auckland, Auckland, New Zealand; 
3Glaucoma Research Unit, Centre for Eye Research 
Australia, Melbourne, Australia; 4University of 
Melbourne, Center for Eye Research Australia, 
Melbourne, Australia. 
Grand H




6948 — 1:15 Seeing With Subretinal Electronic 
Implants: Study in Ten Patients With Wireless 
Implant Alpha-IMS. Eberhart Zrenner1, K-U. 
Bartz-Schmidt1, F. Gekeler1, U. Greppmaier2, 
S. Hipp1, G. Hoertdoerfer3, C. Kernstock1, A. 
Kusnyerik4, H. Sachs5, K. Stingl1. 1Institute for 
Ophthalmic Research, Centre for Ophthalmology, 
Tuebingen, Germany; 2Retina Implant AG, 
Reutlingen, Germany; 3Mobility Training, 
Tuebingen, Germany; 4Semmelweis University, 
Budapest, Hungary; 5Städtisches Klinikum Dresden-
Friedrichstadt, Dresden, Germany.*CR, f 
6949 — 1:30 Cortical Responses to Repetitive 
Electrical Stimulation of the Retina using 
Suprachoroidal Visual Prostheses. Sam E. John1, 
M.N. Shivdasani2, J.B. Fallon2, G. Rathbone1, C.E. 
Williams2. 1Bionics Institute/Latrobe University, 
East Melbourne, Australia; 2Bionics Institute, East 
Melbourne, Australia. 
6950 — 1:45 Low Contrast Trip Hazard 
Avoidance using Simulated Prosthetic Vision. 
Chris McCarthy1,2, P. Lieby1,2, J.G. Walker1, 
A.F. Scott1, V. Botea1, N. Barnes1,2. 1Canberra 
Research Laboratory, NICTA, Canberra, Australia; 
2Engineering, Australian National University, 
Canberra, Australia.*CR 
6951 — 2:00 The influence of visual 
information on walking behaviour in the Graz 
Mobility Test. Thomas Georgi1, D. Ivastinovic1, 
M. Brandner1, R. Hornig2, M. Velikay-Parel1. 
1Ophthalmology, Medical University of Graz, Graz, 
Austria; 2IMI Intelligent Medical Implants GmbH, 
Bonn, Germany. 
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6952 — 2:15 Patients blinded by outer retinal 
dystrophies are able to perceive simultaneous 
colors using the Argus® II Retinal Prosthesis 
System. Paulo E. Stanga1,2, J.A. Sahel, Jr.3, L. 
daCruz4, F. Hafezi5, F. Merlini6, B. Coley6, R.J. 
Greenberg7, Argus II Study Group. 1Manchester 
Royal Eye Hospital and University of Manchester, 
Manchester, United Kingdom; 2Manchester 
Biomedical Research Centre, Manchester, United 
Kingdom; 3UMR-S 968, Institut de la Vision, Paris, 
France; 4Moorfields Eye Hospital, London, United 
Kingdom; 5Ophthalmology, Geneva University 
Hospitals, Geneva, Switzerland; 6Second Sight 
Medical Products (Switzerland), Lausanne, 
Switzerland; 7Second Sight Medical Products, Inc, 
Sylmar, CA.*CR, f 
6953 — 2:30 Results Update from Second 
Sight’s Argus® II Retinal Prosthesis Study. 
Mark S. Humayun1, L. da Cruz2, G. Dagnelie3, 
J-A. Sahel4, P.E. Stanga5, E. Filley6, D. Eliott7, J. 
Duncan8, R.J. Greenberg9, Argus II Study Group. 
1Ophthalmology, Doheny Eye Institute - USC, Los 
Angeles, CA; 2Moorfields Eye Hospital, London, 
United Kingdom; 3Lions Vision Research and 
Rehab Center, Johns Hopkins University, Baltimore, 
MD; 4Centre Hospitalier National d‘Ophtalmologie 
des Quinze-Vingts, Paris, France; 5Manchester 
Royal Eye Hospital, Manchester, United Kingdom; 
6Retina Foundation of the Southwest, Dallas, 
TX; 7Ophthalmology, Massachusetts Eye and Ear 
Infirmary, Harvard Medical School, Boston, MA; 
8University of California, San Francisco School 
of Medicine, San Francisco, CA; 9Second Sight 
Medical Products, Sylmar, CA.*CR, f 
6954 — 2:45 An Eye-surface Conformable 
Retinal Prosthesis using Liquid Crystal Polymers. 
Joonsoo Jeong1A,1B, S. Lee2, K. Min1A,1B, S. Shin1A,1B, S. 
Bae3, J-M. Seo3,1A, H. Chung3, S. Kim1A,1B. AElectrical 
Engineering & Computer Science, BInter-University 
Semiconductor Research Center, 1Seoul National 
University, Seoul, Republic of Korea; 2Department 
of Neurosurgery, Massachusetts General Hospital, 
Boston, MA; 3Ophthalmology, Seoul National 
University Hospital, Seoul, Republic of Korea. 
Thursday – Papers – 6952 – 6954
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